1	HUMAN	JJ	O	human	amod	6	SENT_1	[p1l159t81r284b102],
2	PSYCHOPHARMACOLOGY	NN	O	psychopharmacology	nn	6	SENT_1	[p1l299t81r697b102],
3	Hum	NNP	O	Hum	nn	6	SENT_1	[p1l158t119r230b145],
4	Psychopharmacol	NNP	O	Psychopharmacol	nn	6	SENT_1	[p1l242t118r512b152],
5	Clin	NNP	O	Clin	nn	6	SENT_1	[p1l525t118r587b145],
6	Exp	NNP	O	Exp	_	0	SENT_1	[p1l599t119r656b152],
7	2004	CD	DATE	2004	num	6	SENT_1	[p1l669t118r751b149],
8	;	:	O	;	_	0	SENT_1	[p1l669t118r751b149],
9	19	CD	NUMBER	19	num	11	SENT_1	[p1l767t118r809b145],
10	:	:	O	:	_	0	SENT_1	[p1l767t118r809b145],
11	17-23	CD	DATE	17-23	dep	6	SENT_1	[p1l828t119r924b145],
12	.	.	O	.	_	0	SENT_1	[p1l828t119r924b145],

1	Published	VBN	O	publish	_	0	SENT_2	[p1l159t161r306b187],
2	online	NN	O	online	dep	1	SENT_2	[p1l318t161r410b187],
3	in	IN	O	in	_	0	SENT_2	[p1l423t161r451b187],
4	Wiley	NNP	ORGANIZATION	Wiley	nn	5	SENT_2	[p1l463t161r552b195],
5	InterScience	NNP	ORGANIZATION	InterScience	prep_in	1	SENT_2	[p1l564t161r751b187],
6	(	CD	NUMBER	(	num	7	SENT_2	[p1l764t161r1225b195],
7	www.interscience.wiley.com	NNP	O	www.interscience.wiley.com	dep	5	SENT_2	[p1l764t161r1225b195],
8	)	CD	NUMBER	)	num	7	SENT_2	[p1l764t161r1225b195],
9	.	.	O	.	_	0	SENT_2	[p1l764t161r1225b195],

1	DOI	NNP	O	DOI	_	0	SENT_3	[p1l1239t161r1317b188],
2	:	:	O	:	_	0	SENT_3	[p1l1239t161r1317b188],
3	10.1002	CD	NUMBER	10.1002	dep	1	SENT_3	[p1l1335t162r1583b195],
4	/	:	O	/	punct	5	SENT_3	[p1l1335t162r1583b195],
5	hup	NN	O	hup	dep	3	SENT_3	[p1l1335t162r1583b195],
6	.539	CD	NUMBER	.539	num	5	SENT_3	[p1l1335t162r1583b195],

1	No	DT	O	no	det	2	SENT_4	[p1l159t271r248b322],
2	evidence	NN	O	evidence	_	0	SENT_4	[p1l274t270r535b322],
3	of	IN	O	of	_	0	SENT_4	[p1l562t270r626b321],
4	increased	VBN	O	increase	amod	7	SENT_4	[p1l645t270r926b321],
5	adverse	JJ	O	adverse	amod	7	SENT_4	[p1l952t270r1175b322],
6	drug	NN	O	drug	nn	7	SENT_4	[p1l1201t270r1335b337],
7	reactions	NNS	O	reaction	prep_of	2	SENT_4	[p1l1359t270r1627b321],
8	in	IN	O	in	_	0	SENT_4	[p1l1653t270r1709b321],
9	cytochrome	NN	O	cytochrome	nn	13	SENT_4	[p1l160t351r510b418],
10	P450	NN	O	p450	nn	13	SENT_4	[p1l535t351r686b403],
11	CYPZD6	NN	O	cypzd6	nn	13	SENT_4	[p1l715t351r977b403],
12	poor	JJ	O	poor	amod	13	SENT_4	[p1l998t368r1135b418],
13	metabolizers	NNS	O	metabolizer	prep_in	7	SENT_4	[p1l1158t351r1538b403],
14	treated	VBN	O	treat	partmod	7	SENT_4	[p1l1564t351r1767b403],
15	with	IN	O	with	_	0	SENT_4	[p1l160t433r291b485],
16	ﬂuoxetine	NN	O	ﬂuoxetine	prep_with	14	SENT_4	[p1l316t433r611b485],
17	or	CC	O	or	_	0	SENT_4	[p1l637t450r698b485],
18	nortriptyline	NN	O	nortriptyline	prep_with	14	SENT_4	[p1l721t433r1093b500],

1	Rebecca	NNP	PERSON	Rebecca	nn	3	SENT_5	[p1l159t585r314b617],
2	L.	NNP	PERSON	L.	nn	3	SENT_5	[p1l325t586r361b617],
3	Robertsl	NNP	PERSON	Robertsl	_	0	SENT_5	[p1l375t575r543b622],
4	,	,	O	,	_	0	SENT_5	[p1l375t575r543b622],
5	Roger	NNP	PERSON	Roger	nn	7	SENT_5	[p1l557t586r668b626],
6	T.	NNP	PERSON	T.	nn	7	SENT_5	[p1l679t586r712b617],
7	Mulderz	NNP	PERSON	Mulderz	conj_and	3	SENT_5	[p1l726t575r886b622],
8	,	,	O	,	_	0	SENT_5	[p1l726t575r886b622],
9	Peter	NNP	PERSON	Peter	nn	12	SENT_5	[p1l900t586r994b617],
10	R.	NNP	PERSON	R.	nn	12	SENT_5	[p1l1005t586r1043b617],
11	J	NNP	PERSON	J	nn	12	SENT_5	[p1l1057t586r1074b617],
12	oycez	NN	PERSON	oycez	conj_and	3	SENT_5	[p1l1076t575r1187b626],
13	,	,	O	,	_	0	SENT_5	[p1l1076t575r1187b626],
14	Suzanne	NNP	PERSON	Suzanne	nn	16	SENT_5	[p1l1202t585r1354b617],
15	E.	NNP	PERSON	E.	nn	16	SENT_5	[p1l1366t586r1402b617],
16	Lutyz	NNP	PERSON	Lutyz	conj_and	3	SENT_5	[p1l1416t575r1519b626],
17	and	CC	O	and	_	0	SENT_5	[p1l1532t585r1597b617],
18	Martin	NNP	PERSON	Martin	nn	20	SENT_5	[p1l1608t585r1731b617],
19	A.	NNP	O	A.	nn	20	SENT_5	[p1l1743t585r1784b617],
20	Kennedy1	NNP	O	Kennedy1	conj_and	3	SENT_5	[p1l1799t575r1999b626],
21	*	CD	NUMBER	*	num	22	SENT_5	[p1l1799t575r1999b626],
22	1Department	NN	O	1department	rcmod	20	SENT_5	[p1l162t662r352b703],
23	of	IN	O	of	_	0	SENT_5	[p1l363t670r397b703],
24	Pathology	NN	O	pathology	prep_of	22	SENT_5	[p1l403t670r557b703],
25	,	,	O	,	_	0	SENT_5	[p1l403t670r557b703],
26	Christchurch	NNP	ORGANIZATION	Christchurch	nn	27	SENT_5	[p1l575t670r768b696],
27	School	NNP	ORGANIZATION	School	appos	22	SENT_5	[p1l780t670r881b696],
28	of	IN	ORGANIZATION	of	_	0	SENT_5	[p1l893t670r926b703],
29	Medicine	NNP	ORGANIZATION	Medicine	nn	32	SENT_5	[p1l932t670r1071b696],
30	&	CC	ORGANIZATION	&	_	0	SENT_5	[p1l1086t671r1110b696],
31	Health	NNP	ORGANIZATION	Health	nn	32	SENT_5	[p1l1123t670r1225b696],
32	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	27	SENT_5	[p1l1237t671r1371b700],
33	,	,	O	,	_	0	SENT_5	[p1l1237t671r1371b700],
34	University	NNP	ORGANIZATION	University	appos	22	SENT_5	[p1l1390t671r1542b703],
35	of	IN	ORGANIZATION	of	_	0	SENT_5	[p1l1554t670r1588b703],
36	Otago	NNP	ORGANIZATION	Otago	prep_of	34	SENT_5	[p1l1596t671r1692b703],
37	,	,	O	,	_	0	SENT_5	[p1l1596t671r1692b703],
38	P.o.	NNP	O	P.o.	nn	39	SENT_5	[p1l159t711r218b736],
39	Box	NNP	O	Box	appos	22	SENT_5	[p1l233t711r292b736],
40	4345	CD	NUMBER	4345	dep	39	SENT_5	[p1l303t710r383b740],
41	,	,	O	,	_	0	SENT_5	[p1l303t710r383b740],
42	Christchurch	NNP	LOCATION	Christchurch	appos	22	SENT_5	[p1l401t710r599b740],
43	,	,	O	,	_	0	SENT_5	[p1l401t710r599b740],
44	New	NNP	LOCATION	New	nn	46	SENT_5	[p1l613t711r680b736],
45	Zealand	NNP	LOCATION	Zealand	nn	46	SENT_5	[p1l691t710r815b736],
46	2Department	NN	O	2department	appos	22	SENT_5	[p1l159t743r352b784],
47	of	IN	O	of	_	0	SENT_5	[p1l363t751r397b784],
48	Psychological	JJ	O	psychological	amod	49	SENT_5	[p1l403t751r615b784],
49	Medicine	NN	O	medicine	prep_of	46	SENT_5	[p1l625t751r771b781],
50	,	,	O	,	_	0	SENT_5	[p1l625t751r771b781],
51	Christchurch	NNP	ORGANIZATION	Christchurch	nn	52	SENT_5	[p1l788t751r981b777],
52	School	NNP	ORGANIZATION	School	appos	22	SENT_5	[p1l993t751r1094b777],
53	of	IN	ORGANIZATION	of	_	0	SENT_5	[p1l1106t751r1140b784],
54	Medicine	NNP	ORGANIZATION	Medicine	nn	57	SENT_5	[p1l1145t751r1284b777],
55	&	CC	ORGANIZATION	&	_	0	SENT_5	[p1l1299t751r1324b777],
56	Health	NNP	ORGANIZATION	Health	nn	57	SENT_5	[p1l1337t751r1438b777],
57	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	52	SENT_5	[p1l1451t751r1584b781],
58	,	,	O	,	_	0	SENT_5	[p1l1451t751r1584b781],
59	University	NNP	ORGANIZATION	University	appos	22	SENT_5	[p1l1603t752r1755b784],
60	of	IN	ORGANIZATION	of	_	0	SENT_5	[p1l1768t751r1801b784],
61	Otago	NNP	ORGANIZATION	Otago	prep_of	59	SENT_5	[p1l1809t751r1906b784],
62	,	,	O	,	_	0	SENT_5	[p1l1809t751r1906b784],
63	P.o.	NNP	O	P.o.	nn	64	SENT_5	[p1l159t792r218b817],
64	Box	NNP	O	Box	appos	22	SENT_5	[p1l233t792r292b817],
65	4345	CD	NUMBER	4345	dep	64	SENT_5	[p1l303t791r383b821],
66	,	,	O	,	_	0	SENT_5	[p1l303t791r383b821],
67	Christchurch	NNP	LOCATION	Christchurch	appos	22	SENT_5	[p1l401t791r599b821],
68	,	,	O	,	_	0	SENT_5	[p1l401t791r599b821],
69	New	NNP	LOCATION	New	nn	70	SENT_5	[p1l614t792r680b817],
70	Zealand	NNP	LOCATION	Zealand	dep	3	SENT_5	[p1l691t791r815b817],

1	The	DT	O	the	det	6	SENT_6	[p1l159t896r216b922],
2	polymorphic	JJ	O	polymorphic	amod	6	SENT_6	[p1l225t896r415b929],
3	enzyme	NN	O	enzyme	nn	6	SENT_6	[p1l426t904r541b929],
4	cytochrome	NN	O	cytochrome	nn	6	SENT_6	[p1l551t896r726b929],
5	P450	NN	O	p450	nn	6	SENT_6	[p1l736t896r812b922],
6	CYP2D6	NN	O	cyp2d6	nsubjpass	8	SENT_6	[p1l821t896r956b922],
7	is	VBZ	O	be	auxpass	8	SENT_6	[p1l966t896r989b922],
8	involved	VBN	O	involve	_	0	SENT_6	[p1l999t896r1128b922],
9	in	IN	O	in	_	0	SENT_6	[p1l1137t896r1165b921],
10	the	DT	O	the	det	11	SENT_6	[p1l1174t896r1219b922],
11	metabolism	NN	O	metabolism	prep_in	8	SENT_6	[p1l1229t896r1403b922],
12	of	IN	O	of	_	0	SENT_6	[p1l1413t896r1445b922],
13	many	JJ	O	many	amod	14	SENT_6	[p1l1452t904r1534b929],
14	antidepressants	NNS	O	antidepressant	prep_of	11	SENT_6	[p1l1544t896r1779b929],
15	,	,	O	,	_	0	SENT_6	[p1l1544t896r1779b929],
16	including	VBG	O	include	_	0	SENT_6	[p1l1790t896r1930b929],
17	nortriptyline	NN	O	nortriptyline	prep_including	11	SENT_6	[p1l1940t904r2000b922, p1l159t936r295b970],
18	and	CC	O	and	_	0	SENT_6	[p1l308t936r361b962],
19	ﬂuoxetine	NN	O	ﬂuoxetine	prep_including	11	SENT_6	[p1l373t936r529b962],
20	.	.	O	.	_	0	SENT_6	[p1l373t936r529b962],

1	Some	DT	O	some	_	0	SENT_7	[p1l543t936r626b962],
2	7	CD	PERCENT	7	num	3	SENT_7	[p1l638t936r772b963],
3	%	NN	PERCENT	%	dep	1	SENT_7	[p1l638t936r772b963],
4	.	.	O	.	_	0	SENT_7	[p1l638t936r772b963],

1	—	NN	O	—	_	0	SENT_8	[p1l638t936r772b963],
2	.	.	O	.	_	0	SENT_8	[p1l638t936r772b963],

1	l0	CD	PERCENT	l0	num	2	SENT_9	[p1l638t936r772b963],
2	%	NN	PERCENT	%	nsubj	23	SENT_9	[p1l638t936r772b963],
3	Caucasians	NNPS	MISC	Caucasians	nsubjpass	18	SENT_9	[p1l786t936r952b962],
4	have	VBP	O	have	rcmod	2	SENT_9	[p1l965t936r1033b962],
5	inactivating	VBG	O	inactivate	amod	6	SENT_9	[p1l1046t936r1220b970],
6	mutations	NNS	O	mutation	dobj	4	SENT_9	[p1l1232t936r1378b962],
7	in	IN	O	in	_	0	SENT_9	[p1l1391t936r1419b962],
8	both	DT	O	both	det	9	SENT_9	[p1l1430t936r1497b962],
9	alleles	NNS	O	allele	prep_in	4	SENT_9	[p1l1509t936r1602b962],
10	of	IN	O	of	_	0	SENT_9	[p1l1615t936r1648b962],
11	the	DT	O	the	det	14	SENT_9	[p1l1657t936r1701b962],
12	C	NN	O	c	nn	14	SENT_9	[p1l1715t937r1739b963],
13	YPZD6	NN	O	ypzd6	nn	14	SENT_9	[p1l1741t936r1847b962],
14	gene	NN	O	gene	prep_of	9	SENT_9	[p1l1857t944r1935b970],
15	,	,	O	,	_	0	SENT_9	[p1l1857t944r1935b970],
16	and	CC	O	and	_	0	SENT_9	[p1l1948t936r2001b962],
17	are	VBP	O	be	auxpass	18	SENT_9	[p1l160t985r204b1003],
18	referred	VBN	O	refer	conj_and	4	SENT_9	[p1l217t977r336b1003],
19	to	TO	O	to	xcomp	18	SENT_9	[p1l349t981r377b1003],
20	as	IN	O	as	_	0	SENT_9	[p1l392t985r421b1003],
21	poor	JJ	O	poor	amod	22	SENT_9	[p1l435t985r503b1010],
22	metabolizers	NNS	O	metabolizer	prep_as	18	SENT_9	[p1l517t977r707b1003],
23	(	VBP	O	(	_	0	SENT_9	[p1l722t977r821b1009],
24	PMs	NNS	O	pm	dobj	23	SENT_9	[p1l722t977r821b1009],
25	)	CD	NUMBER	)	tmod	23	SENT_9	[p1l722t977r821b1009],
26	.	.	O	.	_	0	SENT_9	[p1l722t977r821b1009],

1	Several	JJ	O	several	amod	3	SENT_10	[p1l837t977r946b1003],
2	case	NN	O	case	nn	3	SENT_10	[p1l961t985r1024b1003],
3	reports	NNS	O	report	nsubj	7	SENT_10	[p1l1037t981r1140b1010],
4	and	CC	O	and	_	0	SENT_10	[p1l1155t977r1208b1003],
5	clinical	JJ	O	clinical	amod	6	SENT_10	[p1l1222t977r1331b1003],
6	studies	NNS	O	study	conj_and	3	SENT_10	[p1l1346t977r1447b1003],
7	suggest	VBP	O	suggest	_	0	SENT_10	[p1l1463t981r1573b1010],
8	that	IN	O	that	complm	11	SENT_10	[p1l1587t977r1642b1003],
9	CYP2D6	NN	O	cyp2d6	nn	10	SENT_10	[p1l1656t977r1791b1003],
10	PMs	NNS	O	pm	nsubj	11	SENT_10	[p1l1805t977r1872b1003],
11	are	VBP	O	be	ccomp	7	SENT_10	[p1l1887t985r1931b1003],
12	at	IN	O	at	_	0	SENT_10	[p1l1946t981r1972b1003],
13	a	DT	O	a	det	15	SENT_10	[p1l1986t985r2001b1003],
14	greater	JJR	O	greater	amod	15	SENT_10	[p1l159t1021r263b1050],
15	risk	NN	O	risk	prep_at	11	SENT_10	[p1l281t1017r337b1043],
16	of	IN	O	of	_	0	SENT_10	[p1l356t1017r388b1043],
17	developing	VBG	O	develop	prepc_of	15	SENT_10	[p1l405t1017r569b1050],
18	adverse	JJ	O	adverse	amod	20	SENT_10	[p1l589t1017r701b1043],
19	drug	NN	O	drug	nn	20	SENT_10	[p1l721t1017r787b1050],
20	reactions	NNS	O	reaction	nsubj	23	SENT_10	[p1l806t1017r940b1043],
21	(	JJ	O	(	amod	23	SENT_10	[p1l961t1017r1076b1049],
22	ADRS	NN	O	adr	nn	23	SENT_10	[p1l961t1017r1076b1049],
23	)	NN	O	)	xcomp	17	SENT_10	[p1l961t1017r1076b1049],
24	on	IN	O	on	_	0	SENT_10	[p1l1097t1025r1133b1043],
25	antidepressant	JJ	O	antidepressant	amod	26	SENT_10	[p1l1152t1017r1365b1050],
26	medication	NN	O	medication	prep_on	23	SENT_10	[p1l1384t1017r1550b1043],
27	than	IN	O	than	mark	30	SENT_10	[p1l1569t1017r1633b1043],
28	extensive	JJ	O	extensive	amod	29	SENT_10	[p1l1652t1017r1790b1043],
29	metabolizers	NNS	O	metabolizer	nsubj	30	SENT_10	[p1l1810t1017r2000b1043],
30	(	VBP	O	(	advcl	17	SENT_10	[p1l160t1057r261b1089],
31	EMs	NNS	MISC	em	dobj	30	SENT_10	[p1l160t1057r261b1089],
32	)	CD	NUMBER	)	tmod	30	SENT_10	[p1l160t1057r261b1089],
33	.	.	O	.	_	0	SENT_10	[p1l160t1057r261b1089],

1	However	RB	O	however	advmod	7	SENT_11	[p1l274t1057r415b1087],
2	,	,	O	,	_	0	SENT_11	[p1l274t1057r415b1087],
3	few	JJ	O	few	amod	5	SENT_11	[p1l427t1057r481b1083],
4	clinical	JJ	O	clinical	amod	5	SENT_11	[p1l492t1057r602b1083],
5	trials	NNS	O	trial	nsubj	7	SENT_11	[p1l613t1057r686b1083],
6	have	VBP	O	have	aux	7	SENT_11	[p1l698t1057r767b1083],
7	investigated	VBN	O	investigate	_	0	SENT_11	[p1l778t1057r957b1090],
8	whether	IN	O	whether	complm	13	SENT_11	[p1l968t1057r1088b1083],
9	CYPZD6	NNP	O	CYPZD6	nn	11	SENT_11	[p1l1100t1057r1231b1083],
10	PM	NNP	O	PM	nn	11	SENT_11	[p1l1241t1057r1294b1082],
11	genotype	NN	O	genotype	nsubj	13	SENT_11	[p1l1305t1061r1441b1090],
12	is	VBZ	O	be	cop	13	SENT_11	[p1l1452t1057r1475b1083],
13	predictive	JJ	O	predictive	ccomp	7	SENT_11	[p1l1486t1057r1635b1090],
14	of	IN	O	of	_	0	SENT_11	[p1l1646t1057r1679b1083],
15	ADRs	NNS	MISC	adr	prep_of	13	SENT_11	[p1l1687t1057r1778b1083],
16	during	IN	O	during	_	0	SENT_11	[p1l1790t1057r1886b1090],
17	antidepressant	JJ	O	antidepressant	amod	18	SENT_11	[p1l1898t1057r2000b1083, p1l159t1102r281b1131],
18	treatment	NN	O	treatment	prep_during	15	SENT_11	[p1l292t1101r440b1123],
19	.	.	O	.	_	0	SENT_11	[p1l292t1101r440b1123],

1	This	DT	O	this	det	2	SENT_12	[p1l453t1097r518b1123],
2	paper	NN	O	paper	nsubj	3	SENT_12	[p1l529t1106r613b1131],
3	explores	VBZ	O	explore	_	0	SENT_12	[p1l623t1097r748b1131],
4	the	DT	O	the	det	5	SENT_12	[p1l759t1097r804b1123],
5	link	NN	O	link	dobj	3	SENT_12	[p1l815t1097r874b1123],
6	between	IN	O	between	_	0	SENT_12	[p1l883t1097r1008b1123],
7	C	NN	O	c	nn	9	SENT_12	[p1l1021t1098r1044b1124],
8	YPZD6	NN	O	ypzd6	nn	9	SENT_12	[p1l1046t1097r1152b1123],
9	genotype	NN	O	genotype	prep_between	5	SENT_12	[p1l1162t1101r1298b1131],
10	and	CC	O	and	_	0	SENT_12	[p1l1310t1097r1362b1123],
11	antidepressant-associated	JJ	O	antidepressant-associated	amod	12	SENT_12	[p1l1374t1097r1753b1131],
12	ADRs	NNS	MISC	adr	prep_between	5	SENT_12	[p1l1764t1098r1855b1123],
13	in	IN	O	in	_	0	SENT_12	[p1l1867t1097r1895b1123],
14	outpatients	NNS	O	outpatient	prep_in	3	SENT_12	[p1l1907t1101r2000b1131, p1l159t1138r239b1164],
15	being	VBG	O	be	auxpass	16	SENT_12	[p1l254t1138r336b1171],
16	treated	VBN	O	treat	partmod	14	SENT_12	[p1l351t1138r453b1164],
17	for	IN	O	for	_	0	SENT_12	[p1l468t1138r511b1164],
18	major	JJ	O	major	amod	19	SENT_12	[p1l525t1138r612b1171],
19	depression	NN	O	depression	prep_for	16	SENT_12	[p1l627t1138r786b1171],
20	with	IN	O	with	_	0	SENT_12	[p1l801t1138r866b1164],
21	either	CC	O	either	preconj	22	SENT_12	[p1l881t1138r966b1164],
22	nortriptyline	NN	O	nortriptyline	prep_with	16	SENT_12	[p1l981t1138r1167b1171],
23	or	CC	O	or	_	0	SENT_12	[p1l1182t1146r1213b1164],
24	ﬂuoxetine	NN	O	ﬂuoxetine	conj_or	22	SENT_12	[p1l1227t1138r1383b1164],
25	.	.	O	.	_	0	SENT_12	[p1l1227t1138r1383b1164],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_13	[p1l1400t1138r1516b1164],
2	were	VBD	O	be	auxpass	3	SENT_13	[p1l1532t1146r1603b1164],
3	randomized	VBN	O	randomize	_	0	SENT_13	[p1l1618t1138r1794b1164],
4	to	TO	O	to	aux	5	SENT_13	[p1l1809t1142r1837b1164],
5	ﬂuoxetine	VB	O	ﬂuoxetine	xcomp	3	SENT_13	[p1l1853t1138r2001b1164],
6	(	NN	O	(	nn	7	SENT_13	[p1l160t1178r189b1210],
7	n	NN	O	n	dobj	5	SENT_13	[p1l160t1178r189b1210],
8	:	:	O	:	_	0	SENT_13	[p1l198t1189r223b1198],
9	65	CD	NUMBER	65	number	10	SENT_13	[p1l232t1178r279b1210],
10	)	CD	NUMBER	)	dep	7	SENT_13	[p1l232t1178r279b1210],
11	or	CC	O	or	_	0	SENT_13	[p1l295t1186r325b1204],
12	nortriptyline	NN	O	nortriptyline	nn	14	SENT_13	[p1l338t1178r524b1211],
13	(	NN	O	(	nn	14	SENT_13	[p1l540t1178r568b1210],
14	n	NN	O	n	conj_or	7	SENT_13	[p1l540t1178r568b1210],
15	:	:	O	:	_	0	SENT_13	[p1l577t1189r603b1198],
16	60	CD	NUMBER	60	num	17	SENT_13	[p1l612t1178r659b1210],
17	)	NN	O	)	dep	14	SENT_13	[p1l612t1178r659b1210],
18	for	IN	O	for	_	0	SENT_13	[p1l674t1178r717b1204],
19	the	DT	DURATION	the	det	22	SENT_13	[p1l730t1178r775b1204],
20	6	CD	DURATION	6	num	22	SENT_13	[p1l789t1178r806b1204],
21	week	NN	NUMBER	week	nn	22	SENT_13	[p1l821t1178r899b1204],
22	trial	NN	O	trial	prep_for	17	SENT_13	[p1l912t1178r980b1204],
23	.	.	O	.	_	0	SENT_13	[p1l912t1178r980b1204],

1	CYPZD6	NN	O	cypzd6	nn	2	SENT_14	[p1l997t1178r1129b1204],
2	genotypes	NNS	O	genotype	nsubj	3	SENT_14	[p1l1141t1182r1291b1211],
3	predicted	VBD	O	predict	dep	16	SENT_14	[p1l1305t1178r1445b1211],
4	that	IN	O	that	complm	10	SENT_14	[p1l1458t1178r1514b1204],
5	of	IN	O	of	_	0	SENT_14	[p1l1528t1178r1560b1204],
6	these	DT	O	these	det	7	SENT_14	[p1l1571t1178r1647b1204],
7	patients	NNS	O	patient	prep_of	10	SENT_14	[p1l1661t1178r1776b1211],
8	115	CD	NUMBER	115	nsubj	10	SENT_14	[p1l1795t1178r1844b1204],
9	were	VBD	O	be	cop	10	SENT_14	[p1l1860t1186r1932b1204],
10	EM	NNP	O	EM	ccomp	3	SENT_14	[p1l1946t1178r2001b1203],
11	and	CC	O	and	_	0	SENT_14	[p1l160t1218r212b1244],
12	the	DT	O	the	conj_and	10	SENT_14	[p1l225t1218r269b1244],
13	remaining	VBG	O	remain	amod	12	SENT_14	[p1l282t1218r434b1252],
14	10	CD	NUMBER	10	nsubj	16	SENT_14	[p1l450t1218r483b1244],
15	were	VBD	O	be	cop	16	SENT_14	[p1l496t1226r567b1244],
16	PMs	NNS	O	pm	_	0	SENT_14	[p1l581t1219r655b1244],
17	.	.	O	.	_	0	SENT_14	[p1l581t1219r655b1244],

1	ADRs	NNPS	MISC	ADRs	nsubj	2	SENT_15	[p1l670t1218r761b1244],
2	attributed	VBD	O	attribute	_	0	SENT_15	[p1l775t1218r918b1244],
3	to	TO	O	to	_	0	SENT_15	[p1l930t1222r958b1244],
4	antidepressant	JJ	O	antidepressant	amod	5	SENT_15	[p1l972t1218r1185b1252],
5	usage	NN	O	usage	prep_to	2	SENT_15	[p1l1197t1226r1281b1252],
6	were	VBD	O	be	auxpass	7	SENT_15	[p1l1294t1226r1365b1244],
7	recorded	VBN	O	record	rcmod	5	SENT_15	[p1l1378t1218r1509b1244],
8	over	IN	O	over	_	0	SENT_15	[p1l1522t1226r1587b1244],
9	the	DT	O	the	det	11	SENT_15	[p1l1599t1218r1643b1244],
10	6-week	JJ	DURATION	6-week	amod	11	SENT_15	[p1l1657t1218r1767b1244],
11	trial	NN	O	trial	prep_over	7	SENT_15	[p1l1779t1218r1846b1244],
12	.	.	O	.	_	0	SENT_15	[p1l1779t1218r1846b1244],

1	Although	IN	O	although	mark	9	SENT_16	[p1l1860t1218r2001b1252],
2	the	DT	O	the	det	3	SENT_16	[p1l159t1259r204b1285],
3	type	NN	O	type	nsubjpass	9	SENT_16	[p1l215t1263r278b1292],
4	of	IN	O	of	_	0	SENT_16	[p1l289t1259r321b1285],
5	ADR	NN	O	adr	prep_of	3	SENT_16	[p1l330t1259r408b1284],
6	was	VBD	O	be	auxpass	9	SENT_16	[p1l418t1267r483b1289],
7	,	,	O	,	_	0	SENT_16	[p1l418t1267r483b1289],
8	as	IN	O	as	prep	9	SENT_16	[p1l495t1267r524b1285],
9	expected	VBN	O	expect	advcl	19	SENT_16	[p1l536t1259r675b1292],
10	,	,	O	,	_	0	SENT_16	[p1l536t1259r675b1292],
11	different	JJ	O	different	nsubj	19	SENT_16	[p1l688t1259r815b1285],
12	between	IN	O	between	_	0	SENT_16	[p1l825t1259r949b1285],
13	drugs	NNS	O	drug	prep_between	11	SENT_16	[p1l960t1259r1050b1292],
14	,	,	O	,	_	0	SENT_16	[p1l960t1259r1050b1292],
15	the	DT	O	the	det	16	SENT_16	[p1l1062t1259r1106b1285],
16	frequency	NN	O	frequency	appos	13	SENT_16	[p1l1117t1259r1265b1292],
17	of	IN	O	of	_	0	SENT_16	[p1l1277t1259r1309b1285],
18	ADRs	NNPS	MISC	ADRs	prep_of	16	SENT_16	[p1l1317t1259r1408b1285],
19	experienced	VBD	O	experience	_	0	SENT_16	[p1l1420t1259r1600b1292],
20	did	VBD	O	do	aux	22	SENT_16	[p1l1610t1259r1657b1285],
21	not	RB	O	not	neg	22	SENT_16	[p1l1668t1263r1715b1285],
22	differ	VB	O	differ	ccomp	19	SENT_16	[p1l1725t1259r1807b1285],
23	signiﬁcantly	RB	O	signiﬁcantly	advmod	22	SENT_16	[p1l1818t1259r2000b1292],
24	between	IN	O	between	_	0	SENT_16	[p1l159t1299r283b1325],
25	the	DT	O	the	det	27	SENT_16	[p1l293t1299r338b1325],
26	two	CD	NUMBER	two	num	27	SENT_16	[p1l348t1303r403b1325],
27	antidepressants	NNS	O	antidepressant	prep_between	22	SENT_16	[p1l414t1299r640b1332],
28	or	CC	O	or	_	0	SENT_16	[p1l652t1307r682b1325],
29	between	IN	O	between	_	0	SENT_16	[p1l691t1299r815b1325],
30	CYP2D6	CD	NUMBER	cyp2d6	num	31	SENT_16	[p1l826t1299r961b1325],
31	PMs	NNS	O	pm	conj_or	27	SENT_16	[p1l971t1299r1038b1325],
32	and	CC	O	and	_	0	SENT_16	[p1l1049t1299r1102b1325],
33	EMS	NNP	O	EMS	conj_or	27	SENT_16	[p1l1112t1299r1189b1325],
34	.	.	O	.	_	0	SENT_16	[p1l1112t1299r1189b1325],

1	In	IN	O	in	_	0	SENT_17	[p1l1201t1300r1231b1324],
2	addition	NN	O	addition	prep_in	15	SENT_17	[p1l1242t1299r1371b1329],
3	,	,	O	,	_	0	SENT_17	[p1l1242t1299r1371b1329],
4	the	DT	O	the	det	5	SENT_17	[p1l1382t1299r1427b1325],
5	frequency	NN	O	frequency	nsubj	15	SENT_17	[p1l1438t1299r1586b1332],
6	at	IN	O	at	_	0	SENT_17	[p1l1597t1303r1623b1325],
7	which	WDT	O	which	rel	9	SENT_17	[p1l1633t1299r1723b1325],
8	PMs	NNP	O	PMs	nsubj	9	SENT_17	[p1l1733t1299r1800b1325],
9	discontinued	VBN	O	discontinue	rcmod	5	SENT_17	[p1l1811t1299r2001b1325],
10	antidepressant	JJ	O	antidepressant	amod	11	SENT_17	[p1l160t1339r373b1373],
11	medication	NN	O	medication	dobj	9	SENT_17	[p1l382t1339r548b1365],
12	was	VBD	O	be	cop	15	SENT_17	[p1l558t1347r614b1365],
13	not	RB	O	not	neg	15	SENT_17	[p1l624t1343r671b1365],
14	noticeably	RB	O	noticeably	advmod	15	SENT_17	[p1l680t1339r835b1373],
15	different	JJ	O	different	_	0	SENT_17	[p1l846t1339r973b1365],
16	from	IN	O	from	_	0	SENT_17	[p1l983t1339r1055b1365],
17	EMs	NNS	O	em	prep_from	15	SENT_17	[p1l1063t1340r1141b1370],
18	,	,	O	,	_	0	SENT_17	[p1l1063t1340r1141b1370],
19	although	IN	O	although	mark	28	SENT_17	[p1l1153t1339r1282b1373],
20	with	IN	O	with	_	0	SENT_17	[p1l1292t1339r1358b1365],
21	only	RB	O	only	quantmod	22	SENT_17	[p1l1367t1339r1432b1373],
22	10	CD	NUMBER	10	num	23	SENT_17	[p1l1446t1339r1478b1365],
23	PMs	NNS	O	pm	prep_with	28	SENT_17	[p1l1488t1340r1554b1365],
24	the	DT	O	the	det	25	SENT_17	[p1l1564t1339r1609b1365],
25	study	NN	O	study	nsubjpass	28	SENT_17	[p1l1620t1339r1699b1373],
26	is	VBZ	O	be	auxpass	28	SENT_17	[p1l1709t1339r1732b1365],
27	under	IN	O	under	advmod	28	SENT_17	[p1l1742t1339r1827b1365],
28	powered	VBN	O	power	advcl	15	SENT_17	[p1l1835t1339r1963b1373],
29	to	TO	O	to	aux	30	SENT_17	[p1l1973t1343r2000b1365],
30	detect	VB	O	detect	xcomp	28	SENT_17	[p1l159t1380r248b1406],
31	moderate	JJ	O	moderate	amod	34	SENT_17	[p1l259t1380r397b1406],
32	or	CC	O	or	_	0	SENT_17	[p1l409t1388r439b1406],
33	small	JJ	O	small	amod	34	SENT_17	[p1l450t1380r529b1406],
34	differences	NNS	O	difference	dobj	30	SENT_17	[p1l541t1380r712b1406],
35	.	.	O	.	_	0	SENT_17	[p1l541t1380r712b1406],

1	These	DT	O	these	det	2	SENT_18	[p1l725t1380r813b1406],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_18	[p1l825t1380r942b1413],
3	suggest	VBP	O	suggest	_	0	SENT_18	[p1l955t1384r1065b1413],
4	that	IN	O	that	complm	17	SENT_18	[p1l1076t1380r1131b1406],
5	inability	NN	O	inability	nsubj	17	SENT_18	[p1l1142t1380r1266b1413],
6	to	TO	O	to	aux	8	SENT_18	[p1l1277t1384r1305b1406],
7	efﬁciently	RB	O	efﬁciently	advmod	8	SENT_18	[p1l1316t1380r1465b1413],
8	metabolize	VBZ	O	metabolize	infmod	5	SENT_18	[p1l1477t1380r1640b1406],
9	antidepressants	NNS	O	antidepressant	dobj	8	SENT_18	[p1l1652t1380r1878b1413],
10	that	WDT	O	that	nsubj	13	SENT_18	[p1l1890t1380r1946b1406],
11	are	VBP	O	be	cop	13	SENT_18	[p1l1957t1388r2001b1406],
12	CYP2D6	NN	O	cyp2d6	nn	13	SENT_18	[p1l159t1420r294b1446],
13	substrates	NNS	O	substrate	rcmod	9	SENT_18	[p1l308t1420r453b1446],
14	does	VBZ	O	do	aux	17	SENT_18	[p1l466t1420r532b1446],
15	not	RB	O	not	neg	17	SENT_18	[p1l545t1424r593b1446],
16	necessarily	RB	O	necessarily	advmod	17	SENT_18	[p1l604t1420r769b1453],
17	lead	VB	O	lead	ccomp	3	SENT_18	[p1l782t1420r844b1446],
18	to	TO	O	to	_	0	SENT_18	[p1l856t1424r883b1446],
19	increased	VBN	O	increase	amod	20	SENT_18	[p1l896t1420r1037b1446],
20	occurrence	NN	O	occurrence	prep_to	17	SENT_18	[p1l1049t1428r1212b1446],
21	of	IN	O	of	_	0	SENT_18	[p1l1225t1420r1257b1446],
22	antidepressant-associated	JJ	O	antidepressant-associated	amod	23	SENT_18	[p1l1268t1420r1647b1453],
23	ADRs	NNS	MISC	adr	prep_of	20	SENT_18	[p1l1659t1420r1758b1446],
24	.	.	O	.	_	0	SENT_18	[p1l1659t1420r1758b1446],

1	Thus	RB	O	thus	advmod	11	SENT_19	[p1l1772t1420r1854b1450],
2	,	,	O	,	_	0	SENT_19	[p1l1772t1420r1854b1450],
3	for	IN	O	for	_	0	SENT_19	[p1l1868t1420r1911b1446],
4	clinicians	NNS	O	clinician	nsubj	5	SENT_19	[p1l1923t1420r2000b1446, p1l159t1460r234b1486],
5	prescribing	VBG	O	prescribe	prepc_for	11	SENT_19	[p1l244t1460r411b1494],
6	antidepressant	JJ	O	antidepressant	amod	7	SENT_19	[p1l421t1460r634b1494],
7	monotherapy	NN	O	monotherapy	dobj	5	SENT_19	[p1l643t1460r845b1494],
8	,	,	O	,	_	0	SENT_19	[p1l643t1460r845b1494],
9	CYPZD6	NN	O	cypzd6	nn	10	SENT_19	[p1l856t1460r991b1486],
10	polymorphisms	NNS	O	polymorphism	nsubj	11	SENT_19	[p1l1000t1460r1231b1494],
11	are	VBP	O	be	_	0	SENT_19	[p1l1242t1468r1286b1486],
12	probably	RB	O	probably	advmod	11	SENT_19	[p1l1295t1460r1427b1494],
13	not	RB	O	not	neg	11	SENT_19	[p1l1436t1464r1484b1486],
14	of	IN	O	of	_	0	SENT_19	[p1l1493t1460r1525b1486],
15	relevance	NN	O	relevance	prep_of	11	SENT_19	[p1l1531t1460r1672b1486],
16	to	TO	O	to	_	0	SENT_19	[p1l1682t1464r1710b1486],
17	antidepressant	JJ	O	antidepressant	amod	19	SENT_19	[p1l1720t1460r1933b1494],
18	side	JJ	O	side	amod	19	SENT_19	[p1l1943t1460r2000b1486],
19	effects	NNS	O	effect	prep_to	11	SENT_19	[p1l159t1501r256b1527],
20	and	CC	O	and	_	0	SENT_19	[p1l270t1501r323b1527],
21	therapy	NN	O	therapy	conj_and	19	SENT_19	[p1l335t1501r451b1535],
22	.	.	O	.	_	0	SENT_19	[p1l335t1501r451b1535],

1	Copyright	NN	O	copyright	nn	5	SENT_20	[p1l466t1501r617b1535],
2	©	CD	NUMBER	©	num	5	SENT_20	[p1l631t1501r662b1533],
3	2004	CD	DATE	2004	num	5	SENT_20	[p1l677t1501r750b1527],
4	John	NNP	ORGANIZATION	John	nn	5	SENT_20	[p1l762t1501r832b1527],
5	Wiley	NNP	ORGANIZATION	Wiley	_	0	SENT_20	[p1l844t1501r934b1535],
6	&	CC	ORGANIZATION	&	_	0	SENT_20	[p1l947t1501r973b1527],
7	Sons	NNP	ORGANIZATION	Sons	conj_and	5	SENT_20	[p1l987t1501r1065b1532],
8	,	,	ORGANIZATION	,	_	0	SENT_20	[p1l987t1501r1065b1532],
9	Ltd.	NNP	ORGANIZATION	Ltd.	appos	5	SENT_20	[p1l1079t1501r1138b1527],
10	.	.	O	.	_	0	SENT_20	[p1l1079t1501r1138b1527],

1	KEY	JJ	O	key	amod	2	SENT_21	[p1l159t1595r218b1614],
2	woRDs	NNS	O	word	_	0	SENT_21	[p1l230t1588r496b1614],
3	—	JJ	O	—	amod	6	SENT_21	[p1l230t1588r496b1614],
4	adverse	JJ	O	adverse	amod	6	SENT_21	[p1l230t1588r496b1614],
5	drug	NN	O	drug	nn	6	SENT_21	[p1l509t1588r576b1622],
6	reaction	NN	O	reaction	dep	2	SENT_21	[p1l588t1588r717b1619],
7	;	:	O	;	_	0	SENT_21	[p1l588t1588r717b1619],
8	ﬂuoxetine	NN	O	ﬂuoxetine	dep	2	SENT_21	[p1l731t1588r888b1619],
9	;	:	O	;	_	0	SENT_21	[p1l731t1588r888b1619],
10	nortriptyline	NN	O	nortriptyline	dep	8	SENT_21	[p1l902t1588r1097b1622],
11	;	:	O	;	_	0	SENT_21	[p1l902t1588r1097b1622],
12	C	NN	O	c	nn	14	SENT_21	[p1l1113t1589r1137b1615],
13	YP2D6	NN	O	yp2d6	nn	14	SENT_21	[p1l1138t1588r1244b1614],
14	genotype	NN	O	genotype	dep	10	SENT_21	[p1l1255t1592r1400b1622],
15	;	:	O	;	_	0	SENT_21	[p1l1255t1592r1400b1622],
16	major	JJ	O	major	amod	17	SENT_21	[p1l1414t1588r1501b1622],
17	depression	NN	O	depression	dep	14	SENT_21	[p1l1513t1588r1680b1622],
18	;	:	O	;	_	0	SENT_21	[p1l1513t1588r1680b1622],
19	antidepressants	NNS	O	antidepressant	dep	8	SENT_21	[p1l1695t1588r1921b1622],

1	INTRODUCTION	NN	O	introduction	_	0	SENT_22	[p1l9t1801r752b1870],

1	Polymorphisms	NNS	O	polymorphism	nsubj	30	SENT_23	[p1l8t2019r627b2109],
2	within	IN	O	within	_	0	SENT_23	[p1l670t2019r920b2089],
3	the	DT	O	the	det	5	SENT_23	[p1l959t2019r1078b2088],
4	liver	NN	O	liver	nn	5	SENT_23	[p1l1118t2019r1298b2089],
5	enzyme	NN	O	enzyme	prep_within	1	SENT_23	[p1l1336t2041r1641b2109],
6	cytochrome	NN	O	cytochrome	nn	8	SENT_23	[p1l1682t2019r2147b2109],
7	P450	NN	O	p450	nn	8	SENT_23	[p1l8t2126r209b2197],
8	2D6	NN	O	2d6	dep	17	SENT_23	[p1l234t2127r399b2197],
9	(	CD	NUMBER	(	num	10	SENT_23	[p1l426t2127r838b2212],
10	CYP2D6	NN	O	cyp2d6	dep	8	SENT_23	[p1l426t2127r838b2212],
11	,	,	O	,	_	0	SENT_23	[p1l426t2127r838b2212],
12	debrisoquine/sparteine	NN	O	debrisoquine/sparteine	nn	13	SENT_23	[p1l865t2127r1763b2217],
13	hydroXy	NN	O	hydroxy	appos	10	SENT_23	[p1l1786t2127r2146b2217],
14	—	CD	NUMBER	—	num	15	SENT_23	[p1l1786t2127r2146b2217],
15	lase	NN	O	lase	dep	17	SENT_23	[p1l9t2235r191b2321],
16	)	CD	NUMBER	)	num	17	SENT_23	[p1l9t2235r191b2321],
17	lead	NN	O	lead	dep	5	SENT_23	[p1l225t2235r390b2305],
18	to	TO	O	to	_	0	SENT_23	[p1l420t2246r494b2305],
19	distinct	JJ	O	distinct	amod	20	SENT_23	[p1l527t2235r819b2305],
20	subgroups	NNS	O	subgroup	prep_to	17	SENT_23	[p1l852t2235r1251b2325],
21	of	IN	O	of	_	0	SENT_23	[p1l1286t2235r1372b2305],
22	the	DT	O	the	det	23	SENT_23	[p1l1396t2235r1514b2305],
23	population	NN	O	population	prep_of	20	SENT_23	[p1l1545t2235r1970b2325],
24	that	WDT	O	that	nsubj	25	SENT_23	[p1l2001t2235r2150b2305],
25	differ	VBP	O	differ	rcmod	5	SENT_23	[p1l9t2343r227b2412],
26	in	IN	O	in	_	0	SENT_23	[p1l271t2343r345b2412],
27	their	PRP$	O	they	poss	28	SENT_23	[p1l390t2343r572b2412],
28	ability	NN	O	ability	prep_in	25	SENT_23	[p1l618t2343r869b2433],
29	to	TO	O	to	infmod	28	SENT_23	[p1l915t2353r988b2412],
30	metabolize	VBZ	O	metabolize	_	0	SENT_23	[p1l1034t2343r1469b2412],
31	many	JJ	O	many	amod	35	SENT_23	[p1l1516t2365r1734b2433],
32	clinically	RB	O	clinically	advmod	33	SENT_23	[p1l1780t2343r2147b2433],
33	signiﬁcant	JJ	O	signiﬁcant	amod	35	SENT_23	[p1l12t2451r421b2541],
34	psychoactive	JJ	O	psychoactive	amod	35	SENT_23	[p1l468t2451r984b2541],
35	drugs	NNS	O	drug	dobj	30	SENT_23	[p1l1034t2451r1249b2541],
36	(	VBP	O	(	rcmod	35	SENT_23	[p1l1304t2452r1607b2541],
37	Meyer	NNP	PERSON	Meyer	dobj	36	SENT_23	[p1l1304t2452r1607b2541],
38	,	,	O	,	_	0	SENT_23	[p1l1304t2452r1607b2541],
39	1994	CD	DATE	1994	num	40	SENT_23	[p1l1670t2451r1909b2536],
40	)	NN	O	)	appos	37	SENT_23	[p1l1670t2451r1909b2536],
41	.	.	O	.	_	0	SENT_23	[p1l1670t2451r1909b2536],

1	Poor	NNP	O	Poor	nsubj	2	SENT_24	[p1l1964t2453r2150b2521],
2	metabolizers	VBZ	O	metabolizer	_	0	SENT_24	[p1l8t2559r514b2629],
3	(	CD	NUMBER	(	num	5	SENT_24	[p1l563t2560r762b2645],
4	PM	NN	O	pm	nn	5	SENT_24	[p1l563t2560r762b2645],
5	)	NN	O	)	nsubj	7	SENT_24	[p1l563t2560r762b2645],
6	completely	RB	O	completely	advmod	7	SENT_24	[p1l811t2559r1250b2649],
7	lack	VBP	O	lack	ccomp	2	SENT_24	[p1l1295t2559r1460b2629],
8	enzyme	NN	O	enzyme	nn	9	SENT_24	[p1l1503t2581r1809b2649],
9	activity	NN	O	activity	dobj	7	SENT_24	[p1l1855t2559r2147b2649],

1	*	NN	O	*	nn	2	SENT_25	[p1l13t2887r42b2920],
2	Correspondence	NN	O	correspondence	_	0	SENT_25	[p1l62t2886r574b2958],
3	to	TO	O	to	_	0	SENT_25	[p1l611t2895r687b2942],
4	:	:	O	:	_	0	SENT_25	[p1l611t2895r687b2942],
5	Dr	NNP	O	Dr	nn	7	SENT_25	[p1l730t2888r813b2941],
6	M.	NNP	PERSON	M.	nn	7	SENT_25	[p1l848t2888r933b2942],
7	Kennedy	NNP	PERSON	Kennedy	prep_to	2	SENT_25	[p1l975t2886r1268b2958],
8	,	,	O	,	_	0	SENT_25	[p1l975t2886r1268b2958],
9	Department	NNP	ORGANIZATION	Department	appos	7	SENT_25	[p1l1308t2888r1683b2958],
10	of	IN	ORGANIZATION	of	_	0	SENT_25	[p1l1719t2886r1788b2942],
11	Pathology	NNP	ORGANIZATION	Pathology	prep_of	9	SENT_25	[p1l1819t2886r2150b2958],
12	,	,	O	,	_	0	SENT_25	[p1l1819t2886r2150b2958],
13	Christchurch	NNP	ORGANIZATION	Christchurch	nn	14	SENT_25	[p1l9t2975r417b3031],
14	School	NNP	ORGANIZATION	School	appos	7	SENT_25	[p1l453t2975r669b3031],
15	of	IN	ORGANIZATION	of	_	0	SENT_25	[p1l704t2975r773b3031],
16	Medicine	NNP	ORGANIZATION	Medicine	nn	19	SENT_25	[p1l801t2975r1100b3031],
17	and	CC	ORGANIZATION	and	_	0	SENT_25	[p1l1137t2975r1249b3031],
18	Health	NNP	ORGANIZATION	Health	nn	19	SENT_25	[p1l1283t2975r1493b3031],
19	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	14	SENT_25	[p1l1529t2975r1820b3041],
20	,	,	O	,	_	0	SENT_25	[p1l1529t2975r1820b3041],
21	PO	NNP	O	PO	nn	22	SENT_25	[p1l1890t2976r1987b3031],
22	Box	NNP	O	Box	appos	7	SENT_25	[p1l2023t2976r2153b3030],
23	4345	CD	NUMBER	4345	dep	22	SENT_25	[p1l8t3063r182b3129],
24	,	,	O	,	_	0	SENT_25	[p1l8t3063r182b3129],
25	Christchurch	NNP	LOCATION	Christchurch	appos	7	SENT_25	[p1l205t3064r628b3129],
26	,	,	O	,	_	0	SENT_25	[p1l205t3064r628b3129],
27	New	NNP	LOCATION	New	nn	28	SENT_25	[p1l651t3065r796b3119],
28	Zealand	NNP	LOCATION	Zealand	appos	25	SENT_25	[p1l816t3064r1087b3119],
29	.	.	O	.	_	0	SENT_25	[p1l816t3064r1087b3119],

1	Tel	NNP	O	Tel	_	0	SENT_26	[p1l1110t3064r1226b3119],
2	:	:	O	:	_	0	SENT_26	[p1l1110t3064r1226b3119],
3	(	CD	NUMBER	(	num	5	SENT_26	[p1l1254t3064r1445b3132],
4	64-3	CD	NUMBER	64-3	num	5	SENT_26	[p1l1254t3064r1445b3132],
5	)	NN	O	)	dep	1	SENT_26	[p1l1254t3064r1445b3132],
6	364	CD	NUMBER	364	number	7	SENT_26	[p1l1469t3064r1583b3119],
7	1222	CD	DATE	1222	dep	5	SENT_26	[p1l1611t3064r1776b3119],
8	.	.	O	.	_	0	SENT_26	[p1l1611t3064r1776b3119],

1	Fax	NN	O	fax	_	0	SENT_27	[p1l1799t3065r1931b3119],
2	:	:	O	:	_	0	SENT_27	[p1l1799t3065r1931b3119],
3	(	CD	NUMBER	(	num	5	SENT_27	[p1l1959t3064r2151b3132],
4	64-3	CD	NUMBER	64-3	num	5	SENT_27	[p1l1959t3064r2151b3132],
5	)	NN	O	)	dep	1	SENT_27	[p1l1959t3064r2151b3132],
6	364	CD	NUMBER	364	number	7	SENT_27	[p1l10t3152r124b3208],
7	0009	CD	DATE	0009	dep	5	SENT_27	[p1l151t3153r323b3209],
8	.	.	O	.	_	0	SENT_27	[p1l151t3153r323b3209],

1	E-mail	NN	O	e-mail	_	0	SENT_28	[p1l352t3152r584b3208],
2	:	:	O	:	_	0	SENT_28	[p1l352t3152r584b3208],
3	martin.kennedy@chmeds.ac.nz	NNP	O	martin.kennedy@chmeds.ac.nz	nn	4	SENT_28	[p1l615t3152r1609b3224],
4	Contract	NNP	O	Contract	dep	1	SENT_28	[p1l9t3241r304b3297],
5	/	:	O	/	punct	1	SENT_28	[p1l9t3241r304b3297],
6	grant	NN	O	grant	nn	7	SENT_28	[p1l306t3249r466b3313],
7	sponsors	NNS	O	sponsor	dep	1	SENT_28	[p1l491t3259r779b3313],
8	:	:	O	:	_	0	SENT_28	[p1l491t3259r779b3313],
9	Health	NNP	ORGANIZATION	Health	nn	11	SENT_28	[p1l806t3241r1017b3296],
10	Research	NNP	ORGANIZATION	Research	nn	11	SENT_28	[p1l1039t3241r1329b3296],
11	Council	NNP	ORGANIZATION	Council	dep	7	SENT_28	[p1l1351t3241r1600b3297],
12	of	IN	ORGANIZATION	of	_	0	SENT_28	[p1l1623t3241r1692b3296],
13	New	NNP	ORGANIZATION	New	nn	14	SENT_28	[p1l1708t3242r1853b3297],
14	Zealand	NNP	ORGANIZATION	Zealand	prep_of	11	SENT_28	[p1l1876t3241r2150b3307],
15	;	:	O	;	_	0	SENT_28	[p1l1876t3241r2150b3307],
16	University	NNP	ORGANIZATION	University	dep	11	SENT_28	[p1l8t3330r338b3402],
17	of	IN	ORGANIZATION	of	_	0	SENT_28	[p1l365t3330r434b3386],
18	Otago	NNP	ORGANIZATION	Otago	prep_of	16	SENT_28	[p1l455t3331r662b3402],
19	.	.	O	.	_	0	SENT_28	[p1l455t3331r662b3402],

1	Copyright	NN	O	copyright	nn	5	SENT_29	[p1l9t3581r329b3654],
2	©	CD	NUMBER	©	num	5	SENT_29	[p1l358t3582r425b3650],
3	2004	CD	DATE	2004	num	5	SENT_29	[p1l457t3582r613b3637],
4	John	NNP	ORGANIZATION	John	nn	5	SENT_29	[p1l638t3582r786b3637],
5	Wiley	NNP	ORGANIZATION	Wiley	_	0	SENT_29	[p1l811t3582r1000b3654],
6	&	CC	ORGANIZATION	&	_	0	SENT_29	[p1l1028t3582r1085b3637],
7	Sons	NNP	ORGANIZATION	Sons	conj_and	5	SENT_29	[p1l1114t3582r1281b3647],
8	,	,	ORGANIZATION	,	_	0	SENT_29	[p1l1114t3582r1281b3647],
9	Ltd.	NNP	ORGANIZATION	Ltd.	appos	5	SENT_29	[p1l1308t3582r1433b3637],
10	.	.	O	.	_	0	SENT_29	[p1l1308t3582r1433b3637],

1	because	IN	O	because	_	0	SENT_30	[p2l7t96r320b165],
2	of	IN	O	of	_	0	SENT_30	[p2l383t96r469b165],
3	inactivating	VBG	O	inactivate	amod	4	SENT_30	[p2l522t96r985b186],
4	mutations	NNS	O	mutation	prep_because_of	19	SENT_30	[p2l1048t96r1436b165],
5	in	IN	O	in	_	0	SENT_30	[p2l1499t96r1573b165],
6	both	DT	O	both	det	7	SENT_30	[p2l1633t96r1808b165],
7	alleles	NNS	O	allele	prep_in	4	SENT_30	[p2l1871t96r2142b178],
8	,	,	O	,	_	0	SENT_30	[p2l1871t96r2142b178],
9	whereas	IN	O	whereas	mark	15	SENT_30	[p2l9t203r329b272],
10	individuals	NNS	O	individual	dep	15	SENT_30	[p2l400t203r836b272],
11	with	IN	O	with	_	0	SENT_30	[p2l907t203r1080b272],
12	at	IN	O	at	quantmod	14	SENT_30	[p2l1151t214r1220b272],
13	least	JJS	O	least	mwe	12	SENT_30	[p2l1287t203r1468b272],
14	one	CD	NUMBER	one	prep_with	10	SENT_30	[p2l1537t225r1675b272],
15	functional	JJ	O	functional	dep	7	SENT_30	[p2l1745t203r2146b272],
16	C	NN	O	c	nn	18	SENT_30	[p2l14t312r76b381],
17	YPZD6	NN	O	ypzd6	nn	18	SENT_30	[p2l81t311r362b380],
18	gene	NN	O	gene	nsubj	19	SENT_30	[p2l440t333r622b401],
19	exhibit	VBP	O	exhibit	_	0	SENT_30	[p2l705t311r979b380],
20	an	DT	O	a	det	24	SENT_30	[p2l1059t333r1148b380],
21	extensive	JJ	O	extensive	amod	24	SENT_30	[p2l1229t311r1598b381],
22	metabolizer	NN	O	metabolizer	nn	24	SENT_30	[p2l1678t311r2148b380],
23	(	NN	O	(	nn	24	SENT_30	[p2l12t420r217b504],
24	EM	NN	O	em	nsubj	26	SENT_30	[p2l12t420r217b504],
25	)	CD	NUMBER	)	num	26	SENT_30	[p2l12t420r217b504],
26	phenotype	NN	O	phenotype	xcomp	19	SENT_30	[p2l285t419r698b509],
27	and	CC	O	and	_	0	SENT_30	[p2l767t419r906b488],
28	show	VBP	O	show	conj_and	19	SENT_30	[p2l975t419r1175b489],
29	a	DT	O	a	det	31	SENT_30	[p2l1243t441r1284b488],
30	broad	JJ	O	broad	amod	31	SENT_30	[p2l1347t419r1573b488],
31	spectrum	NN	O	spectrum	dobj	28	SENT_30	[p2l1642t429r2002b509],
32	of	IN	O	of	_	0	SENT_30	[p2l2067t419r2153b488],
33	enzyme	NN	O	enzyme	nn	34	SENT_30	[p2l9t549r314b617],
34	activity	NN	O	activity	prep_of	31	SENT_30	[p2l379t527r671b617],
35	from	IN	O	from	_	0	SENT_30	[p2l733t527r924b597],
36	relatively	RB	O	relatively	advmod	37	SENT_30	[p2l982t527r1355b617],
37	low	JJ	O	low	amod	43	SENT_30	[p2l1416t527r1560b597],
38	to	TO	O	to	aux	39	SENT_30	[p2l1621t537r1694b597],
39	ultra	VB	O	ultra	xcomp	37	SENT_30	[p2l1755t527r2147b617],
40	—	RB	O	—	advmod	41	SENT_30	[p2l1755t527r2147b617],
41	high	JJ	O	high	amod	42	SENT_30	[p2l1755t527r2147b617],
42	(	NN	O	(	dobj	39	SENT_30	[p2l12t636r316b725],
43	Meyer	NNP	PERSON	Meyer	prep_from	34	SENT_30	[p2l12t636r316b725],
44	,	,	O	,	_	0	SENT_30	[p2l12t636r316b725],
45	1994	CD	DATE	1994	num	46	SENT_30	[p2l361t635r600b720],
46	)	NN	O	)	appos	43	SENT_30	[p2l361t635r600b720],
47	.	.	O	.	_	0	SENT_30	[p2l361t635r600b720],

1	Approximately	RB	O	approximately	quantmod	6	SENT_31	[p2l638t635r1239b725],
2	5	CD	PERCENT	5	number	6	SENT_31	[p2l1273t634r1397b705],
3	%	NN	PERCENT	%	dep	6	SENT_31	[p2l1273t634r1397b705],
4	to	TO	O	to	dep	6	SENT_31	[p2l1434t646r1508b704],
5	10	CD	PERCENT	10	number	6	SENT_31	[p2l1551t635r1716b705],
6	%	NN	PERCENT	%	nsubj	10	SENT_31	[p2l1551t635r1716b705],
7	of	IN	O	of	_	0	SENT_31	[p2l1755t635r1841b704],
8	Caucasians	NNPS	MISC	Caucasians	prep_of	6	SENT_31	[p2l1869t635r2143b705, p2l12t743r202b813],
9	are	VBP	O	be	cop	10	SENT_31	[p2l244t765r360b813],
10	PMs	NNS	O	pm	_	0	SENT_31	[p2l399t745r597b813],
11	.	.	O	.	_	0	SENT_31	[p2l399t745r597b813],

1	These	DT	O	these	det	2	SENT_32	[p2l640t743r874b813],
2	individuals	NNS	O	individual	nsubj	4	SENT_32	[p2l913t743r1348b813],
3	may	MD	O	may	aux	4	SENT_32	[p2l1388t765r1555b833],
4	have	VB	O	have	dep	27	SENT_32	[p2l1593t743r1777b813],
5	a	DT	O	a	det	7	SENT_32	[p2l1817t765r1858b813],
6	heightened	VBN	O	heighten	amod	7	SENT_32	[p2l1894t743r2144b833, p2l8t851r222b921],
7	risk	NN	O	risk	dobj	4	SENT_32	[p2l268t851r418b921],
8	of	IN	O	of	_	0	SENT_32	[p2l464t851r549b921],
9	concentration	NN	O	concentration	nn	14	SENT_32	[p2l591t851r1573b941],
10	—	NN	O	—	nn	14	SENT_32	[p2l591t851r1573b941],
11	dependent	JJ	O	dependent	amod	14	SENT_32	[p2l591t851r1573b941],
12	adverse	JJ	O	adverse	amod	14	SENT_32	[p2l1622t851r1919b921],
13	drug	NN	O	drug	nn	14	SENT_32	[p2l1968t851r2145b941],
14	reactions	NNS	O	reaction	nn	17	SENT_32	[p2l8t959r363b1029],
15	(	JJ	O	(	amod	17	SENT_32	[p2l404t960r709b1045],
16	ADRS	NN	O	adr	nn	17	SENT_32	[p2l404t960r709b1045],
17	)	NN	O	)	prep_of	7	SENT_32	[p2l404t960r709b1045],
18	at	IN	O	at	_	0	SENT_32	[p2l749t970r818b1029],
19	standard	JJ	O	standard	amod	20	SENT_32	[p2l857t959r1188b1029],
20	doses	NNS	O	dose	prep_at	7	SENT_32	[p2l1223t959r1438b1029],
21	of	IN	O	of	_	0	SENT_32	[p2l1477t959r1562b1029],
22	drugs	NNS	O	drug	prep_of	20	SENT_32	[p2l1592t959r1807b1049],
23	that	WDT	O	that	nsubj	26	SENT_32	[p2l1845t959r1992b1029],
24	are	VBP	O	be	cop	26	SENT_32	[p2l2029t981r2146b1029],
25	CYP2D6	NN	O	cyp2d6	nn	26	SENT_32	[p2l10t1067r368b1137],
26	substrates	NNS	O	substrate	rcmod	22	SENT_32	[p2l415t1067r799b1136],
27	(	VBP	O	(	_	0	SENT_32	[p2l847t1067r1278b1152],
28	Bertilsson	NNP	O	Bertilsson	dobj	27	SENT_32	[p2l847t1067r1278b1152],
29	et	FW	O	et	nn	30	SENT_32	[p2l1322t1080r1393b1136],
30	al.	FW	O	al.	nsubj	27	SENT_32	[p2l1434t1067r1555b1149],
31	,	,	O	,	_	0	SENT_32	[p2l1434t1067r1555b1149],
32	1981	CD	DATE	1981	appos	30	SENT_32	[p2l1610t1067r1820b1149],
33	;	:	O	;	_	0	SENT_32	[p2l1610t1067r1820b1149],
34	Nordin	NNP	PERSON	Nordin	dep	30	SENT_32	[p2l1868t1067r2147b1136],
35	and	CC	O	and	_	0	SENT_32	[p2l11t1174r150b1243],
36	Bertilsson	NNP	PERSON	Bertilsson	conj_and	34	SENT_32	[p2l186t1174r608b1255],
37	,	,	O	,	_	0	SENT_32	[p2l186t1174r608b1255],
38	1995	CD	DATE	1995	appos	34	SENT_32	[p2l657t1174r867b1255],
39	;	:	O	;	_	0	SENT_32	[p2l657t1174r867b1255],
40	Bertilsson	NNP	O	Bertilsson	dep	30	SENT_32	[p2l908t1174r1309b1243],
41	et	FW	O	et	nn	42	SENT_32	[p2l1346t1188r1418b1243],
42	al.	FW	O	al.	dep	40	SENT_32	[p2l1451t1174r1572b1256],
43	,	,	O	,	_	0	SENT_32	[p2l1451t1174r1572b1256],
44	1997	CD	DATE	1997	appos	42	SENT_32	[p2l1621t1175r1831b1256],
45	;	:	O	;	_	0	SENT_32	[p2l1621t1175r1831b1256],
46	Vandel	NNP	PERSON	Vandel	dep	30	SENT_32	[p2l1872t1174r2145b1243],
47	et	FW	O	et	nn	48	SENT_32	[p2l10t1296r81b1351],
48	al.	FW	O	al.	dep	46	SENT_32	[p2l111t1282r232b1364],
49	,	,	O	,	_	0	SENT_32	[p2l111t1282r232b1364],
50	1999	CD	DATE	1999	appos	48	SENT_32	[p2l277t1283r487b1364],
51	;	:	O	;	_	0	SENT_32	[p2l277t1283r487b1364],
52	Bertilsson	NNP	O	Bertilsson	dep	30	SENT_32	[p2l524t1282r924b1351],
53	et	FW	O	et	nn	54	SENT_32	[p2l958t1296r1030b1351],
54	al.	FW	O	al.	dep	52	SENT_32	[p2l1059t1282r1180b1364],
55	,	,	O	,	_	0	SENT_32	[p2l1059t1282r1180b1364],
56	2002	CD	DATE	2002	num	57	SENT_32	[p2l1217t1283r1464b1368],
57	)	NN	O	)	appos	30	SENT_32	[p2l1217t1283r1464b1368],
58	.	.	O	.	_	0	SENT_32	[p2l1217t1283r1464b1368],

1	Most	JJS	O	most	amod	2	SENT_33	[p2l107t1392r310b1460],
2	antidepressants	NNS	O	antidepressant	nsubjpass	4	SENT_33	[p2l358t1390r959b1480],
3	are	VBP	O	be	auxpass	4	SENT_33	[p2l1010t1412r1126b1460],
4	metabolized	VBN	O	metabolize	_	0	SENT_33	[p2l1174t1390r1659b1460],
5	and	CC	O	and	_	0	SENT_33	[p2l1708t1390r1848b1460],
6	inactivated	VBN	O	inactivate	conj_and	4	SENT_33	[p2l1894t1390r2144b1460, p2l9t1498r221b1568],
7	as	IN	O	as	_	0	SENT_33	[p2l292t1520r368b1568],
8	a	DT	O	a	det	9	SENT_33	[p2l442t1520r483b1568],
9	result	NN	O	result	prep_as	4	SENT_33	[p2l551t1498r771b1568],
10	of	IN	O	of	_	0	SENT_33	[p2l842t1498r927b1568],
11	hydroxylation	NN	O	hydroxylation	prep_of	9	SENT_33	[p2l990t1498r1547b1588],
12	mediated	VBN	O	mediate	partmod	11	SENT_33	[p2l1616t1498r1980b1568],
13	by	IN	O	by	_	0	SENT_33	[p2l2049t1498r2146b1588],
14	CYP2D6	NN	O	cyp2d6	nn	16	SENT_33	[p2l10t1606r368b1676],
15	(	CD	NUMBER	(	num	16	SENT_33	[p2l433t1606r937b1692],
16	Eichelbaum	NNP	PERSON	Eichelbaum	agent	12	SENT_33	[p2l433t1606r937b1692],
17	and	CC	O	and	_	0	SENT_33	[p2l999t1606r1139b1675],
18	Gross	NNP	NUMBER	Gross	agent	12	SENT_33	[p2l1200t1607r1447b1688],
19	,	,	NUMBER	,	_	0	SENT_33	[p2l1200t1607r1447b1688],
20	1990	CD	DATE	1990	appos	18	SENT_33	[p2l1521t1607r1731b1688],
21	;	:	O	;	_	0	SENT_33	[p2l1521t1607r1731b1688],
22	Kroemer	NNP	PERSON	Kroemer	agent	12	SENT_33	[p2l1797t1608r2148b1675],

1	Received	VBN	O	receive	_	0	SENT_34	[p2l1409t1871r1701b1928],
2	23	CD	DATE	23	num	3	SENT_34	[p2l1722t1872r1799b1927],
3	May	NNP	DATE	May	dobj	1	SENT_34	[p2l1823t1873r1965b1943],
4	2003	CD	DATE	2003	num	3	SENT_34	[p2l1990t1872r2146b1927],
5	Accepted	JJ	O	accepted	amod	3	SENT_34	[p2l1324t1970r1622b2042],
6	21	CD	DATE	21	tmod	5	SENT_34	[p2l1644t1971r1716b2025],
7	August	NNP	DATE	August	tmod	1	SENT_34	[p2l1742t1971r1967b2042],
8	2003	CD	DATE	2003	num	7	SENT_34	[p2l1990t1971r2146b2026],

1	18	CD	NUMBER	18	_	0	SENT_35	[p2l540t2117r575b2146],
2	R.	NNP	PERSON	R.	nn	5	SENT_35	[p2l1292t2125r1320b2146],
3	L.	NNP	PERSON	L.	nn	5	SENT_35	[p2l1336t2125r1363b2146],
4	ROBERTS	NNP	PERSON	ROBERTS	nn	5	SENT_35	[p2l1379t2124r1520b2146],
5	ETAL	NNP	O	ETAL	dep	1	SENT_35	[p2l1534t2124r1619b2146],
6	.	.	O	.	_	0	SENT_35	[p2l1534t2124r1619b2146],

1	and	CC	O	and	dep	2	SENT_36	[p2l10t2294r150b2364],
2	Eichelbaum	NNP	PERSON	Eichelbaum	_	0	SENT_36	[p2l182t2294r679b2377],
3	,	,	O	,	_	0	SENT_36	[p2l182t2294r679b2377],
4	1995	CD	DATE	1995	num	5	SENT_36	[p2l725t2294r965b2380],
5	)	NN	O	)	appos	2	SENT_36	[p2l725t2294r965b2380],
6	.	.	O	.	_	0	SENT_36	[p2l725t2294r965b2380],

1	This	DT	O	this	nsubj	2	SENT_37	[p2l1004t2294r1175b2364],
2	includes	VBZ	O	include	_	0	SENT_37	[p2l1212t2294r1539b2364],
3	many	JJ	O	many	amod	5	SENT_37	[p2l1575t2317r1793b2384],
4	tricyclic	JJ	O	tricyclic	amod	5	SENT_37	[p2l1826t2294r2149b2384],
5	antidepressants	NNS	O	antidepressant	nsubj	6	SENT_37	[p2l10t2402r612b2492],
6	(	VBP	O	(	ccomp	2	SENT_37	[p2l648t2402r943b2488],
7	TCAs	NNS	O	tca	dobj	6	SENT_37	[p2l648t2402r943b2488],
8	)	CD	NUMBER	)	num	7	SENT_37	[p2l648t2402r943b2488],
9	such	JJ	O	such	_	0	SENT_37	[p2l980t2402r1156b2472],
10	as	IN	O	as	_	0	SENT_37	[p2l1188t2424r1264b2472],
11	nortriptyline	NN	O	nortriptyline	prep_such_as	7	SENT_37	[p2l1297t2402r1814b2492],
12	,	,	O	,	_	0	SENT_37	[p2l1297t2402r1814b2492],
13	monoa	FW	O	monoa	nn	14	SENT_37	[p2l1849t2424r2147b2472],
14	—	FW	O	—	amod	17	SENT_37	[p2l1849t2424r2147b2472],
15	mine	NN	O	mine	nn	17	SENT_37	[p2l8t2510r204b2580],
16	oxidase	NN	O	oxidase	nn	17	SENT_37	[p2l236t2510r535b2580],
17	inhibitors	NNS	O	inhibitor	appos	11	SENT_37	[p2l566t2510r967b2593],
18	,	,	O	,	_	0	SENT_37	[p2l566t2510r967b2593],
19	and	CC	O	and	_	0	SENT_37	[p2l1003t2510r1143b2580],
20	some	DT	O	some	det	24	SENT_37	[p2l1175t2533r1378b2580],
21	selective	JJ	O	selective	amod	24	SENT_37	[p2l1412t2510r1753b2580],
22	serotonin	NN	O	serotonin	nn	24	SENT_37	[p2l1786t2510r2151b2580],
23	reuptake	NN	O	reuptake	nn	24	SENT_37	[p2l7t2618r347b2708],
24	inhibitors	NNS	O	inhibitor	nsubj	25	SENT_37	[p2l384t2618r761b2688],
25	(	VBP	O	(	conj_and	2	SENT_37	[p2l802t2619r1132b2704],
26	SSRIS	NNP	O	SSRIS	dobj	25	SENT_37	[p2l802t2619r1132b2704],
27	)	CD	NUMBER	)	num	26	SENT_37	[p2l802t2619r1132b2704],
28	,	,	O	,	_	0	SENT_37	[p2l802t2619r1132b2704],
29	including	VBG	O	include	_	0	SENT_37	[p2l1170t2618r1544b2708],
30	ﬂuoxetine	NN	O	ﬂuoxetine	prep_including	26	SENT_37	[p2l1581t2618r1975b2688],
31	and	CC	O	and	_	0	SENT_37	[p2l2012t2618r2152b2688],
32	paroxetine	NN	O	paroxetine	nn	34	SENT_37	[p2l7t2726r425b2816],
33	(	CD	NUMBER	(	num	34	SENT_37	[p2l469t2726r912b2812],
34	Mellstrom	NNP	PERSON	Mellstrom	conj_and	30	SENT_37	[p2l469t2726r912b2812],
35	et	FW	O	et	nn	36	SENT_37	[p2l952t2739r1023b2796],
36	al.	FW	O	al.	dep	30	SENT_37	[p2l1060t2726r1181b2808],
37	,	,	O	,	_	0	SENT_37	[p2l1060t2726r1181b2808],
38	1981	CD	DATE	1981	appos	36	SENT_37	[p2l1234t2726r1444b2808],
39	;	:	O	;	_	0	SENT_37	[p2l1234t2726r1444b2808],
40	Venkatakrishnan	NNP	O	Venkatakrishnan	dep	36	SENT_37	[p2l1488t2726r2152b2796],
41	et	FW	O	et	nn	42	SENT_37	[p2l9t2848r80b2904],
42	al.	FW	O	al.	dep	40	SENT_37	[p2l122t2834r243b2917],
43	,	,	O	,	_	0	SENT_37	[p2l122t2834r243b2917],
44	1999	CD	DATE	1999	appos	42	SENT_37	[p2l299t2835r510b2916],
45	;	:	O	;	_	0	SENT_37	[p2l299t2835r510b2916],
46	Hamelin	NNP	PERSON	Hamelin	dep	36	SENT_37	[p2l559t2834r900b2904],
47	et	FW	O	et	nn	48	SENT_37	[p2l945t2847r1017b2904],
48	al.	FW	O	al.	dep	46	SENT_37	[p2l1058t2834r1179b2916],
49	,	,	O	,	_	0	SENT_37	[p2l1058t2834r1179b2916],
50	1996	CD	DATE	1996	appos	48	SENT_37	[p2l1236t2834r1447b2917],
51	;	:	O	;	_	0	SENT_37	[p2l1236t2834r1447b2917],
52	Fjordside	NNP	O	Fjordside	dep	36	SENT_37	[p2l1494t2834r1867b2924],
53	et	FW	O	et	nn	54	SENT_37	[p2l1914t2848r1985b2904],
54	al.	FW	O	al.	dep	52	SENT_37	[p2l2026t2834r2148b2916],
55	,	,	O	,	_	0	SENT_37	[p2l2026t2834r2148b2916],
56	1999	CD	DATE	1999	appos	54	SENT_37	[p2l18t2943r227b3024],
57	;	:	O	;	_	0	SENT_37	[p2l18t2943r227b3024],
58	Morita	NNP	PERSON	Morita	dep	36	SENT_37	[p2l264t2942r535b3011],
59	et	FW	O	et	nn	60	SENT_37	[p2l567t2956r639b3011],
60	al.	FW	O	al.	dep	58	SENT_37	[p2l669t2942r790b3025],
61	,	,	O	,	_	0	SENT_37	[p2l669t2942r790b3025],
62	2000	CD	DATE	2000	num	63	SENT_37	[p2l827t2943r1075b3028],
63	)	NN	O	)	appos	30	SENT_37	[p2l827t2943r1075b3028],
64	.	.	O	.	_	0	SENT_37	[p2l827t2943r1075b3028],

1	Several	JJ	O	several	amod	3	SENT_38	[p2l109t3050r401b3120],
2	case	NN	O	case	nn	3	SENT_38	[p2l432t3072r598b3120],
3	reports	NNS	O	report	nsubj	4	SENT_38	[p2l628t3061r901b3140],
4	suggest	VBP	O	suggest	_	0	SENT_38	[p2l937t3060r1231b3140],
5	that	IN	O	that	complm	14	SENT_38	[p2l1259t3050r1408b3120],
6	individuals	NNS	O	individual	nsubj	14	SENT_38	[p2l1437t3050r1873b3120],
7	with	IN	O	with	_	0	SENT_38	[p2l1906t3050r2080b3120],
8	a	DT	O	a	det	12	SENT_38	[p2l2112t3072r2152b3120],
9	C	NN	O	c	nn	12	SENT_38	[p2l13t3160r75b3229],
10	YPZD6	NN	O	ypzd6	nn	12	SENT_38	[p2l80t3158r362b3228],
11	PM	NN	O	pm	nn	12	SENT_38	[p2l381t3160r521b3227],
12	genotype	NN	O	genotype	prep_with	6	SENT_38	[p2l546t3169r907b3248],
13	may	MD	O	may	aux	14	SENT_38	[p2l931t3180r1100b3248],
14	be	VB	O	be	ccomp	4	SENT_38	[p2l1122t3158r1214b3228],
15	at	IN	O	at	_	0	SENT_38	[p2l1240t3169r1309b3228],
16	greater	JJR	O	greater	amod	17	SENT_38	[p2l1332t3169r1608b3248],
17	risk	NN	O	risk	prep_at	14	SENT_38	[p2l1628t3158r1778b3228],
18	of	IN	O	of	_	0	SENT_38	[p2l1800t3158r1886b3228],
19	severe	JJ	O	severe	amod	20	SENT_38	[p2l1905t3180r2151b3228],
20	ADRs	NNS	MISC	adr	prep_of	17	SENT_38	[p2l8t3267r250b3336],
21	on	IN	O	on	_	0	SENT_38	[p2l312t3289r408b3336],
22	antidepressants	NNS	O	antidepressant	prep_on	20	SENT_38	[p2l469t3266r1072b3356],
23	than	IN	O	than	mark	27	SENT_38	[p2l1132t3266r1302b3336],
24	CYP2D6	NN	O	cyp2d6	nn	26	SENT_38	[p2l1362t3266r1720b3336],
25	extensive	JJ	O	extensive	amod	26	SENT_38	[p2l1781t3266r2152b3336],
26	metabolizers	NNS	O	metabolizer	nsubj	27	SENT_38	[p2l8t3374r514b3443],
27	(	VBP	O	(	advcl	14	SENT_38	[p2l554t3374r822b3459],
28	EMS	NNP	O	EMS	dobj	27	SENT_38	[p2l554t3374r822b3459],
29	)	CD	NUMBER	)	num	28	SENT_38	[p2l554t3374r822b3459],
30	.	.	O	.	_	0	SENT_38	[p2l554t3374r822b3459],

1	For	IN	O	for	_	0	SENT_39	[p2l861t3375r997b3443],
2	example	NN	O	example	prep_for	15	SENT_39	[p2l1031t3374r1387b3464],
3	,	,	O	,	_	0	SENT_39	[p2l1031t3374r1387b3464],
4	an	DT	O	a	det	6	SENT_39	[p2l1427t3396r1516b3443],
5	elderly	JJ	O	elderly	amod	6	SENT_39	[p2l1552t3374r1825b3464],
6	woman	NN	O	woman	nsubjpass	15	SENT_39	[p2l1861t3396r2151b3443],
7	on	IN	O	on	_	0	SENT_39	[p2l9t3504r104b3552],
8	a	DT	O	a	det	11	SENT_39	[p2l141t3504r182b3552],
9	low	JJ	O	low	amod	11	SENT_39	[p2l215t3482r359b3552],
10	daily	JJ	SET	daily	amod	11	SENT_39	[p2l395t3482r590b3572],
11	dose	NN	O	dose	prep_on	6	SENT_39	[p2l627t3482r805b3552],
12	of	IN	O	of	_	0	SENT_39	[p2l841t3482r928b3552],
13	nortriptyline	NN	O	nortriptyline	prep_of	11	SENT_39	[p2l955t3482r1452b3572],
14	was	VBD	O	be	auxpass	15	SENT_39	[p2l1485t3504r1634b3552],
15	hospitalized	VBN	O	hospitalize	_	0	SENT_39	[p2l1670t3482r2152b3572],
16	with	IN	O	with	_	0	SENT_39	[p2l8t3590r182b3660],
17	fatigue	NN	O	fatigue	prep_with	15	SENT_39	[p2l246t3590r543b3680],
18	,	,	O	,	_	0	SENT_39	[p2l246t3590r543b3680],
19	vertigo	NN	O	vertigo	conj_and	17	SENT_39	[p2l611t3590r889b3680],
20	and	CC	O	and	_	0	SENT_39	[p2l957t3590r1096b3660],
21	confusion	NN	O	confusion	conj_and	17	SENT_39	[p2l1161t3590r1550b3660],
22	6	CD	DURATION	6	num	23	SENT_39	[p2l1617t3590r1660b3660],
23	days	NNS	NUMBER	day	npadvmod	15	SENT_39	[p2l1727t3590r1903b3680],
24	after	IN	O	after	_	0	SENT_39	[p2l1972t3590r2153b3660],
25	commencing	VBG	O	commence	prepc_after	15	SENT_39	[p2l9t3698r520b3788],
26	antidepressant	JJ	O	antidepressant	amod	27	SENT_39	[p2l571t3698r1138b3788],
27	treatment	NN	O	treatment	dobj	25	SENT_39	[p2l1184t3708r1580b3767],
28	.	.	O	.	_	0	SENT_39	[p2l1184t3708r1580b3767],

1	Nortriptyline	NN	O	nortriptyline	nn	2	SENT_40	[p2l1632t3698r2150b3788],
2	levels	NNS	O	level	nsubj	9	SENT_40	[p3l8t16r233b86],
3	in	IN	O	in	_	0	SENT_40	[p3l269t16r345b85],
4	the	DT	O	the	det	5	SENT_40	[p3l379t16r498b86],
5	patient	NN	O	patient	poss	7	SENT_40	[p3l532t16r868b106],
6	’s	POS	O	’s	_	0	SENT_40	[p3l532t16r868b106],
7	plasma	NN	O	plasma	prep_in	2	SENT_40	[p3l904t16r1186b106],
8	far	RB	O	far	advmod	9	SENT_40	[p3l1220t16r1330b86],
9	exceeded	VBD	O	exceed	_	0	SENT_40	[p3l1364t16r1732b86],
10	the	DT	O	the	det	12	SENT_40	[p3l1766t16r1885b86],
11	therapeutic	JJ	O	therapeutic	amod	12	SENT_40	[p3l1921t16r2147b86, p3l7t124r247b214],
12	range	NN	O	range	dobj	9	SENT_40	[p3l312t147r552b214],
13	.	.	O	.	_	0	SENT_40	[p3l312t147r552b214],

1	Retrospective	JJ	MISC	retrospective	amod	2	SENT_41	[p3l621t124r1166b214],
2	genotyping	NN	O	genotyping	nsubj	3	SENT_41	[p3l1229t124r1673b214],
3	found	VBD	O	find	_	0	SENT_41	[p3l1739t124r1968b194],
4	the	DT	O	the	det	5	SENT_41	[p3l2031t124r2150b194],
5	woman	NN	O	woman	nsubj	8	SENT_41	[p3l8t254r298b301],
6	was	VBD	O	be	cop	8	SENT_41	[p3l332t254r481b301],
7	a	DT	O	a	det	8	SENT_41	[p3l520t254r561b301],
8	CYP2D6	NN	O	cyp2d6	ccomp	3	SENT_41	[p3l596t231r955b301],
9	PM	NN	O	pm	nn	11	SENT_41	[p3l990t233r1130b300],
10	(	CD	NUMBER	(	num	11	SENT_41	[p3l1168t231r1600b317],
11	Bertilsson	NNP	O	Bertilsson	dep	8	SENT_41	[p3l1168t231r1600b317],
12	et	FW	O	et	nn	13	SENT_41	[p3l1636t245r1707b301],
13	al.	FW	O	al.	dep	8	SENT_41	[p3l1738t232r1859b314],
14	,	,	O	,	_	0	SENT_41	[p3l1738t232r1859b314],
15	1981	CD	DATE	1981	num	16	SENT_41	[p3l1906t232r2146b317],
16	)	NN	O	)	appos	8	SENT_41	[p3l1906t232r2146b317],
17	.	.	O	.	_	0	SENT_41	[p3l1906t232r2146b317],

1	In	IN	O	in	_	0	SENT_42	[p3l8t342r88b409],
2	two	CD	NUMBER	two	num	4	SENT_42	[p3l111t351r257b410],
3	separate	JJ	O	separate	amod	4	SENT_42	[p3l286t351r607b430],
4	cases	NNS	O	case	prep_in	12	SENT_42	[p3l632t362r837b410],
5	a	DT	O	a	det	7	SENT_42	[p3l865t362r906b410],
6	7-year-old	JJ	DURATION	7-year-old	amod	7	SENT_42	[p3l930t340r1342b430],
7	child	NN	O	child	dep	4	SENT_42	[p3l1365t340r1562b410],
8	and	CC	O	and	_	0	SENT_42	[p3l1588t340r1728b410],
9	a	DT	O	a	det	11	SENT_42	[p3l1754t362r1794b410],
10	21yearold	JJ	O	21yearold	amod	11	SENT_42	[p3l1819t341r2148b430, p3l9t448r133b518],
11	woman	NN	O	woman	conj_and	4	SENT_42	[p3l161t471r451b518],
12	died	VBD	O	die	_	0	SENT_42	[p3l481t448r649b518],
13	while	IN	O	while	mark	14	SENT_42	[p3l677t448r895b518],
14	receiving	VBG	O	receive	advcl	12	SENT_42	[p3l923t448r1291b538],
15	the	DT	O	the	det	17	SENT_42	[p3l1320t448r1439b518],
16	TCA	NNP	ORGANIZATION	TCA	nn	17	SENT_42	[p3l1468t449r1665b518],
17	imipramine	NN	O	imipramine	dobj	14	SENT_42	[p3l1693t448r2151b538],
18	(	CD	NUMBER	(	dep	14	SENT_42	[p3l11t556r396b641],
19	Swanson	NNP	PERSON	Swanson	dep	18	SENT_42	[p3l11t556r396b641],
20	et	FW	O	et	nn	21	SENT_42	[p3l441t569r512b625],
21	al.	FW	O	al.	nsubj	12	SENT_42	[p3l552t556r673b638],
22	,	,	O	,	_	0	SENT_42	[p3l552t556r673b638],
23	1997	CD	DATE	1997	num	24	SENT_42	[p3l729t556r968b641],
24	)	NN	O	)	appos	21	SENT_42	[p3l729t556r968b641],
25	.	.	O	.	_	0	SENT_42	[p3l729t556r968b641],

1	Although	IN	O	although	mark	5	SENT_43	[p3l1016t556r1391b646],
2	neither	DT	O	neither	det	3	SENT_43	[p3l1432t556r1709b625],
3	individual	NN	O	individual	nsubj	5	SENT_43	[p3l1751t556r2150b625],
4	had	VBD	O	have	aux	5	SENT_43	[p3l7t664r150b734],
5	ingested	VBN	O	ingest	advcl	16	SENT_43	[p3l176t664r506b754],
6	an	DT	O	a	det	8	SENT_43	[p3l535t686r625b734],
7	acute	JJ	O	acute	amod	8	SENT_43	[p3l653t675r859b734],
8	overdose	NN	O	overdose	dobj	5	SENT_43	[p3l888t664r1263b746],
9	,	,	O	,	_	0	SENT_43	[p3l888t664r1263b746],
10	a	DT	O	a	det	12	SENT_43	[p3l1296t686r1337b734],
11	lethal	JJ	O	lethal	amod	12	SENT_43	[p3l1363t664r1581b734],
12	concentration	NN	O	concentration	nsubjpass	16	SENT_43	[p3l1611t664r2151b734],
13	of	IN	O	of	_	0	SENT_43	[p3l9t772r94b842],
14	drug	NN	O	drug	prep_of	12	SENT_43	[p3l131t772r309b862],
15	was	VBD	O	be	auxpass	16	SENT_43	[p3l354t795r503b842],
16	found	VBN	O	find	_	0	SENT_43	[p3l549t772r778b842],
17	in	IN	O	in	_	0	SENT_43	[p3l820t772r895b841],
18	their	PRP$	O	they	poss	19	SENT_43	[p3l938t772r1120b842],
19	plasma	NN	O	plasma	prep_in	16	SENT_43	[p3l1161t772r1463b862],
20	,	,	O	,	_	0	SENT_43	[p3l1161t772r1463b862],
21	suggesting	VBG	O	suggest	xcomp	16	SENT_43	[p3l1514t772r1932b862],
22	both	CC	O	both	nsubj	25	SENT_43	[p3l1975t772r2151b842],
23	were	VBD	O	be	cop	25	SENT_43	[p3l8t902r197b949],
24	CYP2D6	CD	NUMBER	cyp2d6	num	25	SENT_43	[p3l247t879r606b950],
25	PMs	NNS	O	pm	ccomp	21	SENT_43	[p3l654t881r852b949],
26	.	.	O	.	_	0	SENT_43	[p3l654t881r852b949],

1	Similarly	RB	O	similarly	advmod	10	SENT_44	[p3l907t879r1289b970],
2	,	,	O	,	_	0	SENT_44	[p3l907t879r1289b970],
3	a	DT	O	a	det	9	SENT_44	[p3l1342t902r1383b949],
4	9-year-old	JJ	DURATION	9-year-old	amod	9	SENT_44	[p3l1430t880r1842b970],
5	with	IN	O	with	_	0	SENT_44	[p3l1888t879r2062b949],
6	a	DT	O	a	det	8	SENT_44	[p3l2112t902r2153b949],
7	CYP2D6	NN	O	cyp2d6	nn	8	SENT_44	[p3l13t987r362b1058],
8	PM	NN	O	pm	prep_with	4	SENT_44	[p3l409t990r549b1057],
9	genotype	NN	O	genotype	nsubj	10	SENT_44	[p3l602t999r963b1078],
10	died	VBD	O	die	_	0	SENT_44	[p3l1016t988r1185b1057],
11	after	IN	O	after	_	0	SENT_44	[p3l1238t988r1418b1057],
12	being	VBG	O	be	auxpass	13	SENT_44	[p3l1466t988r1686b1078],
13	prescribed	VBN	O	prescribe	prepc_after	10	SENT_44	[p3l1737t988r2152b1078],
14	ﬂuoxetine	NN	O	ﬂuoxetine	dobj	13	SENT_44	[p3l9t1096r402b1166],
15	over	IN	O	over	_	0	SENT_44	[p3l465t1119r638b1166],
16	a	DT	O	a	det	18	SENT_44	[p3l700t1119r741b1166],
17	10-month	JJ	DURATION	10-month	amod	18	SENT_44	[p3l810t1096r1185b1166],
18	period	NN	O	period	prep_over	13	SENT_44	[p3l1245t1096r1500b1186],
19	(	CD	NUMBER	(	num	20	SENT_44	[p3l1563t1096r1834b1183],
20	Sallee	NNP	PERSON	Sallee	dep	18	SENT_44	[p3l1563t1096r1834b1183],
21	et	FW	O	et	nn	22	SENT_44	[p3l1897t1110r1969b1166],
22	al.	FW	O	al.	dep	18	SENT_44	[p3l2026t1096r2148b1179],
23	,	,	O	,	_	0	SENT_44	[p3l2026t1096r2148b1179],
24	2000	CD	DATE	2000	num	25	SENT_44	[p3l9t1204r256b1289],
25	)	NN	O	)	appos	18	SENT_44	[p3l9t1204r256b1289],
26	.	.	O	.	_	0	SENT_44	[p3l9t1204r256b1289],

1	At	IN	O	at	_	0	SENT_45	[p3l291t1204r389b1273],
2	autopsy	NN	O	autopsy	prep_at	10	SENT_45	[p3l419t1214r739b1294],
3	,	,	O	,	_	0	SENT_45	[p3l419t1214r739b1294],
4	blood	NN	O	blood	nn	6	SENT_45	[p3l771t1204r1018b1286],
5	,	,	O	,	_	0	SENT_45	[p3l771t1204r1018b1286],
6	brain	NN	O	brain	nn	9	SENT_45	[p3l1050t1204r1253b1273],
7	and	CC	O	and	_	0	SENT_45	[p3l1285t1204r1424b1273],
8	other	JJ	O	other	nn	9	SENT_45	[p3l1454t1204r1658b1273],
9	tissues	NNS	O	tissue	nsubj	10	SENT_45	[p3l1685t1204r1946b1273],
10	contained	VBD	O	contain	_	0	SENT_45	[p3l1977t1226r2147b1273, p3l8t1312r250b1381],
11	toxic	JJ	O	toxic	amod	12	SENT_45	[p3l279t1312r474b1381],
12	levels	NNS	O	level	dobj	10	SENT_45	[p3l506t1312r731b1382],
13	of	IN	O	of	_	0	SENT_45	[p3l764t1312r850b1381],
14	the	DT	O	the	det	16	SENT_45	[p3l872t1312r991b1381],
15	parent	NN	O	parent	nn	16	SENT_45	[p3l1020t1323r1270b1402],
16	drug	NN	O	drug	prep_of	12	SENT_45	[p3l1298t1312r1476b1402],
17	and	CC	O	and	_	0	SENT_45	[p3l1509t1312r1648b1381],
18	the	DT	O	the	det	20	SENT_45	[p3l1678t1312r1796b1381],
19	metabolite	NN	O	metabolite	nn	20	SENT_45	[p3l1826t1312r2148b1381, p3l8t1420r133b1489],
20	norﬂuoxetine	NN	O	norﬂuoxetine	prep_of	12	SENT_45	[p3l192t1420r740b1489],
21	.	.	O	.	_	0	SENT_45	[p3l192t1420r740b1489],

1	A	DT	O	a	det	2	SENT_46	[p3l804t1420r874b1488],
2	range	NN	O	range	nsubj	6	SENT_46	[p3l930t1442r1149b1510],
3	of	IN	O	of	_	0	SENT_46	[p3l1210t1419r1295b1489],
4	other	JJ	O	other	amod	5	SENT_46	[p3l1349t1420r1552b1489],
5	reports	NNS	O	report	prep_of	2	SENT_46	[p3l1607t1430r1881b1510],
6	exist	VBP	O	exist	_	0	SENT_46	[p3l1942t1420r2147b1502],
7	,	,	O	,	_	0	SENT_46	[p3l1942t1420r2147b1502],
8	suggesting	VBG	O	suggest	parataxis	6	SENT_46	[p3l11t1528r429b1618],
9	that	IN	O	that	complm	14	SENT_46	[p3l488t1528r636b1597],
10	PM	NNP	O	PM	nn	11	SENT_46	[p3l693t1529r832b1596],
11	status	NN	O	status	nsubjpass	14	SENT_46	[p3l893t1538r1111b1597],
12	can	MD	O	can	aux	14	SENT_46	[p3l1171t1550r1306b1597],
13	be	VB	O	be	auxpass	14	SENT_46	[p3l1363t1528r1454b1597],
14	associated	VBN	O	associate	ccomp	8	SENT_46	[p3l1514t1528r1920b1597],
15	with	IN	O	with	_	0	SENT_46	[p3l1977t1528r2151b1597],
16	severe	JJ	O	severe	amod	19	SENT_46	[p3l11t1658r255b1705],
17	or	CC	O	or	_	0	SENT_46	[p3l289t1658r370b1705],
18	fatal	JJ	O	fatal	conj_or	16	SENT_46	[p3l399t1636r574b1705],
19	ADRs	NNS	MISC	adr	prep_with	14	SENT_46	[p3l606t1636r850b1705],
20	(	VBP	O	(	dep	8	SENT_46	[p3l885t1636r1318b1721],
21	Bertilsson	NNP	O	Bertilsson	dobj	20	SENT_46	[p3l885t1636r1318b1721],
22	et	FW	O	et	nn	23	SENT_46	[p3l1350t1649r1421b1705],
23	al.	FW	O	al.	nsubj	8	SENT_46	[p3l1449t1636r1570b1718],
24	,	,	O	,	_	0	SENT_46	[p3l1449t1636r1570b1718],
25	2002	CD	DATE	2002	appos	23	SENT_46	[p3l1607t1636r1825b1718],
26	;	:	O	;	_	0	SENT_46	[p3l1607t1636r1825b1718],
27	Marchioni	NNP	PERSON	Marchioni	dep	23	SENT_46	[p3l1861t1636r2147b1705, p3l8t1743r159b1812],
28	er	FW	O	er	nn	29	SENT_46	[p3l196t1756r267b1812],
29	al.	FW	O	al.	dep	27	SENT_46	[p3l298t1743r419b1825],
30	,	,	O	,	_	0	SENT_46	[p3l298t1743r419b1825],
31	1996	CD	DATE	1996	appos	29	SENT_46	[p3l465t1742r676b1825],
32	;	:	O	;	_	0	SENT_46	[p3l465t1742r676b1825],
33	Lessard	NNP	PERSON	Lessard	dep	23	SENT_46	[p3l714t1743r1022b1812],
34	et	FW	O	et	nn	35	SENT_46	[p3l1057t1756r1128b1812],
35	al.	FW	O	al.	dep	33	SENT_46	[p3l1159t1743r1280b1825],
36	,	,	O	,	_	0	SENT_46	[p3l1159t1743r1280b1825],
37	1999	CD	DATE	1999	appos	35	SENT_46	[p3l1327t1743r1537b1825],
38	;	:	O	;	_	0	SENT_46	[p3l1327t1743r1537b1825],
39	Perucca	NNP	PERSON	Perucca	dep	23	SENT_46	[p3l1576t1744r1891b1812],
40	er	FW	O	er	nn	41	SENT_46	[p3l1924t1756r1995b1812],
41	al.	FW	O	al.	dep	39	SENT_46	[p3l2026t1743r2148b1825],
42	,	,	O	,	_	0	SENT_46	[p3l2026t1743r2148b1825],
43	1997	CD	DATE	1997	num	44	SENT_46	[p3l17t1852r258b1937],
44	)	NN	O	)	appos	23	SENT_46	[p3l17t1852r258b1937],
45	,	,	O	,	_	0	SENT_46	[p3l17t1852r258b1937],
46	although	IN	O	although	mark	53	SENT_46	[p3l329t1852r674b1942],
47	the	DT	O	the	det	48	SENT_46	[p3l739t1852r857b1921],
48	frequency	NN	O	frequency	nsubj	53	SENT_46	[p3l924t1852r1318b1942],
49	of	IN	O	of	_	0	SENT_46	[p3l1385t1852r1470b1921],
50	such	JJ	O	such	amod	51	SENT_46	[p3l1532t1852r1709b1921],
51	events	NNS	O	event	prep_of	48	SENT_46	[p3l1775t1863r2021b1921],
52	is	VBZ	O	be	cop	53	SENT_46	[p3l2087t1852r2149b1921],
53	unclear	JJ	O	unclear	advcl	6	SENT_46	[p3l7t1959r314b2028],
54	.	.	O	.	_	0	SENT_46	[p3l7t1959r314b2028],

1	Despite	IN	O	despite	_	0	SENT_47	[p3l106t2067r408b2157],
2	such	JJ	O	such	amod	4	SENT_47	[p3l441t2067r617b2137],
3	case	NN	O	case	nn	4	SENT_47	[p3l646t2089r814b2137],
4	reports	NNS	O	report	nsubj	5	SENT_47	[p3l842t2078r1115b2157],
5	documenting	VBG	O	document	prepc_despite	14	SENT_47	[p3l1147t2067r1664b2157],
6	severe	JJ	O	severe	amod	8	SENT_47	[p3l1696t2089r1941b2137],
7	antidepressant-associated	JJ	O	antidepressant-associated	amod	8	SENT_47	[p3l1972t2067r2147b2137, p3l9t2175r870b2265],
8	ADRs	NNS	MISC	adr	dobj	5	SENT_47	[p3l909t2175r1152b2244],
9	in	IN	O	in	_	0	SENT_47	[p3l1194t2175r1270b2243],
10	CYP2D6	NN	O	cyp2d6	nn	11	SENT_47	[p3l1310t2175r1670b2245],
11	PMs	NNS	O	pm	prep_in	5	SENT_47	[p3l1710t2176r1910b2257],
12	,	,	O	,	_	0	SENT_47	[p3l1710t2176r1910b2257],
13	there	EX	O	there	expl	14	SENT_47	[p3l1954t2175r2150b2244],
14	are	VBP	O	be	_	0	SENT_47	[p3l10t2305r126b2353],
15	few	JJ	O	few	amod	17	SENT_47	[p3l167t2283r311b2353],
16	clinical	JJ	O	clinical	amod	17	SENT_47	[p3l353t2283r643b2353],
17	studies	NNS	O	study	nsubj	14	SENT_47	[p3l689t2283r956b2353],
18	examining	VBG	O	examine	partmod	17	SENT_47	[p3l1000t2283r1417b2373],
19	the	DT	O	the	det	22	SENT_47	[p3l1458t2283r1576b2353],
20	more	RBR	O	more	advmod	21	SENT_47	[p3l1618t2305r1819b2353],
21	general	JJ	O	general	amod	22	SENT_47	[p3l1861t2283r2150b2373],
22	relationship	NN	O	relationship	dobj	18	SENT_47	[p3l7t2391r475b2481],
23	between	IN	O	between	_	0	SENT_47	[p3l549t2391r881b2461],
24	the	DT	O	the	det	26	SENT_47	[p3l954t2391r1073b2461],
25	CYPZD6	NN	O	cypzd6	nn	26	SENT_47	[p3l1153t2391r1502b2462],
26	genotype	NN	O	genotype	prep_between	22	SENT_47	[p3l1574t2402r1934b2481],
27	and	CC	O	and	_	0	SENT_47	[p3l2012t2391r2152b2461],
28	ADRs	NNPS	MISC	ADRs	dobj	18	SENT_47	[p3l8t2499r250b2568],
29	(	FW	O	(	nn	30	SENT_47	[p3l281t2499r401b2584],
30	de	FW	O	de	advmod	31	SENT_47	[p3l281t2499r401b2584],
31	Leon	NNP	O	Leon	rcmod	28	SENT_47	[p3l426t2500r629b2568],
32	er	FW	O	er	nn	33	SENT_47	[p3l655t2512r726b2568],
33	al.	FW	O	al.	dep	31	SENT_47	[p3l748t2499r869b2581],
34	,	,	O	,	_	0	SENT_47	[p3l748t2499r869b2581],
35	1998	CD	DATE	1998	appos	33	SENT_47	[p3l907t2499r1117b2581],
36	;	:	O	;	_	0	SENT_47	[p3l907t2499r1117b2581],
37	Vandel	NNP	PERSON	Vandel	dep	33	SENT_47	[p3l1146t2499r1420b2568],
38	er	FW	O	er	nn	39	SENT_47	[p3l1447t2512r1519b2568],
39	al.	FW	O	al.	dep	37	SENT_47	[p3l1540t2499r1661b2581],
40	,	,	O	,	_	0	SENT_47	[p3l1540t2499r1661b2581],
41	1999	CD	DATE	1999	appos	39	SENT_47	[p3l1699t2499r1909b2581],
42	;	:	O	;	_	0	SENT_47	[p3l1699t2499r1909b2581],
43	Chou	NNP	PERSON	Chou	dep	33	SENT_47	[p3l1940t2499r2151b2569],
44	et	FW	O	et	nn	45	SENT_47	[p3l9t2620r80b2677],
45	al.	FW	O	al.	dep	43	SENT_47	[p3l110t2607r231b2689],
46	,	,	O	,	_	0	SENT_47	[p3l110t2607r231b2689],
47	2000	CD	DATE	2000	appos	45	SENT_47	[p3l269t2607r487b2689],
48	;	:	O	;	_	0	SENT_47	[p3l269t2607r487b2689],
49	Chen	NNP	PERSON	Chen	dep	33	SENT_47	[p3l526t2607r733b2677],
50	et	FW	O	et	nn	51	SENT_47	[p3l767t2620r838b2677],
51	al.	FW	O	al.	dep	49	SENT_47	[p3l869t2607r989b2689],
52	,	,	O	,	_	0	SENT_47	[p3l869t2607r989b2689],
53	1996	CD	DATE	1996	num	54	SENT_47	[p3l1035t2607r1275b2693],
54	)	NN	O	)	appos	51	SENT_47	[p3l1035t2607r1275b2693],
55	.	.	O	.	_	0	SENT_47	[p3l1035t2607r1275b2693],

1	This	DT	O	this	det	2	SENT_48	[p3l1314t2607r1485b2677],
2	study	NN	O	study	nsubj	3	SENT_48	[p3l1524t2607r1733b2697],
3	examined	VBD	O	examine	_	0	SENT_48	[p3l1767t2607r2152b2677],
4	whether	IN	O	whether	complm	9	SENT_48	[p3l8t2715r328b2785],
5	the	DT	O	the	det	8	SENT_48	[p3l351t2715r470b2785],
6	CYPZD6	NNP	O	CYPZD6	nn	8	SENT_48	[p3l502t2715r851b2786],
7	PM	NNP	O	PM	nn	8	SENT_48	[p3l873t2717r1013b2784],
8	genotype	NN	O	genotype	nsubj	9	SENT_48	[p3l1040t2726r1401b2805],
9	increased	VBD	O	increase	ccomp	3	SENT_48	[p3l1427t2715r1802b2785],
10	susceptibility	NN	O	susceptibility	dobj	9	SENT_48	[p3l1831t2726r2148b2805, p3l8t2823r243b2913],
11	to	TO	O	to	_	0	SENT_48	[p3l275t2833r349b2892],
12	ADRs	NNS	MISC	adr	prep_to	9	SENT_48	[p3l382t2823r626b2892],
13	with	IN	O	with	_	0	SENT_48	[p3l659t2823r833b2893],
14	the	DT	O	the	det	16	SENT_48	[p3l865t2823r984b2892],
15	antidepressants	NNS	O	antidepressant	nn	16	SENT_48	[p3l1018t2823r1620b2913],
16	nortriptyline	NN	O	nortriptyline	prep_with	9	SENT_48	[p3l1654t2823r2150b2913],
17	and	CC	O	and	_	0	SENT_48	[p3l10t2931r150b3001],
18	ﬂuoxetine	NN	O	ﬂuoxetine	conj_and	16	SENT_48	[p3l179t2931r595b3013],
19	,	,	O	,	_	0	SENT_48	[p3l179t2931r595b3013],
20	in	IN	O	in	_	0	SENT_48	[p3l627t2931r702b3000],
21	a	DT	O	a	det	22	SENT_48	[p3l733t2953r774b3001],
22	group	NN	O	group	prep_in	9	SENT_48	[p3l803t2953r1029b3021],
23	of	IN	O	of	_	0	SENT_48	[p3l1061t2931r1146b3001],
24	outpatients	NNS	O	outpatient	prep_of	22	SENT_48	[p3l1170t2931r1603b3021],
25	being	VBG	O	be	auxpass	26	SENT_48	[p3l1632t2931r1852b3021],
26	treated	VBN	O	treat	partmod	24	SENT_48	[p3l1881t2931r2152b3001],
27	for	IN	O	for	_	0	SENT_48	[p3l8t3039r123b3109],
28	major	JJ	O	major	amod	29	SENT_48	[p3l153t3039r385b3129],
29	depression	NN	O	depression	prep_for	26	SENT_48	[p3l417t3039r859b3129],
30	.	.	O	.	_	0	SENT_48	[p3l417t3039r859b3129],

1	MATERIALS	NNS	O	material	_	0	SENT_49	[p3l7t3309r559b3378],
2	AND	CC	O	and	_	0	SENT_49	[p3l596t3310r806b3378],
3	METHODS	NNS	O	method	conj_and	1	SENT_49	[p3l840t3309r1313b3378],

1	Subjects	NNS	O	subject	_	0	SENT_50	[p3l8t3472r338b3561],

1	Patients	NNS	O	patient	nsubj	2	SENT_51	[p4l8t47r317b117],
2	(	VBP	O	(	_	0	SENT_51	[p4l354t48r518b137],
3	age	NN	O	age	dobj	2	SENT_51	[p4l354t48r518b137],
4	18-64	CD	NUMBER	18-64	num	5	SENT_51	[p4l559t47r795b117],
5	years	NNS	NUMBER	year	tmod	2	SENT_51	[p4l826t48r1063b137],
6	)	CD	NUMBER	)	nsubjpass	8	SENT_51	[p4l826t48r1063b137],
7	were	VBD	O	be	auxpass	8	SENT_51	[p4l1097t69r1287b117],
8	included	VBN	O	include	dep	2	SENT_51	[p4l1319t47r1660b117],
9	for	IN	O	for	_	0	SENT_51	[p4l1690t47r1805b117],
10	whom	WP	O	whom	dobj	19	SENT_51	[p4l1834t47r2080b117],
11	a	DT	O	a	det	14	SENT_51	[p4l2112t69r2152b117],
12	major	JJ	O	major	amod	14	SENT_51	[p4l8t155r240b245],
13	depressive	JJ	O	depressive	amod	14	SENT_51	[p4l288t155r703b245],
14	episode	NN	O	episode	nsubj	19	SENT_51	[p4l752t155r1052b245],
15	was	VBD	O	be	cop	19	SENT_51	[p4l1101t178r1250b225],
16	the	DT	O	the	det	19	SENT_51	[p4l1301t155r1419b225],
17	current	JJ	DATE	current	amod	19	SENT_51	[p4l1470t166r1751b225],
18	principal	JJ	O	principal	amod	19	SENT_51	[p4l1797t155r2150b245],
19	diagnosis	NN	O	diagnosis	prepc_for	8	SENT_51	[p4l9t263r402b353],
20	,	,	O	,	_	0	SENT_51	[p4l9t263r402b353],
21	and	CC	O	and	_	0	SENT_51	[p4l435t263r575b333],
22	for	IN	O	for	dep	27	SENT_51	[p4l602t263r717b333],
23	whom	WP	O	whom	pobj	22	SENT_51	[p4l743t263r989b333],
24	the	DT	O	the	det	26	SENT_51	[p4l1015t263r1134b333],
25	treating	VBG	O	treat	amod	26	SENT_51	[p4l1162t263r1464b353],
26	psychiatrist	NN	O	psychiatrist	nsubj	27	SENT_51	[p4l1491t263r1951b353],
27	considered	VBN	O	consider	conj_and	8	SENT_51	[p4l1977t285r2147b333, p4l11t371r293b441],
28	that	IN	O	that	complm	34	SENT_51	[p4l323t371r472b441],
29	treatment	NN	O	treatment	nsubjpass	34	SENT_51	[p4l500t382r877b441],
30	with	IN	O	with	_	0	SENT_51	[p4l907t371r1081b441],
31	antidepressant	JJ	O	antidepressant	amod	32	SENT_51	[p4l1113t371r1680b461],
32	medication	NN	O	medication	prep_with	29	SENT_51	[p4l1709t371r2151b441],
33	was	VBD	O	be	auxpass	34	SENT_51	[p4l8t500r157b547],
34	indicated	VBN	O	indicate	ccomp	27	SENT_51	[p4l226t478r609b547],
35	.	.	O	.	_	0	SENT_51	[p4l226t478r609b547],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_52	[p4l683t478r993b547],
2	were	VBD	O	be	auxpass	3	SENT_52	[p4l1064t500r1253b547],
3	excluded	VBN	O	exclude	_	0	SENT_52	[p4l1322t478r1679b547],
4	if	IN	O	if	_	0	SENT_52	[p4l1745t478r1810b546],
5	current	JJ	DATE	current	prep_if	3	SENT_52	[p4l1872t489r2152b547],

1	Copyright	NN	O	copyright	nn	5	SENT_53	[p4l9t727r370b807],
2	©	CD	NUMBER	©	num	5	SENT_53	[p4l403t727r479b803],
3	2004	CD	DATE	2004	num	5	SENT_53	[p4l515t727r689b789],
4	John	NNP	ORGANIZATION	John	nn	5	SENT_53	[p4l719t727r886b789],
5	Wiley	NNP	ORGANIZATION	Wiley	nsubjpass	18	SENT_53	[p4l913t727r1128b807],
6	&	CC	ORGANIZATION	&	_	0	SENT_53	[p4l1160t727r1223b789],
7	Sons	NNP	ORGANIZATION	Sons	nsubjpass	18	SENT_53	[p4l1256t727r1444b800],
8	,	,	ORGANIZATION	,	_	0	SENT_53	[p4l1256t727r1444b800],
9	Ltd.	NNP	ORGANIZATION	Ltd.	appos	5	SENT_53	[p4l1476t727r1617b789],
10	moderate	JJ	O	moderate	amod	9	SENT_53	[p4l7t828r374b898],
11	to	TO	O	to	_	0	SENT_53	[p4l415t839r489b898],
12	severe	JJ	O	severe	amod	13	SENT_53	[p4l534t851r779b898],
13	alcohol	NN	O	alcohol	prep_to	10	SENT_53	[p4l821t828r1109b898],
14	or	CC	O	or	_	0	SENT_53	[p4l1151t851r1232b898],
15	drug	NN	O	drug	nn	16	SENT_53	[p4l1271t828r1448b918],
16	dependence	NN	O	dependence	prep_to	10	SENT_53	[p4l1490t828r1956b918],
17	was	VBD	O	be	auxpass	18	SENT_53	[p4l1996t851r2145b898],
18	deemed	VBN	O	deem	_	0	SENT_53	[p4l8t936r314b1006],
19	to	TO	O	to	aux	25	SENT_53	[p4l337t946r411b1006],
20	be	VB	O	be	cop	25	SENT_53	[p4l434t936r526b1006],
21	the	DT	O	the	det	25	SENT_53	[p4l550t936r669b1006],
22	principal	JJ	O	principal	amod	25	SENT_53	[p4l692t936r1044b1026],
23	current	JJ	DATE	current	amod	25	SENT_53	[p4l1069t947r1349b1006],
24	diagnosis	NN	O	diagnosis	nn	25	SENT_53	[p4l1372t936r1742b1026],
25	(	NN	O	(	xcomp	18	SENT_53	[p4l1771t936r2147b1026],
26	although	IN	O	although	mark	35	SENT_53	[p4l1771t936r2147b1026],
27	many	JJ	O	many	amod	28	SENT_53	[p4l7t1066r225b1134],
28	patients	NNS	O	patient	nsubjpass	35	SENT_53	[p4l256t1044r564b1134],
29	with	IN	O	with	_	0	SENT_53	[p4l599t1044r773b1114],
30	alcohol	NN	O	alcohol	nn	33	SENT_53	[p4l808t1044r1096b1114],
31	or	CC	O	or	_	0	SENT_53	[p4l1132t1066r1213b1114],
32	drug	NN	O	drug	conj_or	30	SENT_53	[p4l1245t1044r1422b1134],
33	dependence	NN	O	dependence	prep_with	28	SENT_53	[p4l1457t1044r1923b1134],
34	were	VBD	O	be	auxpass	35	SENT_53	[p4l1957t1066r2145b1114],
35	included	VBN	O	include	advcl	25	SENT_53	[p4l7t1152r349b1222],
36	if	IN	O	if	mark	40	SENT_53	[p4l372t1152r437b1221],
37	the	DT	O	the	det	39	SENT_53	[p4l454t1152r573b1222],
38	treating	VBG	O	treat	amod	39	SENT_53	[p4l598t1152r899b1242],
39	clinician	NN	O	clinician	nsubj	40	SENT_53	[p4l926t1152r1267b1222],
40	considered	VBN	O	consider	advcl	35	SENT_53	[p4l1292t1152r1721b1222],
41	that	IN	O	that	complm	49	SENT_53	[p4l1744t1152r1893b1222],
42	major	JJ	O	major	amod	43	SENT_53	[p4l1916t1152r2148b1242],
43	depression	NN	O	depression	nsubj	49	SENT_53	[p4l8t1260r430b1350],
44	was	VBD	O	be	cop	49	SENT_53	[p4l506t1282r655b1330],
45	the	DT	O	the	det	49	SENT_53	[p4l734t1260r853b1330],
46	principal	JJ	O	principal	amod	49	SENT_53	[p4l929t1260r1282b1350],
47	current	JJ	DATE	current	amod	49	SENT_53	[p4l1360t1271r1640b1330],
48	diagnosis	NN	O	diagnosis	nn	49	SENT_53	[p4l1717t1260r2141b1350],
49	)	NN	O	)	ccomp	40	SENT_53	[p4l1717t1260r2141b1350],
50	.	.	O	.	_	0	SENT_53	[p4l1717t1260r2141b1350],

1	Patients	NNS	O	patient	nsubjpass	4	SENT_54	[p4l7t1368r317b1438],
2	were	VBD	O	be	auxpass	4	SENT_54	[p4l359t1390r548b1438],
3	also	RB	O	also	advmod	4	SENT_54	[p4l591t1368r746b1438],
4	excluded	VBN	O	exclude	_	0	SENT_54	[p4l788t1368r1145b1438],
5	if	IN	O	if	mark	7	SENT_54	[p4l1184t1368r1249b1437],
6	they	PRP	O	they	nsubj	7	SENT_54	[p4l1282t1368r1450b1458],
7	had	VBD	O	have	advcl	4	SENT_54	[p4l1490t1368r1632b1438],
8	a	DT	O	a	det	9	SENT_54	[p4l1674t1390r1714b1438],
9	history	NN	O	history	dobj	7	SENT_54	[p4l1752t1368r2026b1458],
10	of	IN	O	of	_	0	SENT_54	[p4l2068t1368r2153b1438],
11	mania	NN	O	mania	prep_of	9	SENT_54	[p4l7t1476r249b1546],
12	(	CD	NUMBER	(	num	11	SENT_54	[p4l281t1476r436b1563],
13	but	CC	O	but	_	0	SENT_54	[p4l281t1476r436b1563],
14	not	RB	O	not	_	0	SENT_54	[p4l463t1487r589b1546],
15	hypomania	NN	O	hypomanium	conj_negcc	9	SENT_54	[p4l617t1476r1088b1566],
16	)	CD	NUMBER	)	num	15	SENT_54	[p4l617t1476r1088b1566],
17	or	CC	O	or	_	0	SENT_54	[p4l1121t1499r1202b1546],
18	schizophrenia	NN	O	schizophrenia	conj_negcc	9	SENT_54	[p4l1233t1476r1801b1566],
19	.	.	O	.	_	0	SENT_54	[p4l1233t1476r1801b1566],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_55	[p4l1835t1476r2144b1546],
2	were	VBD	O	be	auxpass	3	SENT_55	[p4l7t1606r196b1654],
3	required	VBN	O	require	_	0	SENT_55	[p4l227t1584r558b1674],
4	to	TO	O	to	aux	6	SENT_55	[p4l587t1595r661b1654],
5	be	VB	O	be	cop	6	SENT_55	[p4l690t1584r782b1654],
6	free	JJ	O	free	ccomp	3	SENT_55	[p4l813t1584r964b1654],
7	of	IN	O	of	_	0	SENT_55	[p4l996t1584r1082b1654],
8	any	DT	O	any	det	11	SENT_55	[p4l1107t1606r1245b1674],
9	major	JJ	O	major	amod	11	SENT_55	[p4l1275t1584r1507b1674],
10	physical	JJ	O	physical	amod	11	SENT_55	[p4l1534t1584r1864b1674],
11	illness	NN	O	illness	prep_of	6	SENT_55	[p4l1895t1584r2144b1654],
12	and	CC	O	and	_	0	SENT_55	[p4l9t1692r148b1762],
13	to	TO	O	to	aux	15	SENT_55	[p4l181t1703r255b1762],
14	be	VB	O	be	cop	15	SENT_55	[p4l288t1692r380b1762],
15	free	JJ	O	free	conj_and	6	SENT_55	[p4l415t1692r566b1762],
16	of	IN	O	of	_	0	SENT_55	[p4l602t1692r687b1762],
17	prescribed	VBN	O	prescribe	prepc_of	15	SENT_55	[p4l713t1692r1127b1782],
18	psychotropic	JJ	O	psychotropic	amod	19	SENT_55	[p4l1159t1692r1669b1782],
19	medication	NN	O	medication	dobj	17	SENT_55	[p4l1705t1692r2146b1762],
20	for	IN	O	for	_	0	SENT_55	[p4l7t1800r122b1870],
21	a	DT	O	a	det	22	SENT_55	[p4l158t1823r199b1870],
22	minimum	NN	O	minimum	prep_for	19	SENT_55	[p4l233t1800r619b1870],
23	of	IN	O	of	_	0	SENT_55	[p4l656t1800r741b1870],
24	2	CD	DURATION	2	num	25	SENT_55	[p4l772t1801r816b1869],
25	weeks	NNS	NUMBER	week	prep_of	22	SENT_55	[p4l853t1800r1119b1883],
26	,	,	O	,	_	0	SENT_55	[p4l853t1800r1119b1883],
27	except	IN	O	except	_	0	SENT_55	[p4l1160t1811r1417b1890],
28	for	IN	O	for	prepc_except_for	17	SENT_55	[p4l1452t1800r1567b1870],
29	an	DT	O	a	det	33	SENT_55	[p4l1603t1823r1692b1870],
30	occasional	JJ	O	occasional	amod	33	SENT_55	[p4l1729t1800r2146b1870],
31	hypnotic	JJ	O	hypnotic	amod	33	SENT_55	[p4l6t1907r351b1998],
32	for	IN	O	for	prep	31	SENT_55	[p4l388t1908r503b1977],
33	sleep	NN	O	sleep	pobj	17	SENT_55	[p4l539t1908r757b1998],
34	.	.	O	.	_	0	SENT_55	[p4l539t1908r757b1998],

1	After	IN	O	after	_	0	SENT_56	[p4l797t1907r1006b1977],
2	giving	VBG	O	give	prepc_after	75	SENT_56	[p4l1040t1908r1287b1998],
3	consent	NN	O	consent	dobj	2	SENT_56	[p4l1324t1918r1646b1990],
4	,	,	O	,	_	0	SENT_56	[p4l1324t1918r1646b1990],
5	the	DT	O	the	det	6	SENT_56	[p4l1684t1908r1803b1977],
6	patients	NNS	O	patient	nsubj	7	SENT_56	[p4l1838t1908r2144b1998],
7	attended	VBD	O	attend	dep	2	SENT_56	[p4l9t2016r343b2086],
8	for	IN	O	for	_	0	SENT_56	[p4l389t2016r504b2086],
9	a	DT	O	a	det	14	SENT_56	[p4l550t2039r591b2086],
10	detailed	JJ	O	detailed	amod	14	SENT_56	[p4l638t2016r950b2086],
11	clinical	JJ	O	clinical	amod	14	SENT_56	[p4l998t2016r1288b2086],
12	and	CC	O	and	_	0	SENT_56	[p4l1338t2016r1477b2086],
13	neurobiological	JJ	O	neurobiological	conj_and	11	SENT_56	[p4l1523t2016r2146b2106],
14	assessment	NN	O	assessment	prep_for	7	SENT_56	[p4l9t2134r447b2193],
15	including	VBG	O	include	_	0	SENT_56	[p4l475t2123r848b2214],
16	the	DT	O	the	det	19	SENT_56	[p4l879t2124r997b2193],
17	structured	JJ	O	structured	amod	19	SENT_56	[p4l1031t2124r1424b2193],
18	clinical	JJ	O	clinical	amod	19	SENT_56	[p4l1454t2124r1745b2193],
19	interview	NN	O	interview	prep_including	14	SENT_56	[p4l1774t2124r2146b2194],
20	for	IN	O	for	_	0	SENT_56	[p4l7t2232r122b2301],
21	DSM	NNP	ORGANIZATION	DSM	nn	23	SENT_56	[p4l147t2232r358b2301],
22	(	CD	NUMBER	(	num	23	SENT_56	[p4l389t2232r673b2317],
23	SCID	NN	O	scid	prep_for	19	SENT_56	[p4l389t2232r673b2317],
24	)	NN	O	)	nn	26	SENT_56	[p4l389t2232r673b2317],
25	(	CD	NUMBER	(	num	26	SENT_56	[p4l706t2232r1018b2322],
26	Spitzer	NNP	PERSON	Spitzer	dep	19	SENT_56	[p4l706t2232r1018b2322],
27	et	FW	O	et	nn	28	SENT_56	[p4l1041t2245r1112b2301],
28	al.	FW	O	al.	dep	26	SENT_56	[p4l1137t2232r1258b2314],
29	,	,	O	,	_	0	SENT_56	[p4l1137t2232r1258b2314],
30	1992	CD	DATE	1992	num	31	SENT_56	[p4l1298t2232r1515b2317],
31	)	NN	O	)	appos	19	SENT_56	[p4l1298t2232r1515b2317],
32	and	CC	O	and	_	0	SENT_56	[p4l1547t2232r1687b2301],
33	for	IN	O	for	mark	41	SENT_56	[p4l1714t2232r1828b2301],
34	clinical	JJ	O	clinical	amod	35	SENT_56	[p4l1855t2232r2146b2301],
35	ratings	NNS	O	rating	nsubj	41	SENT_56	[p4l6t2340r273b2430],
36	on	IN	O	on	_	0	SENT_56	[p4l325t2363r421b2410],
37	the	DT	O	the	det	40	SENT_56	[p4l469t2340r588b2410],
38	Hamilton	NNP	PERSON	Hamilton	nn	40	SENT_56	[p4l638t2340r1011b2410],
39	(	CD	NUMBER	(	num	40	SENT_56	[p4l1064t2341r1384b2426],
40	HDRS	NNS	O	hdr	prep_on	35	SENT_56	[p4l1064t2341r1384b2426],
41	)	VBP	O	)	dep	2	SENT_56	[p4l1064t2341r1384b2426],
42	(	CD	NUMBER	(	num	43	SENT_56	[p4l1440t2340r1865b2426],
43	Hamilton	NNP	LOCATION	Hamilton	dobj	41	SENT_56	[p4l1440t2340r1865b2426],
44	,	,	O	,	_	0	SENT_56	[p4l1440t2340r1865b2426],
45	1960	CD	DATE	1960	appos	43	SENT_56	[p4l1927t2340r2143b2426],
46	)	CD	NUMBER	)	number	47	SENT_56	[p4l1927t2340r2143b2426],
47	(	CD	NUMBER	(	dep	45	SENT_56	[p4l10t2449r253b2533],
48	mean	NN	O	mean	nn	51	SENT_56	[p4l10t2449r253b2533],
49	17	CD	NUMBER	17	num	51	SENT_56	[p4l315t2448r399b2517],
50	item	NN	O	item	nn	51	SENT_56	[p4l456t2448r632b2517],
51	score	NN	NUMBER	score	dep	41	SENT_56	[p4l688t2470r891b2517],
52	19.9	CD	NUMBER	19.9	dep	51	SENT_56	[p4l953t2448r1380b2533],
53	:	:	O	:	_	0	SENT_56	[p4l953t2448r1380b2533],
54	|	CD	NUMBER	|	number	55	SENT_56	[p4l953t2448r1380b2533],
55	:4.4	CD	NUMBER	:4.4	num	56	SENT_56	[p4l953t2448r1380b2533],
56	)	NN	O	)	dep	51	SENT_56	[p4l953t2448r1380b2533],
57	and	CC	O	and	_	0	SENT_56	[p4l1437t2448r1577b2517],
58	Montgomery	NNP	PERSON	Montgomery	nn	62	SENT_56	[p4l1629t2449r2146b2538],
59	and	CC	O	and	_	0	SENT_56	[p4l9t2556r148b2625],
60	Asberg	NNP	PERSON	Asberg	nn	62	SENT_56	[p4l208t2556r490b2646],
61	(	CD	NUMBER	(	num	62	SENT_56	[p4l554t2556r963b2641],
62	MADRS	NNP	O	MADRS	dep	51	SENT_56	[p4l554t2556r963b2641],
63	)	CD	NUMBER	)	number	64	SENT_56	[p4l554t2556r963b2641],
64	(	CD	NUMBER	(	num	65	SENT_56	[p4l1031t2557r1576b2646],
65	Montgomery	NNP	PERSON	Montgomery	dep	62	SENT_56	[p4l1031t2557r1576b2646],
66	and	CC	O	and	_	0	SENT_56	[p4l1639t2556r1779b2625],
67	Asberg	NNP	LOCATION	Asberg	dep	51	SENT_56	[p4l1839t2556r2143b2646],
68	,	,	O	,	_	0	SENT_56	[p4l1839t2556r2143b2646],
69	1979	CD	DATE	1979	num	73	SENT_56	[p4l16t2665r232b2750],
70	)	CD	NUMBER	)	num	73	SENT_56	[p4l16t2665r232b2750],
71	depression	NN	O	depression	nn	73	SENT_56	[p4l273t2664r694b2754],
72	rating	NN	O	rating	nn	73	SENT_56	[p4l730t2664r960b2754],
73	scales	NNS	O	scale	appos	67	SENT_56	[p4l1002t2664r1231b2734],
74	(	FW	O	(	nsubj	75	SENT_56	[p4l1273t2665r1517b2750],
75	mean	VB	O	mean	_	0	SENT_56	[p4l1273t2665r1517b2750],
76	MADRS	JJ	O	madrs	amod	77	SENT_56	[p4l1553t2665r1898b2734],
77	score	NN	NUMBER	score	dobj	75	SENT_56	[p4l1943t2687r2146b2734],
78	31.0	CD	NUMBER	31.0	num	80	SENT_56	[p4l9t2772r177b2841],
79	:	:	O	:	_	0	SENT_56	[p4l201t2773r267b2840],
80	|	CD	NUMBER	|	dep	77	SENT_56	[p4l201t2773r267b2840],
81	:	:	O	:	_	0	SENT_56	[p4l201t2773r267b2840],
82	6.6	CD	NUMBER	6.6	num	83	SENT_56	[p4l292t2771r464b2857],
83	)	NN	O	)	dep	77	SENT_56	[p4l292t2771r464b2857],
84	.	.	O	.	_	0	SENT_56	[p4l292t2771r464b2857],

1	During	IN	O	during	_	0	SENT_57	[p4l106t2880r383b2970],
2	assessment	NN	O	assessment	prep_during	10	SENT_57	[p4l424t2890r882b2962],
3	,	,	O	,	_	0	SENT_57	[p4l424t2890r882b2962],
4	10	CD	NUMBER	10	num	5	SENT_57	[p4l932t2880r1018b2950],
5	ml	NN	O	ml	nsubjpass	10	SENT_57	[p4l1038t2880r1140b2948],
6	of	IN	O	of	_	0	SENT_57	[p4l1180t2880r1265b2949],
7	peripheral	JJ	O	peripheral	amod	8	SENT_57	[p4l1294t2880r1697b2970],
8	blood	NN	O	blood	prep_of	5	SENT_57	[p4l1733t2880r1959b2949],
9	was	VBD	O	be	auxpass	10	SENT_57	[p4l1996t2902r2145b2950],
10	drawn	VBN	O	draw	_	0	SENT_57	[p4l8t2988r252b3058],
11	from	IN	O	from	_	0	SENT_57	[p4l283t2988r474b3058],
12	each	DT	O	each	det	13	SENT_57	[p4l505t2988r685b3058],
13	subject	NN	O	subject	prep_from	10	SENT_57	[p4l719t2988r996b3078],
14	for	IN	O	for	_	0	SENT_57	[p4l1026t2988r1141b3058],
15	DNA	NN	O	dna	nn	16	SENT_57	[p4l1171t2989r1380b3058],
16	analysis	NN	O	analysis	prep_for	13	SENT_57	[p4l1412t2988r1748b3078],
17	.	.	O	.	_	0	SENT_57	[p4l1412t2988r1748b3078],

1	Genomic	JJ	O	genomic	amod	2	SENT_58	[p4l1786t2988r2144b3058],
2	DNA	NN	O	dna	nsubjpass	4	SENT_58	[p4l7t3096r215b3165],
3	was	VBD	O	be	auxpass	4	SENT_58	[p4l296t3118r445b3166],
4	extracted	VBN	O	extract	_	0	SENT_58	[p4l535t3096r898b3165],
5	from	IN	O	from	_	0	SENT_58	[p4l986t3095r1177b3165],
6	peripheral	JJ	O	peripheral	amod	7	SENT_58	[p4l1263t3096r1666b3186],
7	blood	NN	O	blood	prep_from	4	SENT_58	[p4l1753t3096r1979b3165],
8	as	IN	O	as	amod	7	SENT_58	[p4l2069t3118r2145b3165],
9	described	VBN	O	describe	partmod	7	SENT_58	[p4l8t3204r386b3273],
10	previously	RB	DATE	previously	advmod	12	SENT_58	[p4l442t3204r858b3294],
11	(	CD	NUMBER	(	num	12	SENT_58	[p4l920t3204r1192b3289],
12	Ciulla	NNP	PERSON	Ciulla	dobj	9	SENT_58	[p4l920t3204r1192b3289],
13	et	FW	O	et	nn	14	SENT_58	[p4l1251t3217r1322b3273],
14	al.	FW	O	al.	dep	12	SENT_58	[p4l1376t3204r1497b3286],
15	,	,	O	,	_	0	SENT_58	[p4l1376t3204r1497b3286],
16	1988	CD	DATE	1988	appos	14	SENT_58	[p4l1568t3204r1778b3286],
17	;	:	O	;	_	0	SENT_58	[p4l1568t3204r1778b3286],
18	Roberts	NNP	PERSON	Roberts	dep	14	SENT_58	[p4l1840t3204r2144b3273],
19	et	FW	O	et	nn	20	SENT_58	[p4l8t3325r79b3382],
20	al.	FW	O	al.	dep	18	SENT_58	[p4l163t3312r284b3394],
21	,	,	O	,	_	0	SENT_58	[p4l163t3312r284b3394],
22	2002	CD	DATE	2002	num	23	SENT_58	[p4l376t3312r623b3397],
23	)	NN	O	)	appos	12	SENT_58	[p4l376t3312r623b3397],
24	.	.	O	.	_	0	SENT_58	[p4l376t3312r623b3397],

1	Following	VBG	O	follow	_	0	SENT_59	[p4l715t3312r1117b3402],
2	assessment	NN	O	assessment	prep_following	7	SENT_59	[p4l1208t3322r1667b3394],
3	,	,	O	,	_	0	SENT_59	[p4l1208t3322r1667b3394],
4	depressed	JJ	O	depressed	amod	5	SENT_59	[p4l1758t3312r2147b3402],
5	patients	NNS	O	patient	nsubjpass	7	SENT_59	[p4l6t3420r312b3510],
6	were	VBD	O	be	auxpass	7	SENT_59	[p4l369t3442r558b3489],
7	randomized	VBN	O	randomize	_	0	SENT_59	[p4l612t3420r1082b3489],
8	to	TO	O	to	_	0	SENT_59	[p4l1136t3430r1209b3489],
9	treatment	NN	O	treatment	prep_to	7	SENT_59	[p4l1264t3430r1641b3489],
10	with	IN	O	with	prep	7	SENT_59	[p4l1694t3420r1868b3489],
11	either	CC	O	either	dep	10	SENT_59	[p4l1922t3420r2147b3489],
12	ﬂuoxetine	NN	O	ﬂuoxetine	conj	10	SENT_59	[p4l8t3528r401b3597],
13	or	CC	O	or	_	0	SENT_59	[p4l426t3550r507b3597],
14	nortriptyline	NN	O	nortriptyline	conj	10	SENT_59	[p4l529t3528r1044b3618],
15	.	.	O	.	_	0	SENT_59	[p4l529t3528r1044b3618],

1	More	JJR	O	more	amod	2	SENT_60	[p4l1073t3529r1285b3597],
2	details	NNS	O	detail	nsubjpass	13	SENT_60	[p4l1311t3528r1565b3597],
3	on	IN	O	on	_	0	SENT_60	[p4l1593t3550r1688b3597],
4	the	DT	O	the	det	6	SENT_60	[p4l1711t3528r1830b3597],
5	clinical	JJ	O	clinical	amod	6	SENT_60	[p4l1855t3528r2146b3597],
6	assessment	NN	O	assessment	prep_on	2	SENT_60	[p4l9t3647r447b3706],
7	and	CC	O	and	_	0	SENT_60	[p4l527t3636r667b3706],
8	treatment	NN	O	treatment	prep_on	2	SENT_60	[p4l745t3646r1122b3706],
9	of	IN	O	of	_	0	SENT_60	[p4l1201t3636r1286b3706],
10	these	DT	O	these	det	11	SENT_60	[p4l1358t3636r1561b3706],
11	patients	NNS	O	patient	prep_of	6	SENT_60	[p4l1639t3636r1945b3726],
12	are	VBP	O	be	auxpass	13	SENT_60	[p4l2030t3658r2146b3706],
13	included	VBN	O	include	_	0	SENT_60	[p5l7t16r349b85],
14	in	IN	O	in	_	0	SENT_60	[p5l374t16r449b84],
15	other	JJ	O	other	amod	16	SENT_60	[p5l477t16r680b85],
16	papers	NNS	O	papers	prep_in	13	SENT_60	[p5l704t38r959b106],
17	arising	VBG	O	arise	partmod	16	SENT_60	[p5l990t16r1256b106],
18	from	IN	O	from	_	0	SENT_60	[p5l1284t16r1475b85],
19	this	DT	O	this	det	21	SENT_60	[p5l1502t16r1641b85],
20	clinical	JJ	O	clinical	amod	21	SENT_60	[p5l1670t16r1960b85],
21	trial	NN	O	trial	prep_from	17	SENT_60	[p5l1988t15r2146b85],
22	(	CD	NUMBER	(	num	23	SENT_60	[p5l10t124r288b209],
23	Carter	NNP	PERSON	Carter	dep	21	SENT_60	[p5l10t124r288b209],
24	et	FW	O	et	nn	25	SENT_60	[p5l327t137r398b193],
25	al.	FW	O	al.	dep	21	SENT_60	[p5l437t124r558b206],
26	,	,	O	,	_	0	SENT_60	[p5l437t124r558b206],
27	2000	CD	DATE	2000	appos	25	SENT_60	[p5l606t124r824b206],
28	;	:	O	;	_	0	SENT_60	[p5l606t124r824b206],
29	Joyce	NNP	PERSON	Joyce	dep	25	SENT_60	[p5l871t125r1093b214],
30	et	FW	O	et	nn	31	SENT_60	[p5l1138t137r1209b193],
31	al.	FW	O	al.	dep	29	SENT_60	[p5l1249t124r1370b206],
32	,	,	O	,	_	0	SENT_60	[p5l1249t124r1370b206],
33	2002	CD	DATE	2002	appos	31	SENT_60	[p5l1417t124r1635b206],
34	;	:	O	;	_	0	SENT_60	[p5l1417t124r1635b206],
35	Luty	NNP	O	Luty	dep	25	SENT_60	[p5l1682t125r1866b214],
36	er	FW	O	er	nn	37	SENT_60	[p5l1911t137r1983b193],
37	al.	FW	O	al.	dep	35	SENT_60	[p5l2022t124r2143b206],
38	,	,	O	,	_	0	SENT_60	[p5l2022t124r2143b206],
39	2002	CD	DATE	2002	num	40	SENT_60	[p5l8t232r255b317],
40	)	NN	O	)	appos	21	SENT_60	[p5l8t232r255b317],
41	.	.	O	.	_	0	SENT_60	[p5l8t232r255b317],

1	All	DT	O	all	det	2	SENT_61	[p5l306t232r430b301],
2	patients	NNS	O	patient	nsubj	3	SENT_61	[p5l476t232r782b322],
3	gave	VBD	O	give	_	0	SENT_61	[p5l831t254r1012b322],
4	informed	VBN	O	inform	amod	5	SENT_61	[p5l1060t232r1423b302],
5	consent	NN	O	consent	dobj	3	SENT_61	[p5l1469t243r1791b314],
6	,	,	O	,	_	0	SENT_61	[p5l1469t243r1791b314],
7	and	CC	O	and	_	0	SENT_61	[p5l1842t232r1982b302],
8	the	DT	O	the	det	9	SENT_61	[p5l2027t232r2145b302],
9	study	NN	O	study	nsubjpass	11	SENT_61	[p5l10t340r219b430],
10	was	VBD	O	be	auxpass	11	SENT_61	[p5l259t362r409b409],
11	approved	VBN	O	approve	conj_and	3	SENT_61	[p5l453t340r817b430],
12	by	IN	O	by	_	0	SENT_61	[p5l855t340r952b430],
13	the	DT	O	the	det	16	SENT_61	[p5l992t340r1111b409],
14	Canterbury	NNP	ORGANIZATION	Canterbury	nn	16	SENT_61	[p5l1153t340r1596b430],
15	Ethics	NNPS	ORGANIZATION	Ethics	nn	16	SENT_61	[p5l1635t340r1881b409],
16	Committee	NNP	ORGANIZATION	Committee	agent	11	SENT_61	[p5l1924t340r2143b410, p5l7t448r276b530],
17	,	,	O	,	_	0	SENT_61	[p5l1924t340r2143b410, p5l7t448r276b530],
18	Christchurch	NNP	LOCATION	Christchurch	appos	16	SENT_61	[p5l326t448r858b530],
19	,	,	O	,	_	0	SENT_61	[p5l326t448r858b530],
20	New	NNP	LOCATION	New	nn	21	SENT_61	[p5l907t449r1090b518],
21	Zealand	NNP	LOCATION	Zealand	appos	18	SENT_61	[p5l1136t448r1474b517],
22	.	.	O	.	_	0	SENT_61	[p5l1136t448r1474b517],

1	Of	IN	O	of	_	0	SENT_62	[p5l1528t448r1634b518],
2	the	DT	O	the	det	3	SENT_62	[p5l1674t448r1792b517],
3	patients	NNS	O	patient	prep_of	13	SENT_62	[p5l1838t448r2144b538],
4	recruited	VBN	O	recruit	partmod	3	SENT_62	[p5l6t556r359b626],
5	for	IN	O	for	_	0	SENT_62	[p5l392t556r506b626],
6	this	DT	O	this	det	7	SENT_62	[p5l536t556r675b626],
7	study	NN	O	study	prep_for	4	SENT_62	[p5l713t556r921b646],
8	96	CD	PERCENT	96	num	9	SENT_62	[p5l957t556r1130b627],
9	%	NN	PERCENT	%	nsubj	13	SENT_62	[p5l957t556r1130b627],
10	were	VBD	O	be	cop	13	SENT_62	[p5l1167t578r1356b626],
11	New	NNP	O	New	nn	13	SENT_62	[p5l1389t558r1571b626],
12	Zealand	NNP	O	Zealand	nn	13	SENT_62	[p5l1603t556r1924b626],
13	Caucasians	NNPS	MISC	Caucasians	_	0	SENT_62	[p5l1957t556r2143b626, p5l8t663r312b732],
14	.	.	O	.	_	0	SENT_62	[p5l1957t556r2143b626, p5l8t663r312b732],

1	Following	VBG	O	follow	_	0	SENT_63	[p5l106t771r507b861],
2	randomization	NN	O	randomization	prep_following	6	SENT_63	[p5l562t771r1137b840],
3	the	DT	O	the	det	4	SENT_63	[p5l1191t771r1310b840],
4	patients	NNS	O	patient	nsubjpass	6	SENT_63	[p5l1363t771r1670b861],
5	were	VBD	O	be	auxpass	6	SENT_63	[p5l1728t793r1917b840],
6	seen	VBN	O	see	_	0	SENT_63	[p5l1976t793r2146b840],
7	regularly	RB	O	regularly	advmod	6	SENT_63	[p5l6t879r378b969],
8	,	,	O	,	_	0	SENT_63	[p5l6t879r378b969],
9	initially	RB	O	initially	advmod	7	SENT_63	[p5l414t879r723b969],
10	at	IN	O	at	advmod	7	SENT_63	[p5l758t890r827b949],
11	least	JJS	O	least	pobj	10	SENT_63	[p5l858t879r1040b949],
12	weekly	JJ	SET	weekly	dobj	6	SENT_63	[p5l1072t879r1372b969],
13	,	,	O	,	_	0	SENT_63	[p5l1072t879r1372b969],
14	to	TO	O	to	aux	15	SENT_63	[p5l1407t890r1482b949],
15	optimize	VB	O	optimize	xcomp	6	SENT_63	[p5l1516t879r1862b969],
16	potential	JJ	O	potential	amod	17	SENT_63	[p5l1894t890r2143b969, p5l7t987r132b1057],
17	beneﬁts	NNS	O	beneﬁts	dobj	15	SENT_63	[p5l163t987r469b1057],
18	of	IN	O	of	_	0	SENT_63	[p5l504t987r589b1057],
19	the	DT	O	the	det	21	SENT_63	[p5l616t987r734b1057],
20	antidepressant	JJ	O	antidepressant	amod	21	SENT_63	[p5l769t987r1336b1077],
21	medication	NN	O	medication	prep_of	17	SENT_63	[p5l1368t987r1829b1069],
22	,	,	O	,	_	0	SENT_63	[p5l1368t987r1829b1069],
23	including	VBG	O	include	_	0	SENT_63	[p5l1866t987r2143b1057, p5l7t1095r130b1185],
24	adjustments	NNS	O	adjustment	prep_including	6	SENT_63	[p5l202t1095r671b1185],
25	of	IN	O	of	_	0	SENT_63	[p5l743t1095r829b1164],
26	antidepressant	JJ	O	antidepressant	amod	27	SENT_63	[p5l894t1095r1459b1185],
27	dosage	NN	O	dosage	prep_of	24	SENT_63	[p5l1528t1095r1821b1185],
28	.	.	O	.	_	0	SENT_63	[p5l1528t1095r1821b1185],

1	If	IN	O	if	mark	5	SENT_64	[p5l1895t1095r1965b1163],
2	the	DT	O	the	det	3	SENT_64	[p5l2027t1095r2146b1164],
3	patients	NNS	O	patient	nsubjpass	5	SENT_64	[p5l6t1203r312b1293],
4	were	VBD	O	be	auxpass	5	SENT_64	[p5l349t1225r538b1273],
5	randomized	VBN	O	randomize	advcl	11	SENT_64	[p5l571t1203r1041b1273],
6	to	TO	O	to	_	0	SENT_64	[p5l1074t1214r1148b1273],
7	ﬂuoxetine	NN	O	ﬂuoxetine	prep_to	5	SENT_64	[p5l1185t1203r1599b1285],
8	,	,	O	,	_	0	SENT_64	[p5l1185t1203r1599b1285],
9	they	PRP	O	they	nsubj	11	SENT_64	[p5l1637t1203r1803b1293],
10	initially	RB	O	initially	advmod	11	SENT_64	[p5l1838t1203r2145b1293],
11	received	VBD	O	receive	_	0	SENT_64	[p5l6t1311r341b1381],
12	20	CD	NUMBER	20	num	13	SENT_64	[p5l369t1312r464b1381],
13	mg	NN	O	mg	dobj	11	SENT_64	[p5l484t1333r607b1401],
14	per	IN	O	per	_	0	SENT_64	[p5l637t1333r764b1401],
15	day	NN	DURATION	day	prep_per	13	SENT_64	[p5l792t1311r932b1401],
16	for	IN	O	for	_	0	SENT_64	[p5l962t1311r1076b1381],
17	a	DT	O	a	det	18	SENT_64	[p5l1106t1333r1146b1381],
18	period	NN	O	period	prep_for	11	SENT_64	[p5l1173t1311r1426b1401],
19	of	IN	O	of	_	0	SENT_64	[p5l1456t1311r1542b1381],
20	3	CD	DURATION	3	num	21	SENT_64	[p5l1567t1312r1606b1381],
21	weeks	NNS	NUMBER	week	prep_of	18	SENT_64	[p5l1640t1311r1906b1381],
22	.	.	O	.	_	0	SENT_64	[p5l1640t1311r1906b1381],

1	After	IN	O	after	_	0	SENT_65	[p5l1939t1311r2148b1381],
2	this	DT	O	this	prep_after	7	SENT_65	[p5l7t1419r169b1501],
3	,	,	O	,	_	0	SENT_65	[p5l7t1419r169b1501],
4	the	DT	O	the	det	5	SENT_65	[p5l208t1419r326b1488],
5	clinician	NN	O	clinician	nsubj	7	SENT_65	[p5l364t1419r705b1488],
6	could	MD	O	could	aux	7	SENT_65	[p5l742t1419r960b1488],
7	vary	VB	O	vary	_	0	SENT_65	[p5l995t1441r1166b1509],
8	the	DT	O	the	det	9	SENT_65	[p5l1202t1419r1320b1488],
9	dosage	NN	O	dosage	dobj	7	SENT_65	[p5l1358t1419r1652b1509],
10	,	,	O	,	_	0	SENT_65	[p5l1358t1419r1652b1509],
11	based	VBN	O	base	partmod	9	SENT_65	[p5l1690t1419r1915b1488],
12	upon	IN	O	upon	_	0	SENT_65	[p5l1950t1441r2147b1509],
13	clinical	JJ	O	clinical	amod	14	SENT_65	[p5l8t1527r298b1597],
14	response	NN	O	response	prep_upon	11	SENT_65	[p5l346t1549r691b1617],
15	and	CC	O	and	_	0	SENT_65	[p5l742t1527r882b1597],
16	side	JJ	O	side	amod	17	SENT_65	[p5l933t1527r1086b1597],
17	effects	NNS	O	effect	conj_and	14	SENT_65	[p5l1136t1527r1416b1597],
18	.	.	O	.	_	0	SENT_65	[p5l1136t1527r1416b1597],

1	At	IN	O	at	_	0	SENT_66	[p5l1469t1528r1567b1597],
2	6	CD	DURATION	6	num	3	SENT_66	[p5l1615t1527r1659b1597],
3	weeks	NNS	NUMBER	week	prep_at	11	SENT_66	[p5l1709t1527r1975b1609],
4	,	,	O	,	_	0	SENT_66	[p5l1709t1527r1975b1609],
5	the	DT	O	the	det	8	SENT_66	[p5l2027t1527r2146b1597],
6	mean	NN	O	mean	nn	8	SENT_66	[p5l7t1657r220b1705],
7	ﬂuoxetine	NN	O	ﬂuoxetine	nn	8	SENT_66	[p5l275t1635r667b1705],
8	dose	NN	O	dose	nsubj	11	SENT_66	[p5l722t1635r899b1705],
9	was	VBD	O	be	cop	11	SENT_66	[p5l952t1657r1100b1705],
10	28	CD	NUMBER	28	num	11	SENT_66	[p5l1157t1636r1249b1705],
11	mg	NN	O	mg	_	0	SENT_66	[p5l1271t1657r1417b1725],
12	,	,	O	,	_	0	SENT_66	[p5l1271t1657r1417b1725],
13	with	IN	O	with	_	0	SENT_66	[p5l1474t1635r1648b1705],
14	a	DT	O	a	det	15	SENT_66	[p5l1703t1657r1743b1705],
15	range	NN	O	range	prep_with	11	SENT_66	[p5l1793t1657r2012b1725],
16	of	IN	O	of	_	0	SENT_66	[p5l2068t1635r2153b1705],
17	10-80	CD	NUMBER	10-80	num	18	SENT_66	[p5l16t1743r251b1813],
18	mg	NN	O	mg	prep_of	15	SENT_66	[p5l271t1765r417b1833],
19	,	,	O	,	_	0	SENT_66	[p5l271t1765r417b1833],
20	and	CC	O	and	_	0	SENT_66	[p5l457t1743r596b1813],
21	20	CD	NUMBER	20	num	22	SENT_66	[p5l632t1743r726b1813],
22	mg	NN	O	mg	nsubj	27	SENT_66	[p5l746t1765r870b1833],
23	was	VBD	O	be	cop	27	SENT_66	[p5l905t1765r1054b1813],
24	the	DT	O	the	det	27	SENT_66	[p5l1090t1743r1208b1813],
25	most	RBS	O	most	advmod	26	SENT_66	[p5l1244t1753r1435b1813],
26	common	JJ	O	common	amod	27	SENT_66	[p5l1469t1765r1814b1813],
27	dosage	NN	O	dosage	conj_and	11	SENT_66	[p5l1849t1743r2141b1833],
28	.	.	O	.	_	0	SENT_66	[p5l1849t1743r2141b1833],

1	If	IN	O	if	mark	5	SENT_67	[p5l7t1851r77b1920],
2	the	DT	O	the	det	3	SENT_67	[p5l103t1851r221b1921],
3	patients	NNS	O	patient	nsubjpass	5	SENT_67	[p5l253t1851r560b1941],
4	were	VBD	O	be	auxpass	5	SENT_67	[p5l595t1873r784b1921],
5	randomized	VBN	O	randomize	advcl	10	SENT_67	[p5l816t1851r1286b1921],
6	to	TO	O	to	_	0	SENT_67	[p5l1318t1862r1392b1921],
7	nortriptyline	NN	O	nortriptyline	prep_to	5	SENT_67	[p5l1425t1851r1942b1941],
8	,	,	O	,	_	0	SENT_67	[p5l1425t1851r1942b1941],
9	they	PRP	O	they	nsubj	10	SENT_67	[p5l1978t1851r2146b1941],
10	received	VBD	O	receive	_	0	SENT_67	[p5l6t1959r341b2029],
11	25	CD	NUMBER	25	num	12	SENT_67	[p5l376t1959r467b2029],
12	mg	NN	O	mg	dobj	10	SENT_67	[p5l491t1981r636b2049],
13	,	,	O	,	_	0	SENT_67	[p5l491t1981r636b2049],
14	50	CD	NUMBER	50	num	15	SENT_67	[p5l677t1959r772b2029],
15	mg	NN	O	mg	conj_and	12	SENT_67	[p5l791t1981r937b2049],
16	,	,	O	,	_	0	SENT_67	[p5l791t1981r937b2049],
17	and	CC	O	and	_	0	SENT_67	[p5l978t1959r1118b2029],
18	then	RB	O	then	advmod	20	SENT_67	[p5l1153t1959r1322b2029],
19	75	CD	NUMBER	75	num	20	SENT_67	[p5l1358t1959r1449b2029],
20	mg	NN	O	mg	conj_and	12	SENT_67	[p5l1474t1981r1597b2049],
21	over	IN	O	over	_	0	SENT_67	[p5l1635t1981r1808b2029],
22	the	DT	O	the	det	23	SENT_67	[p5l1841t1959r1960b2029],
23	ﬁrst	NN	O	ﬁrst	prep_over	10	SENT_67	[p5l1998t1959r2148b2029],
24	three	CD	NUMBER	three	num	25	SENT_67	[p5l7t2067r202b2137],
25	nights	NNS	TIME	night	tmod	23	SENT_67	[p5l228t2067r489b2157],
26	,	,	O	,	_	0	SENT_67	[p5l228t2067r489b2157],
27	and	CC	O	and	_	0	SENT_67	[p5l518t2067r658b2137],
28	then	RB	O	then	advmod	32	SENT_67	[p5l682t2067r851b2137],
29	the	DT	O	the	det	30	SENT_67	[p5l874t2067r993b2137],
30	clinicians	NNS	O	clinician	nsubj	32	SENT_67	[p5l1019t2067r1396b2137],
31	were	VBD	O	be	cop	32	SENT_67	[p5l1422t2090r1612b2137],
32	free	JJ	O	free	conj_and	10	SENT_67	[p5l1637t2067r1788b2137],
33	to	TO	O	to	aux	34	SENT_67	[p5l1812t2078r1886b2137],
34	adjust	VB	O	adjust	xcomp	32	SENT_67	[p5l1913t2067r2148b2157],
35	the	DT	O	the	det	36	SENT_67	[p5l7t2175r125b2245],
36	dosage	NN	O	dosage	dobj	34	SENT_67	[p5l162t2175r434b2265],
37	based	VBN	O	base	prep	34	SENT_67	[p5l468t2175r694b2245],
38	upon	IN	O	upon	pcomp	37	SENT_67	[p5l728t2197r925b2265],
39	clinical	JJ	O	clinical	amod	40	SENT_67	[p5l961t2175r1251b2245],
40	response	NN	O	response	pobj	38	SENT_67	[p5l1287t2197r1653b2265],
41	,	,	O	,	_	0	SENT_67	[p5l1287t2197r1653b2265],
42	side	JJ	O	side	amod	43	SENT_67	[p5l1696t2175r1850b2245],
43	effects	NNS	O	effect	pobj	38	SENT_67	[p5l1886t2175r2144b2245],
44	and	CC	O	and	_	0	SENT_67	[p5l9t2283r148b2353],
45	drug	NN	O	drug	nn	46	SENT_67	[p5l192t2283r369b2373],
46	levels	NNS	O	level	pobj	38	SENT_67	[p5l414t2283r662b2353],
47	.	.	O	.	_	0	SENT_67	[p5l414t2283r662b2353],

1	At	IN	O	at	_	0	SENT_68	[p5l710t2284r808b2353],
2	6	CD	DURATION	6	num	3	SENT_68	[p5l852t2283r895b2353],
3	weeks	NNS	NUMBER	week	prep_at	10	SENT_68	[p5l941t2283r1184b2353],
4	the	DT	O	the	det	7	SENT_68	[p5l1230t2283r1348b2353],
5	mean	NN	O	mean	nn	7	SENT_68	[p5l1393t2305r1607b2353],
6	nortriptyline	NN	O	nortriptyline	nn	7	SENT_68	[p5l1651t2283r2146b2373],
7	dose	NN	O	dose	nsubj	10	SENT_68	[p5l8t2391r185b2461],
8	was	VBD	O	be	cop	10	SENT_68	[p5l217t2414r366b2461],
9	90	CD	NUMBER	90	num	10	SENT_68	[p5l402t2392r496b2462],
10	mg	NN	O	mg	_	0	SENT_68	[p5l516t2414r662b2481],
11	,	,	O	,	_	0	SENT_68	[p5l516t2414r662b2481],
12	with	IN	O	with	_	0	SENT_68	[p5l699t2391r872b2461],
13	a	DT	O	a	det	14	SENT_68	[p5l908t2414r949b2461],
14	range	NN	O	range	prep_with	10	SENT_68	[p5l978t2414r1197b2481],
15	of	IN	O	of	_	0	SENT_68	[p5l1233t2391r1318b2461],
16	50-175	CD	NUMBER	50-175	num	17	SENT_68	[p5l1345t2391r1633b2461],
17	mg	NN	O	mg	prep_of	14	SENT_68	[p5l1658t2414r1802b2481],
18	.	.	O	.	_	0	SENT_68	[p5l1658t2414r1802b2481],

1	At	IN	O	at	_	0	SENT_69	[p5l106t2500r204b2569],
2	3	CD	DURATION	3	num	3	SENT_69	[p5l248t2500r287b2569],
3	weeks	NNS	NUMBER	week	prep_at	11	SENT_69	[p5l335t2499r578b2569],
4	and	CC	O	and	_	0	SENT_69	[p5l625t2499r765b2569],
5	6	CD	DURATION	6	num	6	SENT_69	[p5l809t2499r853b2569],
6	weeks	NNS	NUMBER	week	prep_at	11	SENT_69	[p5l897t2499r1163b2582],
7	,	,	O	,	_	0	SENT_69	[p5l897t2499r1163b2582],
8	the	DT	O	the	det	9	SENT_69	[p5l1209t2499r1328b2569],
9	patients	NNS	O	patient	nsubjpass	11	SENT_69	[p5l1370t2499r1678b2589],
10	were	VBD	O	be	auxpass	11	SENT_69	[p5l1723t2521r1912b2569],
11	reassessed	VBN	O	reassess	_	0	SENT_69	[p5l1955t2521r2143b2569, p5l10t2607r258b2677],
12	for	IN	O	for	_	0	SENT_69	[p5l283t2607r397b2677],
13	depression	NN	O	depression	nn	14	SENT_69	[p5l421t2607r843b2697],
14	severity	NN	O	severity	prep_for	11	SENT_69	[p5l871t2607r1176b2697],
15	by	IN	O	by	_	0	SENT_69	[p5l1201t2607r1298b2697],
16	repeating	VBG	O	repeat	agent	11	SENT_69	[p5l1322t2607r1690b2697],
17	the	DT	O	the	det	18	SENT_69	[p5l1717t2607r1835b2677],
18	HDRS	NNS	O	hdr	dobj	16	SENT_69	[p5l1860t2608r2143b2690],
19	,	,	O	,	_	0	SENT_69	[p5l1860t2608r2143b2690],
20	MADRS	NN	ORGANIZATION	madr	conj_and	18	SENT_69	[p5l6t2716r351b2785],
21	and	CC	O	and	_	0	SENT_69	[p5l394t2715r534b2785],
22	a	DT	O	a	det	25	SENT_69	[p5l572t2738r612b2785],
23	global	JJ	O	global	amod	25	SENT_69	[p5l649t2715r894b2805],
24	clinical	JJ	O	clinical	amod	25	SENT_69	[p5l932t2715r1222b2785],
25	rating	NN	O	rating	conj_and	18	SENT_69	[p5l1258t2715r1509b2805],
26	.	.	O	.	_	0	SENT_69	[p5l1258t2715r1509b2805],

1	At	IN	O	at	_	0	SENT_70	[p5l1551t2716r1648b2785],
2	these	DT	O	these	pobj	1	SENT_70	[p5l1683t2715r1885b2785],
3	3	CD	NUMBER	3	dep	2	SENT_70	[p5l1925t2716r1964b2785],
4	and	CC	O	and	cc	3	SENT_70	[p5l2007t2715r2147b2785],

1	Hum	NNP	O	Hum	nn	4	SENT_71	[p5l312t2987r484b3047],
2	Psychopharmacol	NNP	O	Psychopharmacol	nn	4	SENT_71	[p5l513t2985r1157b3064],
3	Clin	NNP	O	Clin	nn	4	SENT_71	[p5l1190t2985r1336b3048],
4	Exp	NNP	O	Exp	_	0	SENT_71	[p5l1364t2987r1502b3064],
5	2004	CD	DATE	2004	num	4	SENT_71	[p5l1534t2985r1730b3058],
6	;	:	O	;	_	0	SENT_71	[p5l1534t2985r1730b3058],
7	19	CD	NUMBER	19	num	9	SENT_71	[p5l1767t2984r1868b3047],
8	:	:	O	:	_	0	SENT_71	[p5l1767t2984r1868b3047],
9	17-23	CD	DATE	17-23	dep	4	SENT_71	[p5l1912t2985r2142b3047],
10	.	.	O	.	_	0	SENT_71	[p5l1912t2985r2142b3047],

1	CYPZD6	NN	O	cypzd6	_	0	SENT_72	[p5l445t3145r555b3169],
2	AND	CC	O	and	_	0	SENT_72	[p5l568t3139r656b3168],
3	ANTIDEPRESSANT	JJ	O	antidepressant	amod	4	SENT_72	[p5l670t3139r1031b3169],
4	ADRs	NNS	MISC	adr	conj_and	1	SENT_72	[p5l1045t3139r1143b3168],
5	19	CD	NUMBER	19	dep	1	SENT_72	[p5l1679t3139r1714b3169],

1	6	CD	DURATION	6	num	3	SENT_73	[p6l17t80r60b149],
2	week	NN	DURATION	week	nn	3	SENT_73	[p6l93t80r300b149],
3	assessments	NNS	O	assessment	nsubjpass	10	SENT_73	[p6l332t91r826b162],
4	,	,	O	,	_	0	SENT_73	[p6l332t91r826b162],
5	all	PDT	O	all	predet	7	SENT_73	[p6l863t80r957b149],
6	the	DT	O	the	det	7	SENT_73	[p6l989t80r1107b149],
7	patients	NNS	O	patient	appos	3	SENT_73	[p6l1138t80r1443b169],
8	were	VBD	O	be	auxpass	10	SENT_73	[p6l1477t102r1665b149],
9	speciﬁcally	RB	O	speciﬁcally	advmod	10	SENT_73	[p6l1701t80r2146b169],
10	asked	VBN	O	ask	_	0	SENT_73	[p6l17t187r238b256],
11	about	IN	O	about	_	0	SENT_73	[p6l263t187r480b256],
12	ADRs	NNS	MISC	adr	prep_about	10	SENT_73	[p6l502t188r744b256],
13	that	WDT	O	that	nsubjpass	17	SENT_73	[p6l769t187r917b256],
14	may	MD	O	may	aux	17	SENT_73	[p6l939t209r1106b276],
15	have	VB	O	have	aux	17	SENT_73	[p6l1129t187r1312b256],
16	been	VBN	O	be	auxpass	17	SENT_73	[p6l1334t187r1521b256],
17	associated	VBN	O	associate	rcmod	12	SENT_73	[p6l1546t187r1951b256],
18	with	IN	O	with	_	0	SENT_73	[p6l1973t187r2147b256],
19	the	DT	O	the	det	21	SENT_73	[p6l14t294r132b363],
20	antidepressant	JJ	O	antidepressant	amod	21	SENT_73	[p6l169t294r733b383],
21	medication	NN	O	medication	prep_with	17	SENT_73	[p6l766t294r1227b376],
22	,	,	O	,	_	0	SENT_73	[p6l766t294r1227b376],
23	although	IN	O	although	mark	33	SENT_73	[p6l1266t294r1609b383],
24	a	DT	O	a	det	25	SENT_73	[p6l1645t316r1686b363],
25	list	NN	O	list	nsubjpass	33	SENT_73	[p6l1718t294r1838b363],
26	of	IN	O	of	_	0	SENT_73	[p6l1872t294r1957b363],
27	speciﬁc	JJ	O	speciﬁc	amod	29	SENT_73	[p6l1988t316r2143b383, p6l15t401r181b470],
28	side	JJ	O	side	amod	29	SENT_73	[p6l230t401r382b470],
29	effects	NNS	O	effect	prep_of	25	SENT_73	[p6l430t401r686b470],
30	was	VBD	O	be	auxpass	33	SENT_73	[p6l734t423r882b470],
31	not	RB	O	not	neg	33	SENT_73	[p6l929t412r1055b470],
32	systematically	RB	O	systematically	advmod	33	SENT_73	[p6l1102t401r1664b490],
33	completed	VBN	O	complete	advcl	10	SENT_73	[p6l1711t401r2141b490],
34	.	.	O	.	_	0	SENT_73	[p6l1711t401r2141b490],

1	Any	DT	O	any	det	3	SENT_74	[p6l14t509r181b597],
2	signiﬁcant	JJ	O	signiﬁcant	amod	3	SENT_74	[p6l212t508r619b597],
3	ADR	NN	O	adr	nsubj	4	SENT_74	[p6l646t509r852b576],
4	reported	VBD	O	report	_	0	SENT_74	[p6l878t508r1209b597],
5	was	VBD	O	be	auxpass	7	SENT_74	[p6l1236t530r1384b577],
6	then	RB	O	then	advmod	7	SENT_74	[p6l1414t508r1582b577],
7	rated	VBN	O	rate	ccomp	4	SENT_74	[p6l1609t508r1807b577],
8	as	IN	O	as	_	0	SENT_74	[p6l1836t530r1912b577],
9	mild	JJ	O	mild	prep_as	7	SENT_74	[p6l1942t508r2142b589],
10	,	,	O	,	_	0	SENT_74	[p6l1942t508r2142b589],
11	moderate	JJ	O	moderate	prep_as	7	SENT_74	[p6l15t615r381b684],
12	or	CC	O	or	_	0	SENT_74	[p6l412t637r492b684],
13	severe	JJ	O	severe	prep_as	7	SENT_74	[p6l522t637r786b684],
14	.	.	O	.	_	0	SENT_74	[p6l522t637r786b684],

1	For	IN	O	for	_	0	SENT_75	[p6l819t617r955b684],
2	the	DT	O	the	det	3	SENT_75	[p6l980t615r1099b684],
3	purposes	NNS	O	purpose	prep_for	10	SENT_75	[p6l1126t637r1475b704],
4	of	IN	O	of	_	0	SENT_75	[p6l1506t615r1591b684],
5	this	DT	O	this	det	6	SENT_75	[p6l1612t615r1751b684],
6	paper	NN	O	paper	prep_of	3	SENT_75	[p6l1780t637r2017b704],
7	,	,	O	,	_	0	SENT_75	[p6l1780t637r2017b704],
8	all	DT	O	all	det	9	SENT_75	[p6l2051t615r2145b684],
9	ADRs	NNS	MISC	adr	nsubj	10	SENT_75	[p6l14t723r256b791],
10	reported	VBD	O	report	_	0	SENT_75	[p6l283t722r614b811],
11	at	IN	O	at	advmod	15	SENT_75	[p6l641t733r709b791],
12	either	CC	O	either	dep	13	SENT_75	[p6l735t722r960b791],
13	visit	NN	O	visit	nsubjpass	15	SENT_75	[p6l985t722r1154b791],
14	were	VBD	O	be	auxpass	15	SENT_75	[p6l1179t744r1369b791],
15	combined	VBN	O	combine	ccomp	10	SENT_75	[p6l1397t722r1804b791],
16	.	.	O	.	_	0	SENT_75	[p6l1397t722r1804b791],

1	Patients	NNS	O	patient	nsubj	3	SENT_76	[p6l1836t722r2144b791],
2	were	VBD	O	be	cop	3	SENT_76	[p6l15t851r203b898],
3	able	JJ	O	able	_	0	SENT_76	[p6l239t829r399b898],
4	to	TO	O	to	aux	5	SENT_76	[p6l432t840r505b898],
5	report	VB	O	report	xcomp	3	SENT_76	[p6l537t840r774b918],
6	as	IN	O	as	_	0	SENT_76	[p6l806t851r882b898],
7	many	JJ	O	many	amod	9	SENT_76	[p6l916t851r1133b918],
8	side	JJ	O	side	amod	9	SENT_76	[p6l1168t829r1320b898],
9	effects	NNS	O	effect	prep_as	5	SENT_76	[p6l1354t829r1611b898],
10	as	IN	O	as	mark	13	SENT_76	[p6l1647t851r1723b898],
11	they	PRP	O	they	nsubj	13	SENT_76	[p6l1757t829r1923b918],
12	were	VBD	O	be	aux	13	SENT_76	[p6l1957t851r2145b898],
13	experiencing	VBG	O	experience	advcl	5	SENT_76	[p6l15t936r545b1025],
14	,	,	O	,	_	0	SENT_76	[p6l15t936r545b1025],
15	and	CC	O	and	_	0	SENT_76	[p6l576t936r715b1005],
16	each	DT	O	each	nsubjpass	18	SENT_76	[p6l740t936r919b1005],
17	was	VBD	O	be	auxpass	18	SENT_76	[p6l945t958r1093b1005],
18	rated	VBN	O	rate	conj_and	3	SENT_76	[p6l1119t936r1316b1005],
19	as	IN	O	as	_	0	SENT_76	[p6l1342t958r1418b1005],
20	mild	JJ	O	mild	prep_as	18	SENT_76	[p6l1445t936r1646b1018],
21	,	,	O	,	_	0	SENT_76	[p6l1445t936r1646b1018],
22	moderate	JJ	O	moderate	prep_as	18	SENT_76	[p6l1674t936r2040b1005],
23	or	CC	O	or	_	0	SENT_76	[p6l2068t958r2148b1005],
24	severe	JJ	O	severe	prep_as	18	SENT_76	[p6l18t1064r282b1111],
25	.	.	O	.	_	0	SENT_76	[p6l18t1064r282b1111],

1	The	DT	O	the	det	4	SENT_77	[p6l342t1042r493b1111],
2	most	RBS	O	most	advmod	4	SENT_77	[p6l549t1053r740b1111],
3	severe	JJ	O	severe	amod	4	SENT_77	[p6l797t1064r1041b1111],
4	ADRs	NNS	MISC	adr	nsubj	5	SENT_77	[p6l1096t1043r1338b1111],
5	contributed	VBD	O	contribute	_	0	SENT_77	[p6l1396t1042r1844b1111],
6	to	TO	O	to	_	0	SENT_77	[p6l1898t1053r1971b1111],
7	the	DT	O	the	det	9	SENT_77	[p6l2028t1042r2146b1111],
8	severity	NN	O	severity	nn	9	SENT_77	[p6l18t1149r323b1238],
9	rating	NN	O	rating	prep_to	5	SENT_77	[p6l363t1149r591b1238],
10	of	IN	O	of	_	0	SENT_77	[p6l634t1149r719b1217],
11	any	DT	O	any	det	12	SENT_77	[p6l754t1170r892b1238],
12	ADRs	NNS	MISC	adr	prep_of	9	SENT_77	[p6l932t1149r1196b1230],
13	,	,	O	,	_	0	SENT_77	[p6l932t1149r1196b1230],
14	and	CC	O	and	_	0	SENT_77	[p6l1242t1149r1382b1217],
15	because	IN	O	because	mark	18	SENT_77	[p6l1420t1149r1732b1217],
16	few	JJ	O	few	nsubjpass	18	SENT_77	[p6l1773t1149r1915b1217],
17	were	VBD	O	be	auxpass	18	SENT_77	[p6l1957t1170r2145b1217],
18	rated	VBN	O	rate	advcl	24	SENT_77	[p6l13t1256r211b1325],
19	as	IN	O	as	_	0	SENT_77	[p6l237t1278r312b1325],
20	severe	JJ	O	severe	prep_as	18	SENT_77	[p6l342t1278r608b1338],
21	,	,	O	,	_	0	SENT_77	[p6l342t1278r608b1338],
22	these	DT	O	these	nsubjpass	24	SENT_77	[p6l634t1256r835b1325],
23	were	VBD	O	be	auxpass	24	SENT_77	[p6l858t1278r1046b1325],
24	combined	VBN	O	combine	conj_and	5	SENT_77	[p6l1073t1256r1462b1325],
25	with	IN	O	with	_	0	SENT_77	[p6l1485t1256r1659b1325],
26	ADRs	NNS	MISC	adr	prep_with	24	SENT_77	[p6l1682t1257r1925b1325],
27	rated	VBN	O	rate	partmod	26	SENT_77	[p6l1949t1256r2147b1325],
28	as	IN	O	as	_	0	SENT_77	[p6l17t1385r92b1432],
29	moderate	JJ	O	moderate	prep_as	27	SENT_77	[p6l126t1363r513b1432],
30	.	.	O	.	_	0	SENT_77	[p6l126t1363r513b1432],

1	C	NN	O	c	_	0	SENT_78	[p6l20t1612r81b1680],
2	YP2D6	NN	O	yp2d6	nn	3	SENT_78	[p6l87t1611r367b1679],
3	genotyping	NN	O	genotyping	dep	1	SENT_78	[p6l395t1613r833b1699],

1	The	DT	O	the	det	3	SENT_79	[p6l15t1773r166b1841],
2	CYPZD6	NN	O	cypzd6	nn	3	SENT_79	[p6l208t1773r557b1842],
3	gene	NN	O	gene	nsubj	5	SENT_79	[p6l591t1794r774b1862],
4	is	VBZ	O	be	cop	5	SENT_79	[p6l812t1773r873b1841],
5	located	JJ	O	located	_	0	SENT_79	[p6l912t1773r1198b1841],
6	adjacent	JJ	O	adjacent	advmod	5	SENT_79	[p6l1236t1773r1564b1862],
7	to	TO	O	to	_	0	SENT_79	[p6l1601t1783r1674b1841],
8	two	CD	NUMBER	two	num	11	SENT_79	[p6l1712t1783r1857b1842],
9	highly	RB	O	highly	advmod	10	SENT_79	[p6l1895t1773r2145b1862],
10	homologous	JJ	O	homologous	amod	11	SENT_79	[p6l14t1881r500b1970],
11	pseudogenes	NNS	O	pseudogene	prep_to	6	SENT_79	[p6l553t1881r1056b1970],
12	(	VBP	O	(	rcmod	11	SENT_79	[p6l1114t1881r1494b1966],
13	CYP2D8	NN	O	cyp2d8	nn	16	SENT_79	[p6l1114t1881r1494b1966],
14	and	CC	O	and	_	0	SENT_79	[p6l1548t1881r1688b1950],
15	CYPZD7	NN	O	cypzd7	nn	16	SENT_79	[p6l1745t1881r2141b1966],
16	)	NN	O	)	dobj	12	SENT_79	[p6l1745t1881r2141b1966],
17	.	.	O	.	_	0	SENT_79	[p6l1745t1881r2141b1966],

1	Of	IN	O	of	_	0	SENT_80	[p6l17t1987r123b2056],
2	the	DT	O	the	det	3	SENT_80	[p6l140t1987r259b2055],
3	mutations	NNS	O	mutation	prep_of	13	SENT_80	[p6l284t1987r671b2055],
4	so	RB	O	so	advmod	5	SENT_80	[p6l701t2008r781b2055],
5	far	RB	O	far	advmod	6	SENT_80	[p6l807t1987r915b2055],
6	found	VBN	O	find	partmod	3	SENT_80	[p6l939t1987r1167b2055],
7	in	IN	O	in	_	0	SENT_80	[p6l1191t1987r1266b2055],
8	CYPZD6	NN	O	cypzd6	prep_in	6	SENT_80	[p6l1295t1986r1642b2056],
9	several	JJ	O	several	nsubjpass	13	SENT_80	[p6l1667t1987r1939b2055],
10	have	VBP	O	have	aux	13	SENT_80	[p6l1963t1987r2145b2055],
11	also	RB	O	also	advmod	13	SENT_80	[p6l17t2095r170b2163],
12	been	VBN	O	be	auxpass	13	SENT_80	[p6l213t2095r399b2163],
13	detected	VBN	O	detect	_	0	SENT_80	[p6l443t2095r771b2163],
14	in	IN	O	in	_	0	SENT_80	[p6l813t2095r888b2163],
15	CYP2D8	NN	O	cyp2d8	prep_in	13	SENT_80	[p6l935t2095r1279b2164],
16	and	CC	O	and	_	0	SENT_80	[p6l1323t2095r1463b2163],
17	CYP2D7	NN	O	cyp2d7	nn	19	SENT_80	[p6l1509t2095r1857b2164],
18	(	CD	NUMBER	(	num	19	SENT_80	[p6l1899t2095r2147b2179],
19	Heim	NNP	PERSON	Heim	prep_in	13	SENT_80	[p6l1899t2095r2147b2179],
20	and	CC	O	and	_	0	SENT_80	[p6l17t2202r156b2271],
21	Meyer	NNP	PERSON	Meyer	prep_in	13	SENT_80	[p6l197t2204r470b2291],
22	,	,	O	,	_	0	SENT_80	[p6l197t2204r470b2291],
23	1990	CD	DATE	1990	num	24	SENT_80	[p6l526t2202r764b2287],
24	)	NN	O	)	appos	21	SENT_80	[p6l526t2202r764b2287],
25	.	.	O	.	_	0	SENT_80	[p6l526t2202r764b2287],

1	To	TO	O	to	aux	2	SENT_81	[p6l811t2204r911b2271],
2	avoid	VB	O	avoid	purpcl	23	SENT_81	[p6l956t2202r1171b2271],
3	false	JJ	O	false	amod	6	SENT_81	[p6l1213t2202r1741b2291],
4	—	NN	O	—	nn	6	SENT_81	[p6l1213t2202r1741b2291],
5	positive	JJ	O	positive	amod	6	SENT_81	[p6l1213t2202r1741b2291],
6	detection	NN	O	detection	dobj	2	SENT_81	[p6l1785t2202r2146b2271],
7	of	IN	O	of	_	0	SENT_81	[p6l16t2309r101b2377],
8	mutations	NNS	O	mutation	prep_of	6	SENT_81	[p6l127t2309r514b2377],
9	through	IN	O	through	_	0	SENT_81	[p6l549t2309r855b2398],
10	co-ampliﬁcation	NN	O	co-ampliﬁcation	prep_through	2	SENT_81	[p6l888t2309r1535b2398],
11	of	IN	O	of	_	0	SENT_81	[p6l1570t2309r1654b2377],
12	pseudogene	NN	O	pseudogene	nn	13	SENT_81	[p6l1680t2309r2145b2398],
13	sequences	NNS	O	sequence	prep_of	10	SENT_81	[p6l18t2437r435b2505],
14	,	,	O	,	_	0	SENT_81	[p6l18t2437r435b2505],
15	initial	JJ	O	initial	amod	16	SENT_81	[p6l470t2416r699b2485],
16	ampliﬁcation	NN	O	ampliﬁcation	nsubjpass	23	SENT_81	[p6l732t2416r1252b2505],
17	of	IN	O	of	_	0	SENT_81	[p6l1284t2416r1369b2484],
18	the	DT	O	the	det	21	SENT_81	[p6l1392t2416r1511b2484],
19	entire	JJ	O	entire	amod	21	SENT_81	[p6l1544t2416r1765b2484],
20	CYPZD6	NN	O	cypzd6	nn	21	SENT_81	[p6l1803t2416r2150b2485],
21	gene	NN	O	gene	prep_of	16	SENT_81	[p6l16t2545r198b2612],
22	was	VBD	O	be	auxpass	23	SENT_81	[p6l226t2545r374b2592],
23	carried	VBN	O	carry	_	0	SENT_81	[p6l406t2523r679b2592],
24	out	RP	O	out	prt	23	SENT_81	[p6l708t2534r832b2592],
25	using	VBG	O	use	xcomp	23	SENT_81	[p6l858t2523r1069b2612],
26	primers	NNS	O	primer	nsubj	27	SENT_81	[p6l1097t2523r1397b2612],
27	complementary	JJ	O	complementary	xcomp	25	SENT_81	[p6l1428t2523r2042b2612],
28	to	TO	O	to	_	0	SENT_81	[p6l2072t2534r2145b2592],
29	unique	JJ	O	unique	amod	31	SENT_81	[p6l14t2629r281b2718],
30	intronic	JJ	O	intronic	amod	31	SENT_81	[p6l308t2629r612b2697],
31	sequences	NNS	O	sequence	prep_to	27	SENT_81	[p6l643t2650r1037b2718],
32	of	IN	O	of	_	0	SENT_81	[p6l1065t2629r1151b2697],
33	CYPZD6	NN	O	cypzd6	prep_of	31	SENT_81	[p6l1175t2628r1538b2698],
34	.	.	O	.	_	0	SENT_81	[p6l1175t2628r1538b2698],

1	The	DT	O	the	det	2	SENT_82	[p6l1569t2629r1720b2697],
2	method	NN	O	method	_	0	SENT_82	[p6l1746t2629r2041b2697],
3	of	IN	O	of	_	0	SENT_82	[p6l2068t2629r2153b2697],
4	Sachse	NNP	PERSON	Sachse	prep_of	2	SENT_82	[p6l18t2737r286b2806],
5	er	FW	O	er	nn	7	SENT_82	[p6l313t2750r384b2806],
6	al.	FW	O	al.	nn	7	SENT_82	[p6l406t2737r495b2806],
7	(	FW	O	(	dep	4	SENT_82	[p6l532t2738r787b2822],
8	1997	CD	DATE	1997	num	9	SENT_82	[p6l532t2738r787b2822],
9	)	NN	O	)	dep	7	SENT_82	[p6l532t2738r787b2822],
10	was	VBD	O	be	auxpass	11	SENT_82	[p6l815t2759r963b2806],
11	used	VBN	O	use	rcmod	9	SENT_82	[p6l990t2737r1169b2806],
12	with	IN	O	with	_	0	SENT_82	[p6l1194t2737r1367b2806],
13	the	DT	O	the	det	15	SENT_82	[p6l1391t2737r1509b2806],
14	following	VBG	O	follow	amod	15	SENT_82	[p6l1535t2737r1914b2826],
15	modiﬁcations	NNS	O	modiﬁcations	prep_with	11	SENT_82	[p6l1940t2737r2143b2806, p6l15t2843r394b2912],
16	.	.	O	.	_	0	SENT_82	[p6l1940t2737r2143b2806, p6l15t2843r394b2912],

1	Reaction	NN	O	reaction	nn	2	SENT_83	[p6l457t2843r808b2912],
2	volumes	NNS	O	volume	nsubj	5	SENT_83	[p6l862t2843r1192b2912],
3	were	VBD	O	be	cop	5	SENT_83	[p6l1252t2865r1439b2912],
4	25	CD	NUMBER	25	num	5	SENT_83	[p6l1499t2843r1589b2912],
5	ul	NN	O	ul	_	0	SENT_83	[p6l1617t2843r1714b2931],
6	,	,	O	,	_	0	SENT_83	[p6l1617t2843r1714b2931],
7	and	CC	O	and	_	0	SENT_83	[p6l1777t2843r1916b2912],
8	contained	VBD	O	contain	conj_and	5	SENT_83	[p6l1973t2865r2143b2912, p6l14t2951r256b3020],
9	2mM	NN	O	2mm	nn	10	SENT_83	[p6l295t2952r500b3019],
10	MgCl2	NN	O	mgcl2	nsubj	8	SENT_83	[p6l538t2951r825b3040],
11	,	,	O	,	_	0	SENT_83	[p6l538t2951r825b3040],
12	1.25	CD	NUMBER	1.25	num	13	SENT_83	[p6l876t2951r1033b3020],
13	uM	NN	O	um	appos	10	SENT_83	[p6l1060t2970r1175b3039],
14	of	IN	O	of	_	0	SENT_83	[p6l1214t2951r1299b3020],
15	each	DT	O	each	det	16	SENT_83	[p6l1332t2951r1510b3020],
16	primer	NN	O	primer	prep_of	13	SENT_83	[p6l1547t2951r1829b3040],
17	,	,	O	,	_	0	SENT_83	[p6l1547t2951r1829b3040],
18	2	CD	NUMBER	2	num	19	SENT_83	[p6l1873t2952r1917b3019],
19	units	NNS	O	unit	prep_of	13	SENT_83	[p6l1955t2951r2144b3020],
20	of	IN	O	of	_	0	SENT_83	[p6l16t3058r101b3126],
21	ELONGASE	NNP	O	ELONGASE	nn	26	SENT_83	[p6l119t3058r638b3127],
22	Enzyme	NNP	O	Enzyme	nn	26	SENT_83	[p6l664t3059r986b3147],
23	Mix	NNP	O	Mix	nn	26	SENT_83	[p6l1012t3058r1174b3126],
24	(	NNP	O	(	nn	26	SENT_83	[p6l1203t3058r1471b3143],
25	Gibco	NNP	ORGANIZATION	Gibco	nn	26	SENT_83	[p6l1203t3058r1471b3143],
26	BRL	NN	ORGANIZATION	brl	prep_of	19	SENT_83	[p6l1497t3059r1708b3139],
27	,	,	O	,	_	0	SENT_83	[p6l1497t3059r1708b3139],
28	Rockville	NNP	LOCATION	Rockville	nn	32	SENT_83	[p6l1738t3058r2142b3139],
29	,	,	O	,	_	0	SENT_83	[p6l1738t3058r2142b3139],
30	MD	NNP	O	MD	appos	32	SENT_83	[p6l14t3167r192b3246],
31	,	,	O	,	_	0	SENT_83	[p6l14t3167r192b3246],
32	USA	NNP	LOCATION	USA	conj_and	16	SENT_83	[p6l230t3165r454b3250],
33	)	CD	NUMBER	)	num	32	SENT_83	[p6l230t3165r454b3250],
34	and	CC	O	and	_	0	SENT_83	[p6l493t3165r632b3234],
35	w	NN	O	w	nn	37	SENT_83	[p6l680t3196r746b3220],
36	100	CD	NUMBER	100	num	37	SENT_83	[p6l771t3165r907b3234],
37	ng	NN	O	ng	conj_and	16	SENT_83	[p6l927t3187r1022b3254],
38	of	IN	O	of	_	0	SENT_83	[p6l1059t3165r1144b3234],
39	genomic	JJ	O	genomic	amod	40	SENT_83	[p6l1172t3165r1509b3254],
40	DNA	NN	O	dna	prep_of	13	SENT_83	[p6l1545t3166r1772b3234],
41	.	.	O	.	_	0	SENT_83	[p6l1545t3166r1772b3234],

1	Thermal	JJ	O	thermal	amod	2	SENT_84	[p6l1812t3165r2145b3234],
2	cycling	NN	O	cycling	nsubjpass	4	SENT_84	[p6l15t3272r303b3361],
3	was	VBD	O	be	auxpass	4	SENT_84	[p6l334t3294r482b3341],
4	performed	VBN	O	perform	_	0	SENT_84	[p6l514t3272r927b3361],
5	with	IN	O	with	_	0	SENT_84	[p6l957t3272r1130b3341],
6	an	DT	O	a	det	8	SENT_84	[p6l1162t3294r1251b3341],
7	initial	JJ	O	initial	amod	8	SENT_84	[p6l1282t3272r1510b3341],
8	denaturation	NN	O	denaturation	prep_with	4	SENT_84	[p6l1543t3272r2035b3341],
9	of	IN	O	of	_	0	SENT_84	[p6l2068t3272r2153b3341],
10	30s	CD	NUMBER	30s	prep_of	8	SENT_84	[p6l18t3379r163b3448],
11	at	IN	O	at	_	0	SENT_84	[p6l205t3390r274b3448],
12	94	CD	NUMBER	94	number	13	SENT_84	[p6l311t3379r532b3460],
13	°	CD	NUMBER	°	num	14	SENT_84	[p6l311t3379r532b3460],
14	C	NN	O	c	prep_at	4	SENT_84	[p6l311t3379r532b3460],
15	,	,	O	,	_	0	SENT_84	[p6l311t3379r532b3460],
16	followed	VBN	O	follow	partmod	14	SENT_84	[p6l574t3379r922b3448],
17	by	IN	O	by	_	0	SENT_84	[p6l957t3379r1054b3468],
18	35	CD	NUMBER	35	num	19	SENT_84	[p6l1095t3379r1183b3448],
19	cycles	NNS	O	cycle	agent	16	SENT_84	[p6l1227t3379r1469b3468],
20	of	IN	O	of	_	0	SENT_84	[p6l1509t3379r1594b3448],
21	30s	NNS	O	30	prep_of	19	SENT_84	[p6l1628t3379r1774b3448],
22	at	IN	O	at	_	0	SENT_84	[p6l1815t3389r1883b3448],
23	94	CD	NUMBER	94	number	24	SENT_84	[p6l1921t3379r2142b3460],
24	°	CD	NUMBER	°	num	25	SENT_84	[p6l1921t3379r2142b3460],
25	C	NN	O	c	prep_at	21	SENT_84	[p6l1921t3379r2142b3460],
26	,	,	O	,	_	0	SENT_84	[p6l1921t3379r2142b3460],
27	6min	NN	O	6min	prep_of	19	SENT_84	[p6l17t3485r232b3554],
28	at	IN	O	at	_	0	SENT_84	[p6l275t3495r343b3554],
29	68	CD	NUMBER	68	number	30	SENT_84	[p6l384t3485r605b3566],
30	°	CD	NUMBER	°	num	31	SENT_84	[p6l384t3485r605b3566],
31	C	NN	O	c	prep_at	27	SENT_84	[p6l384t3485r605b3566],
32	,	,	O	,	_	0	SENT_84	[p6l384t3485r605b3566],
33	and	CC	O	and	_	0	SENT_84	[p6l652t3485r791b3554],
34	a	DT	O	a	det	36	SENT_84	[p6l833t3507r874b3554],
35	terminal	JJ	O	terminal	amod	36	SENT_84	[p6l912t3485r1240b3554],
36	extension	NN	O	extension	conj_and	21	SENT_84	[p6l1282t3485r1658b3554],
37	of	IN	O	of	_	0	SENT_84	[p6l1700t3485r1785b3554],
38	7min	NN	O	7min	prep_of	36	SENT_84	[p6l1820t3485r2037b3554],
39	at	IN	O	at	_	0	SENT_84	[p6l2079t3495r2147b3554],
40	68	CD	NUMBER	68	number	41	SENT_84	[p6l17t3591r236b3660],
41	°	CD	NUMBER	°	prep_at	16	SENT_84	[p6l17t3591r236b3660],
42	C.	NNP	O	C.	dep	41	SENT_84	[p6l17t3591r236b3660],

1	The	DT	O	the	det	4	SENT_85	[p7l114t27r264b96],
2	CYPZD6-speciﬁc	JJ	O	cypzd6-speciﬁc	amod	4	SENT_85	[p7l300t27r976b116],
3	PCR	NN	O	pcr	nn	4	SENT_85	[p7l1008t27r1192b96],
4	product	NN	O	product	nsubjpass	9	SENT_85	[p7l1220t27r1522b116],
5	from	IN	O	from	_	0	SENT_85	[p7l1551t27r1741b96],
6	each	DT	O	each	det	7	SENT_85	[p7l1771t27r1950b96],
7	subject	NN	O	subject	prep_from	4	SENT_85	[p7l1983t27r2144b96, p7l6t134r157b223],
8	was	VBD	O	be	auxpass	9	SENT_85	[p7l186t156r334b203],
9	tested	VBN	O	test	_	0	SENT_85	[p7l366t134r596b203],
10	for	IN	O	for	mark	14	SENT_85	[p7l626t134r739b203],
11	the	DT	O	the	det	13	SENT_85	[p7l767t134r886b203],
12	CYPZD6	NN	O	cypzd6	nn	13	SENT_85	[p7l921t134r1268b204],
13	alleles	NNS	O	allele	nsubj	14	SENT_85	[p7l1297t134r1544b203],
14	*	VBP	O	*	advcl	9	SENT_85	[p7l1581t135r1665b202],
15	1	CD	NUMBER	1	number	17	SENT_85	[p7l1581t135r1665b202],
16	to	TO	O	to	dep	17	SENT_85	[p7l1702t145r1775b203],
17	*	CD	NUMBER	*	num	19	SENT_85	[p7l1811t135r1895b202],
18	1	CD	NUMBER	1	number	19	SENT_85	[p7l1811t135r1895b202],
19	6	CD	NUMBER	6	dobj	14	SENT_85	[p7l1906t134r1973b215],
20	,	,	O	,	_	0	SENT_85	[p7l1906t134r1973b215],
21	and	CC	O	and	_	0	SENT_85	[p7l2008t134r2147b203],
22	CYP2D6	NN	O	cyp2d6	nn	24	SENT_85	[p7l19t241r513b311],
23	*	CD	NUMBER	*	num	24	SENT_85	[p7l19t241r513b311],
24	I9	NN	O	i9	dobj	14	SENT_85	[p7l19t241r513b311],
25	and	CC	O	and	_	0	SENT_85	[p7l559t241r698b310],
26	CYP2D6	NN	O	cyp2d6	conj_and	19	SENT_85	[p7l747t241r1258b311],
27	*	CD	NUMBER	*	number	28	SENT_85	[p7l747t241r1258b311],
28	20	CD	NUMBER	20	dep	26	SENT_85	[p7l747t241r1258b311],
29	.	.	O	.	_	0	SENT_85	[p7l747t241r1258b311],

1	Alleles	NNS	O	allele	nsubjpass	8	SENT_86	[p7l1308t241r1584b310],
2	deﬁned	VBN	O	deﬁned	partmod	1	SENT_86	[p7l1633t241r1921b310],
3	by	IN	O	by	_	0	SENT_86	[p7l1962t241r2059b330],
4	a	DT	O	a	det	6	SENT_86	[p7l2106t263r2147b310],
5	point	NN	O	point	nn	6	SENT_86	[p7l13t348r217b437],
6	mutation	NN	O	mutation	agent	2	SENT_86	[p7l258t348r610b417],
7	were	VBD	O	be	auxpass	8	SENT_86	[p7l653t370r842b417],
8	identiﬁed	VBN	O	identiﬁed	dep	15	SENT_86	[p7l885t348r1258b417],
9	in	IN	O	in	_	0	SENT_86	[p7l1300t348r1375b416],
10	parallel	NN	O	parallel	prep_in	8	SENT_86	[p7l1416t348r1713b437],
11	by	IN	O	by	_	0	SENT_86	[p7l1754t348r1852b437],
12	nested	JJ	O	nested	amod	14	SENT_86	[p7l1896t348r2147b417],
13	PCR-RFLP	NN	O	pcr-rflp	nn	14	SENT_86	[p7l14t456r468b524],
14	analyses	NNS	O	analysis	agent	8	SENT_86	[p7l493t455r823b544],
15	(	VBP	O	(	_	0	SENT_86	[p7l852t455r1154b540],
16	Sachse	NNP	PERSON	Sachse	nsubj	18	SENT_86	[p7l852t455r1154b540],
17	et	FW	O	et	nn	18	SENT_86	[p7l1181t468r1251b524],
18	al.	FW	O	al.	xcomp	15	SENT_86	[p7l1273t455r1394b537],
19	,	,	O	,	_	0	SENT_86	[p7l1273t455r1394b537],
20	1997	CD	DATE	1997	num	21	SENT_86	[p7l1432t456r1647b540],
21	)	NN	O	)	conj_and	18	SENT_86	[p7l1432t456r1647b540],
22	and	CC	O	and	_	0	SENT_86	[p7l1677t455r1815b524],
23	a	DT	O	a	det	25	SENT_86	[p7l1842t477r1883b524],
24	multiplex	JJ	O	multiplex	amod	25	SENT_86	[p7l1905t455r2144b524, p7l13t562r182b651],
25	PCR	NN	O	pcr	conj_and	18	SENT_86	[p7l242t563r426b631],
26	(	CD	NUMBER	(	num	27	SENT_86	[p7l488t562r821b648],
27	Roberts	NNP	PERSON	Roberts	dep	25	SENT_86	[p7l488t562r821b648],
28	et	FW	O	et	nn	29	SENT_86	[p7l885t576r956b631],
29	al.	FW	O	al.	nsubj	15	SENT_86	[p7l1012t562r1133b644],
30	,	,	O	,	_	0	SENT_86	[p7l1012t562r1133b644],
31	2000	CD	DATE	2000	num	32	SENT_86	[p7l1197t563r1444b647],
32	)	NN	O	)	appos	29	SENT_86	[p7l1197t563r1444b647],
33	.	.	O	.	_	0	SENT_86	[p7l1197t563r1444b647],

1	Allelic	JJ	MISC	allelic	amod	2	SENT_87	[p7l1509t562r1774b631],
2	variants	NNS	O	variant	nsubj	21	SENT_87	[p7l1836t562r2144b631],
3	involving	VBG	O	involve	partmod	2	SENT_87	[p7l14t669r388b758],
4	duplications	NNS	O	duplication	dobj	3	SENT_87	[p7l500t669r980b758],
5	(	CD	NUMBER	(	num	6	SENT_87	[p7l1096t669r1612b754],
6	CYP2D6	NN	O	cyp2d6	dep	4	SENT_87	[p7l1096t669r1612b754],
7	*	CD	NUMBER	*	num	8	SENT_87	[p7l1096t669r1612b754],
8	M	NN	O	m	dep	18	SENT_87	[p7l1096t669r1612b754],
9	X	NN	O	x	nn	11	SENT_87	[p7l1639t688r1687b736],
10	N	NN	O	n	nn	11	SENT_87	[p7l1715t670r1836b754],
11	)	NN	O	)	dep	8	SENT_87	[p7l1715t670r1836b754],
12	,	,	O	,	_	0	SENT_87	[p7l1715t670r1836b754],
13	deletion	NN	O	deletion	appos	11	SENT_87	[p7l1951t669r2143b738, p7l14t776r167b845],
14	(	CD	NUMBER	(	num	13	SENT_87	[p7l231t776r739b861],
15	CYP2D6	NN	O	cyp2d6	dep	18	SENT_87	[p7l231t776r739b861],
16	*	CD	NUMBER	*	num	15	SENT_87	[p7l231t776r739b861],
17	5	CD	NUMBER	5	num	18	SENT_87	[p7l231t776r739b861],
18	)	NN	O	)	dep	4	SENT_87	[p7l231t776r739b861],
19	or	CC	O	or	_	0	SENT_87	[p7l805t798r885b845],
20	rearrangements	NNS	O	rearrangement	dep	4	SENT_87	[p7l944t787r1552b865],
21	(	VBP	O	(	dep	30	SENT_87	[p7l1619t776r2145b861],
22	CYP2D6	NN	O	cyp2d6	nn	24	SENT_87	[p7l1619t776r2145b861],
23	*	CD	NUMBER	*	num	24	SENT_87	[p7l1619t776r2145b861],
24	I3	NN	O	i3	dobj	21	SENT_87	[p7l1619t776r2145b861],
25	and	CC	O	and	_	0	SENT_87	[p7l17t883r156b952],
26	*	NN	O	*	nn	28	SENT_87	[p7l250t883r420b968],
27	16	CD	NUMBER	16	num	28	SENT_87	[p7l250t883r420b968],
28	)	NN	O	)	dobj	21	SENT_87	[p7l250t883r420b968],
29	were	VBD	O	be	auxpass	30	SENT_87	[p7l513t905r701b952],
30	detected	VBN	O	detect	_	0	SENT_87	[p7l794t883r1121b952],
31	using	VBG	O	use	xcomp	30	SENT_87	[p7l1210t883r1421b972],
32	Southern	NN	MISC	southern	nn	33	SENT_87	[p7l1515t883r1866b952],
33	blots	NNS	O	blot	dobj	31	SENT_87	[p7l1955t883r2144b952],
34	(	RB	O	(	advmod	31	SENT_87	[p7l18t989r588b1078],
35	Chomczynski	NNP	PERSON	Chomczynski	nsubjpass	30	SENT_87	[p7l18t989r588b1078],
36	and	CC	O	and	_	0	SENT_87	[p7l663t989r802b1057],
37	Qasba	NNP	LOCATION	Qasba	conj_and	35	SENT_87	[p7l874t989r1137b1074],
38	,	,	O	,	_	0	SENT_87	[p7l874t989r1137b1074],
39	1984	CD	DATE	1984	appos	35	SENT_87	[p7l1222t989r1431b1070],
40	;	:	O	;	_	0	SENT_87	[p7l1222t989r1431b1070],
41	Roberts	NNP	PERSON	Roberts	dep	39	SENT_87	[p7l1506t989r1809b1057],
42	et	FW	O	et	nn	43	SENT_87	[p7l1884t1002r1954b1057],
43	al.	FW	O	al.	dep	41	SENT_87	[p7l2023t989r2142b1070],
44	,	,	O	,	_	0	SENT_87	[p7l2023t989r2142b1070],
45	2000	CD	DATE	2000	num	46	SENT_87	[p7l16t1098r262b1182],
46	)	NN	O	)	appos	43	SENT_87	[p7l16t1098r262b1182],
47	.	.	O	.	_	0	SENT_87	[p7l16t1098r262b1182],

1	The	DT	O	the	det	4	SENT_88	[p7l295t1097r446b1166],
2	1.6	CD	NUMBER	1.6	num	4	SENT_88	[p7l483t1097r593b1166],
3	kb	NN	O	kb	nn	4	SENT_88	[p7l613t1097r709b1166],
4	probe	NN	O	probe	nsubjpass	11	SENT_88	[p7l737t1097r960b1186],
5	used	VBN	O	use	partmod	4	SENT_88	[p7l987t1097r1167b1166],
6	to	TO	O	to	aux	7	SENT_88	[p7l1194t1107r1268b1166],
7	screen	VB	O	screen	xcomp	5	SENT_88	[p7l1300t1119r1546b1166],
8	Southern	NN	MISC	southern	nn	9	SENT_88	[p7l1577t1097r1929b1166],
9	blots	NNS	O	blot	dobj	7	SENT_88	[p7l1955t1097r2144b1166],
10	was	VBD	O	be	auxpass	11	SENT_88	[p7l15t1226r163b1273],
11	generated	VBN	O	generate	_	0	SENT_88	[p7l245t1204r629b1293],
12	by	IN	O	by	_	0	SENT_88	[p7l706t1204r802b1293],
13	PCR	NN	O	pcr	agent	11	SENT_88	[p7l882t1205r1066b1273],
14	using	VBG	O	use	partmod	13	SENT_88	[p7l1143t1204r1354b1293],
15	primers	NNS	O	primer	nn	16	SENT_88	[p7l1433t1204r1733b1293],
16	P61	NN	O	p61	dobj	14	SENT_88	[p7l1814t1204r1956b1273],
17	(	CD	NUMBER	(	number	18	SENT_88	[p7l2046t1197r2142b1290],
18	5	CD	NUMBER	5	num	23	SENT_88	[p7l2046t1197r2142b1290],
19	’	NN	O	’	nn	23	SENT_88	[p7l2046t1197r2142b1290],
20	CCCGTTCTGTCCCGAGTATG	NN	O	cccgttctgtcccgagtatg	nn	23	SENT_88	[p7l16t1311r1315b1380],
21	3	CD	NUMBER	3	num	23	SENT_88	[p7l1401t1303r1499b1396],
22	’	NN	O	’	nn	23	SENT_88	[p7l1401t1303r1499b1396],
23	)	NN	O	)	dep	16	SENT_88	[p7l1401t1303r1499b1396],
24	and	CC	O	and	_	0	SENT_88	[p7l1587t1311r1726b1380],
25	P92	NN	O	p92	dobj	14	SENT_88	[p7l1809t1311r1959b1381],
26	(	CD	NUMBER	(	number	27	SENT_88	[p7l2046t1303r2142b1396],
27	5	CD	NUMBER	5	num	32	SENT_88	[p7l2046t1303r2142b1396],
28	’	NN	O	’	nn	32	SENT_88	[p7l2046t1303r2142b1396],
29	CTCAGCCTCAACGTACCCCT	NN	O	ctcagcctcaacgtacccct	nn	32	SENT_88	[p7l16t1420r1324b1489],
30	3	CD	NUMBER	3	num	32	SENT_88	[p7l1421t1412r1541b1505],
31	’	NN	O	’	nn	32	SENT_88	[p7l1421t1412r1541b1505],
32	)	NN	O	)	dep	25	SENT_88	[p7l1421t1412r1541b1505],
33	.	.	O	.	_	0	SENT_88	[p7l1421t1412r1541b1505],

1	PCRs	NNS	O	pcr	nsubj	4	SENT_89	[p7l1640t1420r1859b1489],
2	were	VBD	O	be	cop	4	SENT_89	[p7l1956t1441r2145b1489],
3	25	CD	NUMBER	25	num	4	SENT_89	[p7l16t1527r106b1596],
4	pl	NN	O	pl	_	0	SENT_89	[p7l134t1527r231b1616],
5	,	,	O	,	_	0	SENT_89	[p7l134t1527r231b1616],
6	and	CC	O	and	_	0	SENT_89	[p7l276t1527r415b1596],
7	contained	VBD	O	contain	conj_and	4	SENT_89	[p7l455t1527r838b1596],
8	2mM	NN	O	2mm	nn	9	SENT_89	[p7l878t1528r1083b1595],
9	MgCl2	NN	O	mgcl2	dobj	7	SENT_89	[p7l1122t1527r1409b1616],
10	,	,	O	,	_	0	SENT_89	[p7l1122t1527r1409b1616],
11	0.625	CD	NUMBER	0.625	num	12	SENT_89	[p7l1453t1527r1667b1596],
12	uM	NN	O	um	dobj	7	SENT_89	[p7l1695t1546r1808b1615],
13	of	IN	O	of	_	0	SENT_89	[p7l1849t1527r1934b1596],
14	each	DT	O	each	det	17	SENT_89	[p7l1968t1527r2146b1596],
15	primer	NN	O	primer	nn	17	SENT_89	[p7l13t1633r279b1722],
16	(	CD	NUMBER	(	num	17	SENT_89	[p7l318t1632r489b1717],
17	P61	NN	O	p61	prep_of	12	SENT_89	[p7l318t1632r489b1717],
18	and	CC	O	and	_	0	SENT_89	[p7l538t1633r676b1701],
19	P92	NN	O	p92	nn	20	SENT_89	[p7l714t1633r918b1717],
20	)	NN	O	)	prep_of	12	SENT_89	[p7l714t1633r918b1717],
21	,	,	O	,	_	0	SENT_89	[p7l714t1633r918b1717],
22	200	CD	NUMBER	200	num	24	SENT_89	[p7l961t1633r1104b1702],
23	uM	NN	O	um	nn	24	SENT_89	[p7l1128t1651r1242b1721],
24	dNTPs	NNS	O	dntp	dep	34	SENT_89	[p7l1280t1633r1572b1714],
25	,	,	O	,	_	0	SENT_89	[p7l1280t1633r1572b1714],
26	1	CD	NUMBER	1	num	27	SENT_89	[p7l1622t1633r1651b1701],
27	unit	NN	O	unit	appos	24	SENT_89	[p7l1696t1633r1851b1701],
28	of	IN	O	of	_	0	SENT_89	[p7l1888t1633r1973b1701],
29	Taq	NN	O	taq	nn	30	SENT_89	[p7l2008t1635r2146b1721],
30	DNA	NN	O	dna	prep_of	24	SENT_89	[p7l14t1741r223b1810],
31	polymerase	NN	O	polymerase	dep	34	SENT_89	[p7l244t1741r699b1830],
32	(	CD	NUMBER	(	num	31	SENT_89	[p7l726t1741r1006b1826],
33	Roche	NNP	ORGANIZATION	Roche	nn	34	SENT_89	[p7l726t1741r1006b1826],
34	Biochemicals	NNPS	ORGANIZATION	Biochemicals	dep	17	SENT_89	[p7l1030t1741r1623b1825],
35	)	NN	O	)	dep	34	SENT_89	[p7l1030t1741r1623b1825],
36	,	,	O	,	_	0	SENT_89	[p7l1030t1741r1623b1825],
37	and	CC	O	and	_	0	SENT_89	[p7l1651t1741r1790b1809],
38	approximately	RB	O	approximately	quantmod	39	SENT_89	[p7l1815t1741r2143b1830, p7l14t1848r282b1937],
39	100	CD	NUMBER	100	num	40	SENT_89	[p7l318t1849r453b1917],
40	ng	NN	O	ng	dobj	7	SENT_89	[p7l474t1870r568b1937],
41	of	IN	O	of	_	0	SENT_89	[p7l596t1848r681b1917],
42	genomic	JJ	O	genomic	amod	43	SENT_89	[p7l701t1848r1036b1937],
43	DNA	NN	O	dna	prep_of	40	SENT_89	[p7l1064t1849r1291b1917],
44	.	.	O	.	_	0	SENT_89	[p7l1064t1849r1291b1917],

1	Thermal	JJ	O	thermal	amod	2	SENT_90	[p7l1322t1848r1655b1917],
2	cycling	NN	O	cycling	nsubj	3	SENT_90	[p7l1682t1848r1970b1937],
3	was	VBD	O	be	_	0	SENT_90	[p7l1996t1870r2144b1917],

1	Copyright	NN	O	copyright	nn	5	SENT_91	[p7l15t2116r374b2196],
2	©	CD	NUMBER	©	num	5	SENT_91	[p7l408t2116r483b2192],
3	2004	CD	DATE	2004	num	5	SENT_91	[p7l519t2116r693b2178],
4	John	NNP	ORGANIZATION	John	nn	5	SENT_91	[p7l722t2116r888b2178],
5	Wiley	NNP	ORGANIZATION	Wiley	nsubj	23	SENT_91	[p7l916t2116r1130b2196],
6	&	CC	ORGANIZATION	&	_	0	SENT_91	[p7l1160t2116r1224b2178],
7	Sons	NNP	ORGANIZATION	Sons	nsubj	23	SENT_91	[p7l1257t2116r1443b2189],
8	,	,	ORGANIZATION	,	_	0	SENT_91	[p7l1257t2116r1443b2189],
9	Ltd.	NNP	ORGANIZATION	Ltd.	nsubj	10	SENT_91	[p7l1476t2116r1615b2178],
10	performed	VBD	O	perform	dep	5	SENT_91	[p7l14t2217r427b2307],
11	with	IN	O	with	_	0	SENT_91	[p7l453t2217r627b2287],
12	an	DT	O	a	det	14	SENT_91	[p7l654t2240r744b2287],
13	initial	JJ	O	initial	amod	14	SENT_91	[p7l769t2217r999b2287],
14	denaturation	NN	O	denaturation	prep_with	10	SENT_91	[p7l1027t2217r1521b2287],
15	of	IN	O	of	_	0	SENT_91	[p7l1549t2217r1634b2287],
16	30	CD	NUMBER	30	num	17	SENT_91	[p7l1655t2218r1748b2287],
17	s	NNS	O	s	prep_of	14	SENT_91	[p7l1772t2240r1802b2287],
18	at	IN	O	at	_	0	SENT_91	[p7l1832t2228r1900b2287],
19	94	CD	NUMBER	94	number	20	SENT_91	[p7l1926t2218r2148b2300],
20	°	CD	NUMBER	°	num	21	SENT_91	[p7l1926t2218r2148b2300],
21	C	NN	O	c	prep_at	10	SENT_91	[p7l1926t2218r2148b2300],
22	,	,	O	,	_	0	SENT_91	[p7l1926t2218r2148b2300],
23	followed	VBN	O	follow	_	0	SENT_91	[p7l15t2325r364b2395],
24	by	IN	O	by	_	0	SENT_91	[p7l400t2325r497b2415],
25	30	CD	NUMBER	30	num	26	SENT_91	[p7l538t2325r631b2395],
26	cycles	NNS	O	cycle	prep_by	23	SENT_91	[p7l670t2325r913b2415],
27	of	IN	O	of	_	0	SENT_91	[p7l953t2325r1038b2395],
28	30s	NNS	O	30	prep_of	26	SENT_91	[p7l1072t2325r1218b2395],
29	at	IN	O	at	_	0	SENT_91	[p7l1260t2335r1328b2395],
30	94	CD	NUMBER	94	number	31	SENT_91	[p7l1366t2325r1588b2407],
31	°	CD	NUMBER	°	num	32	SENT_91	[p7l1366t2325r1588b2407],
32	C	NN	O	c	prep_at	28	SENT_91	[p7l1366t2325r1588b2407],
33	,	,	O	,	_	0	SENT_91	[p7l1366t2325r1588b2407],
34	30s	CD	NUMBER	30s	prep_of	26	SENT_91	[p7l1632t2325r1778b2395],
35	at	IN	O	at	_	0	SENT_91	[p7l1821t2336r1889b2395],
36	58	CD	NUMBER	58	number	37	SENT_91	[p7l1927t2325r2148b2407],
37	°	CD	NUMBER	°	num	38	SENT_91	[p7l1927t2325r2148b2407],
38	C	NN	O	c	prep_at	34	SENT_91	[p7l1927t2325r2148b2407],
39	,	,	O	,	_	0	SENT_91	[p7l1927t2325r2148b2407],
40	2min	NN	O	2min	prep_of	26	SENT_91	[p7l16t2432r234b2500],
41	at	IN	O	at	_	0	SENT_91	[p7l276t2443r344b2501],
42	72	CD	NUMBER	72	number	43	SENT_91	[p7l384t2433r607b2514],
43	°	CD	NUMBER	°	num	44	SENT_91	[p7l384t2433r607b2514],
44	C	NN	O	c	prep_at	40	SENT_91	[p7l384t2433r607b2514],
45	,	,	O	,	_	0	SENT_91	[p7l384t2433r607b2514],
46	and	CC	O	and	_	0	SENT_91	[p7l653t2432r793b2501],
47	a	DT	O	a	det	49	SENT_91	[p7l835t2454r876b2501],
48	terminal	JJ	O	terminal	amod	49	SENT_91	[p7l914t2432r1243b2501],
49	extension	NN	O	extension	prep_of	26	SENT_91	[p7l1286t2432r1663b2501],
50	of	IN	O	of	_	0	SENT_91	[p7l1704t2432r1790b2501],
51	4min	NN	O	4min	prep_of	49	SENT_91	[p7l1823t2432r2042b2500],
52	at	IN	O	at	_	0	SENT_91	[p7l2085t2443r2153b2501],
53	72	CD	NUMBER	72	num	54	SENT_91	[p7l15t2540r237b2608],
54	°	CD	NUMBER	°	prep_at	51	SENT_91	[p7l15t2540r237b2608],
55	C.	NNP	O	C.	dobj	23	SENT_91	[p7l15t2540r237b2608],
56	Approximately	RB	O	approximately	quantmod	57	SENT_91	[p7l285t2539r884b2629],
57	25	CD	NUMBER	25	num	58	SENT_91	[p7l930t2539r1020b2608],
58	ng	NN	O	ng	nsubjpass	63	SENT_91	[p7l1044t2561r1140b2629],
59	of	IN	O	of	_	0	SENT_91	[p7l1186t2539r1271b2608],
60	puriﬁed	JJ	O	puriﬁed	amod	61	SENT_91	[p7l1306t2539r1614b2629],
61	product	NN	O	product	prep_of	58	SENT_91	[p7l1655t2539r1958b2629],
62	was	VBD	O	be	auxpass	63	SENT_91	[p7l2001t2561r2150b2608],
63	labelled	VBN	O	label	rcmod	55	SENT_91	[p7l15t2648r328b2718],
64	with	IN	O	with	_	0	SENT_91	[p7l362t2648r536b2718],
65	[	CD	NUMBER	[	prep_with	63	SENT_91	[p7l576t2627r1090b2732],
66	oz	NN	O	oz	amod	65	SENT_91	[p7l576t2627r1090b2732],
67	-	:	O	-	_	0	SENT_91	[p7l576t2627r1090b2732],
68	°	CD	NUMBER	°	num	69	SENT_91	[p7l576t2627r1090b2732],
69	2P	NN	O	2p	dep	66	SENT_91	[p7l576t2627r1090b2732],
70	]	CD	NUMBER	]	num	71	SENT_91	[p7l576t2627r1090b2732],
71	dCTP	NN	O	dctp	dep	69	SENT_91	[p7l576t2627r1090b2732],
72	and	CC	O	and	_	0	SENT_91	[p7l1124t2648r1263b2718],
73	used	VBN	O	use	conj_and	63	SENT_91	[p7l1295t2648r1475b2718],
74	as	IN	O	as	_	0	SENT_91	[p7l1511t2670r1586b2718],
75	a	DT	O	a	det	76	SENT_91	[p7l1624t2670r1665b2718],
76	probe	NN	O	probe	prep_as	73	SENT_91	[p7l1696t2648r1940b2738],
77	.	.	O	.	_	0	SENT_91	[p7l1696t2648r1940b2738],

1	This	DT	O	this	det	2	SENT_92	[p7l1978t2648r2150b2718],
2	probe	NN	O	probe	nsubj	3	SENT_92	[p7l14t2756r237b2846],
3	contained	VBD	O	contain	_	0	SENT_92	[p7l265t2756r649b2826],
4	sequences	NNS	O	sequence	dobj	3	SENT_92	[p7l679t2778r1072b2846],
5	derived	VBN	O	derive	partmod	4	SENT_92	[p7l1102t2756r1395b2826],
6	from	IN	O	from	_	0	SENT_92	[p7l1420t2756r1611b2826],
7	CYP2D6	NN	O	cyp2d6	prep_from	5	SENT_92	[p7l1641t2756r1990b2827],
8	and	CC	O	and	_	0	SENT_92	[p7l2013t2756r2153b2826],
9	the	DT	O	the	det	12	SENT_92	[p7l15t2864r133b2934],
10	pseudogenes	NNS	O	pseudogene	nn	12	SENT_92	[p7l194t2864r697b2954],
11	C	NN	O	c	nn	12	SENT_92	[p7l767t2866r829b2935],
12	YP2D7	NN	O	yp2d7	conj_and	4	SENT_92	[p7l834t2865r1117b2934],
13	and	CC	O	and	_	0	SENT_92	[p7l1175t2864r1315b2934],
14	C	NN	O	c	nn	15	SENT_92	[p7l1381t2866r1443b2935],
15	YPZD8	NN	O	ypzd8	conj_and	4	SENT_92	[p7l1448t2865r1746b2947],
16	,	,	O	,	_	0	SENT_92	[p7l1448t2865r1746b2947],
17	enabling	VBG	O	enable	partmod	3	SENT_92	[p7l1813t2864r2151b2954],
18	detection	NN	O	detection	dobj	17	SENT_92	[p7l16t2971r378b3040],
19	of	IN	O	of	_	0	SENT_92	[p7l438t2971r524b3040],
20	the	DT	O	the	det	23	SENT_92	[p7l575t2971r694b3040],
21	deletion	NN	O	deletion	nn	23	SENT_92	[p7l754t2971r1073b3040],
22	allele	NN	O	allele	nn	23	SENT_92	[p7l1133t2971r1344b3040],
23	CYP2D6	NN	O	cyp2d6	prep_of	18	SENT_92	[p7l1409t2971r1854b3040],
24	*	CD	NUMBER	*	number	25	SENT_92	[p7l1409t2971r1854b3040],
25	5	CD	NUMBER	5	num	23	SENT_92	[p7l1409t2971r1854b3040],
26	which	WDT	O	which	nsubj	27	SENT_92	[p7l1913t2971r2152b3040],
27	results	VBZ	O	result	rcmod	18	SENT_92	[p7l14t3079r270b3149],
28	from	IN	O	from	_	0	SENT_92	[p7l309t3079r500b3149],
29	the	DT	O	the	det	31	SENT_92	[p7l536t3079r654b3149],
30	complete	JJ	O	complete	amod	31	SENT_92	[p7l693t3079r1055b3169],
31	loss	NN	O	loss	prep_from	27	SENT_92	[p7l1093t3079r1242b3149],
32	of	IN	O	of	_	0	SENT_92	[p7l1283t3079r1368b3149],
33	CYPZD6	NN	O	cypzd6	nn	35	SENT_92	[p7l1403t3079r1752b3150],
34	(	CD	NUMBER	(	num	35	SENT_92	[p7l1788t3079r2154b3169],
35	Gaedigk	NNP	O	Gaedigk	prep_of	31	SENT_92	[p7l1788t3079r2154b3169],
36	et	FW	O	et	nn	37	SENT_92	[p7l17t3200r87b3255],
37	al.	FW	O	al.	dep	35	SENT_92	[p7l117t3186r238b3268],
38	,	,	O	,	_	0	SENT_92	[p7l117t3186r238b3268],
39	1991	CD	DATE	1991	num	40	SENT_92	[p7l283t3187r522b3272],
40	)	NN	O	)	appos	35	SENT_92	[p7l283t3187r522b3272],
41	.	.	O	.	_	0	SENT_92	[p7l283t3187r522b3272],

1	Where	WRB	O	where	advmod	7	SENT_93	[p7l113t3295r376b3364],
2	a	DT	O	a	det	5	SENT_93	[p7l422t3317r463b3364],
3	9-16	CD	NUMBER	9-16	num	5	SENT_93	[p7l505t3294r697b3365],
4	kb	NN	O	kb	nn	5	SENT_93	[p7l717t3295r813b3364],
5	band	NN	O	band	nsubjpass	7	SENT_93	[p7l857t3295r1049b3364],
6	was	VBD	O	be	auxpass	7	SENT_93	[p7l1091t3317r1239b3364],
7	detected	VBN	O	detect	advcl	29	SENT_93	[p7l1285t3295r1615b3364],
8	by	IN	O	by	_	0	SENT_93	[p7l1656t3295r1753b3385],
9	Southern	NN	MISC	southern	nn	10	SENT_93	[p7l1799t3295r2153b3365],
10	blotting	NN	O	blotting	agent	7	SENT_93	[p7l13t3403r343b3493],
11	,	,	O	,	_	0	SENT_93	[p7l13t3403r343b3493],
12	a	DT	O	a	det	16	SENT_93	[p7l391t3425r431b3473],
13	long	JJ	O	long	amod	16	SENT_93	[p7l471t3403r644b3493],
14	PCR	NN	O	pcr	nn	16	SENT_93	[p7l687t3404r872b3473],
15	(	NN	O	(	nn	16	SENT_93	[p7l916t3403r1351b3489],
16	Johansson	NNP	PERSON	Johansson	appos	10	SENT_93	[p7l916t3403r1351b3489],
17	et	FW	O	et	nn	18	SENT_93	[p7l1394t3417r1464b3473],
18	al.	FW	O	al.	dep	16	SENT_93	[p7l1503t3403r1623b3485],
19	,	,	O	,	_	0	SENT_93	[p7l1503t3403r1623b3485],
20	1996	CD	DATE	1996	appos	10	SENT_93	[p7l1678t3403r1888b3486],
21	;	:	O	;	_	0	SENT_93	[p7l1678t3403r1888b3486],
22	Steen	NNP	PERSON	Steen	dep	20	SENT_93	[p7l1937t3404r2152b3473],
23	et	FW	O	et	nn	24	SENT_93	[p7l17t3525r87b3581],
24	al.	FW	O	al.	dep	22	SENT_93	[p7l129t3511r250b3594],
25	,	,	O	,	_	0	SENT_93	[p7l129t3511r250b3594],
26	1995	CD	DATE	1995	num	27	SENT_93	[p7l308t3511r524b3598],
27	)	NN	O	)	nsubjpass	29	SENT_93	[p7l308t3511r524b3598],
28	was	VBD	O	be	auxpass	29	SENT_93	[p7l573t3534r721b3581],
29	performed	VBN	O	perform	dep	36	SENT_93	[p7l767t3511r1180b3601],
30	to	TO	O	to	aux	31	SENT_93	[p7l1225t3522r1299b3581],
31	distinguish	VB	O	distinguish	xcomp	29	SENT_93	[p7l1346t3511r1778b3601],
32	between	IN	O	between	_	0	SENT_93	[p7l1821t3511r2153b3581],
33	the	DT	O	the	det	35	SENT_93	[p7l15t3619r133b3688],
34	hybrid	NN	O	hybrid	nn	35	SENT_93	[p7l219t3619r477b3709],
35	alleles	NNS	O	allele	prep_between	31	SENT_93	[p7l565t3619r813b3688],
36	(	VBP	O	(	_	0	SENT_93	[p7l905t3618r1432b3704],
37	CYP2D6	NN	O	cyp2d6	dobj	36	SENT_93	[p7l905t3618r1432b3704],
38	*	CD	NUMBER	*	num	39	SENT_93	[p7l905t3618r1432b3704],
39	I3	NN	O	i3	nsubj	36	SENT_93	[p7l905t3618r1432b3704],
40	and	CC	O	and	_	0	SENT_93	[p7l1521t3619r1660b3688],
41	*	NN	O	*	nn	43	SENT_93	[p7l1752t3618r1923b3704],
42	16	CD	NUMBER	16	num	43	SENT_93	[p7l1752t3618r1923b3704],
43	)	NN	O	)	conj_and	39	SENT_93	[p7l1752t3618r1923b3704],
44	and	CC	O	and	_	0	SENT_93	[p7l2013t3619r2153b3688],
45	CYP2D6	NN	O	cyp2d6	conj_and	39	SENT_93	[p7l20t3727r484b3797],
46	*	CD	NUMBER	*	number	47	SENT_93	[p7l20t3727r484b3797],
47	5	CD	NUMBER	5	dep	45	SENT_93	[p7l20t3727r484b3797],
48	.	.	O	.	_	0	SENT_93	[p7l20t3727r484b3797],

1	Statistical	JJ	O	statistical	amod	2	SENT_94	[p8l15t167r413b236],
2	analysis	NN	O	analysis	_	0	SENT_94	[p8l444t167r766b255],

1	All	DT	O	all	det	5	SENT_95	[p8l14t329r138b397],
2	clinical	JJ	O	clinical	amod	5	SENT_95	[p8l167t329r458b398],
3	and	CC	O	and	_	0	SENT_95	[p8l488t329r628b398],
4	genotyping	NN	O	genotyping	conj_and	2	SENT_95	[p8l656t329r1098b419],
5	data	NNS	O	datum	nsubjpass	15	SENT_95	[p8l1128t329r1291b398],
6	were	VBD	O	be	auxpass	7	SENT_95	[p8l1317t351r1506b398],
7	entered	VBN	O	enter	_	0	SENT_95	[p8l1536t329r1827b398],
8	into	IN	O	into	_	0	SENT_95	[p8l1853t329r2004b398],
9	the	DT	O	the	det	12	SENT_95	[p8l2033t329r2151b398],
10	relational	NN	O	relational	nn	12	SENT_95	[p8l14t436r388b505],
11	database	NN	O	database	nn	12	SENT_95	[p8l441t436r778b505],
12	PARADOX	NN	O	paradox	prep_into	7	SENT_95	[p8l831t436r1315b517],
13	,	,	O	,	_	0	SENT_95	[p8l831t436r1315b517],
14	and	CC	O	and	_	0	SENT_95	[p8l1371t436r1511b505],
15	transferred	VBN	O	transfer	conj_and	7	SENT_95	[p8l1561t436r1990b505],
16	for	IN	O	for	_	0	SENT_95	[p8l2039t436r2154b505],
17	statistical	JJ	O	statistical	amod	18	SENT_95	[p8l18t544r388b614],
18	analysis	NN	O	analysis	prep_for	15	SENT_95	[p8l434t544r748b634],
19	to	TO	O	to	_	0	SENT_95	[p8l792t555r866b614],
20	SYSTAT	NNP	O	SYSTAT	prep_to	15	SENT_95	[p8l912t544r1275b614],
21	.	.	O	.	_	0	SENT_95	[p8l912t544r1275b614],

1	Statistical	JJ	O	statistical	amod	2	SENT_96	[p8l1326t544r1712b614],
2	tests	NNS	O	test	nsubj	4	SENT_96	[p8l1756t555r1928b614],
3	used	VBN	O	use	partmod	2	SENT_96	[p8l1972t544r2152b614],
4	included	VBD	O	include	_	0	SENT_96	[p8l15t652r356b721],
5	descriptive	JJ	O	descriptive	amod	6	SENT_96	[p8l411t652r841b742],
6	statistics	NNS	O	statistics	dobj	4	SENT_96	[p8l900t652r1234b721],
7	and	CC	O	and	_	0	SENT_96	[p8l1293t652r1433b721],
8	chi	NN	O	chus	nn	11	SENT_96	[p8l1488t652r1898b742],
9	—	NN	O	—	nn	11	SENT_96	[p8l1488t652r1898b742],
10	square	NN	O	square	nn	11	SENT_96	[p8l1488t652r1898b742],
11	tests	NNS	O	test	dobj	4	SENT_96	[p8l1953t662r2148b734],
12	,	,	O	,	_	0	SENT_96	[p8l1953t662r2148b734],
13	with	IN	O	with	_	0	SENT_96	[p8l15t760r189b830],
14	corrections	NNS	O	correction	prep_with	4	SENT_96	[p8l221t760r657b829],
15	for	IN	O	for	_	0	SENT_96	[p8l691t760r805b829],
16	small	JJ	O	small	amod	17	SENT_96	[p8l838t760r1047b829],
17	numbers	NNS	O	number	prep_for	14	SENT_96	[p8l1079t760r1415b829],
18	where	WRB	O	where	advmod	19	SENT_96	[p8l1449t760r1688b830],
19	applicable	JJ	O	applicable	dep	17	SENT_96	[p8l1722t760r2147b850],
20	.	.	O	.	_	0	SENT_96	[p8l1722t760r2147b850],

1	RESULTS	NNS	O	result	_	0	SENT_97	[p8l15t1029r430b1097],
2	AND	CC	O	and	cc	3	SENT_97	[p8l466t1029r676b1097],
3	DISCUSSION	NN	O	discussion	dep	1	SENT_97	[p8l710t1029r1289b1097],

1	Although	IN	O	although	mark	15	SENT_98	[p8l15t1191r388b1281],
2	195	CD	NUMBER	195	num	4	SENT_98	[p8l431t1191r562b1262],
3	depressed	JJ	O	depressed	amod	4	SENT_98	[p8l602t1191r991b1281],
4	patients	NNS	O	patient	nsubjpass	15	SENT_98	[p8l1023t1191r1328b1281],
5	(	IN	O	(	_	0	SENT_98	[p8l1368t1191r1573b1277],
6	57	CD	PERCENT	57	number	7	SENT_98	[p8l1368t1191r1573b1277],
7	%	NN	PERCENT	%	amod	8	SENT_98	[p8l1368t1191r1573b1277],
8	female	NN	O	female	prep_(	4	SENT_98	[p8l1612t1191r1901b1274],
9	,	,	O	,	_	0	SENT_98	[p8l1612t1191r1901b1274],
10	mean	VB	O	mean	dep	8	SENT_98	[p8l1939t1214r2152b1261],
11	age	NN	O	age	nn	13	SENT_98	[p8l17t1321r149b1389],
12	31.6	CD	NUMBER	31.6	num	13	SENT_98	[p8l179t1298r377b1384],
13	)	NN	O	)	dobj	10	SENT_98	[p8l179t1298r377b1384],
14	were	VBD	O	be	auxpass	15	SENT_98	[p8l407t1321r596b1368],
15	entered	VBN	O	enter	advcl	25	SENT_98	[p8l623t1299r913b1368],
16	into	IN	O	into	_	0	SENT_98	[p8l939t1299r1090b1368],
17	the	DT	O	the	det	19	SENT_98	[p8l1117t1299r1235b1368],
18	clinical	JJ	O	clinical	amod	19	SENT_98	[p8l1263t1298r1553b1368],
19	trial	NN	O	trial	prep_into	15	SENT_98	[p8l1580t1299r1759b1381],
20	,	,	O	,	_	0	SENT_98	[p8l1580t1299r1759b1381],
21	complete	JJ	O	complete	amod	23	SENT_98	[p8l1790t1299r2151b1389],
22	CYPZD6	NN	O	cypzd6	nn	23	SENT_98	[p8l20t1407r368b1478],
23	genotypes	NNS	O	genotype	nsubj	25	SENT_98	[p8l437t1418r834b1497],
24	were	VBD	O	be	cop	25	SENT_98	[p8l907t1429r1096b1477],
25	available	JJ	O	available	_	0	SENT_98	[p8l1171t1407r1522b1477],
26	on	IN	O	on	_	0	SENT_98	[p8l1595t1429r1691b1477],
27	only	JJ	O	only	quantmod	28	SENT_98	[p8l1763t1407r1935b1497],
28	125	CD	NUMBER	125	num	29	SENT_98	[p8l2015t1407r2147b1477],
29	patients	NNS	O	patient	prep_on	25	SENT_98	[p8l14t1515r343b1605],
30	,	,	O	,	_	0	SENT_98	[p8l14t1515r343b1605],
31	who	WP	O	who	nsubj	34	SENT_98	[p8l388t1515r554b1585],
32	are	VBP	O	be	cop	34	SENT_98	[p8l599t1538r715b1585],
33	the	DT	O	the	det	34	SENT_98	[p8l757t1515r875b1585],
34	subjects	NNS	O	subject	rcmod	29	SENT_98	[p8l920t1515r1233b1605],
35	for	IN	O	for	_	0	SENT_98	[p8l1276t1515r1390b1585],
36	this	DT	O	this	det	37	SENT_98	[p8l1429t1515r1568b1585],
37	paper	NN	O	paper	prep_for	34	SENT_98	[p8l1610t1538r1844b1605],
38	.	.	O	.	_	0	SENT_98	[p8l1610t1538r1844b1605],

1	Of	IN	O	of	_	0	SENT_99	[p8l1892t1515r1999b1585],
2	the	DT	O	the	det	4	SENT_99	[p8l2033t1515r2152b1585],
3	125	CD	NUMBER	125	num	4	SENT_99	[p8l24t1622r156b1692],
4	patients	NNS	O	patient	prep_of	8	SENT_99	[p8l197t1623r525b1713],
5	,	,	O	,	_	0	SENT_99	[p8l197t1623r525b1713],
6	115	CD	NUMBER	115	nsubjpass	8	SENT_99	[p8l576t1622r709b1692],
7	were	VBD	O	be	auxpass	8	SENT_99	[p8l751t1645r940b1692],
8	inferred	VBN	O	infer	_	0	SENT_99	[p8l978t1623r1292b1692],
9	as	IN	O	as	_	0	SENT_99	[p8l1330t1645r1406b1692],
10	EMS	NNP	O	EMS	prep_as	8	SENT_99	[p8l1445t1624r1627b1692],
11	on	IN	O	on	_	0	SENT_99	[p8l1668t1645r1763b1692],
12	the	DT	O	the	det	13	SENT_99	[p8l1801t1623r1919b1692],
13	basis	NN	O	basis	prep_on	8	SENT_99	[p8l1955t1623r2150b1692],
14	of	IN	O	of	_	0	SENT_99	[p8l16t1731r101b1800],
15	genotype	NN	O	genotype	prep_of	13	SENT_99	[p8l141t1742r500b1821],
16	as	IN	O	as	mark	18	SENT_99	[p8l549t1753r625b1800],
17	they	PRP	O	they	nsubj	18	SENT_99	[p8l672t1731r839b1821],
18	carried	VBD	O	carry	advcl	8	SENT_99	[p8l886t1731r1160b1800],
19	wild	JJ	O	wild	amod	23	SENT_99	[p8l1205t1731r1379b1801],
20	type	NN	O	type	nn	23	SENT_99	[p8l1423t1741r1591b1821],
21	(	CD	NUMBER	(	num	23	SENT_99	[p8l1640t1731r2149b1816],
22	CYP2D6	NN	O	cyp2d6	nn	23	SENT_99	[p8l1640t1731r2149b1816],
23	*	NN	O	*	nsubj	25	SENT_99	[p8l1640t1731r2149b1816],
24	1	CD	NUMBER	1	num	25	SENT_99	[p8l1640t1731r2149b1816],
25	)	CD	NUMBER	)	xcomp	18	SENT_99	[p8l1640t1731r2149b1816],
26	or	CC	O	or	_	0	SENT_99	[p8l16t1861r97b1908],
27	intermediate	JJ	O	intermediate	amod	30	SENT_99	[p8l133t1839r629b1908],
28	(	NN	O	(	nn	30	SENT_99	[p8l672t1839r1172b1925],
29	CYP2D6	NN	O	cyp2d6	nn	30	SENT_99	[p8l672t1839r1172b1925],
30	*	NN	O	*	xcomp	18	SENT_99	[p8l672t1839r1172b1925],
31	2	CD	NUMBER	2	dep	30	SENT_99	[p8l672t1839r1172b1925],
32	,	,	O	,	_	0	SENT_99	[p8l672t1839r1172b1925],
33	*	CD	NUMBER	*	number	37	SENT_99	[p8l1219t1840r1311b1909],
34	9	CD	NUMBER	9	number	37	SENT_99	[p8l1219t1840r1311b1909],
35	or	CC	O	or	_	0	SENT_99	[p8l1349t1861r1430b1908],
36	*	CD	NUMBER	*	conj_or	37	SENT_99	[p8l1472t1840r1642b1925],
37	10	CD	NUMBER	10	num	39	SENT_99	[p8l1472t1840r1642b1925],
38	)	NN	O	)	nn	39	SENT_99	[p8l1472t1840r1642b1925],
39	alleles	NNS	O	allele	conj_or	25	SENT_99	[p8l1686t1839r1956b1908],
40	.	.	O	.	_	0	SENT_99	[p8l1686t1839r1956b1908],

1	The	DT	O	the	det	4	SENT_100	[p8l2000t1839r2151b1908],
2	other	JJ	O	other	amod	4	SENT_100	[p8l16t1947r219b2016],
3	ten	CD	NUMBER	ten	num	4	SENT_100	[p8l248t1957r368b2016],
4	patients	NNS	O	patient	nsubjpass	6	SENT_100	[p8l397t1946r703b2037],
5	were	VBD	O	be	auxpass	6	SENT_100	[p8l738t1969r927b2017],
6	classiﬁed	VBN	O	classiﬁed	_	0	SENT_100	[p8l961t1947r1327b2016],
7	as	IN	O	as	_	0	SENT_100	[p8l1359t1969r1435b2016],
8	PMs	NNS	O	pm	prep_as	6	SENT_100	[p8l1469t1948r1645b2016],
9	on	IN	O	on	_	0	SENT_100	[p8l1679t1969r1775b2016],
10	the	DT	O	the	det	11	SENT_100	[p8l1806t1947r1924b2016],
11	basis	NN	O	basis	prep_on	8	SENT_100	[p8l1955t1947r2150b2016],
12	of	IN	O	of	_	0	SENT_100	[p8l16t2055r101b2124],
13	genotype	NN	O	genotype	prep_of	11	SENT_100	[p8l129t2065r511b2145],
14	,	,	O	,	_	0	SENT_100	[p8l129t2065r511b2145],
15	as	IN	O	as	mark	18	SENT_100	[p8l550t2077r626b2124],
16	they	PRP	O	they	nsubj	18	SENT_100	[p8l660t2055r828b2145],
17	were	VBD	O	be	cop	18	SENT_100	[p8l861t2077r1050b2125],
18	homozygous	JJ	O	homozygous	advcl	6	SENT_100	[p8l1084t2055r1587b2145],
19	or	CC	O	or	_	0	SENT_100	[p8l1624t2077r1704b2124],
20	compound	JJ	O	compound	amod	21	SENT_100	[p8l1736t2055r2153b2145],
21	heterozygous	JJ	O	heterozygous	advcl	6	SENT_100	[p8l14t2163r540b2253],
22	for	IN	O	for	mark	26	SENT_100	[p8l569t2163r683b2233],
23	two	CD	NUMBER	two	num	25	SENT_100	[p8l707t2174r852b2233],
24	defective	JJ	O	defective	amod	25	SENT_100	[p8l879t2163r1239b2233],
25	alleles	NNS	O	allele	nsubj	26	SENT_100	[p8l1267t2163r1515b2233],
26	(	VBP	O	(	advcl	18	SENT_100	[p8l1546t2163r2152b2249],
27	CYP2D6	NN	O	cyp2d6	dobj	26	SENT_100	[p8l1546t2163r2152b2249],
28	*	CD	NUMBER	*	number	29	SENT_100	[p8l1546t2163r2152b2249],
29	4	CD	NUMBER	4	dep	27	SENT_100	[p8l1546t2163r2152b2249],
30	/	:	O	/	punct	35	SENT_100	[p8l1546t2163r2152b2249],
31	*	CD	NUMBER	*	number	35	SENT_100	[p8l1546t2163r2152b2249],
32	4	CD	NUMBER	4	number	35	SENT_100	[p8l1546t2163r2152b2249],
33	or	CC	O	or	_	0	SENT_100	[p8l16t2293r97b2340],
34	*	CD	NUMBER	*	dep	29	SENT_100	[p8l131t2271r402b2356],
35	4	CD	NUMBER	4	dep	29	SENT_100	[p8l131t2271r402b2356],
36	/	:	O	/	punct	35	SENT_100	[p8l131t2271r402b2356],
37	*	CD	NUMBER	*	number	38	SENT_100	[p8l131t2271r402b2356],
38	5	CD	NUMBER	5	num	39	SENT_100	[p8l131t2271r402b2356],
39	)	NN	O	)	dep	29	SENT_100	[p8l131t2271r402b2356],
40	.	.	O	.	_	0	SENT_100	[p8l131t2271r402b2356],

1	No	DT	O	no	det	9	SENT_101	[p8l437t2272r554b2340],
2	duplicated	JJ	O	duplicated	amod	9	SENT_101	[p8l587t2271r1000b2361],
3	(	NN	O	(	nn	9	SENT_101	[p8l1033t2271r1130b2356],
4	C	NN	O	c	nn	9	SENT_101	[p8l1033t2271r1130b2356],
5	YP2D6	NN	O	yp2d6	nn	9	SENT_101	[p8l1136t2270r1537b2341],
6	*	CD	NUMBER	*	num	9	SENT_101	[p8l1136t2270r1537b2341],
7	N	NN	O	n	nn	9	SENT_101	[p8l1136t2270r1537b2341],
8	X	NN	O	x	nn	9	SENT_101	[p8l1562t2290r1610b2338],
9	M	NN	O	m	nsubjpass	15	SENT_101	[p8l1638t2271r1752b2356],
10	)	CD	NUMBER	)	dep	9	SENT_101	[p8l1638t2271r1752b2356],
11	or	CC	O	or	_	0	SENT_101	[p8l1786t2293r1867b2340],
12	hybrid	NN	O	hybrid	nn	13	SENT_101	[p8l1895t2271r2153b2361],
13	alleles	NNS	O	allele	nsubjpass	15	SENT_101	[p8l17t2379r265b2448],
14	were	VBD	O	be	auxpass	15	SENT_101	[p8l301t2401r489b2449],
15	detected	VBN	O	detect	_	0	SENT_101	[p8l524t2379r853b2448],
16	in	IN	O	in	_	0	SENT_101	[p8l886t2379r961b2447],
17	this	DT	O	this	det	18	SENT_101	[p8l993t2379r1132b2448],
18	population	NN	O	population	prep_in	15	SENT_101	[p8l1166t2379r1609b2469],
19	.	.	O	.	_	0	SENT_101	[p8l1166t2379r1609b2469],

1	Of	IN	O	of	_	0	SENT_102	[p8l116t2487r222b2557],
2	the	DT	O	the	det	4	SENT_102	[p8l261t2487r380b2557],
3	125	CD	NUMBER	125	num	4	SENT_102	[p8l437t2487r569b2557],
4	patients	NNS	O	patient	prep_of	37	SENT_102	[p8l618t2487r925b2577],
5	who	WP	O	who	nsubj	6	SENT_102	[p8l974t2487r1140b2557],
6	commenced	VBD	O	commence	rcmod	4	SENT_102	[p8l1188t2487r1666b2557],
7	the	DT	O	the	det	20	SENT_102	[p8l1712t2487r1831b2557],
8	antidepressant	JJ	O	antidepressant	amod	20	SENT_102	[p8l1880t2487r2149b2557, p8l14t2605r339b2685],
9	to	TO	O	to	_	0	SENT_102	[p8l386t2605r460b2664],
10	which	WDT	O	which	dobj	14	SENT_102	[p8l507t2595r746b2664],
11	they	PRP	O	they	nsubjpass	14	SENT_102	[p8l795t2595r962b2685],
12	had	VBD	O	have	aux	14	SENT_102	[p8l1009t2595r1152b2664],
13	been	VBN	O	be	auxpass	14	SENT_102	[p8l1198t2595r1385b2664],
14	randomized	VBN	O	randomize	prepc_to	8	SENT_102	[p8l1432t2595r1921b2677],
15	,	,	O	,	_	0	SENT_102	[p8l1432t2595r1921b2677],
16	15	CD	PERCENT	15	num	17	SENT_102	[p8l1982t2594r2147b2665],
17	%	NN	PERCENT	%	dobj	14	SENT_102	[p8l1982t2594r2147b2665],
18	(	CD	NUMBER	(	number	19	SENT_102	[p8l18t2702r301b2788],
19	10/65	CD	NUMBER	10/65	num	20	SENT_102	[p8l18t2702r301b2788],
20	)	NN	O	)	dobj	6	SENT_102	[p8l18t2702r301b2788],
21	who	WP	O	who	nsubjpass	23	SENT_102	[p8l366t2703r532b2773],
22	were	VBD	O	be	auxpass	23	SENT_102	[p8l593t2725r782b2773],
23	prescribed	VBN	O	prescribe	rcmod	20	SENT_102	[p8l842t2703r1255b2793],
24	ﬂuoxetine	NN	O	ﬂuoxetine	dobj	23	SENT_102	[p8l1317t2703r1709b2772],
25	and	CC	O	and	_	0	SENT_102	[p8l1773t2703r1912b2772],
26	30	CD	PERCENT	30	num	27	SENT_102	[p8l1976t2703r2147b2773],
27	%	NN	PERCENT	%	dobj	23	SENT_102	[p8l1976t2703r2147b2773],
28	(	CD	NUMBER	(	number	29	SENT_102	[p8l18t2810r301b2895],
29	18/60	CD	NUMBER	18/60	num	30	SENT_102	[p8l18t2810r301b2895],
30	)	NN	O	)	nsubj	37	SENT_102	[p8l18t2810r301b2895],
31	who	WP	O	who	nsubjpass	33	SENT_102	[p8l361t2810r526b2879],
32	were	VBD	O	be	auxpass	33	SENT_102	[p8l582t2832r771b2879],
33	prescribed	VBN	O	prescribe	rcmod	30	SENT_102	[p8l827t2810r1241b2899],
34	nortriptyline	NN	O	nortriptyline	dobj	33	SENT_102	[p8l1296t2810r1790b2899],
35	did	VBD	O	do	aux	37	SENT_102	[p8l1849t2810r1973b2879],
36	not	RB	O	not	neg	37	SENT_102	[p8l2028t2820r2154b2879],
37	complete	VB	O	complete	_	0	SENT_102	[p8l16t2919r377b3009],
38	an	DT	O	a	det	44	SENT_102	[p8l461t2941r550b2988],
39	adequate	JJ	O	adequate	amod	44	SENT_102	[p8l632t2919r980b3009],
40	6	CD	DURATION	6	tmod	39	SENT_102	[p8l1063t2919r1107b2989],
41	Week	NN	DURATION	week	nn	44	SENT_102	[p8l1189t2919r1399b2989],
42	trial	NN	O	trial	nn	44	SENT_102	[p8l1476t2919r1634b2988],
43	(	CD	NUMBER	(	num	44	SENT_102	[p8l1718t2898r1844b3008],
44	X2	NN	O	x2	dobj	37	SENT_102	[p8l1718t2898r1844b3008],
45	=	JJ	O	=	amod	44	SENT_102	[p8l1867t2950r1934b2974],
46	3.83	CD	NUMBER	3.83	tmod	45	SENT_102	[p8l1959t2919r2148b3001],
47	,	,	O	,	_	0	SENT_102	[p8l1959t2919r2148b3001],
48	p	NN	O	p	appos	44	SENT_102	[p8l6t3051r60b3116],
49	=	JJ	O	=	amod	51	SENT_102	[p8l85t3027r398b3112],
50	0.05	CD	NUMBER	0.05	tmod	49	SENT_102	[p8l85t3027r398b3112],
51	)	NN	O	)	dep	48	SENT_102	[p8l85t3027r398b3112],
52	.	.	O	.	_	0	SENT_102	[p8l85t3027r398b3112],

1	One	CD	NUMBER	one	num	2	SENT_103	[p8l444t3027r604b3097],
2	patient	NN	O	patient	nsubj	9	SENT_103	[p8l643t3027r913b3117],
3	on	IN	O	on	_	0	SENT_103	[p8l954t3049r1049b3096],
4	ﬂuoxetine	NN	O	ﬂuoxetine	prep_on	2	SENT_103	[p8l1090t3027r1482b3096],
5	and	CC	O	and	_	0	SENT_103	[p8l1525t3027r1664b3096],
6	six	CD	NUMBER	six	conj_and	2	SENT_103	[p8l1706t3027r1815b3096],
7	on	IN	O	on	_	0	SENT_103	[p8l1857t3049r1951b3096],
8	nortriptyline	NN	O	nortriptyline	prep_on	6	SENT_103	[p8l1990t3049r2149b3096, p8l15t3135r376b3225],
9	discontinued	VBN	O	discontinue	_	0	SENT_103	[p8l421t3135r926b3205],
10	the	DT	O	the	det	11	SENT_103	[p8l969t3135r1087b3205],
11	antidepressant	JJ	O	antidepressant	dobj	9	SENT_103	[p8l1132t3135r1697b3225],
12	within	IN	O	within	_	0	SENT_103	[p8l1740t3135r1991b3205],
13	the	DT	O	the	det	15	SENT_103	[p8l2033t3135r2151b3205],
14	ﬁrst	NN	O	ﬁrst	nn	15	SENT_103	[p8l16t3243r166b3312],
15	week	NN	DURATION	week	prep_within	11	SENT_103	[p8l190t3243r420b3325],
16	;	:	O	;	_	0	SENT_103	[p8l190t3243r420b3325],
17	six	CD	NUMBER	six	dep	15	SENT_103	[p8l452t3243r561b3312],
18	on	IN	O	on	_	0	SENT_103	[p8l588t3265r683b3312],
19	ﬂuoxetine	NN	O	ﬂuoxetine	prep_on	17	SENT_103	[p8l709t3242r1101b3312],
20	and	CC	O	and	_	0	SENT_103	[p8l1128t3243r1267b3312],
21	seven	CD	NUMBER	seven	dep	15	SENT_103	[p8l1295t3265r1512b3313],
22	on	IN	O	on	_	0	SENT_103	[p8l1537t3265r1633b3312],
23	nortriptyline	NN	O	nortriptyline	prep_on	21	SENT_103	[p8l1656t3243r2151b3333],
24	discontinued	VBN	O	discontinue	partmod	23	SENT_103	[p8l16t3351r521b3420],
25	during	IN	O	during	_	0	SENT_103	[p8l552t3351r807b3441],
26	weeks	NNS	DURATION	week	prep_during	24	SENT_103	[p8l839t3351r1082b3420],
27	1-3	CD	NUMBER	1-3	num	11	SENT_103	[p8l1124t3351r1284b3433],
28	;	:	O	;	_	0	SENT_103	[p8l1124t3351r1284b3433],
29	and	CC	O	and	_	0	SENT_103	[p8l1321t3351r1460b3420],
30	three	CD	NUMBER	three	num	31	SENT_103	[p8l1491t3351r1686b3420],
31	patients	NNS	O	patient	dobj	9	SENT_103	[p8l1717t3351r2023b3441],
32	on	IN	O	on	_	0	SENT_103	[p8l2057t3373r2152b3420],
33	ﬂuoxetine	NN	O	ﬂuoxetine	prep_on	31	SENT_103	[p8l17t3459r408b3529],
34	and	CC	O	and	_	0	SENT_103	[p8l480t3459r619b3529],
35	four	CD	NUMBER	four	conj_and	11	SENT_103	[p8l687t3459r851b3529],
36	on	IN	O	on	_	0	SENT_103	[p8l919t3481r1014b3529],
37	nortriptyline	NN	O	nortriptyline	prep_on	35	SENT_103	[p8l1083t3459r1577b3549],
38	discontinued	VBN	O	discontinue	partmod	37	SENT_103	[p8l1648t3459r2153b3529],
39	between	IN	O	between	_	0	SENT_103	[p8l14t3567r344b3636],
40	weeks	NNS	DURATION	week	prep_between	38	SENT_103	[p8l376t3567r619b3636],
41	3	CD	NUMBER	3	num	40	SENT_103	[p8l656t3567r695b3637],
42	and	CC	O	and	_	0	SENT_103	[p8l734t3567r873b3636],
43	6	CD	NUMBER	6	prep_between	38	SENT_103	[p8l906t3566r971b3636],
44	.	.	O	.	_	0	SENT_103	[p8l906t3566r971b3636],

1	One	CD	NUMBER	one	num	2	SENT_104	[p8l1010t3567r1170b3637],
2	patient	NN	O	patient	nsubj	11	SENT_104	[p8l1202t3567r1472b3657],
3	on	IN	O	on	_	0	SENT_104	[p8l1505t3589r1601b3636],
4	nortriptyline	NN	O	nortriptyline	prep_on	2	SENT_104	[p8l1631t3567r2148b3657],
5	,	,	O	,	_	0	SENT_104	[p8l1631t3567r2148b3657],
6	with	IN	O	with	_	0	SENT_104	[p8l15t3675r189b3745],
7	moderate	JJ	O	moderate	amod	9	SENT_104	[p8l222t3675r590b3744],
8	postural	JJ	O	postural	amod	9	SENT_104	[p8l623t3675r941b3765],
9	hypotension	NN	O	hypotension	prep_with	2	SENT_104	[p8l975t3675r1480b3765],
10	,	,	O	,	_	0	SENT_104	[p8l975t3675r1480b3765],
11	took	VBD	O	take	_	0	SENT_104	[p8l1517t3675r1693b3744],
12	the	DT	O	the	det	13	SENT_104	[p8l1725t3675r1844b3744],
13	antidepressant	JJ	O	antidepressant	dobj	11	SENT_104	[p8l1880t3675r2148b3744, p9l14t27r339b106],

1	for	IN	O	for	_	0	SENT_105	[p9l380t16r494b86],
2	6	CD	DURATION	6	num	3	SENT_105	[p9l536t16r579b86],
3	weeks	NNS	NUMBER	week	pobj	1	SENT_105	[p9l623t16r866b86],
4	but	CC	O	but	dep	5	SENT_105	[p9l909t16r1036b86],
5	at	IN	O	at	dep	3	SENT_105	[p9l1077t27r1146b86],
6	an	DT	O	a	det	8	SENT_105	[p9l1188t38r1278b86],
7	inadequate	JJ	O	inadequate	amod	8	SENT_105	[p9l1320t16r1748b106],
8	dose	NN	O	dose	pobj	5	SENT_105	[p9l1792t16r1969b86],
9	and	CC	O	and	_	0	SENT_105	[p9l2013t16r2153b86],
10	with	IN	O	with	conj_and	1	SENT_105	[p9l15t124r189b193],
11	inadequate	JJ	O	inadequate	amod	13	SENT_105	[p9l236t124r665b214],
12	plasma	NN	O	plasma	nn	13	SENT_105	[p9l711t124r992b214],
13	levels	NNS	O	level	pobj	10	SENT_105	[p9l1039t124r1286b206],
14	,	,	O	,	_	0	SENT_105	[p9l1039t124r1286b206],
15	and	CC	O	and	_	0	SENT_105	[p9l1339t124r1478b193],
16	was	VBD	O	be	auxpass	17	SENT_105	[p9l1525t146r1674b193],
17	deemed	VBN	O	deem	conj_and	1	SENT_105	[p9l1724t124r2030b193],
18	to	TO	O	to	xcomp	17	SENT_105	[p9l2078t134r2151b193],

1	Hum	NNP	O	Hum	nn	4	SENT_106	[p9l320t396r492b456],
2	Psychopharmacol	NNP	O	Psychopharmacol	nn	4	SENT_106	[p9l520t394r1164b473],
3	Clin	NNP	O	Clin	nn	4	SENT_106	[p9l1197t394r1343b457],
4	Exp	NNP	O	Exp	_	0	SENT_106	[p9l1371t396r1508b473],
5	2004	CD	DATE	2004	num	4	SENT_106	[p9l1540t394r1735b467],
6	;	:	O	;	_	0	SENT_106	[p9l1540t394r1735b467],
7	19	CD	NUMBER	19	num	9	SENT_106	[p9l1773t393r1875b456],
8	:	:	O	:	_	0	SENT_106	[p9l1773t393r1875b456],
9	17-23	CD	DATE	17-23	dep	4	SENT_106	[p9l1918t394r2148b456],
10	.	.	O	.	_	0	SENT_106	[p9l1918t394r2148b456],

1	20	CD	NUMBER	20	_	0	SENT_107	[p9l539t548r578b577],
2	R.	NNP	PERSON	R.	nn	5	SENT_107	[p9l1294t556r1322b577],
3	L.	NNP	PERSON	L.	nn	5	SENT_107	[p9l1338t556r1365b577],
4	ROBERTS	NNP	PERSON	ROBERTS	nn	5	SENT_107	[p9l1381t556r1522b577],
5	ETAL	NNP	O	ETAL	dep	1	SENT_107	[p9l1536t555r1621b577],
6	.	.	O	.	_	0	SENT_107	[p9l1536t555r1621b577],

1	Table	NNP	O	Table	_	0	SENT_108	[p9l8t725r182b780],
2	1	CD	NUMBER	1	dep	1	SENT_108	[p9l209t725r255b780],
3	.	.	O	.	_	0	SENT_108	[p9l209t725r255b780],

1	Frequency	NN	O	frequency	_	0	SENT_109	[p9l339t726r671b797],
2	of	IN	O	of	_	0	SENT_109	[p9l692t725r760b780],
3	patients	NNS	O	patient	prep_of	1	SENT_109	[p9l773t725r1018b797],
4	who	WP	O	who	nsubj	5	SENT_109	[p9l1039t725r1172b780],
5	failed	VBD	O	fail	rcmod	3	SENT_109	[p9l1193t725r1373b780],
6	to	TO	O	to	aux	7	SENT_109	[p9l1391t733r1449b780],
7	complete	VB	O	complete	xcomp	5	SENT_109	[p9l1470t725r1759b797],
8	an	DT	O	a	det	13	SENT_109	[p9l1780t743r1852b780],
9	adequate	JJ	O	adequate	amod	13	SENT_109	[p9l1872t725r2152b797],
10	6	CD	DURATION	6	number	12	SENT_109	[p9l10t813r45b869],
11	week	NN	NUMBER	week	dep	12	SENT_109	[p9l75t813r242b869],
12	antidepressant	JJ	O	antidepressant	amod	13	SENT_109	[p9l270t814r722b886],
13	trial	NN	O	trial	dobj	7	SENT_109	[p9l749t814r876b869],
14	by	IN	O	by	_	0	SENT_109	[p9l903t813r981b886],
15	drug	NN	O	drug	nn	18	SENT_109	[p9l1010t814r1152b886],
16	and	CC	O	and	_	0	SENT_109	[p9l1183t814r1294b869],
17	metabolizer	NN	O	metabolizer	nn	18	SENT_109	[p9l1322t813r1698b869],
18	status	NN	O	status	prep_by	7	SENT_109	[p9l1727t822r1902b869],

1	Metabolizer	NNP	O	Metabolizer	nn	2	SENT_110	[p9l8t994r393b1050],
2	status	NN	O	status	nsubj	3	SENT_110	[p9l419t1003r594b1050],
3	Percent	NN	O	percent	_	0	SENT_110	[p9l840t996r1077b1050],
4	(	CD	NUMBER	(	num	6	SENT_110	[p9l1105t995r1189b1063],
5	n	NN	O	n	nn	6	SENT_110	[p9l1105t995r1189b1063],
6	)	NN	O	)	dobj	3	SENT_110	[p9l1105t995r1189b1063],
7	who	WP	O	who	nsubj	8	SENT_110	[p9l1218t994r1351b1050],
8	failed	VBD	O	fail	rcmod	6	SENT_110	[p9l1378t994r1558b1050],
9	to	TO	O	to	aux	10	SENT_110	[p9l1583t1003r1642b1050],
10	complete	VB	O	complete	xcomp	8	SENT_110	[p9l1669t994r1958b1066],

1	6	CD	DURATION	6	num	2	SENT_111	[p9l1210t1083r1245b1138],
2	week	NN	DURATION	week	_	0	SENT_111	[p9l1272t1083r1439b1138],
3	trial	NN	O	trial	dep	2	SENT_111	[p9l1463t1083r1589b1138],

1	Fluoxetine	NNP	O	Fluoxetine	nn	3	SENT_112	[p9l719t1279r1056b1335],
2	Nortriptyline	NNP	O	Nortriptyline	nn	3	SENT_112	[p9l1192t1279r1605b1351],
3	Total	NNP	O	Total	_	0	SENT_112	[p9l1847t1279r2006b1335],

1	EM	NNP	ORGANIZATION	EM	dep	11	SENT_113	[p9l8t1473r125b1526],
2	14	CD	PERCENT	14	num	3	SENT_113	[p9l736t1472r868b1527],
3	%	NN	PERCENT	%	dep	1	SENT_113	[p9l736t1472r868b1527],
4	(	CD	PERCENT	(	number	5	SENT_113	[p9l899t1472r1086b1540],
5	8/59	CD	PERCENT	8/59	num	3	SENT_113	[p9l899t1472r1086b1540],
6	)	CD	PERCENT	)	num	8	SENT_113	[p9l899t1472r1086b1540],
7	30	CD	PERCENT	30	num	8	SENT_113	[p9l1224t1472r1362b1527],
8	%	NN	PERCENT	%	dep	3	SENT_113	[p9l1224t1472r1362b1527],
9	(	CD	NUMBER	(	dep	11	SENT_113	[p9l1393t1472r1620b1540],
10	17/56	CD	NUMBER	17/56	num	11	SENT_113	[p9l1393t1472r1620b1540],
11	)	NN	O	)	dep	19	SENT_113	[p9l1393t1472r1620b1540],
12	22	CD	PERCENT	22	num	13	SENT_113	[p9l1697t1472r1836b1527],
13	%	NN	PERCENT	%	dep	11	SENT_113	[p9l1697t1472r1836b1527],
14	(	CD	NUMBER	(	number	15	SENT_113	[p9l1867t1472r2134b1540],
15	25/115	CD	NUMBER	25/115	num	13	SENT_113	[p9l1867t1472r2134b1540],
16	)	CD	NUMBER	)	num	17	SENT_113	[p9l1867t1472r2134b1540],
17	PM	NN	O	pm	dep	13	SENT_113	[p9l8t1560r120b1613],
18	33	CD	PERCENT	33	num	19	SENT_113	[p9l730t1559r868b1614],
19	%	NN	PERCENT	%	dep	29	SENT_113	[p9l730t1559r868b1614],
20	(	CD	NUMBER	(	number	21	SENT_113	[p9l899t1558r1047b1627],
21	2/6	CD	NUMBER	2/6	num	22	SENT_113	[p9l899t1558r1047b1627],
22	)	NN	O	)	dep	19	SENT_113	[p9l899t1558r1047b1627],
23	25	CD	PERCENT	25	num	24	SENT_113	[p9l1223t1558r1362b1614],
24	%	NN	PERCENT	%	dep	22	SENT_113	[p9l1223t1558r1362b1614],
25	(	CD	PERCENT	(	number	26	SENT_113	[p9l1393t1559r1540b1627],
26	1/4	CD	PERCENT	1/4	num	24	SENT_113	[p9l1393t1559r1540b1627],
27	)	CD	PERCENT	)	num	29	SENT_113	[p9l1393t1559r1540b1627],
28	30	CD	PERCENT	30	num	29	SENT_113	[p9l1698t1559r1836b1614],
29	%	NN	PERCENT	%	dep	35	SENT_113	[p9l1698t1559r1836b1614],
30	(	CD	NUMBER	(	dep	29	SENT_113	[p9l1867t1559r2054b1627],
31	3/10	CD	NUMBER	3/10	number	32	SENT_113	[p9l1867t1559r2054b1627],
32	)	CD	NUMBER	)	num	33	SENT_113	[p9l1867t1559r2054b1627],
33	Total	JJ	O	total	dep	30	SENT_113	[p9l8t1646r168b1701],
34	15	CD	PERCENT	15	num	35	SENT_113	[p9l736t1646r868b1702],
35	%	NN	PERCENT	%	dep	43	SENT_113	[p9l736t1646r868b1702],
36	(	CD	PERCENT	(	number	37	SENT_113	[p9l899t1646r1126b1714],
37	10/65	CD	PERCENT	10/65	dep	35	SENT_113	[p9l899t1646r1126b1714],
38	)	CD	PERCENT	)	num	40	SENT_113	[p9l899t1646r1126b1714],
39	30	CD	PERCENT	30	num	40	SENT_113	[p9l1224t1646r1362b1702],
40	%	NN	PERCENT	%	dep	37	SENT_113	[p9l1224t1646r1362b1702],
41	(	CD	NUMBER	(	num	43	SENT_113	[p9l1393t1646r1620b1714],
42	18/60	CD	NUMBER	18/60	num	43	SENT_113	[p9l1393t1646r1620b1714],
43	)	NN	O	)	_	0	SENT_113	[p9l1393t1646r1620b1714],
44	22	CD	PERCENT	22	num	45	SENT_113	[p9l1697t1646r1836b1702],
45	%	NN	PERCENT	%	dep	43	SENT_113	[p9l1697t1646r1836b1702],
46	(	CD	NUMBER	(	number	47	SENT_113	[p9l1867t1646r2134b1714],
47	28/125	CD	NUMBER	28/125	num	48	SENT_113	[p9l1867t1646r2134b1714],
48	)	NN	O	)	dep	45	SENT_113	[p9l1867t1646r2134b1714],

1	have	VB	O	have	aux	3	SENT_114	[p9l7t1965r190b2035],
2	not	RB	O	not	neg	3	SENT_114	[p9l227t1976r352b2035],
3	completed	VBN	O	complete	_	0	SENT_114	[p9l387t1965r800b2055],
4	an	DT	O	a	det	6	SENT_114	[p9l838t1987r927b2035],
5	adequate	JJ	O	adequate	amod	6	SENT_114	[p9l964t1965r1314b2055],
6	trial	NN	O	trial	dobj	3	SENT_114	[p9l1350t1965r1529b2035],
7	.	.	O	.	_	0	SENT_114	[p9l1350t1965r1529b2035],

1	Table	NNP	O	Table	nsubj	3	SENT_115	[p9l1569t1965r1786b2035],
2	1	CD	NUMBER	1	num	1	SENT_115	[p9l1832t1966r1861b2034],
3	shows	VBZ	O	show	_	0	SENT_115	[p9l1908t1965r2145b2035],
4	the	DT	O	the	det	5	SENT_115	[p9l8t2073r126b2143],
5	likelihood	NN	O	likelihood	dobj	3	SENT_115	[p9l173t2073r575b2143],
6	of	IN	O	of	_	0	SENT_115	[p9l621t2073r707b2143],
7	completing	VBG	O	complete	prepc_of	5	SENT_115	[p9l747t2073r1191b2163],
8	an	DT	O	a	det	10	SENT_115	[p9l1240t2096r1330b2143],
9	antidepressant	JJ	O	antidepressant	amod	10	SENT_115	[p9l1377t2073r1944b2163],
10	trial	NN	O	trial	dobj	7	SENT_115	[p9l1989t2073r2147b2143],
11	by	IN	O	by	_	0	SENT_115	[p9l7t2181r104b2271],
12	drug	NN	O	drug	nn	15	SENT_115	[p9l130t2181r307b2271],
13	and	CC	O	and	_	0	SENT_115	[p9l335t2181r474b2250],
14	metabolizer	NN	O	metabolizer	nn	15	SENT_115	[p9l499t2181r970b2250],
15	status	NN	O	status	prep_by	7	SENT_115	[p9l996t2191r1236b2250],
16	.	.	O	.	_	0	SENT_115	[p9l996t2191r1236b2250],

1	While	IN	O	while	mark	7	SENT_116	[p9l1265t2181r1507b2250],
2	patients	NNS	O	patient	nsubj	7	SENT_116	[p9l1531t2181r1838b2271],
3	on	IN	O	on	_	0	SENT_116	[p9l1866t2203r1962b2250],
4	nortriptyline	NN	O	nortriptyline	prep_on	2	SENT_116	[p9l1986t2203r2145b2250, p9l8t2289r370b2379],
5	were	VBD	O	be	cop	7	SENT_116	[p9l418t2311r607b2359],
6	less	RBR	O	less	advmod	7	SENT_116	[p9l656t2289r800b2359],
7	likely	JJ	O	likely	advcl	15	SENT_116	[p9l849t2289r1074b2379],
8	to	TO	O	to	aux	9	SENT_116	[p9l1122t2300r1196b2359],
9	complete	VB	O	complete	xcomp	7	SENT_116	[p9l1245t2289r1607b2379],
10	an	DT	O	a	det	12	SENT_116	[p9l1658t2311r1748b2359],
11	adequate	JJ	O	adequate	amod	12	SENT_116	[p9l1798t2289r2146b2379],
12	trial	NN	O	trial	dobj	9	SENT_116	[p9l8t2397r187b2480],
13	,	,	O	,	_	0	SENT_116	[p9l8t2397r187b2480],
14	there	EX	O	there	expl	15	SENT_116	[p9l215t2397r411b2467],
15	was	VBD	O	be	_	0	SENT_116	[p9l434t2420r582b2467],
16	no	DT	O	no	det	18	SENT_116	[p9l608t2420r704b2467],
17	signiﬁcant	JJ	O	signiﬁcant	amod	18	SENT_116	[p9l732t2397r1141b2487],
18	effect	NN	O	effect	nsubj	15	SENT_116	[p9l1164t2397r1387b2467],
19	of	IN	O	of	_	0	SENT_116	[p9l1411t2397r1497b2467],
20	metabolizer	NN	O	metabolizer	nn	21	SENT_116	[p9l1514t2397r1985b2467],
21	status	NN	O	status	prep_of	18	SENT_116	[p9l2010t2408r2145b2467, p9l8t2515r119b2574],
22	(	CD	NUMBER	(	num	21	SENT_116	[p9l155t2505r299b2590],
23	i.e.	FW	O	i.e.	nsubj	28	SENT_116	[p9l155t2505r299b2590],
24	PMs	NNS	O	pm	dep	23	SENT_116	[p9l335t2506r511b2574],
25	were	VBD	O	be	cop	28	SENT_116	[p9l545t2527r734b2574],
26	not	RB	O	not	neg	28	SENT_116	[p9l766t2515r892b2574],
27	more	RBR	O	more	advmod	28	SENT_116	[p9l922t2527r1123b2574],
28	likely	JJ	O	likely	rcmod	18	SENT_116	[p9l1155t2505r1379b2595],
29	to	TO	O	to	aux	30	SENT_116	[p9l1411t2515r1484b2574],
30	fail	VB	O	fail	xcomp	28	SENT_116	[p9l1517t2505r1647b2574],
31	to	TO	O	to	aux	32	SENT_116	[p9l1678t2515r1752b2574],
32	complete	VB	O	complete	xcomp	30	SENT_116	[p9l1785t2505r2147b2595],
33	an	DT	O	a	det	36	SENT_116	[p9l10t2635r99b2683],
34	adequate	JJ	O	adequate	amod	36	SENT_116	[p9l127t2613r477b2703],
35	trial	NN	O	trial	nn	36	SENT_116	[p9l504t2613r715b2699],
36	)	NN	O	)	dobj	32	SENT_116	[p9l504t2613r715b2699],
37	.	.	O	.	_	0	SENT_116	[p9l504t2613r715b2699],

1	Of	IN	O	of	_	0	SENT_117	[p9l749t2613r855b2683],
2	the	DT	O	the	det	4	SENT_117	[p9l875t2613r994b2683],
3	three	CD	NUMBER	three	num	4	SENT_117	[p9l1021t2613r1217b2683],
4	PMs	NNS	O	pm	prep_of	19	SENT_117	[p9l1245t2615r1421b2683],
5	who	WP	O	who	nsubj	8	SENT_117	[p9l1450t2613r1616b2683],
6	did	VBD	O	do	aux	8	SENT_117	[p9l1645t2613r1769b2683],
7	not	RB	O	not	neg	8	SENT_117	[p9l1794t2624r1920b2683],
8	complete	VB	O	complete	rcmod	4	SENT_117	[p9l1946t2635r2145b2683, p9l7t2721r198b2811],
9	an	DT	O	a	det	11	SENT_117	[p9l239t2744r328b2791],
10	adequate	JJ	O	adequate	amod	11	SENT_117	[p9l367t2721r717b2811],
11	trial	NN	O	trial	dobj	8	SENT_117	[p9l755t2721r912b2791],
12	one	CD	NUMBER	one	nsubj	19	SENT_117	[p9l952t2744r1091b2791],
13	on	IN	O	on	_	0	SENT_117	[p9l1130t2744r1226b2791],
14	ﬂuoxetine	NN	O	ﬂuoxetine	prep_on	12	SENT_117	[p9l1264t2721r1657b2791],
15	and	CC	O	and	_	0	SENT_117	[p9l1696t2721r1836b2791],
16	one	CD	NUMBER	one	nsubj	19	SENT_117	[p9l1874t2744r2013b2791],
17	on	IN	O	on	_	0	SENT_117	[p9l2052t2744r2148b2791],
18	nortriptyline	NN	O	nortriptyline	prep_on	16	SENT_117	[p9l8t2829r503b2919],
19	discontinued	VBN	O	discontinue	_	0	SENT_117	[p9l555t2828r1061b2898],
20	between	IN	O	between	_	0	SENT_117	[p9l1110t2829r1440b2898],
21	weeks	NNS	DURATION	week	prep_between	19	SENT_117	[p9l1491t2829r1734b2898],
22	1	CD	NUMBER	1	num	21	SENT_117	[p9l1797t2829r1825b2897],
23	and	CC	O	and	_	0	SENT_117	[p9l1887t2829r2026b2898],
24	3	CD	DATE	3	prep_between	19	SENT_117	[p9l2079t2829r2144b2911],
25	,	,	O	,	_	0	SENT_117	[p9l2079t2829r2144b2911],
26	and	CC	O	and	_	0	SENT_117	[p9l10t2937r149b3007],
27	one	CD	NUMBER	one	num	28	SENT_117	[p9l193t2959r332b3007],
28	patient	NN	O	patient	nsubj	31	SENT_117	[p9l376t2937r647b3027],
29	on	IN	O	on	_	0	SENT_117	[p9l691t2959r786b3007],
30	ﬂuoxetine	NN	O	ﬂuoxetine	prep_on	28	SENT_117	[p9l831t2937r1225b3007],
31	discontinued	VBN	O	discontinue	conj_and	19	SENT_117	[p9l1269t2937r1776b3007],
32	between	IN	O	between	_	0	SENT_117	[p9l1817t2937r2148b3007],
33	weeks	NNS	DURATION	week	prep_between	31	SENT_117	[p9l8t3044r251b3113],
34	3	CD	NUMBER	3	num	33	SENT_117	[p9l289t3045r328b3113],
35	and	CC	O	and	_	0	SENT_117	[p9l367t3044r507b3113],
36	6	CD	NUMBER	6	prep_between	31	SENT_117	[p9l541t3044r606b3113],
37	.	.	O	.	_	0	SENT_117	[p9l541t3044r606b3113],

1	Of	IN	O	of	_	0	SENT_118	[p10l108t27r215b97],
2	the	DT	O	the	det	3	SENT_118	[p10l239t27r357b96],
3	PMs	NNS	O	pm	prep_of	14	SENT_118	[p10l388t28r564b96],
4	on	IN	O	on	_	0	SENT_118	[p10l598t49r693b96],
5	ﬂuoxetine	NN	O	ﬂuoxetine	prep_on	3	SENT_118	[p10l724t26r1140b109],
6	,	,	O	,	_	0	SENT_118	[p10l724t26r1140b109],
7	their	PRP$	O	they	poss	8	SENT_118	[p10l1173t27r1355b96],
8	dosages	NNS	O	dosage	nsubj	14	SENT_118	[p10l1384t26r1693b117],
9	at	IN	O	at	_	0	SENT_118	[p10l1728t37r1796b96],
10	6	CD	DURATION	6	num	11	SENT_118	[p10l1827t26r1870b97],
11	Weeks	NNS	DURATION	week	prep_at	8	SENT_118	[p10l1902t27r2145b96],
12	were	VBD	O	be	cop	14	SENT_118	[p10l8t157r197b205],
13	10	CD	NUMBER	10	num	14	SENT_118	[p10l240t135r326b205],
14	mg	NN	O	mg	_	0	SENT_118	[p10l346t157r492b225],
15	,	,	O	,	_	0	SENT_118	[p10l346t157r492b225],
16	20	CD	NUMBER	20	num	17	SENT_118	[p10l529t135r624b205],
17	mg	NN	O	mg	conj_and	14	SENT_118	[p10l645t157r767b225],
18	(	CD	NUMBER	(	num	20	SENT_118	[p10l805t136r979b220],
19	two	CD	NUMBER	two	num	20	SENT_118	[p10l805t136r979b220],
20	patients	NNS	O	patient	tmod	17	SENT_118	[p10l1012t135r1375b225],
21	)	RB	O	)	advmod	20	SENT_118	[p10l1012t135r1375b225],
22	,	,	O	,	_	0	SENT_118	[p10l1012t135r1375b225],
23	40	CD	NUMBER	40	num	24	SENT_118	[p10l1411t135r1507b205],
24	mg	NN	O	mg	conj_and	14	SENT_118	[p10l1527t157r1673b225],
25	,	,	O	,	_	0	SENT_118	[p10l1527t157r1673b225],
26	and	CC	O	and	_	0	SENT_118	[p10l1711t135r1851b204],
27	60	CD	NUMBER	60	num	28	SENT_118	[p10l1884t135r1978b205],
28	mg	NN	O	mg	conj_and	14	SENT_118	[p10l1998t157r2142b225],
29	.	.	O	.	_	0	SENT_118	[p10l1998t157r2142b225],

1	It	PRP	O	it	nsubj	4	SENT_119	[p10l8t245r67b313],
2	was	VBD	O	be	cop	4	SENT_119	[p10l97t266r246b313],
3	the	DT	O	the	det	4	SENT_119	[p10l279t243r398b313],
4	patient	NN	O	patient	_	0	SENT_119	[p10l429t243r700b333],
5	on	IN	O	on	_	0	SENT_119	[p10l731t266r827b313],
6	60	CD	NUMBER	60	num	7	SENT_119	[p10l860t243r954b313],
7	mg	NN	O	mg	prep_on	4	SENT_119	[p10l974t266r1097b333],
8	who	WP	O	who	nsubj	9	SENT_119	[p10l1130t243r1296b313],
9	reported	VBD	O	report	rcmod	7	SENT_119	[p10l1327t243r1659b333],
10	fatigue	NN	O	fatigue	dobj	9	SENT_119	[p10l1689t243r1963b333],
11	as	IN	O	as	_	0	SENT_119	[p10l1997t266r2073b313],
12	a	DT	O	a	det	14	SENT_119	[p10l2108t266r2149b313],
13	side	JJ	O	side	amod	14	SENT_119	[p10l11t351r165b420],
14	effect	NN	O	effect	prep_as	9	SENT_119	[p10l191t351r433b420],
15	.	.	O	.	_	0	SENT_119	[p10l191t351r433b420],

1	For	IN	O	for	_	0	SENT_120	[p10l463t352r600b420],
2	the	DT	O	the	det	4	SENT_120	[p10l622t351r741b420],
3	poor	JJ	O	poor	amod	4	SENT_120	[p10l766t373r949b441],
4	metabolizers	NNS	O	metabolizer	prep_for	9	SENT_120	[p10l972t351r1477b420],
5	on	IN	O	on	_	0	SENT_120	[p10l1506t373r1601b420],
6	nortriptyline	NN	O	nortriptyline	prep_on	4	SENT_120	[p10l1627t351r2144b441],
7	,	,	O	,	_	0	SENT_120	[p10l1627t351r2144b441],
8	all	DT	O	all	nsubj	9	SENT_120	[p10l10t459r104b528],
9	were	VBD	O	be	_	0	SENT_120	[p10l131t481r320b529],
10	on	IN	O	on	_	0	SENT_120	[p10l347t481r442b528],
11	75	CD	NUMBER	75	num	12	SENT_120	[p10l468t459r559b529],
12	mg	NN	O	mg	prep_on	9	SENT_120	[p10l584t481r706b549],
13	at	IN	O	at	_	0	SENT_120	[p10l735t469r804b528],
14	6	CD	DURATION	6	num	15	SENT_120	[p10l830t459r873b529],
15	Weeks	NNS	DURATION	week	prep_at	12	SENT_120	[p10l901t459r1166b541],
16	,	,	O	,	_	0	SENT_120	[p10l901t459r1166b541],
17	with	IN	O	with	_	0	SENT_120	[p10l1196t459r1370b528],
18	blood	NN	O	blood	nn	19	SENT_120	[p10l1393t459r1619b528],
19	levels	NNS	O	level	prep_with	9	SENT_120	[p10l1644t459r1870b529],
20	within	IN	O	within	_	0	SENT_120	[p10l1896t459r2147b529],
21	the	DT	O	the	det	25	SENT_120	[p10l8t567r126b637],
22	therapeutic	JJ	O	therapeutic	amod	25	SENT_120	[p10l160t567r599b657],
23	range	NN	O	range	nn	25	SENT_120	[p10l632t590r851b657],
24	200-400	CD	NUMBER	200-400	num	25	SENT_120	[p10l886t568r1229b637],
25	nmol/l	NN	O	nmol/l	prep_within	19	SENT_120	[p10l1249t567r1527b637],
26	.	.	O	.	_	0	SENT_120	[p10l1249t567r1527b637],

1	Table	NNP	O	Table	nsubj	3	SENT_121	[p10l106t675r323b744],
2	2	CD	NUMBER	2	num	1	SENT_121	[p10l360t675r405b743],
3	shows	VBZ	O	show	_	0	SENT_121	[p10l443t675r680b744],
4	the	DT	O	the	det	5	SENT_121	[p10l717t675r835b744],
5	number	NN	O	number	dobj	3	SENT_121	[p10l870t675r1173b744],
6	of	IN	O	of	_	0	SENT_121	[p10l1208t675r1293b744],
7	patients	NNS	O	patient	prep_of	5	SENT_121	[p10l1319t674r1625b765],
8	by	IN	O	by	_	0	SENT_121	[p10l1661t675r1758b765],
9	drug	NN	O	drug	nn	12	SENT_121	[p10l1794t674r1971b765],
10	and	CC	O	and	_	0	SENT_121	[p10l2008t675r2148b744],
11	metabolizer	NN	O	metabolizer	nn	12	SENT_121	[p10l8t783r479b852],
12	status	NN	O	status	prep_by	7	SENT_121	[p10l518t793r736b852],
13	that	WDT	O	that	nsubj	14	SENT_121	[p10l776t783r924b852],
14	reported	VBD	O	report	rcmod	5	SENT_121	[p10l960t783r1292b873],
15	clinically	RB	O	clinically	advmod	16	SENT_121	[p10l1330t783r1698b873],
16	signiﬁcant	JJ	O	signiﬁcant	amod	17	SENT_121	[p10l1739t783r2148b873],
17	ADRs	NNS	MISC	adr	dobj	14	SENT_121	[p10l8t891r250b960],
18	during	IN	O	during	_	0	SENT_121	[p10l303t891r558b981],
19	the	DT	O	the	det	20	SENT_121	[p10l610t891r729b960],
20	ﬁrst	NN	O	ﬁrst	prep_during	14	SENT_121	[p10l781t890r932b960],
21	6	CD	DURATION	6	num	22	SENT_121	[p10l982t891r1026b960],
22	weeks	NNS	NUMBER	week	tmod	20	SENT_121	[p10l1078t891r1342b960],
23	.	.	O	.	_	0	SENT_121	[p10l1078t891r1342b960],

1	From	IN	O	from	_	0	SENT_122	[p10l1398t892r1611b960],
2	this	DT	O	this	det	3	SENT_122	[p10l1661t891r1800b960],
3	table	NN	O	table	prep_from	7	SENT_122	[p10l1853t891r2043b960],
4	it	PRP	O	it	nsubjpass	7	SENT_122	[p10l2094t891r2149b960],
5	can	MD	O	can	aux	7	SENT_122	[p10l8t1022r142b1069],
6	be	VB	O	be	auxpass	7	SENT_122	[p10l166t999r258b1069],
7	seen	VBN	O	see	_	0	SENT_122	[p10l288t1022r459b1069],
8	that	IN	O	that	complm	23	SENT_122	[p10l484t999r632b1069],
9	nausea	NN	O	nausea	nsubj	23	SENT_122	[p10l656t1022r926b1069],
10	or	CC	O	or	_	0	SENT_122	[p10l952t1022r1032b1069],
11	gastrointestinal	JJ	O	gastrointestinal	amod	12	SENT_122	[p10l1056t999r1661b1089],
12	upset	NN	O	upset	conj_or	9	SENT_122	[p10l1686t1010r1915b1089],
13	,	,	O	,	_	0	SENT_122	[p10l1686t1010r1915b1089],
14	anxiety	NN	O	anxiety	conj_or	12	SENT_122	[p10l1946t999r2143b1069, p10l8t1118r141b1197],
15	,	,	O	,	_	0	SENT_122	[p10l1946t999r2143b1069, p10l8t1118r141b1197],
16	agitation	NN	O	agitation	conj_or	12	SENT_122	[p10l185t1107r530b1197],
17	or	CC	O	or	_	0	SENT_122	[p10l569t1129r650b1177],
18	restlessness	NN	O	restlessness	conj_or	12	SENT_122	[p10l686t1107r1145b1177],
19	were	VBD	O	be	cop	23	SENT_122	[p10l1186t1129r1374b1177],
20	the	DT	O	the	det	23	SENT_122	[p10l1414t1107r1532b1177],
21	most	RBS	O	most	advmod	23	SENT_122	[p10l1571t1118r1764b1177],
22	common	JJ	O	common	amod	23	SENT_122	[p10l1802t1129r2146b1177],
23	ADRs	NNS	MISC	adr	ccomp	7	SENT_122	[p10l7t1216r249b1285],
24	with	IN	O	with	_	0	SENT_122	[p10l293t1215r466b1285],
25	ﬂuoxetine	NN	O	ﬂuoxetine	prep_with	23	SENT_122	[p10l509t1215r924b1297],
26	,	,	O	,	_	0	SENT_122	[p10l509t1215r924b1297],
27	whereas	IN	O	whereas	mark	38	SENT_122	[p10l969t1215r1289b1285],
28	dry	JJ	O	dry	amod	29	SENT_122	[p10l1334t1215r1461b1305],
29	mouth	NN	O	mouth	nsubj	38	SENT_122	[p10l1503t1215r1755b1285],
30	and	CC	O	and	_	0	SENT_122	[p10l1799t1215r1938b1285],
31	postural	JJ	O	postural	amod	32	SENT_122	[p10l1977t1237r2143b1305, p10l7t1323r186b1393],
32	hypotension	NN	O	hypotension	nsubj	38	SENT_122	[p10l219t1323r704b1413],
33	were	VBD	O	be	cop	38	SENT_122	[p10l736t1346r925b1393],
34	the	DT	O	the	det	38	SENT_122	[p10l958t1323r1077b1393],
35	most	RBS	O	most	advmod	37	SENT_122	[p10l1110t1334r1302b1393],
36	clinically	RB	O	clinically	advmod	37	SENT_122	[p10l1334t1323r1703b1413],
37	signiﬁcant	JJ	O	signiﬁcant	amod	38	SENT_122	[p10l1738t1323r2148b1413],
38	ADRS	NN	O	adr	advcl	23	SENT_122	[p10l7t1432r249b1501],
39	associated	VBN	O	associate	partmod	38	SENT_122	[p10l297t1431r703b1501],
40	with	IN	O	with	_	0	SENT_122	[p10l748t1431r921b1501],
41	nortriptyline	NN	O	nortriptyline	prep_with	39	SENT_122	[p10l965t1431r1481b1521],
42	.	.	O	.	_	0	SENT_122	[p10l965t1431r1481b1521],

1	From	IN	O	from	_	0	SENT_123	[p10l1530t1433r1743b1501],
2	the	DT	O	the	det	3	SENT_123	[p10l1787t1431r1905b1501],
3	summary	NN	O	summary	prep_from	16	SENT_123	[p10l1954t1453r2144b1501, p10l7t1561r208b1629],
4	of	IN	O	of	_	0	SENT_123	[p10l236t1539r322b1609],
5	ADRS	NNS	O	adr	prep_of	3	SENT_123	[p10l342t1540r585b1609],
6	at	IN	O	at	_	0	SENT_123	[p10l615t1550r685b1609],
7	the	DT	O	the	det	8	SENT_123	[p10l710t1539r828b1609],
8	bottom	NN	O	bottom	prep_at	5	SENT_123	[p10l854t1539r1137b1609],
9	of	IN	O	of	_	0	SENT_123	[p10l1164t1539r1249b1609],
10	Table	NNP	O	Table	prep_of	8	SENT_123	[p10l1269t1539r1486b1609],
11	2	CD	NUMBER	2	num	10	SENT_123	[p10l1515t1540r1581b1621],
12	,	,	O	,	_	0	SENT_123	[p10l1515t1540r1581b1621],
13	it	PRP	O	it	nsubjpass	16	SENT_123	[p10l1612t1539r1667b1609],
14	can	MD	O	can	aux	16	SENT_123	[p10l1693t1561r1828b1609],
15	be	VB	O	be	auxpass	16	SENT_123	[p10l1853t1539r1945b1609],
16	seen	VBN	O	see	_	0	SENT_123	[p10l1976t1561r2146b1609],
17	that	IN	O	that	complm	22	SENT_123	[p10l7t1647r155b1717],
18	PMs	NNS	O	pm	nsubj	22	SENT_123	[p10l198t1649r374b1717],
19	were	VBD	O	be	cop	22	SENT_123	[p10l420t1670r611b1717],
20	no	RB	O	no	advmod	21	SENT_123	[p10l655t1670r750b1717],
21	more	RBR	O	more	advmod	22	SENT_123	[p10l795t1670r997b1717],
22	likely	JJ	O	likely	ccomp	16	SENT_123	[p10l1042t1647r1266b1737],
23	to	TO	O	to	aux	24	SENT_123	[p10l1310t1658r1384b1717],
24	experience	VB	O	experience	xcomp	22	SENT_123	[p10l1430t1647r1857b1737],
25	ADRs	NNS	MISC	adr	dobj	24	SENT_123	[p10l1902t1648r2145b1717],
26	than	IN	O	than	_	0	SENT_123	[p10l7t1755r176b1825],
27	EMS	NNP	ORGANIZATION	EMS	prep_than	24	SENT_123	[p10l202t1757r407b1837],
28	,	,	O	,	_	0	SENT_123	[p10l202t1757r407b1837],
29	and	CC	O	and	_	0	SENT_123	[p10l440t1755r580b1825],
30	of	IN	O	of	_	0	SENT_123	[p10l607t1755r692b1825],
31	the	DT	O	the	det	33	SENT_123	[p10l712t1755r830b1825],
32	17	CD	NUMBER	17	num	33	SENT_123	[p10l867t1756r950b1824],
33	patients	NNS	O	patient	prep_of	45	SENT_123	[p10l980t1755r1286b1845],
34	who	WP	O	who	nsubj	35	SENT_123	[p10l1315t1755r1481b1825],
35	developed	VBD	O	develop	rcmod	33	SENT_123	[p10l1510t1755r1914b1845],
36	moderate	JJ	O	moderate	amod	39	SENT_123	[p10l1939t1755r2144b1825, p10l8t1874r197b1933],
37	or	CC	O	or	_	0	SENT_123	[p10l223t1885r304b1933],
38	severe	JJ	O	severe	conj_or	36	SENT_123	[p10l328t1885r573b1933],
39	ADRs	NNS	MISC	adr	dobj	35	SENT_123	[p10l596t1864r863b1946],
40	,	,	O	,	_	0	SENT_123	[p10l596t1864r863b1946],
41	only	RB	O	only	advmod	42	SENT_123	[p10l891t1863r1063b1953],
42	one	CD	NUMBER	one	nsubj	45	SENT_123	[p10l1088t1885r1227b1933],
43	was	VBD	O	be	cop	45	SENT_123	[p10l1250t1885r1398b1933],
44	a	DT	O	a	det	45	SENT_123	[p10l1425t1885r1466b1933],
45	PM	NN	O	pm	conj_and	16	SENT_123	[p10l1489t1865r1648b1933],
46	.	.	O	.	_	0	SENT_123	[p10l1489t1865r1648b1933],

1	As	IN	O	as	mark	4	SENT_124	[p10l1676t1864r1781b1933],
2	numbers	NNS	O	number	nsubj	4	SENT_124	[p10l1807t1863r2145b1933],
3	are	VBP	O	be	cop	4	SENT_124	[p10l9t1994r125b2041],
4	small	JJ	O	small	advcl	11	SENT_124	[p10l177t1971r408b2054],
5	,	,	O	,	_	0	SENT_124	[p10l177t1971r408b2054],
6	multiple	JJ	O	multiple	amod	8	SENT_124	[p10l459t1971r789b2061],
7	statistical	JJ	O	statistical	amod	8	SENT_124	[p10l841t1971r1210b2041],
8	tests	NNS	O	test	nsubjpass	11	SENT_124	[p10l1259t1982r1431b2041],
9	were	VBD	O	be	auxpass	11	SENT_124	[p10l1481t1994r1670b2041],
10	not	RB	O	not	neg	11	SENT_124	[p10l1719t1982r1844b2041],
11	undertaken	VBN	O	undertake	_	0	SENT_124	[p10l1889t1971r2144b2041, p10l7t2079r239b2147],
12	.	.	O	.	_	0	SENT_124	[p10l1889t1971r2144b2041, p10l7t2079r239b2147],

1	Several	JJ	O	several	amod	4	SENT_125	[p10l109t2187r399b2257],
2	previous	JJ	O	previous	amod	4	SENT_125	[p10l490t2187r827b2277],
3	clinical	JJ	O	clinical	amod	4	SENT_125	[p10l922t2187r1212b2257],
4	studies	NNS	O	study	nsubj	5	SENT_125	[p10l1309t2187r1576b2257],
5	investigated	VBD	O	investigate	_	0	SENT_125	[p10l1671t2187r2147b2277],
6	whether	IN	O	whether	complm	10	SENT_125	[p10l7t2295r327b2365],
7	CYPZD6	NNP	O	CYPZD6	nn	8	SENT_125	[p10l359t2295r718b2365],
8	PMs	NNPS	O	PMs	nsubj	10	SENT_125	[p10l753t2297r929b2365],
9	were	VBD	O	be	cop	10	SENT_125	[p10l965t2318r1154b2365],
10	susceptible	JJ	O	susceptible	ccomp	5	SENT_125	[p10l1193t2295r1629b2385],
11	to	TO	O	to	_	0	SENT_125	[p10l1663t2306r1737b2365],
12	ADRs	NNS	MISC	adr	prep_to	10	SENT_125	[p10l1772t2296r2014b2365],
13	on	IN	O	on	_	0	SENT_125	[p10l2051t2318r2147b2365],
14	psychoactive	JJ	O	psychoactive	amod	15	SENT_125	[p10l6t2403r522b2493],
15	medication	NN	O	medication	prep_on	12	SENT_125	[p10l566t2403r1027b2472],
16	.	.	O	.	_	0	SENT_125	[p10l566t2403r1027b2472],

1	A	DT	O	a	det	3	SENT_126	[p10l1076t2403r1146b2471],
2	pilot	NN	O	pilot	nn	3	SENT_126	[p10l1189t2403r1371b2493],
3	study	NN	O	study	nsubj	11	SENT_126	[p10l1418t2403r1627b2493],
4	of	IN	O	of	_	0	SENT_126	[p10l1673t2403r1759b2472],
5	CYP2D6	NN	O	cyp2d6	nn	6	SENT_126	[p10l1801t2402r2151b2473],
6	genotyping	NN	O	genotyping	prep_of	3	SENT_126	[p10l8t2511r451b2601],
7	in	IN	O	in	_	0	SENT_126	[p10l498t2511r573b2580],
8	a	DT	O	a	det	10	SENT_126	[p10l621t2533r661b2581],
9	psychiatric	JJ	O	psychiatric	amod	10	SENT_126	[p10l705t2511r1139b2601],
10	hospital	NN	O	hospital	prep_in	6	SENT_126	[p10l1187t2511r1499b2601],
11	concluded	VBD	O	conclude	_	0	SENT_126	[p10l1547t2511r1954b2581],
12	that	IN	O	that	complm	19	SENT_126	[p10l1999t2511r2147b2581],
13	patients	NNS	O	patient	nsubj	19	SENT_126	[p10l6t2619r312b2709],
14	of	IN	O	of	_	0	SENT_126	[p10l357t2619r443b2689],
15	PM	NNP	O	PM	nn	16	SENT_126	[p10l478t2621r617b2688],
16	genotype	NN	O	genotype	prep_of	13	SENT_126	[p10l660t2630r1021b2709],
17	were	VBD	O	be	cop	19	SENT_126	[p10l1061t2642r1251b2689],
18	more	RBR	O	more	advmod	19	SENT_126	[p10l1293t2642r1494b2689],
19	likely	JJ	O	likely	ccomp	11	SENT_126	[p10l1537t2619r1761b2709],
20	to	TO	O	to	aux	21	SENT_126	[p10l1803t2630r1877b2689],
21	suffer	VB	O	suffer	xcomp	19	SENT_126	[p10l1923t2619r2148b2689],
22	ADRs	NNS	MISC	adr	dobj	21	SENT_126	[p10l7t2727r249b2796],
23	than	IN	O	than	_	0	SENT_126	[p10l312t2727r481b2796],
24	those	DT	O	those	prep_than	22	SENT_126	[p10l541t2727r747b2796],
25	of	IN	O	of	_	0	SENT_126	[p10l810t2726r896b2796],
26	the	DT	O	the	det	28	SENT_126	[p10l950t2727r1068b2796],
27	EM	NNP	O	EM	nn	28	SENT_126	[p10l1129t2728r1275b2795],
28	genotype	NN	O	genotype	prep_of	24	SENT_126	[p10l1337t2738r1698b2817],
29	(	CD	NUMBER	(	num	28	SENT_126	[p10l1762t2727r1883b2812],
30	de	IN	O	de	amod	22	SENT_126	[p10l1762t2727r1883b2812],
31	Leon	NNP	O	Leon	dep	22	SENT_126	[p10l1944t2728r2147b2796],
32	et	FW	O	et	nn	33	SENT_126	[p10l8t2849r79b2905],
33	al.	FW	O	al.	dep	31	SENT_126	[p10l107t2835r228b2918],
34	,	,	O	,	_	0	SENT_126	[p10l107t2835r228b2918],
35	1998	CD	DATE	1998	num	36	SENT_126	[p10l272t2836r512b2921],
36	)	NN	O	)	appos	33	SENT_126	[p10l272t2836r512b2921],
37	.	.	O	.	_	0	SENT_126	[p10l272t2836r512b2921],

1	Another	DT	O	another	det	2	SENT_127	[p10l548t2835r872b2905],
2	study	NN	O	study	nsubj	13	SENT_127	[p10l905t2835r1114b2925],
3	examined	VBD	O	examine	dep	35	SENT_127	[p10l1147t2835r1531b2905],
4	the	DT	O	the	det	5	SENT_127	[p10l1561t2835r1680b2905],
5	occurrence	NN	O	occurrence	dobj	3	SENT_127	[p10l1713t2858r2146b2905],
6	of	IN	O	of	_	0	SENT_127	[p10l8t2943r93b3013],
7	extrapyramidal	JJ	O	extrapyramidal	amod	8	SENT_127	[p10l130t2943r729b3033],
8	ADRs	NNS	MISC	adr	prep_of	5	SENT_127	[p10l773t2944r1015b3013],
9	in	IN	O	in	_	0	SENT_127	[p10l1060t2943r1135b3012],
10	psychiatric	JJ	O	psychiatric	amod	11	SENT_127	[p10l1176t2943r1611b3033],
11	patients	NNS	O	patient	prep_in	3	SENT_127	[p10l1653t2943r1961b3033],
12	and	CC	O	and	_	0	SENT_127	[p10l2007t2943r2147b3013],
13	found	VBD	O	find	conj_and	3	SENT_127	[p10l7t3051r237b3120],
14	that	IN	O	that	complm	22	SENT_127	[p10l261t3051r409b3120],
15	those	DT	O	those	nsubj	22	SENT_127	[p10l433t3051r639b3120],
16	with	IN	O	with	_	0	SENT_127	[p10l663t3051r838b3120],
17	a	DT	O	a	det	19	SENT_127	[p10l864t3073r905b3120],
18	PM	NNP	O	PM	nn	19	SENT_127	[p10l928t3052r1068b3119],
19	genotype	NN	O	genotype	prep_with	15	SENT_127	[p10l1094t3061r1455b3141],
20	were	VBD	O	be	cop	22	SENT_127	[p10l1479t3073r1668b3120],
21	more	RBR	O	more	advmod	22	SENT_127	[p10l1694t3073r1896b3120],
22	likely	JJ	O	likely	ccomp	13	SENT_127	[p10l1922t3051r2146b3141],
23	to	TO	O	to	aux	24	SENT_127	[p10l7t3170r80b3229],
24	develop	VB	O	develop	xcomp	22	SENT_127	[p10l122t3159r429b3249],
25	ADRs	NNS	MISC	adr	dobj	24	SENT_127	[p10l469t3160r711b3229],
26	when	WRB	O	when	advmod	27	SENT_127	[p10l753t3159r966b3229],
27	treated	VBN	O	treat	advcl	24	SENT_127	[p10l1003t3159r1274b3229],
28	with	IN	O	with	_	0	SENT_127	[p10l1313t3159r1487b3229],
29	CYP2D6	NN	O	cyp2d6	nn	32	SENT_127	[p10l1527t3159r2143b3229],
30	—	CD	NUMBER	—	num	32	SENT_127	[p10l1527t3159r2143b3229],
31	meta	NN	O	meta	nn	32	SENT_127	[p10l1527t3159r2143b3229],
32	—	NN	O	—	prep_with	27	SENT_127	[p10l1527t3159r2143b3229],
33	bolized	VBN	O	bolize	partmod	32	SENT_127	[p10l6t3267r298b3336],
34	drugs	NNS	O	drug	dobj	33	SENT_127	[p10l340t3267r554b3357],
35	(	VBP	O	(	_	0	SENT_127	[p10l600t3267r903b3352],
36	Vandel	NNP	PERSON	Vandel	dobj	35	SENT_127	[p10l600t3267r903b3352],
37	et	FW	O	et	nn	38	SENT_127	[p10l946t3280r1017b3336],
38	al.	FW	O	al.	nsubj	35	SENT_127	[p10l1056t3267r1176b3349],
39	,	,	O	,	_	0	SENT_127	[p10l1056t3267r1176b3349],
40	1999	CD	DATE	1999	num	41	SENT_127	[p10l1230t3267r1469b3352],
41	)	NN	O	)	appos	38	SENT_127	[p10l1230t3267r1469b3352],
42	.	.	O	.	_	0	SENT_127	[p10l1230t3267r1469b3352],

1	The	DT	O	the	det	2	SENT_128	[p10l1515t3267r1667b3336],
2	subjects	NNS	O	subject	nsubj	8	SENT_128	[p10l1711t3267r2024b3357],
3	of	IN	O	of	_	0	SENT_128	[p10l2068t3267r2153b3336],
4	these	DT	O	these	det	5	SENT_128	[p10l7t3375r208b3444],
5	studies	NNS	O	study	prep_of	2	SENT_128	[p10l240t3375r508b3444],
6	were	VBD	O	be	cop	8	SENT_128	[p10l537t3397r727b3444],
7	psychiatric	JJ	O	psychiatric	amod	8	SENT_128	[p10l755t3375r1189b3465],
8	inpatients	NNS	O	inpatient	_	0	SENT_128	[p10l1218t3374r1601b3465],
9	being	VBG	O	be	auxpass	10	SENT_128	[p10l1630t3375r1848b3465],
10	treated	VBN	O	treat	partmod	8	SENT_128	[p10l1877t3375r2147b3444],
11	with	IN	O	with	_	0	SENT_128	[p10l7t3483r181b3552],
12	a	DT	O	a	det	13	SENT_128	[p10l206t3505r246b3552],
13	combination	NN	O	combination	prep_with	10	SENT_128	[p10l270t3483r765b3552],
14	of	IN	O	of	_	0	SENT_128	[p10l789t3483r875b3552],
15	antidepressants	NNS	O	antidepressant	prep_of	13	SENT_128	[p10l893t3483r1496b3573],
16	and	CC	O	and	_	0	SENT_128	[p10l1523t3483r1662b3552],
17	antipsycho	JJ	O	antipsycho	amod	19	SENT_128	[p10l1687t3483r2143b3573],
18	—	NN	O	—	nn	19	SENT_128	[p10l1687t3483r2143b3573],
19	tics	NNS	O	tic	prep_of	13	SENT_128	[p10l7t3591r163b3673],
20	,	,	O	,	_	0	SENT_128	[p10l7t3591r163b3673],
21	and	CC	O	and	_	0	SENT_128	[p10l201t3591r340b3660],
22	most	JJS	O	most	nsubj	23	SENT_128	[p10l370t3602r562b3660],
23	had	VBD	O	have	conj_and	8	SENT_128	[p10l592t3591r734b3660],
24	a	DT	O	a	det	25	SENT_128	[p10l767t3613r808b3660],
25	history	NN	O	history	dobj	23	SENT_128	[p10l837t3591r1110b3681],
26	of	IN	O	of	_	0	SENT_128	[p10l1144t3591r1229b3660],
27	exposure	NN	O	exposure	prep_of	25	SENT_128	[p10l1254t3613r1608b3681],
28	to	TO	O	to	_	0	SENT_128	[p10l1640t3601r1713b3660],
29	psychoactive	JJ	O	psychoactive	amod	30	SENT_128	[p10l1745t3591r2144b3681, p10l7t3699r151b3769],
30	medication	NN	O	medication	prep_to	23	SENT_128	[p10l179t3699r640b3768],
31	.	.	O	.	_	0	SENT_128	[p10l179t3699r640b3768],

1	Moreover	RB	O	moreover	_	0	SENT_129	[p10l674t3700r1079b3781],
2	,	,	O	,	_	0	SENT_129	[p10l674t3700r1079b3781],
3	most	JJS	O	most	advmod	4	SENT_129	[p10l1112t3710r1304b3768],
4	of	IN	O	of	dep	1	SENT_129	[p10l1332t3699r1417b3768],
5	the	DT	O	the	det	6	SENT_129	[p10l1440t3699r1558b3768],
6	patients	NNS	O	patient	pobj	4	SENT_129	[p10l1587t3699r1893b3789],
7	in	IN	O	in	_	0	SENT_129	[p10l1924t3699r1999b3767],
8	the	DT	O	the	prep_in	6	SENT_129	[p10l2027t3699r2146b3768],

1	ﬁrst	NN	O	ﬁrst	nn	2	SENT_130	[p11l8t16r158b85],
2	study	NN	O	study	nsubj	4	SENT_130	[p11l196t16r403b106],
3	were	VBD	O	be	aux	4	SENT_130	[p11l439t38r629b86],
4	taking	VBG	O	take	dep	11	SENT_130	[p11l664t16r909b106],
5	two	CD	NUMBER	two	num	6	SENT_130	[p11l945t26r1090b85],
6	drugs	NNS	O	drug	dobj	4	SENT_130	[p11l1128t16r1342b106],
7	that	WDT	O	that	nsubj	10	SENT_130	[p11l1379t16r1527b85],
8	were	VBD	O	be	cop	10	SENT_130	[p11l1561t38r1750b86],
9	CYP2D6	NN	O	cyp2d6	nn	10	SENT_130	[p11l1787t16r2145b86],
10	substrates	NNS	O	substrate	rcmod	6	SENT_130	[p11l10t124r394b193],
11	(	VBP	O	(	_	0	SENT_130	[p11l437t124r741b209],
12	Vandel	NNP	PERSON	Vandel	dobj	11	SENT_130	[p11l437t124r741b209],
13	et	FW	O	et	nn	14	SENT_130	[p11l782t137r853b193],
14	al.	FW	O	al.	nsubj	11	SENT_130	[p11l889t124r1010b206],
15	,	,	O	,	_	0	SENT_130	[p11l889t124r1010b206],
16	1999	CD	DATE	1999	num	17	SENT_130	[p11l1061t124r1301b209],
17	)	NN	O	)	appos	14	SENT_130	[p11l1061t124r1301b209],
18	,	,	O	,	_	0	SENT_130	[p11l1061t124r1301b209],
19	as	IN	O	as	mark	22	SENT_130	[p11l1346t146r1422b193],
20	were	VBD	O	be	cop	22	SENT_130	[p11l1462t146r1651b193],
21	10	CD	PERCENT	10	num	22	SENT_130	[p11l1700t124r1866b193],
22	%	NN	PERCENT	%	dep	17	SENT_130	[p11l1700t124r1866b193],
23	of	IN	O	of	_	0	SENT_130	[p11l1910t124r1995b193],
24	the	DT	O	the	det	25	SENT_130	[p11l2027t124r2145b193],
25	patients	NNS	O	patient	prep_of	22	SENT_130	[p11l6t232r312b322],
26	in	IN	O	in	_	0	SENT_130	[p11l343t232r417b301],
27	the	DT	O	the	det	29	SENT_130	[p11l445t232r564b301],
28	second	JJ	ORDINAL	second	amod	29	SENT_130	[p11l597t232r867b301],
29	study	NN	O	study	prep_in	25	SENT_130	[p11l898t232r1122b322],
30	,	,	O	,	_	0	SENT_130	[p11l898t232r1122b322],
31	with	IN	O	with	_	0	SENT_130	[p11l1155t232r1329b302],
32	a	DT	O	a	det	34	SENT_130	[p11l1358t254r1399b301],
33	similar	JJ	O	similar	amod	34	SENT_130	[p11l1430t232r1702b301],
34	proportion	NN	O	proportion	prep_with	22	SENT_130	[p11l1728t232r2147b322],
35	taking	VBG	O	take	partmod	34	SENT_130	[p11l7t340r252b430],
36	a	DT	DURATION	a	det	38	SENT_130	[p11l295t362r336b410],
37	second	JJ	DURATION	second	amod	38	SENT_130	[p11l377t340r648b410],
38	drug	NN	O	drug	dobj	35	SENT_130	[p11l688t340r865b430],
39	known	VBN	O	know	partmod	38	SENT_130	[p11l905t340r1171b410],
40	to	TO	O	to	aux	41	SENT_130	[p11l1210t351r1284b410],
41	inhibit	VB	O	inhibit	xcomp	39	SENT_130	[p11l1325t340r1583b410],
42	CYP2D6	NN	O	cyp2d6	nn	43	SENT_130	[p11l1623t340r1981b410],
43	(	NN	O	(	dobj	41	SENT_130	[p11l2025t340r2145b426],
44	de	IN	O	de	amod	43	SENT_130	[p11l2025t340r2145b426],
45	Leon	NNP	O	Leon	dep	43	SENT_130	[p11l6t449r209b517],
46	et	FW	O	et	nn	47	SENT_130	[p11l244t461r316b517],
47	al.	FW	O	al.	tmod	35	SENT_130	[p11l346t448r467b530],
48	,	,	O	,	_	0	SENT_130	[p11l346t448r467b530],
49	1998	CD	DATE	1998	num	50	SENT_130	[p11l514t448r753b533],
50	)	NN	O	)	appos	47	SENT_130	[p11l514t448r753b533],
51	.	.	O	.	_	0	SENT_130	[p11l514t448r753b533],

1	Furthermore	RB	O	furthermore	_	0	SENT_131	[p11l792t448r1308b530],
2	,	,	O	,	_	0	SENT_131	[p11l792t448r1308b530],
3	in	IN	O	in	dep	1	SENT_131	[p11l1346t448r1421b516],
4	the	DT	O	the	det	6	SENT_131	[p11l1455t448r1573b517],
5	second	JJ	ORDINAL	second	amod	6	SENT_131	[p11l1612t448r1883b517],
6	study	NN	O	study	pobj	3	SENT_131	[p11l1919t448r2143b538],
7	,	,	O	,	_	0	SENT_131	[p11l1919t448r2143b538],

1	Table	NNP	O	Table	_	0	SENT_132	[p11l157t613r230b636],
2	2	CD	NUMBER	2	dep	1	SENT_132	[p11l245t613r267b636],
3	.	.	O	.	_	0	SENT_132	[p11l245t613r267b636],

1	The	DT	O	the	det	2	SENT_133	[p11l302t613r353b636],
2	frequency	NN	O	frequency	_	0	SENT_133	[p11l368t613r499b643],
3	of	IN	O	of	_	0	SENT_133	[p11l514t613r543b636],
4	clincially	RB	O	clincially	advmod	5	SENT_133	[p11l555t613r678b643],
5	signiﬁcant	JJ	O	signiﬁcant	amod	8	SENT_133	[p11l693t613r832b643],
6	antidepressant	JJ	O	antidepressant	amod	8	SENT_133	[p11l847t613r1036b643],
7	associated	VBN	O	associate	amod	8	SENT_133	[p11l1050t613r1186b636],
8	ADRs	NNS	MISC	adr	prep_of	2	SENT_133	[p11l1200t613r1281b636],
9	by	IN	O	by	_	0	SENT_133	[p11l1295t613r1328b643],
10	drug	NN	O	drug	nn	13	SENT_133	[p11l1343t613r1402b643],
11	and	CC	O	and	_	0	SENT_133	[p11l1417t613r1464b636],
12	metabolizer	NN	O	metabolizer	conj_and	10	SENT_133	[p11l1478t613r1636b636],
13	status	NN	O	status	prep_by	8	SENT_133	[p11l1650t616r1723b636],
14	reported	VBN	O	report	partmod	13	SENT_133	[p11l1738t613r1848b643],
15	during	IN	O	during	_	0	SENT_133	[p11l1863t613r1948b643],
16	the	DT	DURATION	the	det	19	SENT_133	[p11l1962t613r2002b636],
17	6	CD	DURATION	6	num	19	SENT_133	[p11l158t650r173b674],
18	week	NN	NUMBER	week	nn	19	SENT_133	[p11l185t650r255b674],
19	trial	NN	O	trial	prep_during	14	SENT_133	[p11l266t650r319b674],

1	ADR	NNP	O	ADR	nn	2	SENT_134	[p11l7t741r132b781],
2	Fluoxetine	NNP	O	Fluoxetine	_	0	SENT_134	[p11l1499t740r1753b781],

1	EM	NNP	O	EM	_	0	SENT_135	[p11l1167t879r1256b918],
2	(	CD	NUMBER	(	num	3	SENT_135	[p11l1277t878r1323b929],
3	n	NN	O	n	dep	1	SENT_135	[p11l1277t878r1323b929],
4	=	JJ	O	=	amod	6	SENT_135	[p11l1337t896r1377b911],
5	59	CD	NUMBER	59	tmod	4	SENT_135	[p11l1392t877r1467b929],
6	)	NN	O	)	dep	3	SENT_135	[p11l1392t877r1467b929],

1	“	NN	O	“	_	0	SENT_136	[p11l1786t879r1818b918],
2	U	NNP	O	U	nn	3	SENT_136	[p11l1786t879r1818b918],
3	E	NNP	O	E	dep	1	SENT_136	[p11l1819t879r1871b918],
4	/	:	O	/	punct	1	SENT_136	[p11l1892t878r1908b929],
5	‘	CD	NUMBER	‘	num	6	SENT_136	[p11l1892t878r1908b929],
6	\	CD	NUMBER	\	dep	1	SENT_136	[p11l1892t878r1908b929],
7	S	NN	O	s	prep	6	SENT_136	[p11l1910t892r1937b919],
8	II	CD	NUMBER	ii	dep	7	SENT_136	[p11l1952t896r1992b911],

1	Anxiety	NN	O	anxiety	nn	5	SENT_137	[p11l7t1006r207b1060],
2	,	,	O	,	_	0	SENT_137	[p11l7t1006r207b1060],
3	agitation	NN	O	agitation	dep	5	SENT_137	[p11l230t1006r450b1060],
4	,	,	O	,	_	0	SENT_137	[p11l230t1006r450b1060],
5	restlessness	NN	O	restlessness	_	0	SENT_137	[p11l471t1006r747b1048],
6	7	CD	NUMBER	7	num	8	SENT_137	[p11l1246t1007r1272b1048],
7	Postural	JJ	O	postural	amod	8	SENT_137	[p11l7t1074r201b1116],
8	hypotension	NN	O	hypotension	nsubj	13	SENT_137	[p11l220t1074r511b1128],
9	o	NN	O	o	nn	10	SENT_137	[p11l1246t1074r1274b1116],
10	Nausea	NN	MISC	nausea	dep	8	SENT_137	[p11l7t1141r194b1190],
11	,	,	O	,	_	0	SENT_137	[p11l7t1141r194b1190],
12	gastrointestinal	JJ	O	gastrointestinal	amod	8	SENT_137	[p11l216t1140r579b1194],
13	upset	JJ	O	upset	rcmod	5	SENT_137	[p11l599t1147r725b1194],
14	7	CD	NUMBER	7	num	16	SENT_137	[p11l1246t1141r1272b1182],
15	Dry	NNP	O	Dry	nn	16	SENT_137	[p11l7t1208r98b1261],
16	mouth	NN	O	mouth	nsubj	17	SENT_137	[p11l117t1207r269b1249],
17	1	CD	NUMBER	1	xcomp	13	SENT_137	[p11l1252t1207r1269b1248],
18	Sweating	VBG	O	sweat	partmod	17	SENT_137	[p11l9t1274r228b1328],
19	1	CD	NUMBER	1	dobj	18	SENT_137	[p11l1252t1275r1269b1315],
20	Blurred	VBN	O	blur	partmod	19	SENT_137	[p11l7t1342r189b1383],
21	Vision	NNP	O	Vision	nn	24	SENT_137	[p11l208t1342r352b1383],
22	o	NN	O	o	nn	24	SENT_137	[p11l1246t1342r1274b1383],
23	Constipation	NN	ORGANIZATION	constipation	nn	24	SENT_137	[p11l8t1407r311b1462],
24	O	NN	ORGANIZATION	o	dep	31	SENT_137	[p11l1246t1408r1274b1450],
25	Headache	NN	ORGANIZATION	headache	dep	24	SENT_137	[p11l7t1474r241b1515],
26	3	CD	NUMBER	3	num	27	SENT_137	[p11l1247t1474r1271b1516],
27	Sedation	NN	ORGANIZATION	sedation	dep	31	SENT_137	[p11l9t1541r215b1582],
28	1	CD	NUMBER	1	num	31	SENT_137	[p11l1252t1541r1269b1581],
29	Insomnia	NNP	O	Insomnia	nn	31	SENT_137	[p11l7t1606r229b1648],
30	1	CD	NUMBER	1	num	31	SENT_137	[p11l1252t1607r1269b1647],
31	Rash	NNP	O	Rash	dep	36	SENT_137	[p11l7t1672r125b1713],
32	1	CD	NUMBER	1	num	34	SENT_137	[p11l1252t1672r1269b1713],
33	Sexual	JJ	O	sexual	amod	34	SENT_137	[p11l9t1738r167b1780],
34	dysfunction	NN	O	dysfunction	dep	31	SENT_137	[p11l187t1738r468b1792],
35	2	CD	NUMBER	2	num	36	SENT_137	[p11l1247t1738r1274b1779],
36	Fatigue	NN	ORGANIZATION	fatigue	dep	40	SENT_137	[p11l7t1806r184b1860],
37	2	CD	NUMBER	2	num	40	SENT_137	[p11l1247t1806r1274b1847],
38	Percentage	NN	O	percentage	nn	40	SENT_137	[p11l7t1874r268b1927],
39	(	NN	O	(	nn	40	SENT_137	[p11l289t1873r354b1924],
40	n	NN	O	n	dep	5	SENT_137	[p11l289t1873r354b1924],
41	)	VBG	O	)	rcmod	40	SENT_137	[p11l289t1873r354b1924],
42	with	IN	O	with	prep	41	SENT_137	[p11l376t1872r480b1915],

1	Any	DT	O	any	det	4	SENT_138	[p11l66t1940r167b1993],
2	mild	JJ	O	mild	amod	4	SENT_138	[p11l187t1939r295b1981],
3	27	CD	PERCENT	27	num	4	SENT_138	[p11l1213t1939r1318b1981],
4	%	NN	PERCENT	%	dep	14	SENT_138	[p11l1213t1939r1318b1981],
5	(	CD	NUMBER	(	num	7	SENT_138	[p11l1341t1939r1436b1991],
6	16	CD	NUMBER	16	num	7	SENT_138	[p11l1341t1939r1436b1991],
7	)	NN	O	)	dep	4	SENT_138	[p11l1341t1939r1436b1991],
8	17	CD	PERCENT	17	num	9	SENT_138	[p11l1810t1939r1910b1981],
9	%	NN	PERCENT	%	dep	7	SENT_138	[p11l1810t1939r1910b1981],
10	(	CD	NUMBER	(	number	11	SENT_138	[p11l1934t1940r1998b1991],
11	1	CD	NUMBER	1	num	9	SENT_138	[p11l1934t1940r1998b1991],
12	)	CD	NUMBER	)	dep	14	SENT_138	[p11l1934t1940r1998b1991],
13	Any	DT	O	any	det	14	SENT_138	[p11l66t2007r167b2061],
14	moderate/severe	NN	O	moderate/severe	dep	24	SENT_138	[p11l187t2007r575b2049],
15	14	CD	PERCENT	14	num	16	SENT_138	[p11l1218t2007r1318b2049],
16	%	NN	PERCENT	%	dep	14	SENT_138	[p11l1218t2007r1318b2049],
17	(	CD	NUMBER	(	number	18	SENT_138	[p11l1341t2007r1406b2058],
18	8	CD	NUMBER	8	num	20	SENT_138	[p11l1341t2007r1406b2058],
19	)	NN	O	)	nn	20	SENT_138	[p11l1341t2007r1406b2058],
20	o	NN	O	o	dep	16	SENT_138	[p11l1834t2007r1862b2049],
21	Any	DT	O	any	det	24	SENT_138	[p11l66t2074r167b2127],
22	total	JJ	O	total	amod	24	SENT_138	[p11l186t2073r291b2115],
23	41	CD	PERCENT	41	num	24	SENT_138	[p11l1212t2074r1318b2115],
24	%	NN	PERCENT	%	dep	32	SENT_138	[p11l1212t2074r1318b2115],
25	(	CD	NUMBER	(	num	27	SENT_138	[p11l1341t2074r1436b2125],
26	24	CD	NUMBER	24	num	27	SENT_138	[p11l1341t2074r1436b2125],
27	)	NN	O	)	dep	24	SENT_138	[p11l1341t2074r1436b2125],
28	17	CD	PERCENT	17	num	29	SENT_138	[p11l1810t2074r1910b2115],
29	%	NN	PERCENT	%	dep	27	SENT_138	[p11l1810t2074r1910b2115],
30	(	CD	NUMBER	(	number	31	SENT_138	[p11l1934t2074r1998b2125],
31	1	CD	NUMBER	1	num	29	SENT_138	[p11l1934t2074r1998b2125],
32	)	NN	O	)	_	0	SENT_138	[p11l1934t2074r1998b2125],

1	WOOOOOOOOOOOO	NNP	O	WOOOOOOOOOOOO	_	0	SENT_139	[p11l1834t1006r1862b1847],

1	Nortriptyline	NNP	O	Nortriptyline	_	0	SENT_140	[p11l1021t2373r1588b2472],

1	EM	NNP	O	EM	nn	3	SENT_141	[p11l447t2625r609b2698],
2	(	CD	NUMBER	(	num	3	SENT_141	[p11l648t2624r732b2717],
3	n	NN	O	n	_	0	SENT_141	[p11l648t2624r732b2717],
4	=	JJ	O	=	amod	3	SENT_141	[p11l758t2657r830b2683],
5	56	CD	NUMBER	56	tmod	4	SENT_141	[p11l858t2622r995b2717],
6	)	CD	NUMBER	)	num	9	SENT_141	[p11l858t2622r995b2717],
7	PM	NN	O	pm	nn	9	SENT_141	[p11l1632t2625r1785b2698],
8	(	NN	O	(	nn	9	SENT_141	[p11l1824t2623r1907b2717],
9	n	NN	O	n	dep	3	SENT_141	[p11l1824t2623r1907b2717],
10	=	JJ	O	=	amod	12	SENT_141	[p11l1934t2657r2007b2683],
11	4	CD	NUMBER	4	tmod	10	SENT_141	[p11l2031t2623r2117b2717],
12	)	NN	O	)	dep	9	SENT_141	[p11l2031t2623r2117b2717],

1	2	CD	NUMBER	2	number	2	SENT_142	[p11l587t2858r635b2933],
2	7	CD	NUMBER	7	_	0	SENT_142	[p11l585t2982r633b3057],
3	3	CD	NUMBER	3	num	5	SENT_142	[p11l587t3079r630b3155],
4	20	CD	NUMBER	20	num	5	SENT_142	[p11l541t3201r645b3277],
5	l	NN	O	l	dep	2	SENT_142	[p11l584t3325r635b3769],
6	\	CD	NUMBER	\	num	8	SENT_142	[p11l584t3325r635b3769],
7	JU	NNP	O	JU	nn	8	SENT_142	[p11l584t3325r635b3769],
8	~	NN	O	~	dep	2	SENT_142	[p11l584t3325r635b3769],
9	>	JJR	O	>	rcmod	8	SENT_142	[p11l584t3325r635b3769],
10	[	CD	NUMBER	[	num	11	SENT_142	[p11l584t3325r635b3769],
11	\	NN	O	\	dep	9	SENT_142	[p11l584t3325r635b3769],
12	)	SYM	O	)	dep	9	SENT_142	[p11l584t3325r635b3769],
13	-	:	O	-	_	0	SENT_142	[p11l584t3325r635b3769],
14	l	NN	O	l	dep	8	SENT_142	[p11l584t3325r635b3769],
15	>	JJR	O	>	amod	16	SENT_142	[p11l584t3325r635b3769],
16	OOOOUJOOO	NN	O	ooooujooo	dep	14	SENT_142	[p11l1740t2858r1790b3771],

1	i	FW	O	i	nn	7	SENT_143	[p12l585t31r635b601],
2	—	FW	O	—	nn	7	SENT_143	[p12l585t31r635b601],
3	*	FW	O	*	nn	7	SENT_143	[p12l585t31r635b601],
4	©	FW	O	©	nn	7	SENT_143	[p12l585t31r635b601],
5	©	FW	O	©	nn	7	SENT_143	[p12l585t31r635b601],
6	©	FW	O	©	nn	7	SENT_143	[p12l585t31r635b601],
7	©	FW	O	©	_	0	SENT_143	[p12l585t31r635b601],
8	COCO	NN	O	coco	dep	7	SENT_143	[p12l1740t31r1790b602],
9	!	.	O	!	_	0	SENT_143	[p12l1740t31r1790b602],

1	‘	NN	O	‘	_	0	SENT_144	[p12l1740t31r1790b602],

1	Copyright	NN	O	copyright	nn	5	SENT_145	[p12l160t1206r311b1240],
2	©	CD	NUMBER	©	num	5	SENT_145	[p12l325t1207r357b1239],
3	2004	CD	DATE	2004	num	5	SENT_145	[p12l372t1206r445b1233],
4	John	NNP	ORGANIZATION	John	nn	5	SENT_145	[p12l457t1206r527b1233],
5	Wiley	NNP	ORGANIZATION	Wiley	_	0	SENT_145	[p12l538t1206r628b1240],
6	&	CC	ORGANIZATION	&	_	0	SENT_145	[p12l641t1206r668b1233],
7	Sons	NNP	ORGANIZATION	Sons	conj_and	5	SENT_145	[p12l682t1206r760b1237],
8	,	,	ORGANIZATION	,	_	0	SENT_145	[p12l682t1206r760b1237],
9	Ltd.	NNP	ORGANIZATION	Ltd.	appos	5	SENT_145	[p12l773t1206r832b1232],
10	.	.	O	.	_	0	SENT_145	[p12l773t1206r832b1232],

1	Hum	NNP	O	Hum	nn	4	SENT_146	[p12l1234t1207r1307b1232],
2	Psychopharmacol	NNP	O	Psychopharmacol	nn	4	SENT_146	[p12l1318t1206r1588b1240],
3	Clin	NNP	O	Clin	nn	4	SENT_146	[p12l1602t1206r1663b1233],
4	Exp	NNP	O	Exp	_	0	SENT_146	[p12l1675t1207r1732b1240],
5	2004	CD	DATE	2004	num	4	SENT_146	[p12l1746t1206r1828b1237],
6	;	:	O	;	_	0	SENT_146	[p12l1746t1206r1828b1237],
7	19	CD	NUMBER	19	num	9	SENT_146	[p12l1843t1206r1886b1233],
8	:	:	O	:	_	0	SENT_146	[p12l1843t1206r1886b1233],
9	17-23	CD	DATE	17-23	dep	4	SENT_146	[p12l1904t1206r2001b1233],
10	.	.	O	.	_	0	SENT_146	[p12l1904t1206r2001b1233],

1	CYPZD6	NN	O	cypzd6	_	0	SENT_147	[p12l446t1320r557b1344],
2	AND	CC	O	and	_	0	SENT_147	[p12l569t1315r657b1344],
3	ANTIDEPRESSANT	JJ	O	antidepressant	amod	4	SENT_147	[p12l671t1315r1032b1344],
4	ADRs	NNS	MISC	adr	conj_and	1	SENT_147	[p12l1046t1315r1145b1344],
5	21	CD	NUMBER	21	dep	1	SENT_147	[p12l1677t1315r1713b1344],

1	8	CD	NUMBER	8	nsubj	10	SENT_148	[p12l13t1492r51b1561],
2	of	IN	O	of	_	0	SENT_148	[p12l87t1491r172b1561],
3	the	DT	O	the	det	5	SENT_148	[p12l195t1491r314b1561],
4	12	CD	NUMBER	12	num	5	SENT_148	[p12l355t1492r441b1560],
5	patients	NNS	O	patient	prep_of	1	SENT_148	[p12l471t1491r777b1581],
6	with	IN	O	with	_	0	SENT_148	[p12l811t1491r985b1561],
7	CYPZD6	NN	O	cypzd6	nn	9	SENT_148	[p12l1019t1491r1369b1562],
8	PM	NN	O	pm	nn	9	SENT_148	[p12l1395t1493r1535b1560],
9	genotype	NN	O	genotype	prep_with	5	SENT_148	[p12l1567t1502r1926b1581],
10	were	VBD	O	be	_	0	SENT_148	[p12l1956t1514r2145b1561],
11	on	IN	O	on	_	0	SENT_148	[p12l10t1621r105b1669],
12	two	CD	NUMBER	two	num	14	SENT_148	[p12l144t1610r289b1669],
13	CYP2D6	NN	O	cyp2d6	nn	14	SENT_148	[p12l331t1599r1212b1669],
14	—	NN	O	—	prep_on	10	SENT_148	[p12l331t1599r1212b1669],
15	metabolized	VBN	O	metabolize	partmod	14	SENT_148	[p12l331t1599r1212b1669],
16	drugs	NNS	O	drug	dobj	15	SENT_148	[p12l1252t1599r1466b1689],
17	(	CD	NUMBER	(	dep	16	SENT_148	[p12l1511t1599r1631b1685],
18	de	IN	PERSON	de	amod	16	SENT_148	[p12l1511t1599r1631b1685],
19	Leon	NNP	PERSON	Leon	dep	16	SENT_148	[p12l1671t1601r1873b1669],
20	et	FW	O	et	nn	21	SENT_148	[p12l1914t1612r1985b1669],
21	al.	FW	O	al.	dep	19	SENT_148	[p12l2022t1599r2142b1681],
22	,	,	O	,	_	0	SENT_148	[p12l2022t1599r2142b1681],
23	1998	CD	DATE	1998	num	24	SENT_148	[p12l18t1708r257b1793],
24	)	NN	O	)	appos	21	SENT_148	[p12l18t1708r257b1793],
25	.	.	O	.	_	0	SENT_148	[p12l18t1708r257b1793],

1	Chen	NNP	PERSON	Chen	dep	4	SENT_149	[p12l109t1815r315b1885],
2	et	FW	O	et	nn	4	SENT_149	[p12l364t1829r435b1885],
3	al.	FW	O	al.	nn	4	SENT_149	[p12l480t1815r570b1885],
4	(	FW	O	(	dep	7	SENT_149	[p12l630t1815r886b1902],
5	1996	CD	DATE	1996	num	6	SENT_149	[p12l630t1815r886b1902],
6	)	NN	O	)	nsubj	7	SENT_149	[p12l630t1815r886b1902],
7	included	VBD	O	include	_	0	SENT_149	[p12l937t1815r1298b1898],
8	,	,	O	,	_	0	SENT_149	[p12l937t1815r1298b1898],
9	in	IN	O	in	_	0	SENT_149	[p12l1350t1815r1425b1884],
10	their	PRP$	O	they	poss	11	SENT_149	[p12l1473t1815r1654b1885],
11	analysis	NN	O	analysis	prep_in	7	SENT_149	[p12l1703t1815r2017b1905],
12	of	IN	O	of	_	0	SENT_149	[p12l2067t1815r2153b1885],
13	CYPZD6	NN	O	cypzd6	nn	15	SENT_149	[p12l9t1923r368b1993],
14	screening	NN	O	screening	nn	15	SENT_149	[p12l424t1923r797b2013],
15	costs	NNS	O	cost	prep_of	11	SENT_149	[p12l853t1934r1045b1993],
16	and	CC	O	and	_	0	SENT_149	[p12l1101t1923r1240b1993],
17	inﬂuence	NN	O	inﬂuence	prep_in	7	SENT_149	[p12l1292t1923r1652b1993],
18	on	IN	O	on	_	0	SENT_149	[p12l1707t1945r1802b1993],
19	clinical	JJ	O	clinical	amod	20	SENT_149	[p12l1855t1923r2145b1993],
20	outcomes	NNS	O	outcome	prep_on	17	SENT_149	[p12l10t2042r408b2113],
21	,	,	O	,	_	0	SENT_149	[p12l10t2042r408b2113],
22	18	CD	NUMBER	18	num	24	SENT_149	[p12l447t2032r530b2101],
23	depressed	JJ	O	depressed	amod	24	SENT_149	[p12l561t2031r950b2121],
24	patients	NNS	O	patient	appos	20	SENT_149	[p12l974t2031r1280b2121],
25	who	WP	O	who	nsubj	27	SENT_149	[p12l1309t2031r1475b2101],
26	had	VBD	O	have	aux	27	SENT_149	[p12l1501t2031r1643b2101],
27	experienced	VBN	O	experience	rcmod	24	SENT_149	[p12l1669t2031r2146b2121],
28	an	DT	O	a	det	29	SENT_149	[p12l10t2160r100b2207],
29	ADR	NN	MISC	adr	dobj	27	SENT_149	[p12l143t2139r350b2206],
30	when	WRB	O	when	advmod	31	SENT_149	[p12l393t2138r606b2207],
31	treated	VBN	O	treat	advcl	27	SENT_149	[p12l649t2138r919b2207],
32	with	IN	O	with	_	0	SENT_149	[p12l963t2138r1136b2207],
33	a	DT	O	a	det	35	SENT_149	[p12l1181t2160r1222b2207],
34	CYP2D6	NN	O	cyp2d6	nn	35	SENT_149	[p12l1266t2138r2147b2207],
35	—	NN	O	—	prep_with	31	SENT_149	[p12l1266t2138r2147b2207],
36	metabolized	VBN	O	metabolize	partmod	35	SENT_149	[p12l1266t2138r2147b2207],
37	antidepressant	JJ	O	antidepressant	amod	38	SENT_149	[p12l10t2246r576b2336],
38	(	NN	O	(	nsubj	41	SENT_149	[p12l633t2246r870b2331],
39	Chen	NNP	PERSON	Chen	dep	41	SENT_149	[p12l633t2246r870b2331],
40	et	FW	O	et	nn	41	SENT_149	[p12l926t2259r997b2316],
41	al.	FW	O	al.	ccomp	36	SENT_149	[p12l1049t2246r1169b2328],
42	,	,	O	,	_	0	SENT_149	[p12l1049t2246r1169b2328],
43	1996	CD	DATE	1996	num	44	SENT_149	[p12l1236t2246r1475b2331],
44	)	NN	O	)	appos	17	SENT_149	[p12l1236t2246r1475b2331],
45	.	.	O	.	_	0	SENT_149	[p12l1236t2246r1475b2331],

1	A	DT	O	a	det	4	SENT_150	[p12l1535t2247r1604b2315],
2	signiﬁcantly	RB	O	signiﬁcantly	advmod	3	SENT_150	[p12l1661t2246r2146b2336],
3	greater	JJR	O	greater	amod	4	SENT_150	[p12l10t2365r284b2444],
4	frequency	NN	O	frequency	nsubj	9	SENT_150	[p12l368t2354r762b2444],
5	of	IN	O	of	_	0	SENT_150	[p12l849t2354r934b2424],
6	defective	JJ	O	defective	amod	8	SENT_150	[p12l1014t2354r1373b2424],
7	CYPZD6	NN	O	cypzd6	nn	8	SENT_150	[p12l1463t2354r1812b2425],
8	alleles	NNS	O	allele	prep_of	4	SENT_150	[p12l1896t2354r2144b2424],
9	occurred	VBD	O	occur	_	0	SENT_150	[p12l10t2462r354b2532],
10	in	IN	O	in	_	0	SENT_150	[p12l408t2462r483b2531],
11	this	DT	O	this	det	12	SENT_150	[p12l537t2462r677b2532],
12	group	NN	O	group	prep_in	9	SENT_150	[p12l733t2485r959b2552],
13	compared	VBN	O	compare	_	0	SENT_150	[p12l1016t2462r1406b2552],
14	with	IN	O	with	prepc_compared_with	9	SENT_150	[p12l1459t2462r1634b2532],
15	a	DT	O	a	det	16	SENT_150	[p12l1690t2485r1731b2532],
16	group	NN	O	group	pobj	9	SENT_150	[p12l1784t2485r2011b2552],
17	of	IN	O	of	_	0	SENT_150	[p12l2067t2462r2153b2532],
18	depressed	JJ	O	depressed	amod	19	SENT_150	[p12l9t2570r399b2660],
19	patients	NNS	O	patient	prep_of	16	SENT_150	[p12l438t2570r744b2660],
20	who	WP	O	who	nsubj	23	SENT_150	[p12l787t2570r953b2640],
21	had	VBD	O	have	aux	23	SENT_150	[p12l995t2570r1137b2639],
22	not	RB	O	not	neg	23	SENT_150	[p12l1178t2580r1303b2639],
23	reported	VBN	O	report	rcmod	16	SENT_150	[p12l1341t2570r1673b2660],
24	ADRs	NNS	MISC	adr	dobj	23	SENT_150	[p12l1712t2570r1978b2652],
25	,	,	O	,	_	0	SENT_150	[p12l1712t2570r1978b2652],
26	but	CC	O	but	_	0	SENT_150	[p12l2022t2570r2148b2639],
27	Very	RB	O	very	advmod	33	SENT_150	[p12l9t2700r182b2768],
28	few	JJ	O	few	nsubj	33	SENT_150	[p12l213t2678r357b2748],
29	of	IN	O	of	_	0	SENT_150	[p12l390t2678r475b2748],
30	the	DT	O	the	det	31	SENT_150	[p12l500t2678r618b2748],
31	patients	NNS	O	patient	prep_of	28	SENT_150	[p12l650t2678r957b2768],
32	were	VBD	O	be	cop	33	SENT_150	[p12l990t2700r1179b2748],
33	PMs	NNS	O	pm	conj_but	9	SENT_150	[p12l1212t2680r1411b2761],
34	,	,	O	,	_	0	SENT_150	[p12l1212t2680r1411b2761],
35	and	CC	O	and	_	0	SENT_150	[p12l1449t2678r1588b2748],
36	it	PRP	O	it	nsubj	39	SENT_150	[p12l1619t2678r1673b2748],
37	is	VBZ	O	be	cop	39	SENT_150	[p12l1703t2678r1765b2748],
38	not	RB	O	not	neg	39	SENT_150	[p12l1799t2689r1924b2748],
39	clear	JJ	O	clear	conj_and	33	SENT_150	[p12l1955t2678r2148b2748],
40	how	WRB	O	how	advmod	41	SENT_150	[p12l8t2786r173b2856],
41	many	JJ	O	many	dep	48	SENT_150	[p12l209t2809r427b2876],
42	drugs	NNS	O	drug	nsubjpass	48	SENT_150	[p12l463t2786r677b2876],
43	these	DT	O	these	det	44	SENT_150	[p12l714t2786r916b2856],
44	patients	NNS	O	patient	dep	42	SENT_150	[p12l950t2786r1256b2876],
45	were	VBD	O	be	aux	48	SENT_150	[p12l1294t2809r1483b2856],
46	being	VBG	O	be	auxpass	48	SENT_150	[p12l1518t2786r1736b2876],
47	concomitantly	RB	O	concomitantly	advmod	48	SENT_150	[p12l1773t2786r2144b2856, p12l8t2894r232b2984],
48	treated	VBN	O	treat	ccomp	39	SENT_150	[p12l266t2894r536b2963],
49	with	IN	O	with	prep	48	SENT_150	[p12l568t2894r760b2963],
50	.	.	O	.	_	0	SENT_150	[p12l568t2894r760b2963],

1	Differences	NNS	O	difference	nsubj	10	SENT_151	[p12l108t3002r565b3072],
2	between	IN	O	between	_	0	SENT_151	[p12l610t3002r941b3072],
3	the	DT	O	the	det	4	SENT_151	[p12l985t3002r1104b3072],
4	design	NN	O	design	prep_between	1	SENT_151	[p12l1150t3002r1406b3092],
5	of	IN	O	of	_	0	SENT_151	[p12l1451t3002r1537b3072],
6	our	PRP$	O	we	poss	7	SENT_151	[p12l1576t3024r1706b3072],
7	study	NN	O	study	prep_of	4	SENT_151	[p12l1752t3002r1960b3092],
8	and	CC	O	and	_	0	SENT_151	[p12l2007t3002r2147b3072],
9	those	DT	O	those	prep_of	4	SENT_151	[p12l8t3110r215b3180],
10	described	VBN	O	describe	_	0	SENT_151	[p12l269t3110r647b3180],
11	above	IN	O	above	_	0	SENT_151	[p12l700t3110r931b3180],
12	make	VB	O	make	prepc_above	10	SENT_151	[p12l984t3110r1197b3180],
13	it	PRP	O	it	nsubj	14	SENT_151	[p12l1249t3110r1304b3180],
14	difﬁcult	NN	O	difﬁcult	xcomp	12	SENT_151	[p12l1356t3110r1665b3180],
15	to	TO	O	to	aux	17	SENT_151	[p12l1717t3121r1790b3180],
16	directly	RB	O	directly	advmod	17	SENT_151	[p12l1845t3110r2146b3200],
17	compare	VB	O	compare	infmod	14	SENT_151	[p12l9t3240r347b3308],
18	ﬁndings	NNS	O	ﬁndings	dobj	17	SENT_151	[p12l387t3218r721b3308],
19	.	.	O	.	_	0	SENT_151	[p12l387t3218r721b3308],

1	First	RB	ORDINAL	first	advmod	9	SENT_152	[p12l762t3218r962b3300],
2	,	,	O	,	_	0	SENT_152	[p12l762t3218r962b3300],
3	the	DT	O	the	det	5	SENT_152	[p12l1003t3218r1122b3287],
4	nortriptyline	NN	O	nortriptyline	nn	5	SENT_152	[p12l1159t3218r1653b3308],
5	PMs	NNS	O	pm	nsubj	9	SENT_152	[p12l1691t3219r1868b3287],
6	in	IN	O	in	_	0	SENT_152	[p12l1906t3218r1980b3286],
7	our	PRP$	O	we	poss	8	SENT_152	[p12l2018t3240r2148b3287],
8	study	NN	O	study	prep_in	5	SENT_152	[p12l12t3326r220b3416],
9	were	VBD	O	be	_	0	SENT_152	[p12l272t3348r462b3396],
10	on	IN	O	on	_	0	SENT_152	[p12l514t3348r610b3396],
11	slightly	RB	O	slightly	advmod	12	SENT_152	[p12l664t3326r955b3416],
12	lower	JJR	O	lower	amod	13	SENT_152	[p12l1007t3326r1230b3396],
13	doses	NNS	O	dose	prep_on	9	SENT_152	[p12l1280t3326r1494b3396],
14	than	IN	O	than	_	0	SENT_152	[p12l1548t3326r1716b3396],
15	the	DT	O	the	det	16	SENT_152	[p12l1767t3326r1886b3396],
16	EMS	NNP	ORGANIZATION	EMS	prep_than	9	SENT_152	[p12l1937t3328r2142b3408],
17	,	,	O	,	_	0	SENT_152	[p12l1937t3328r2142b3408],
18	because	IN	O	because	_	0	SENT_152	[p12l7t3434r321b3504],
19	clinicians	NNS	O	clinician	prep_because	9	SENT_152	[p12l346t3434r723b3504],
20	adjusted	VBN	O	adjust	partmod	19	SENT_152	[p12l751t3434r1078b3524],
21	the	DT	O	the	det	22	SENT_152	[p12l1102t3434r1220b3504],
22	doses	NNS	O	dose	dobj	20	SENT_152	[p12l1246t3434r1460b3504],
23	based	VBN	O	base	_	0	SENT_152	[p12l1485t3434r1710b3504],
24	on	IN	O	on	prepc_based_on	20	SENT_152	[p12l1735t3457r1831b3504],
25	clinical	JJ	O	clinical	amod	26	SENT_152	[p12l1855t3434r2146b3504],
26	response	NN	O	response	pobj	20	SENT_152	[p12l7t3564r374b3632],
27	,	,	O	,	_	0	SENT_152	[p12l7t3564r374b3632],
28	side	JJ	O	side	amod	29	SENT_152	[p12l412t3542r565b3611],
29	effect	NN	O	effect	conj_and	26	SENT_152	[p12l598t3541r820b3611],
30	and	CC	O	and	_	0	SENT_152	[p12l853t3542r992b3611],
31	blood	NN	O	blood	nn	32	SENT_152	[p12l1020t3542r1246b3611],
32	levels	NNS	O	level	conj_and	26	SENT_152	[p12l1277t3542r1523b3612],
33	.	.	O	.	_	0	SENT_152	[p12l1277t3542r1523b3612],

1	This	DT	DATE	this	nsubj	4	SENT_153	[p12l1559t3542r1731b3611],
2	may	MD	DATE	may	aux	4	SENT_153	[p12l1763t3564r1931b3632],
3	have	VB	O	have	aux	4	SENT_153	[p12l1962t3542r2145b3611],
4	obscured	VBN	O	obscure	_	0	SENT_153	[p12l10t3649r365b3718],
5	effects	NNS	O	effect	dobj	4	SENT_153	[p12l389t3649r646b3718],
6	that	WDT	O	that	nsubj	8	SENT_153	[p12l671t3649r819b3718],
7	could	MD	O	could	aux	8	SENT_153	[p12l842t3649r1060b3718],
8	arise	VB	O	arise	rcmod	5	SENT_153	[p12l1083t3649r1265b3718],
9	in	IN	O	in	_	0	SENT_153	[p12l1290t3649r1365b3717],
10	the	DT	O	the	det	11	SENT_153	[p12l1387t3649r1505b3718],
11	absence	NN	O	absence	prep_in	8	SENT_153	[p12l1531t3649r1841b3718],
12	of	IN	O	of	_	0	SENT_153	[p12l1865t3649r1951b3718],
13	dose	NN	O	dose	nn	14	SENT_153	[p12l1968t3649r2146b3718],
14	adjustment	NN	O	adjustment	prep_of	11	SENT_153	[p13l10t26r463b116],
15	.	.	O	.	_	0	SENT_153	[p13l10t26r463b116],

1	Second	RB	ORDINAL	second	advmod	16	SENT_154	[p13l506t26r814b109],
2	,	,	O	,	_	0	SENT_154	[p13l506t26r814b109],
3	in	IN	O	in	_	0	SENT_154	[p13l854t26r930b95],
4	contrast	NN	O	contrast	prep_in	16	SENT_154	[p13l965t37r1279b96],
5	to	TO	O	to	_	0	SENT_154	[p13l1313t37r1387b96],
6	the	DT	O	the	det	8	SENT_154	[p13l1425t26r1543b96],
7	above	JJ	O	above	amod	8	SENT_154	[p13l1581t26r1812b96],
8	studies	NNS	O	study	prep_to	4	SENT_154	[p13l1851t26r2142b109],
9	,	,	O	,	_	0	SENT_154	[p13l1851t26r2142b109],
10	none	NN	O	none	nsubj	16	SENT_154	[p13l8t156r198b203],
11	of	IN	O	of	_	0	SENT_154	[p13l250t134r336b203],
12	our	PRP$	O	we	poss	13	SENT_154	[p13l381t156r511b203],
13	patients	NNS	O	patient	prep_of	10	SENT_154	[p13l558t134r865b224],
14	were	VBD	O	be	aux	16	SENT_154	[p13l918t156r1107b203],
15	concurrently	RB	O	concurrently	advmod	16	SENT_154	[p13l1159t134r1658b224],
16	taking	VBG	O	take	_	0	SENT_154	[p13l1710t134r1955b224],
17	any	DT	O	any	det	19	SENT_154	[p13l2008t156r2146b224],
18	other	JJ	O	other	amod	19	SENT_154	[p13l10t242r212b311],
19	medication	NN	O	medication	dobj	16	SENT_154	[p13l259t242r720b324],
20	,	,	O	,	_	0	SENT_154	[p13l259t242r720b324],
21	and	CC	O	and	_	0	SENT_154	[p13l775t242r914b311],
22	66	CD	PERCENT	66	num	23	SENT_154	[p13l963t242r1136b312],
23	%	NN	PERCENT	%	nsubj	27	SENT_154	[p13l963t242r1136b312],
24	of	IN	O	of	_	0	SENT_154	[p13l1190t242r1275b311],
25	our	PRP$	O	we	poss	26	SENT_154	[p13l1319t264r1449b311],
26	subjects	NNS	O	subject	prep_of	23	SENT_154	[p13l1499t242r1810b332],
27	had	VBD	O	have	conj_and	16	SENT_154	[p13l1860t242r2003b311],
28	no	DT	O	no	det	30	SENT_154	[p13l2050t264r2145b311],
29	prior	JJ	O	prior	amod	30	SENT_154	[p13l7t350r201b440],
30	exposure	NN	O	exposure	dobj	27	SENT_154	[p13l228t373r581b440],
31	to	TO	O	to	_	0	SENT_154	[p13l610t361r683b420],
32	any	DT	O	any	det	33	SENT_154	[p13l714t373r852b440],
33	antidepressant	JJ	O	antidepressant	prep_to	30	SENT_154	[p13l882t350r1467b440],
34	.	.	O	.	_	0	SENT_154	[p13l882t350r1467b440],

1	It	PRP	O	it	nsubj	3	SENT_155	[p13l1500t352r1559b420],
2	is	VBZ	O	be	cop	3	SENT_155	[p13l1585t350r1646b420],
3	conceivable	JJ	O	conceivable	ccomp	41	SENT_155	[p13l1678t350r2145b420],
4	that	IN	O	that	complm	9	SENT_155	[p13l8t458r156b527],
5	many	JJ	O	many	nsubj	9	SENT_155	[p13l193t480r411b548],
6	of	IN	O	of	_	0	SENT_155	[p13l450t457r535b527],
7	the	DT	O	the	det	8	SENT_155	[p13l566t458r684b527],
8	ADRS	NNP	O	ADRS	prep_of	5	SENT_155	[p13l722t458r964b527],
9	reported	VBN	O	report	ccomp	3	SENT_155	[p13l1003t458r1333b548],
10	by	IN	O	by	_	0	SENT_155	[p13l1370t458r1467b548],
11	others	NNS	O	other	prep_by	9	SENT_155	[p13l1506t458r1743b527],
12	(	CD	NUMBER	(	num	11	SENT_155	[p13l1786t458r1906b543],
13	de	IN	PERSON	de	amod	11	SENT_155	[p13l1786t458r1906b543],
14	Leon	NNP	PERSON	Leon	dep	11	SENT_155	[p13l1944t459r2146b527],
15	et	FW	O	et	nn	16	SENT_155	[p13l10t578r81b634],
16	al.	FW	O	al.	dep	14	SENT_155	[p13l118t565r239b646],
17	,	,	O	,	_	0	SENT_155	[p13l118t565r239b646],
18	1998	CD	DATE	1998	appos	16	SENT_155	[p13l291t565r501b646],
19	;	:	O	;	_	0	SENT_155	[p13l291t565r501b646],
20	Chou	NNP	O	Chou	dep	16	SENT_155	[p13l546t565r758b634],
21	et	FW	O	et	nn	22	SENT_155	[p13l799t578r871b634],
22	al.	FW	O	al.	dep	20	SENT_155	[p13l908t565r1028b646],
23	,	,	O	,	_	0	SENT_155	[p13l908t565r1028b646],
24	2000	CD	DATE	2000	appos	22	SENT_155	[p13l1073t565r1290b646],
25	;	:	O	;	_	0	SENT_155	[p13l1073t565r1290b646],
26	Vandel	NNP	PERSON	Vandel	dep	16	SENT_155	[p13l1335t565r1608b634],
27	et	FW	O	et	nn	28	SENT_155	[p13l1650t578r1721b634],
28	al.	FW	O	al.	dep	26	SENT_155	[p13l1758t565r1879b646],
29	,	,	O	,	_	0	SENT_155	[p13l1758t565r1879b646],
30	1999	CD	DATE	1999	appos	28	SENT_155	[p13l1932t565r2142b646],
31	;	:	O	;	_	0	SENT_155	[p13l1932t565r2142b646],
32	Chen	NNP	PERSON	Chen	dep	16	SENT_155	[p13l9t673r216b743],
33	et	FW	O	et	nn	34	SENT_155	[p13l264t686r335b742],
34	al.	FW	O	al.	dep	32	SENT_155	[p13l378t673r499b755],
35	,	,	O	,	_	0	SENT_155	[p13l378t673r499b755],
36	1996	CD	DATE	1996	num	37	SENT_155	[p13l558t672r775b758],
37	)	NN	O	)	nsubj	41	SENT_155	[p13l558t672r775b758],
38	may	MD	O	may	aux	41	SENT_155	[p13l824t695r992b763],
39	be	VB	O	be	cop	41	SENT_155	[p13l1039t673r1131b742],
40	the	DT	O	the	det	41	SENT_155	[p13l1178t673r1296b742],
41	result	NN	O	result	_	0	SENT_155	[p13l1342t673r1563b742],
42	of	IN	O	of	_	0	SENT_155	[p13l1610t673r1696b742],
43	drug	NN	O	drug	nn	46	SENT_155	[p13l1736t673r2145b763],
44	—	CD	NUMBER	—	num	46	SENT_155	[p13l1736t673r2145b763],
45	drug	NN	O	drug	nn	46	SENT_155	[p13l1736t673r2145b763],
46	interactions	NNS	O	interaction	prep_of	41	SENT_155	[p13l8t780r469b850],
47	exacerbated	VBN	O	exacerbate	partmod	41	SENT_155	[p13l518t781r990b850],
48	by	IN	O	by	_	0	SENT_155	[p13l1034t781r1131b871],
49	CYPZD6	NN	O	cypzd6	nn	51	SENT_155	[p13l1183t780r1531b851],
50	PM	NN	O	pm	nn	51	SENT_155	[p13l1573t782r1713b849],
51	genotype	NN	O	genotype	agent	47	SENT_155	[p13l1760t791r2142b871],
52	,	,	O	,	_	0	SENT_155	[p13l1760t791r2142b871],
53	which	WDT	O	which	nsubjpass	58	SENT_155	[p13l9t888r248b957],
54	would	MD	O	would	aux	58	SENT_155	[p13l287t888r533b957],
55	not	RB	O	not	neg	58	SENT_155	[p13l571t898r697b957],
56	have	VB	O	have	aux	58	SENT_155	[p13l733t888r917b957],
57	been	VBN	O	be	auxpass	58	SENT_155	[p13l955t888r1141b957],
58	observed	VBN	O	observe	rcmod	51	SENT_155	[p13l1181t888r1536b957],
59	in	IN	O	in	_	0	SENT_155	[p13l1573t888r1647b956],
60	our	PRP$	O	we	poss	62	SENT_155	[p13l1687t909r1818b957],
61	clinical	JJ	O	clinical	amod	62	SENT_155	[p13l1855t888r2145b957],
62	trial	NN	O	trial	prep_in	58	SENT_155	[p13l8t995r186b1065],
63	.	.	O	.	_	0	SENT_155	[p13l8t995r186b1065],

1	If	IN	O	if	mark	2	SENT_156	[p13l224t996r294b1064],
2	so	RB	O	so	advcl	6	SENT_156	[p13l323t1018r425b1078],
3	,	,	O	,	_	0	SENT_156	[p13l323t1018r425b1078],
4	this	DT	O	this	nsubj	6	SENT_156	[p13l461t996r600b1065],
5	would	MD	O	would	aux	6	SENT_156	[p13l635t996r880b1065],
6	suggest	VB	O	suggest	_	0	SENT_156	[p13l915t1006r1208b1086],
7	that	IN	O	that	complm	12	SENT_156	[p13l1239t996r1387b1065],
8	CYPZD6	NNP	O	CYPZD6	nn	10	SENT_156	[p13l1423t995r1772b1066],
9	PM	NNP	O	PM	nn	10	SENT_156	[p13l1801t997r1940b1064],
10	genotype	NN	O	genotype	nsubj	12	SENT_156	[p13l1974t1018r2143b1086, p13l10t1115r226b1194],
11	may	MD	O	may	aux	12	SENT_156	[p13l259t1126r427b1194],
12	be	VB	O	be	ccomp	6	SENT_156	[p13l459t1104r550b1173],
13	of	IN	O	of	_	0	SENT_156	[p13l585t1104r670b1173],
14	most	JJS	O	most	amod	15	SENT_156	[p13l695t1115r888b1173],
15	relevance	NN	O	relevance	prep_of	12	SENT_156	[p13l917t1104r1293b1173],
16	in	IN	O	in	_	0	SENT_156	[p13l1326t1104r1401b1172],
17	cases	NNS	O	case	prep_in	12	SENT_156	[p13l1434t1126r1637b1173],
18	where	WRB	O	where	advmod	25	SENT_156	[p13l1673t1104r1912b1174],
19	more	JJR	O	more	mwe	20	SENT_156	[p13l1944t1126r2145b1173],
20	than	IN	O	than	quantmod	21	SENT_156	[p13l8t1212r178b1281],
21	one	CD	NUMBER	one	num	22	SENT_156	[p13l213t1234r352b1281],
22	drug	NN	O	drug	nsubjpass	25	SENT_156	[p13l389t1212r565b1302],
23	is	VBZ	O	be	aux	25	SENT_156	[p13l601t1212r662b1281],
24	being	VBG	O	be	auxpass	25	SENT_156	[p13l698t1212r916b1302],
25	prescribed	VBN	O	prescribe	rcmod	17	SENT_156	[p13l951t1212r1383b1302],
26	.	.	O	.	_	0	SENT_156	[p13l951t1212r1383b1302],

1	A	DT	O	a	det	3	SENT_157	[p13l1424t1212r1493b1280],
2	possible	JJ	O	possible	amod	3	SENT_157	[p13l1526t1212r1849b1302],
3	exception	NN	O	exception	nsubjpass	5	SENT_157	[p13l1885t1234r2143b1302, p13l8t1320r161b1390],
4	is	VBZ	O	be	auxpass	5	SENT_157	[p13l192t1320r253b1390],
5	described	VBN	O	describe	_	0	SENT_157	[p13l287t1320r666b1390],
6	by	IN	O	by	_	0	SENT_157	[p13l695t1320r792b1410],
7	Spina	NNP	PERSON	Spina	agent	5	SENT_157	[p13l827t1320r1048b1410],
8	et	FW	O	et	nn	10	SENT_157	[p13l1080t1333r1151b1390],
9	al.	FW	O	al.	nn	10	SENT_157	[p13l1180t1320r1270b1390],
10	(	FW	O	(	dobj	5	SENT_157	[p13l1314t1320r1593b1406],
11	1997	CD	DATE	1997	num	12	SENT_157	[p13l1314t1320r1593b1406],
12	)	CD	NUMBER	)	dep	5	SENT_157	[p13l1314t1320r1593b1406],
13	,	,	O	,	_	0	SENT_157	[p13l1314t1320r1593b1406],
14	in	IN	O	in	_	0	SENT_157	[p13l1628t1320r1703b1389],
15	a	DT	O	a	det	17	SENT_157	[p13l1736t1342r1777b1390],
16	prospective	JJ	O	prospective	amod	17	SENT_157	[p13l1806t1342r2143b1410, p13l8t1428r153b1498],
17	study	NN	O	study	prep_in	12	SENT_157	[p13l196t1428r403b1518],
18	of	IN	O	of	_	0	SENT_157	[p13l445t1428r530b1497],
19	31	CD	NUMBER	31	num	21	SENT_157	[p13l566t1428r651b1498],
20	depressed	JJ	O	depressed	amod	21	SENT_157	[p13l700t1428r1089b1518],
21	outpatients	NNS	O	outpatient	prep_of	17	SENT_157	[p13l1130t1428r1561b1518],
22	treated	VBN	O	treat	partmod	21	SENT_157	[p13l1603t1428r1872b1497],
23	solely	RB	O	solely	advmod	22	SENT_157	[p13l1914t1428r2145b1518],
24	with	IN	O	with	_	0	SENT_157	[p13l9t1536r183b1606],
25	desipramine	NN	O	desipramine	prep_with	22	SENT_157	[p13l211t1536r715b1626],
26	,	,	O	,	_	0	SENT_157	[p13l211t1536r715b1626],
27	in	IN	O	in	_	0	SENT_157	[p13l746t1536r821b1605],
28	which	WDT	O	which	rel	31	SENT_157	[p13l848t1536r1088b1606],
29	the	DT	O	the	det	30	SENT_157	[p13l1115t1536r1233b1606],
30	two	CD	NUMBER	two	nsubj	31	SENT_157	[p13l1261t1547r1406b1606],
31	enrolled	VBN	O	enrol	rcmod	25	SENT_157	[p13l1436t1536r1759b1606],
32	CYPZD6	NN	O	cypzd6	nn	34	SENT_157	[p13l1787t1536r2145b1606],
33	phenotypic	JJ	O	phenotypic	amod	34	SENT_157	[p13l7t1644r446b1734],
34	PMs	NNS	O	pm	dobj	31	SENT_157	[p13l524t1646r699b1714],
35	both	CC	O	both	dep	34	SENT_157	[p13l775t1644r951b1714],
36	experienced	JJ	O	experienced	amod	38	SENT_157	[p13l1026t1644r1504b1734],
37	severe	JJ	O	severe	amod	38	SENT_157	[p13l1582t1666r1827b1714],
38	ADRS	NN	O	adr	conj	34	SENT_157	[p13l1902t1645r2144b1714],
39	requiring	VBG	O	require	partmod	38	SENT_157	[p13l7t1752r369b1842],
40	dosage	NN	O	dosage	nn	41	SENT_157	[p13l404t1752r675b1842],
41	reduction	NN	O	reduction	dobj	39	SENT_157	[p13l708t1752r1083b1821],
42	(	CD	NUMBER	(	num	41	SENT_157	[p13l1118t1752r1373b1842],
43	Spina	NNP	O	Spina	tmod	39	SENT_157	[p13l1118t1752r1373b1842],
44	et	FW	O	et	nn	45	SENT_157	[p13l1406t1765r1477b1821],
45	al.	FW	O	al.	dep	43	SENT_157	[p13l1507t1752r1628b1834],
46	,	,	O	,	_	0	SENT_157	[p13l1507t1752r1628b1834],
47	1997	CD	DATE	1997	num	48	SENT_157	[p13l1673t1752r1912b1837],
48	)	NN	O	)	conj	34	SENT_157	[p13l1673t1752r1912b1837],
49	.	.	O	.	_	0	SENT_157	[p13l1673t1752r1912b1837],

1	Other	JJ	O	other	amod	2	SENT_158	[p13l110t1860r333b1930],
2	studies	NNS	O	study	nsubj	5	SENT_158	[p13l395t1860r663b1930],
3	have	VBP	O	have	aux	5	SENT_158	[p13l724t1860r907b1930],
4	also	RB	O	also	advmod	5	SENT_158	[p13l970t1860r1125b1930],
5	questioned	VBN	O	question	_	0	SENT_158	[p13l1187t1860r1615b1950],
6	the	DT	O	the	det	8	SENT_158	[p13l1674t1860r1793b1930],
7	clinical	JJ	O	clinical	amod	8	SENT_158	[p13l1855t1860r2145b1930],
8	relevance	NN	O	relevance	dobj	5	SENT_158	[p13l7t1968r383b2038],
9	of	IN	O	of	_	0	SENT_158	[p13l420t1968r506b2038],
10	CYP2D6	NN	O	cyp2d6	nn	12	SENT_158	[p13l534t1968r893b2038],
11	metabolizer	NN	O	metabolizer	nn	12	SENT_158	[p13l928t1968r1399b2038],
12	status	NN	O	status	prep_of	8	SENT_158	[p13l1436t1979r1653b2038],
13	for	IN	O	for	_	0	SENT_158	[p13l1691t1968r1806b2038],
14	predicting	VBG	O	predict	prepc_for	5	SENT_158	[p13l1838t1968r2143b2058, p13l8t2076r131b2166],
15	treatment	NN	O	treatment	nn	16	SENT_158	[p13l175t2086r551b2145],
16	outcome	NN	O	outcome	dobj	14	SENT_158	[p13l594t2086r932b2145],
17	or	CC	O	or	_	0	SENT_158	[p13l977t2098r1058b2145],
18	ADRs	NNS	MISC	adr	dobj	14	SENT_158	[p13l1099t2076r1363b2145],
19	.	.	O	.	_	0	SENT_158	[p13l1099t2076r1363b2145],

1	An	DT	O	a	det	3	SENT_159	[p13l1411t2076r1529b2144],
2	early	JJ	O	early	amod	3	SENT_159	[p13l1573t2076r1767b2166],
3	study	NN	O	study	_	0	SENT_159	[p13l1815t2076r2023b2166],
4	of	IN	O	of	_	0	SENT_159	[p13l2067t2076r2153b2145],
5	imipramine	NN	O	imipramine	nn	6	SENT_159	[p13l8t2184r465b2274],
6	treatment	NN	O	treatment	prep_of	3	SENT_159	[p13l494t2194r871b2254],
7	of	IN	O	of	_	0	SENT_159	[p13l899t2184r984b2254],
8	depression	NN	O	depression	prep_of	3	SENT_159	[p13l1007t2184r1429b2274],
9	in	IN	O	in	_	0	SENT_159	[p13l1457t2184r1531b2253],
10	patients	NNS	O	patient	prep_in	3	SENT_159	[p13l1559t2184r1866b2274],
11	subsequently	RB	O	subsequently	advmod	12	SENT_159	[p13l1899t2184r2144b2254, p13l9t2292r303b2382],
12	phenotyped	VBN	O	phenotype	partmod	3	SENT_159	[p13l335t2292r798b2382],
13	with	IN	O	with	_	0	SENT_159	[p13l830t2292r1004b2362],
14	debrisoquine	NN	O	debrisoquine	nn	18	SENT_159	[p13l1037t2292r1546b2382],
15	and	CC	O	and	_	0	SENT_159	[p13l1581t2292r1720b2362],
16	mepheny	JJ	O	mepheny	conj_and	14	SENT_159	[p13l1752t2292r2144b2382],
17	—	NN	O	—	nn	18	SENT_159	[p13l1752t2292r2144b2382],
18	toin	NN	O	toin	prep_with	12	SENT_159	[p13l8t2400r161b2469],
19	(	CD	NUMBER	(	amod	18	SENT_159	[p13l188t2401r476b2490],
20	Meyer	NNP	PERSON	Meyer	dep	19	SENT_159	[p13l188t2401r476b2490],
21	et	FW	O	et	nn	22	SENT_159	[p13l496t2413r567b2469],
22	al.	FW	O	al.	dep	20	SENT_159	[p13l589t2400r709b2482],
23	,	,	O	,	_	0	SENT_159	[p13l589t2400r709b2482],
24	1988	CD	DATE	1988	num	25	SENT_159	[p13l747t2400r962b2485],
25	)	CD	NUMBER	)	appos	20	SENT_159	[p13l747t2400r962b2485],
26	found	VBN	O	find	partmod	25	SENT_159	[p13l991t2400r1220b2469],
27	no	DT	O	no	det	28	SENT_159	[p13l1243t2422r1338b2469],
28	correlation	NN	O	correlation	dobj	26	SENT_159	[p13l1364t2400r1793b2469],
29	between	IN	O	between	_	0	SENT_159	[p13l1815t2400r2146b2470],
30	PM	NNP	O	PM	nn	31	SENT_159	[p13l8t2510r148b2577],
31	status	NN	O	status	prep_between	28	SENT_159	[p13l191t2519r409b2578],
32	for	IN	O	for	_	0	SENT_159	[p13l451t2508r566b2578],
33	either	CC	O	either	preconj	35	SENT_159	[p13l604t2508r829b2578],
34	probe	NN	O	probe	nn	35	SENT_159	[p13l865t2508r1089b2598],
35	drug	NN	O	drug	prep_for	26	SENT_159	[p13l1130t2508r1307b2598],
36	and	CC	O	and	_	0	SENT_159	[p13l1350t2508r1489b2578],
37	the	DT	O	the	det	38	SENT_159	[p13l1528t2508r1646b2578],
38	intensity	NN	O	intensity	prep_for	26	SENT_159	[p13l1686t2508r2027b2598],
39	or	CC	O	or	_	0	SENT_159	[p13l2067t2530r2148b2578],
40	frequency	NN	O	frequency	conj_and	35	SENT_159	[p13l9t2616r402b2706],
41	of	IN	O	of	_	0	SENT_159	[p13l438t2616r524b2686],
42	side	JJ	O	side	amod	43	SENT_159	[p13l554t2616r707b2686],
43	effects	NNS	O	effect	prep_of	18	SENT_159	[p13l743t2616r1022b2686],
44	.	.	O	.	_	0	SENT_159	[p13l743t2616r1022b2686],

1	However	RB	O	however	advmod	16	SENT_160	[p13l1062t2618r1436b2698],
2	,	,	O	,	_	0	SENT_160	[p13l1062t2618r1436b2698],
3	the	DT	O	the	det	6	SENT_160	[p13l1474t2616r1592b2686],
4	four	CD	NUMBER	four	num	6	SENT_160	[p13l1627t2616r1791b2686],
5	debrisoquine	NN	O	debrisoquine	nn	6	SENT_160	[p13l1824t2616r2144b2686, p13l9t2724r226b2814],
6	PMs	NNS	O	pm	nsubjpass	16	SENT_160	[p13l273t2726r450b2794],
7	in	IN	O	in	_	0	SENT_160	[p13l499t2724r574b2793],
8	the	DT	O	the	det	9	SENT_160	[p13l620t2724r739b2794],
9	group	NN	O	group	prep_in	6	SENT_160	[p13l786t2747r1012b2814],
10	of	IN	O	of	_	0	SENT_160	[p13l1062t2724r1147b2794],
11	42	CD	NUMBER	42	num	13	SENT_160	[p13l1187t2725r1283b2793],
12	phenotyped	JJ	O	phenotyped	amod	13	SENT_160	[p13l1329t2724r1792b2814],
13	patients	NNS	O	patient	prep_of	9	SENT_160	[p13l1838t2724r2144b2814],
14	were	VBD	O	be	auxpass	16	SENT_160	[p13l9t2854r198b2902],
15	all	DT	O	all	advmod	16	SENT_160	[p13l240t2832r335b2902],
16	judged	VBN	O	judge	_	0	SENT_160	[p13l367t2832r643b2922],
17	to	TO	O	to	aux	21	SENT_160	[p13l682t2843r755b2902],
18	be	VB	O	be	cop	21	SENT_160	[p13l794t2832r886b2902],
19	non	JJ	O	non	amod	21	SENT_160	[p13l927t2832r1534b2922],
20	—	NN	O	—	nn	21	SENT_160	[p13l927t2832r1534b2922],
21	responders	NNS	O	responder	xcomp	16	SENT_160	[p13l927t2832r1534b2922],
22	to	TO	O	to	_	0	SENT_160	[p13l1575t2843r1648b2902],
23	imipramine	NN	O	imipramine	nn	25	SENT_160	[p13l1689t2832r2145b2922],
24	(	CD	NUMBER	(	num	25	SENT_160	[p13l12t2941r300b3030],
25	Meyer	NNP	PERSON	Meyer	prep_to	21	SENT_160	[p13l12t2941r300b3030],
26	er	FW	O	er	nn	27	SENT_160	[p13l342t2954r413b3010],
27	al.	FW	O	al.	dep	25	SENT_160	[p13l457t2940r578b3023],
28	,	,	O	,	_	0	SENT_160	[p13l457t2940r578b3023],
29	1988	CD	DATE	1988	num	30	SENT_160	[p13l637t2941r876b3026],
30	)	NN	O	)	appos	25	SENT_160	[p13l637t2941r876b3026],
31	.	.	O	.	_	0	SENT_160	[p13l637t2941r876b3026],

1	In	IN	O	in	_	0	SENT_161	[p13l928t2942r1008b3009],
2	contrast	NN	O	contrast	prep_in	5	SENT_161	[p13l1055t2951r1388b3023],
3	,	,	O	,	_	0	SENT_161	[p13l1055t2951r1388b3023],
4	we	PRP	O	we	nsubj	5	SENT_161	[p13l1438t2962r1550b3010],
5	observed	VBD	O	observe	_	0	SENT_161	[p13l1599t2940r1954b3010],
6	that	IN	O	that	complm	13	SENT_161	[p13l1999t2940r2147b3010],
7	PM	NN	O	pm	nn	8	SENT_161	[p13l8t3050r148b3117],
8	genotypes	NNS	O	genotype	nsubjpass	13	SENT_161	[p13l206t3059r604b3138],
9	were	VBD	O	be	auxpass	13	SENT_161	[p13l663t3071r852b3118],
10	not	RB	O	not	neg	13	SENT_161	[p13l910t3059r1036b3118],
11	over	IN	O	over	_	0	SENT_161	[p13l1093t3048r1755b3138],
12	—	CD	NUMBER	—	prep_over	10	SENT_161	[p13l1093t3048r1755b3138],
13	represented	VBN	O	represent	ccomp	5	SENT_161	[p13l1093t3048r1755b3138],
14	amongst	IN	O	amongst	_	0	SENT_161	[p13l1814t3059r2147b3138],
15	non	JJ	O	non	amod	17	SENT_161	[p13l8t3156r616b3246],
16	—	NN	O	—	nn	17	SENT_161	[p13l8t3156r616b3246],
17	responders	NNS	O	responder	prep_amongst	13	SENT_161	[p13l8t3156r616b3246],
18	being	VBG	O	be	auxpass	19	SENT_161	[p13l695t3156r913b3246],
19	treated	VBN	O	treat	partmod	17	SENT_161	[p13l994t3156r1263b3226],
20	with	IN	O	with	_	0	SENT_161	[p13l1341t3156r1515b3226],
21	ﬂuoxetine	NN	O	ﬂuoxetine	prep_with	19	SENT_161	[p13l1595t3156r1987b3226],
22	or	CC	O	or	_	0	SENT_161	[p13l2067t3178r2148b3226],
23	nortriptyline	NN	O	nortriptyline	conj_or	21	SENT_161	[p13l8t3264r524b3354],
24	.	.	O	.	_	0	SENT_161	[p13l8t3264r524b3354],

1	Copyright	NN	O	copyright	nn	5	SENT_162	[p13l9t3533r369b3613],
2	©	CD	NUMBER	©	num	5	SENT_162	[p13l403t3533r479b3609],
3	2004	CD	DATE	2004	num	5	SENT_162	[p13l514t3533r688b3595],
4	John	NNP	ORGANIZATION	John	nn	5	SENT_162	[p13l718t3533r884b3595],
5	Wiley	NNP	ORGANIZATION	Wiley	_	0	SENT_162	[p13l913t3533r1127b3613],
6	&	CC	ORGANIZATION	&	_	0	SENT_162	[p13l1158t3533r1221b3595],
7	Sons	NNP	ORGANIZATION	Sons	conj_and	5	SENT_162	[p13l1254t3533r1441b3606],
8	,	,	ORGANIZATION	,	_	0	SENT_162	[p13l1254t3533r1441b3606],
9	Ltd.	NNP	ORGANIZATION	Ltd.	appos	5	SENT_162	[p13l1474t3533r1614b3595],
10	.	.	O	.	_	0	SENT_162	[p13l1474t3533r1614b3595],

1	De	NNP	O	De	nn	2	SENT_163	[p14l108t19r220b87],
2	Vries	NNP	O	Vries	_	0	SENT_163	[p14l272t17r481b87],
3	et	FW	O	et	nn	5	SENT_163	[p14l536t31r607b87],
4	al.	FW	O	al.	nn	5	SENT_163	[p14l654t17r744b87],
5	(	FW	O	(	dep	2	SENT_163	[p14l808t18r1063b103],
6	2001	CD	DATE	2001	num	7	SENT_163	[p14l808t18r1063b103],
7	)	CD	NUMBER	)	xcomp	5	SENT_163	[p14l808t18r1063b103],
8	studied	VBN	O	study	partmod	7	SENT_163	[p14l1120t17r1402b87],
9	the	DT	O	the	det	10	SENT_163	[p14l1451t17r1570b87],
10	frequency	NN	O	frequency	dobj	8	SENT_163	[p14l1622t17r2016b107],
11	of	IN	O	of	_	0	SENT_163	[p14l2067t17r2153b87],
12	CYP2D6	NN	O	cyp2d6	nn	15	SENT_163	[p14l13t125r362b195],
13	and	CC	O	and	_	0	SENT_163	[p14l397t125r537b195],
14	CYP2CI9	NN	O	cyp2ci9	nn	15	SENT_163	[p14l578t125r968b195],
15	alleles	NNS	O	allele	prep_of	10	SENT_163	[p14l1006t125r1278b207],
16	,	,	O	,	_	0	SENT_163	[p14l1006t125r1278b207],
17	and	CC	O	and	_	0	SENT_163	[p14l1321t125r1460b195],
18	blood	NN	O	blood	nn	20	SENT_163	[p14l1495t125r1720b195],
19	drug	NN	O	drug	nn	20	SENT_163	[p14l1758t125r1935b215],
20	concentrations	NNS	O	concentration	conj_and	5	SENT_163	[p14l1974t147r2144b195, p14l9t233r464b315],
21	,	,	O	,	_	0	SENT_163	[p14l1974t147r2144b195, p14l9t233r464b315],
22	in	IN	O	in	_	0	SENT_163	[p14l514t233r590b302],
23	39	CD	NUMBER	39	num	25	SENT_163	[p14l638t234r729b304],
24	psychiatric	JJ	O	psychiatric	amod	25	SENT_163	[p14l777t233r1209b323],
25	patients	NNS	O	patient	prep_in	20	SENT_163	[p14l1257t233r1563b323],
26	who	WP	O	who	nsubj	27	SENT_163	[p14l1612t233r1778b303],
27	suffered	VBD	O	suffer	rcmod	25	SENT_163	[p14l1829t233r2146b303],
28	therapeutic	JJ	O	therapeutic	amod	29	SENT_163	[p14l8t341r447b431],
29	failure	NN	O	failure	nsubjpass	36	SENT_163	[p14l491t341r749b411],
30	due	JJ	O	due	_	0	SENT_163	[p14l792t341r931b411],
31	to	TO	O	to	_	0	SENT_163	[p14l974t352r1048b411],
32	severe	JJ	O	severe	amod	33	SENT_163	[p14l1094t364r1339b411],
33	ADRS	NNS	O	adr	prep_due_to	36	SENT_163	[p14l1381t342r1623b411],
34	while	IN	O	while	mark	36	SENT_163	[p14l1668t341r1885b411],
35	being	VBG	O	be	auxpass	36	SENT_163	[p14l1926t341r2145b431],
36	treated	VBN	O	treat	xcomp	27	SENT_163	[p14l8t449r278b519],
37	with	IN	O	with	_	0	SENT_163	[p14l340t449r514b519],
38	drugs	NNS	O	drug	prep_with	36	SENT_163	[p14l577t449r791b539],
39	that	WDT	O	that	nsubj	41	SENT_163	[p14l855t449r1004b519],
40	were	VBD	O	be	cop	41	SENT_163	[p14l1066t471r1255b519],
41	substrates	NNS	O	substrate	rcmod	38	SENT_163	[p14l1321t449r1705b519],
42	for	IN	O	for	_	0	SENT_163	[p14l1770t449r1884b519],
43	these	DT	O	these	det	44	SENT_163	[p14l1944t449r2145b519],
44	enzymes	NNS	O	enzyme	prep_for	41	SENT_163	[p14l9t579r351b647],
45	(	FW	O	(	nn	46	SENT_163	[p14l391t557r512b643],
46	de	FW	O	de	amod	44	SENT_163	[p14l391t557r512b643],
47	Vries	NNP	O	Vries	dep	36	SENT_163	[p14l545t557r756b627],
48	er	FW	O	er	nn	49	SENT_163	[p14l793t571r864b627],
49	al.	FW	O	al.	dep	47	SENT_163	[p14l895t557r1016b640],
50	,	,	O	,	_	0	SENT_163	[p14l895t557r1016b640],
51	2001	CD	DATE	2001	num	52	SENT_163	[p14l1054t558r1301b643],
52	)	NN	O	)	appos	25	SENT_163	[p14l1054t558r1301b643],
53	.	.	O	.	_	0	SENT_163	[p14l1054t558r1301b643],

1	They	PRP	O	they	nsubj	2	SENT_164	[p14l1339t557r1541b647],
2	found	VBD	O	find	_	0	SENT_164	[p14l1574t557r1803b627],
3	a	DT	O	a	det	4	SENT_164	[p14l1838t579r1879b627],
4	distribution	NN	O	distribution	dobj	2	SENT_164	[p14l1912t557r2144b627, p14l7t665r260b735],
5	of	IN	O	of	_	0	SENT_164	[p14l287t665r372b735],
6	PM	NN	O	pm	nn	7	SENT_164	[p14l391t667r531b734],
7	alleles	NNS	O	allele	prep_of	4	SENT_164	[p14l560t665r808b735],
8	in	IN	O	in	_	0	SENT_164	[p14l837t665r912b734],
9	this	DT	O	this	det	10	SENT_164	[p14l938t665r1077b735],
10	group	NN	O	group	prep_in	2	SENT_164	[p14l1106t688r1354b755],
11	,	,	O	,	_	0	SENT_164	[p14l1106t688r1354b755],
12	for	IN	O	for	_	0	SENT_164	[p14l1385t665r1500b735],
13	both	DT	O	both	det	14	SENT_164	[p14l1523t665r1698b735],
14	genes	NNS	O	gene	prep_for	2	SENT_164	[p14l1726t688r1969b755],
15	,	,	O	,	_	0	SENT_164	[p14l1726t688r1969b755],
16	that	IN	O	that	nsubj	24	SENT_164	[p14l1999t665r2147b735],
17	reﬂected	VBD	O	reﬂected	rcmod	14	SENT_164	[p14l7t773r350b843],
18	the	DT	O	the	det	21	SENT_164	[p14l379t773r498b843],
19	normal	JJ	O	normal	amod	21	SENT_164	[p14l528t773r807b843],
20	population	NN	O	population	nn	21	SENT_164	[p14l837t773r1262b863],
21	distribution	NN	O	distribution	dobj	17	SENT_164	[p14l1292t773r1768b855],
22	,	,	O	,	_	0	SENT_164	[p14l1292t773r1768b855],
23	and	CC	O	and	_	0	SENT_164	[p14l1804t773r1943b843],
24	concluded	VBD	O	conclude	rcmod	14	SENT_164	[p14l1974t795r2144b843, p14l9t881r272b951],
25	that	IN	O	that	complm	29	SENT_164	[p14l297t881r445b951],
26	routine	JJ	O	routine	amod	27	SENT_164	[p14l468t881r747b951],
27	genotyping	NN	O	genotyping	nsubj	29	SENT_164	[p14l773t881r1216b971],
28	would	MD	O	would	aux	29	SENT_164	[p14l1242t881r1487b951],
29	be	VB	O	be	ccomp	24	SENT_164	[p14l1511t881r1603b951],
30	of	IN	O	of	_	0	SENT_164	[p14l1629t881r1715b951],
31	no	DT	O	no	det	33	SENT_164	[p14l1733t904r1828b951],
32	clinical	JJ	O	clinical	amod	33	SENT_164	[p14l1856t881r2145b951],
33	relevance	NN	O	relevance	prep_of	29	SENT_164	[p14l7t989r383b1059],
34	for	IN	O	for	_	0	SENT_164	[p14l441t989r555b1059],
35	predicting	VBG	O	predict	prepc_for	29	SENT_164	[p14l608t989r1010b1079],
36	therapeutic	JJ	O	therapeutic	amod	37	SENT_164	[p14l1068t989r1506b1079],
37	failure	NN	O	failure	dobj	35	SENT_164	[p14l1565t989r1821b1059],
38	caused	VBN	O	cause	partmod	37	SENT_164	[p14l1879t989r2146b1059],
39	by	IN	O	by	_	0	SENT_164	[p14l7t1097r104b1187],
40	severe	JJ	O	severe	amod	42	SENT_164	[p14l145t1119r390b1166],
41	side	JJ	O	side	amod	42	SENT_164	[p14l431t1097r584b1166],
42	effects	NNS	O	effect	agent	38	SENT_164	[p14l623t1096r880b1166],
43	after	IN	O	after	_	0	SENT_164	[p14l921t1097r1101b1166],
44	treatment	NN	O	treatment	prep_after	38	SENT_164	[p14l1136t1107r1511b1166],
45	with	IN	O	with	_	0	SENT_164	[p14l1548t1096r1721b1166],
46	CYP2D6	NN	O	cyp2d6	prep_with	38	SENT_164	[p14l1759t1096r2148b1167],
47	/	:	O	/	punct	49	SENT_164	[p14l1759t1096r2148b1167],
48	2C19	NN	O	2c19	nn	49	SENT_164	[p14l10t1206r219b1276],
49	substrates	NNS	O	substrate	dep	46	SENT_164	[p14l247t1205r652b1275],
50	.	.	O	.	_	0	SENT_164	[p14l247t1205r652b1275],

1	Finally	RB	O	finally	advmod	3	SENT_165	[p14l680t1205r975b1295],
2	,	,	O	,	_	0	SENT_165	[p14l680t1205r975b1295],
3	follow	VB	O	follow	_	0	SENT_165	[p14l1001t1205r1256b1275],
4	up	RB	O	up	advmod	23	SENT_165	[p14l1278t1228r1374b1295],
5	of	IN	O	of	_	0	SENT_165	[p14l1400t1205r1485b1275],
6	ADRS	NN	O	adr	prep_of	4	SENT_165	[p14l1500t1206r1742b1275],
7	described	VBN	O	describe	partmod	6	SENT_165	[p14l1769t1205r2146b1275],
8	as	IN	O	as	_	0	SENT_165	[p14l10t1335r86b1382],
9	seizures	NNS	O	seizure	prep_as	7	SENT_165	[p14l126t1313r439b1382],
10	or	CC	O	or	_	0	SENT_165	[p14l476t1335r557b1382],
11	myoclonus	NN	O	myoclonus	prep_as	7	SENT_165	[p14l589t1313r1021b1403],
12	during	IN	O	during	_	0	SENT_165	[p14l1058t1313r1313b1403],
13	treatment	NN	O	treatment	prep_during	7	SENT_165	[p14l1349t1323r1724b1382],
14	with	IN	O	with	_	0	SENT_165	[p14l1758t1313r1932b1382],
15	antidepressants	NNS	O	antidepressant	prep_with	7	SENT_165	[p14l1968t1313r2143b1382, p14l9t1421r462b1511],
16	in	IN	O	in	_	0	SENT_165	[p14l500t1421r574b1489],
17	the	DT	O	the	det	20	SENT_165	[p14l609t1421r727b1490],
18	Swedish	JJ	MISC	swedish	amod	20	SENT_165	[p14l766t1421r1098b1491],
19	national	JJ	O	national	amod	20	SENT_165	[p14l1132t1421r1450b1490],
20	database	NN	O	database	prep_in	15	SENT_165	[p14l1488t1421r1825b1490],
21	did	VBD	O	do	aux	23	SENT_165	[p14l1863t1421r1987b1490],
22	not	RB	O	not	neg	23	SENT_165	[p14l2023t1431r2147b1490],
23	implicate	VB	O	implicate	dep	3	SENT_165	[p14l8t1529r377b1619],
24	CYPZD6	NN	O	cypzd6	nn	28	SENT_165	[p14l402t1529r759b1599],
25	or	CC	O	or	_	0	SENT_165	[p14l785t1552r865b1599],
26	CYP2C19	NN	O	cyp2c19	nn	28	SENT_165	[p14l888t1530r1288b1600],
27	PM	NN	O	pm	nn	28	SENT_165	[p14l1314t1531r1453b1598],
28	status	NN	O	status	dobj	23	SENT_165	[p14l1480t1540r1697b1599],
29	as	IN	O	as	mark	35	SENT_165	[p14l1725t1552r1801b1599],
30	risk	NN	O	risk	nn	31	SENT_165	[p14l1824t1529r1974b1599],
31	factors	NNS	O	factor	nsubj	35	SENT_165	[p14l1994t1529r2143b1599, p14l8t1647r153b1706],
32	for	IN	O	for	_	0	SENT_165	[p14l187t1637r302b1706],
33	these	DT	O	these	det	34	SENT_165	[p14l333t1637r534b1706],
34	ADRS	NNS	O	adr	prep_for	31	SENT_165	[p14l567t1637r809b1706],
35	(	VBP	O	(	advcl	23	SENT_165	[p14l847t1637r1167b1727],
36	Spigset	NNP	O	Spigset	dobj	35	SENT_165	[p14l847t1637r1167b1727],
37	et	FW	O	et	nn	38	SENT_165	[p14l1201t1650r1272b1706],
38	al.	FW	O	al.	nsubj	23	SENT_165	[p14l1302t1637r1423b1719],
39	,	,	O	,	_	0	SENT_165	[p14l1302t1637r1423b1719],
40	1997	CD	DATE	1997	num	41	SENT_165	[p14l1468t1637r1707b1722],
41	)	NN	O	)	appos	38	SENT_165	[p14l1468t1637r1707b1722],
42	.	.	O	.	_	0	SENT_165	[p14l1468t1637r1707b1722],

1	As	IN	O	as	mark	7	SENT_166	[p14l107t1745r212b1814],
2	only	RB	O	only	advmod	5	SENT_166	[p14l262t1745r434b1835],
3	ten	CD	NUMBER	ten	num	5	SENT_166	[p14l482t1755r602b1814],
4	CYPZD6	NN	O	cypzd6	nn	5	SENT_166	[p14l650t1745r1006b1815],
5	PMs	NNS	O	pm	nsubjpass	7	SENT_166	[p14l1056t1746r1232b1814],
6	were	VBD	O	be	auxpass	7	SENT_166	[p14l1281t1767r1470b1815],
7	detected	VBN	O	detect	advcl	15	SENT_166	[p14l1519t1745r1849b1814],
8	in	IN	O	in	_	0	SENT_166	[p14l1895t1745r1970b1814],
9	our	PRP$	O	we	poss	10	SENT_166	[p14l2018t1767r2148b1814],
10	study	NN	O	study	prep_in	7	SENT_166	[p14l12t1853r236b1943],
11	,	,	O	,	_	0	SENT_166	[p14l12t1853r236b1943],
12	further	JJ	O	further	amod	13	SENT_166	[p14l284t1853r553b1923],
13	work	NN	O	work	nsubjpass	15	SENT_166	[p14l596t1853r798b1923],
14	is	VBZ	O	be	auxpass	15	SENT_166	[p14l840t1853r901b1923],
15	needed	VBN	O	need	_	0	SENT_166	[p14l948t1853r1228b1923],
16	to	TO	O	to	aux	17	SENT_166	[p14l1272t1864r1345b1923],
17	determine	VB	O	determine	xcomp	15	SENT_166	[p14l1391t1853r1786b1923],
18	whether	IN	O	whether	complm	21	SENT_166	[p14l1829t1853r2148b1923],
19	our	PRP$	O	we	poss	20	SENT_166	[p14l10t1983r140b2030],
20	observations	NNS	O	observation	nsubj	21	SENT_166	[p14l167t1961r661b2030],
21	hold	VBP	O	hold	ccomp	17	SENT_166	[p14l689t1960r865b2030],
22	for	IN	O	for	_	0	SENT_166	[p14l892t1961r1006b2030],
23	a	DT	O	a	det	25	SENT_166	[p14l1033t1983r1074b2030],
24	larger	JJR	O	larger	amod	25	SENT_166	[p14l1101t1961r1332b2051],
25	group	NN	O	group	prep_for	21	SENT_166	[p14l1357t1983r1605b2051],
26	,	,	O	,	_	0	SENT_166	[p14l1357t1983r1605b2051],
27	and	CC	O	and	_	0	SENT_166	[p14l1638t1961r1777b2030],
28	for	IN	O	for	_	0	SENT_166	[p14l1805t1960r1919b2030],
29	other	JJ	O	other	amod	31	SENT_166	[p14l1946t1961r2148b2030],
30	antidepressant	JJ	O	antidepressant	amod	31	SENT_166	[p14l10t2069r576b2159],
31	drugs	NNS	O	drug	prep_for	21	SENT_166	[p14l613t2069r849b2159],
32	.	.	O	.	_	0	SENT_166	[p14l613t2069r849b2159],

1	Numerous	JJ	O	numerous	amod	3	SENT_167	[p14l890t2070r1299b2138],
2	case	NN	O	case	nn	3	SENT_167	[p14l1338t2091r1505b2138],
3	reports	NNS	O	report	nsubj	4	SENT_167	[p14l1541t2079r1813b2159],
4	support	VBP	O	support	dep	24	SENT_167	[p14l1855t2079r2147b2159],
5	the	DT	O	the	det	6	SENT_167	[p14l8t2177r127b2247],
6	view	NN	O	view	dobj	4	SENT_167	[p14l157t2177r345b2247],
7	that	IN	O	that	complm	18	SENT_167	[p14l377t2177r525b2247],
8	the	DT	O	the	det	9	SENT_167	[p14l556t2177r674b2247],
9	combination	NN	O	combination	nsubj	18	SENT_167	[p14l708t2177r1203b2247],
10	of	IN	O	of	_	0	SENT_167	[p14l1236t2177r1321b2247],
11	antidepressant	JJ	O	antidepressant	amod	12	SENT_167	[p14l1348t2177r1914b2267],
12	medication	NN	O	medication	prep_of	9	SENT_167	[p14l1944t2177r2144b2247, p14l8t2284r277b2354],
13	and	CC	O	and	_	0	SENT_167	[p14l312t2285r451b2354],
14	CYP2D6	NN	O	cyp2d6	nn	16	SENT_167	[p14l487t2284r835b2355],
15	PM	NN	O	pm	nn	16	SENT_167	[p14l864t2286r1003b2353],
16	genotype	NN	O	genotype	conj_and	12	SENT_167	[p14l1036t2295r1396b2375],
17	can	MD	O	can	aux	18	SENT_167	[p14l1430t2307r1565b2354],
18	lead	VB	O	lead	ccomp	4	SENT_167	[p14l1597t2285r1760b2354],
19	to	TO	O	to	_	0	SENT_167	[p14l1791t2295r1865b2354],
20	severe	JJ	O	severe	amod	23	SENT_167	[p14l1901t2307r2146b2354],
21	or	CC	O	or	_	0	SENT_167	[p14l10t2415r91b2462],
22	lethal	JJ	O	lethal	conj_or	20	SENT_167	[p14l120t2393r338b2462],
23	ADRS	NNS	O	adr	prep_to	18	SENT_167	[p14l371t2393r612b2462],
24	(	VBP	O	(	_	0	SENT_167	[p14l649t2393r948b2478],
25	Bluhm	NNP	PERSON	Bluhm	dobj	24	SENT_167	[p14l649t2393r948b2478],
26	er	FW	O	er	nn	27	SENT_167	[p14l980t2406r1051b2462],
27	al.	FW	O	al.	nsubj	24	SENT_167	[p14l1080t2393r1200b2475],
28	,	,	O	,	_	0	SENT_167	[p14l1080t2393r1200b2475],
29	1993	CD	DATE	1993	appos	27	SENT_167	[p14l1244t2393r1454b2475],
30	;	:	O	;	_	0	SENT_167	[p14l1244t2393r1454b2475],
31	Bertilsson	NNP	O	Bertilsson	dep	27	SENT_167	[p14l1489t2393r1890b2462],
32	et	FW	O	et	nn	33	SENT_167	[p14l1923t2406r1994b2462],
33	al.	FW	O	al.	dep	31	SENT_167	[p14l2023t2393r2142b2475],
34	,	,	O	,	_	0	SENT_167	[p14l2023t2393r2142b2475],
35	1981	CD	DATE	1981	appos	33	SENT_167	[p14l18t2501r228b2583],
36	;	:	O	;	_	0	SENT_167	[p14l18t2501r228b2583],
37	Swanson	NNP	PERSON	Swanson	dep	27	SENT_167	[p14l261t2502r613b2571],
38	et	FW	O	et	nn	39	SENT_167	[p14l641t2514r711b2570],
39	al.	FW	O	al.	dep	37	SENT_167	[p14l735t2501r855b2583],
40	,	,	O	,	_	0	SENT_167	[p14l735t2501r855b2583],
41	1997	CD	DATE	1997	appos	39	SENT_167	[p14l894t2501r1103b2583],
42	;	:	O	;	_	0	SENT_167	[p14l894t2501r1103b2583],
43	Sallee	NNP	PERSON	Sallee	dep	27	SENT_167	[p14l1137t2501r1374b2571],
44	et	FW	O	et	nn	45	SENT_167	[p14l1402t2514r1473b2570],
45	al.	FW	O	al.	dep	43	SENT_167	[p14l1496t2501r1617b2583],
46	,	,	O	,	_	0	SENT_167	[p14l1496t2501r1617b2583],
47	2000	CD	DATE	2000	num	48	SENT_167	[p14l1648t2501r1895b2586],
48	)	NN	O	)	appos	27	SENT_167	[p14l1648t2501r1895b2586],
49	.	.	O	.	_	0	SENT_167	[p14l1648t2501r1895b2586],

1	However	RB	O	however	advmod	8	SENT_168	[p14l1926t2503r2143b2571, p14l9t2631r193b2691],
2	,	,	O	,	_	0	SENT_168	[p14l1926t2503r2143b2571, p14l9t2631r193b2691],
3	case	NN	O	case	nn	4	SENT_168	[p14l239t2631r406b2678],
4	reports	NNS	O	report	nsubj	8	SENT_168	[p14l448t2619r721b2699],
5	reﬂect	NN	O	reﬂect	nn	7	SENT_168	[p14l764t2608r1012b2678],
6	extreme	JJ	O	extreme	amod	7	SENT_168	[p14l1054t2619r1370b2678],
7	examples	NNS	O	example	dep	4	SENT_168	[p14l1413t2609r1783b2699],
8	selected	VBN	O	select	_	0	SENT_168	[p14l1831t2609r2146b2678],
9	from	IN	O	from	_	0	SENT_168	[p14l9t2717r200b2786],
10	large	JJ	O	large	amod	11	SENT_168	[p14l230t2717r426b2807],
11	numbers	NNS	O	number	prep_from	8	SENT_168	[p14l458t2717r794b2786],
12	of	IN	O	of	_	0	SENT_168	[p14l829t2717r914b2786],
13	treated	JJ	O	treated	amod	14	SENT_168	[p14l939t2717r1209b2786],
14	patients	NNS	O	patient	prep_of	11	SENT_168	[p14l1239t2717r1567b2807],
15	,	,	O	,	_	0	SENT_168	[p14l1239t2717r1567b2807],
16	and	CC	O	and	_	0	SENT_168	[p14l1605t2717r1744b2786],
17	it	PRP	O	it	nsubj	20	SENT_168	[p14l1775t2717r1830b2786],
18	is	VBZ	O	be	cop	20	SENT_168	[p14l1859t2717r1920b2786],
19	difﬁ	JJ	O	difﬁ	amod	20	SENT_168	[p14l1955t2717r2145b2786],
20	cult	NN	O	cult	conj_and	8	SENT_168	[p14l9t2825r156b2895],
21	to	TO	O	to	aux	22	SENT_168	[p14l187t2836r260b2895],
22	assess	VB	O	assess	infmod	20	SENT_168	[p14l295t2847r530b2895],
23	other	JJ	O	other	amod	24	SENT_168	[p14l564t2825r766b2895],
24	possible	JJ	O	possible	dep	25	SENT_168	[p14l795t2825r1118b2915],
25	genetic	JJ	O	genetic	dobj	22	SENT_168	[p14l1150t2825r1432b2915],
26	or	CC	O	or	_	0	SENT_168	[p14l1467t2847r1548b2895],
27	environmental	JJ	O	environmental	amod	28	SENT_168	[p14l1577t2825r2146b2895],
28	inﬂuences	NNS	O	inﬂuences	conj_or	25	SENT_168	[p14l8t2931r407b3000],
29	in	IN	O	in	_	0	SENT_168	[p14l458t2932r533b3000],
30	these	DT	O	these	det	32	SENT_168	[p14l581t2932r782b3000],
31	isolated	VBN	O	isolate	amod	32	SENT_168	[p14l832t2932r1140b3000],
32	cases	NNS	O	case	prep_in	22	SENT_168	[p14l1189t2953r1414b3000],
33	.	.	O	.	_	0	SENT_168	[p14l1189t2953r1414b3000],

1	A	DT	O	a	det	2	SENT_169	[p14l1468t2932r1537b3000],
2	review	NN	O	review	nsubj	16	SENT_169	[p14l1585t2932r1849b3001],
3	of	IN	O	of	_	0	SENT_169	[p14l1900t2931r1985b3000],
4	the	DT	O	the	det	6	SENT_169	[p14l2027t2932r2146b3000],
5	existing	VBG	O	exist	amod	6	SENT_169	[p14l9t3040r320b3130],
6	literature	NN	O	literature	prep_of	2	SENT_169	[p14l364t3040r721b3109],
7	on	IN	O	on	_	0	SENT_169	[p14l767t3062r863b3109],
8	CYP2D6	NN	O	cyp2d6	nn	12	SENT_169	[p14l911t3040r1259b3110],
9	and	CC	O	and	_	0	SENT_169	[p14l1302t3040r1442b3109],
10	CYP2CI9	NN	O	cyp2ci9	nn	12	SENT_169	[p14l1490t3040r1880b3110],
11	genotype	NN	O	genotype	nn	12	SENT_169	[p14l1924t3062r2143b3130, p14l8t3159r176b3238],
12	effects	NNS	O	effect	prep_on	6	SENT_169	[p14l216t3148r474b3218],
13	on	IN	O	on	_	0	SENT_169	[p14l514t3170r610b3218],
14	antidepressant	JJ	O	antidepressant	amod	15	SENT_169	[p14l650t3148r1215b3238],
15	treatment	NN	O	treatment	prep_on	6	SENT_169	[p14l1252t3158r1628b3218],
16	led	VBD	O	lead	_	0	SENT_169	[p14l1665t3148r1784b3218],
17	to	TO	O	to	_	0	SENT_169	[p14l1821t3159r1894b3218],
18	preliminary	JJ	O	preliminary	amod	20	SENT_169	[p14l1932t3148r2143b3238, p14l9t3256r288b3346],
19	dose	NN	O	dose	nn	20	SENT_169	[p14l358t3256r535b3325],
20	recommendations	NNS	O	recommendation	prep_to	16	SENT_169	[p14l604t3256r1307b3325],
21	for	IN	O	for	mark	26	SENT_169	[p14l1379t3256r1493b3325],
22	individuals	NNS	O	individual	nsubj	26	SENT_169	[p14l1560t3256r1996b3325],
23	of	IN	O	of	_	0	SENT_169	[p14l2067t3255r2153b3325],
24	different	JJ	O	different	amod	25	SENT_169	[p14l10t3364r348b3433],
25	genotypes	NNS	O	genotype	prep_of	22	SENT_169	[p14l402t3375r800b3454],
26	(	VBP	O	(	advcl	16	SENT_169	[p14l859t3364r1363b3449],
27	Kirchheiner	NNP	O	Kirchheiner	nsubj	29	SENT_169	[p14l859t3364r1363b3449],
28	et	FW	O	et	nn	29	SENT_169	[p14l1415t3377r1486b3433],
29	al.	FW	O	al.	xcomp	26	SENT_169	[p14l1537t3364r1657b3446],
30	,	,	O	,	_	0	SENT_169	[p14l1537t3364r1657b3446],
31	2001	CD	DATE	2001	num	32	SENT_169	[p14l1717t3364r1965b3449],
32	)	NN	O	)	appos	29	SENT_169	[p14l1717t3364r1965b3449],
33	,	,	O	,	_	0	SENT_169	[p14l1717t3364r1965b3449],
34	but	CC	O	but	_	0	SENT_169	[p14l2021t3364r2148b3433],
35	identiﬁed	VBD	O	identiﬁed	conj_but	26	SENT_169	[p14l9t3472r383b3542],
36	only	RB	O	only	advmod	39	SENT_169	[p14l406t3472r578b3562],
37	a	DT	O	a	det	39	SENT_169	[p14l604t3494r644b3542],
38	small	JJ	O	small	amod	39	SENT_169	[p14l669t3472r878b3542],
39	number	NN	O	number	nsubj	55	SENT_169	[p14l903t3472r1205b3542],
40	of	IN	O	of	_	0	SENT_169	[p14l1228t3472r1314b3542],
41	studies	NNS	O	study	prep_of	39	SENT_169	[p14l1333t3472r1601b3542],
42	that	WDT	O	that	nsubj	43	SENT_169	[p14l1626t3472r1775b3542],
43	provided	VBD	O	provide	conj_and	43	SENT_169	[p14l1796t3472r2148b3562],
44	efﬁcacy	NN	O	efﬁcacy	nn	45	SENT_169	[p14l9t3580r317b3670],
45	data	NNS	O	datum	dobj	43	SENT_169	[p14l342t3580r505b3650],
46	in	IN	O	in	_	0	SENT_169	[p14l528t3580r604b3649],
47	relation	NN	O	relation	prep_in	43	SENT_169	[p14l625t3580r930b3650],
48	to	TO	O	to	_	0	SENT_169	[p14l952t3591r1026b3650],
49	genotype	NN	O	genotype	prep_to	43	SENT_169	[p14l1052t3591r1434b3670],
50	,	,	O	,	_	0	SENT_169	[p14l1052t3591r1434b3670],
51	and	CC	O	and	_	0	SENT_169	[p14l1464t3580r1603b3650],
52	of	IN	O	of	_	0	SENT_169	[p14l1628t3580r1713b3650],
53	these	DT	O	these	det	54	SENT_169	[p14l1730t3580r1931b3650],
54	none	NN	O	none	prep_of	43	SENT_169	[p14l1956t3602r2145b3650],
55	found	VBD	O	find	ccomp	35	SENT_169	[p14l9t3688r238b3757],
56	a	DT	O	a	det	58	SENT_169	[p14l283t3710r323b3757],
57	signiﬁcant	NN	O	signiﬁcant	nn	58	SENT_169	[p14l368t3688r777b3778],
58	difference	NN	O	difference	dobj	55	SENT_169	[p14l820t3688r1217b3757],
59	between	IN	O	between	_	0	SENT_169	[p14l1260t3688r1590b3758],
60	PM	NNP	O	PM	prep_between	58	SENT_169	[p14l1634t3689r1773b3757],
61	and	CC	O	and	_	0	SENT_169	[p14l1819t3688r1958b3757],
62	EM	NNP	O	EM	prep_between	58	SENT_169	[p14l2000t3689r2146b3756],

1	individuals	NNS	O	individual	nsubj	10	SENT_170	[p15l9t16r444b86],
2	in	IN	O	in	_	0	SENT_170	[p15l496t16r571b85],
3	the	DT	O	the	det	6	SENT_170	[p15l621t16r740b86],
4	per	FW	O	per	nn	6	SENT_170	[p15l790t38r917b106],
5	cent	NN	O	cent	nn	6	SENT_170	[p15l966t26r1129b86],
6	improvement	NN	O	improvement	prep_in	1	SENT_170	[p15l1179t16r1707b106],
7	of	IN	O	of	_	0	SENT_170	[p15l1757t16r1842b86],
8	HDRS	NN	O	hdr	nn	9	SENT_170	[p15l1886t16r2142b86],
9	scores	NNS	O	score	prep_of	6	SENT_170	[p15l12t146r252b193],
10	(	VBP	O	(	_	0	SENT_170	[p15l325t125r734b209],
11	Baumann	NNP	PERSON	Baumann	nsubj	13	SENT_170	[p15l325t125r734b209],
12	et	FW	O	et	nn	13	SENT_170	[p15l803t138r875b193],
13	al.	FW	O	al.	xcomp	10	SENT_170	[p15l940t124r1060b206],
14	,	,	O	,	_	0	SENT_170	[p15l940t124r1060b206],
15	1986	CD	DATE	1986	appos	13	SENT_170	[p15l1141t124r1351b206],
16	;	:	O	;	_	0	SENT_170	[p15l1141t124r1351b206],
17	Morinobu	NNP	PERSON	Morinobu	dep	13	SENT_170	[p15l1423t124r1817b193],
18	et	FW	O	et	nn	19	SENT_170	[p15l1886t138r1957b193],
19	al.	FW	O	al.	dep	17	SENT_170	[p15l2023t124r2143b206],
20	,	,	O	,	_	0	SENT_170	[p15l2023t124r2143b206],
21	1997	CD	DATE	1997	appos	19	SENT_170	[p15l18t232r228b314],
22	;	:	O	;	_	0	SENT_170	[p15l18t232r228b314],
23	Koyama	NNP	PERSON	Koyama	dep	13	SENT_170	[p15l269t233r600b322],
24	et	FW	O	et	nn	25	SENT_170	[p15l637t245r708b301],
25	al.	FW	O	al.	dep	23	SENT_170	[p15l741t232r862b314],
26	,	,	O	,	_	0	SENT_170	[p15l741t232r862b314],
27	1996	CD	DATE	1996	num	28	SENT_170	[p15l910t232r1149b317],
28	)	NN	O	)	appos	13	SENT_170	[p15l910t232r1149b317],
29	.	.	O	.	_	0	SENT_170	[p15l910t232r1149b317],

1	Although	IN	O	although	mark	7	SENT_171	[p15l1191t232r1564b322],
2	several	JJ	O	several	nsubj	7	SENT_171	[p15l1603t232r1874b302],
3	of	IN	O	of	_	0	SENT_171	[p15l1913t232r1998b301],
4	the	DT	O	the	det	6	SENT_171	[p15l2027t232r2145b301],
5	reviewed	VBN	O	review	amod	6	SENT_171	[p15l8t340r368b410],
6	studies	NNS	O	study	prep_of	2	SENT_171	[p15l396t340r664b410],
7	reported	VBD	O	report	advcl	21	SENT_171	[p15l691t340r1022b430],
8	a	DT	O	a	det	10	SENT_171	[p15l1048t362r1089b410],
9	higher	JJR	O	higher	amod	10	SENT_171	[p15l1113t340r1367b430],
10	incidence	NN	O	incidence	dobj	7	SENT_171	[p15l1391t340r1769b410],
11	of	IN	O	of	_	0	SENT_171	[p15l1798t340r1883b410],
12	ADRs	NNS	MISC	adr	prep_of	10	SENT_171	[p15l1902t341r2144b410],
13	in	IN	O	in	_	0	SENT_171	[p15l9t448r84b517],
14	PMs	NNS	O	pm	prep_in	12	SENT_171	[p15l118t450r294b518],
15	than	IN	O	than	_	0	SENT_171	[p15l329t448r498b518],
16	EMs	NNS	O	em	prep_than	7	SENT_171	[p15l532t450r738b530],
17	,	,	O	,	_	0	SENT_171	[p15l532t450r738b530],
18	only	RB	O	only	advmod	20	SENT_171	[p15l777t448r949b538],
19	ﬁve	JJ	O	ﬁve	amod	20	SENT_171	[p15l985t448r1125b518],
20	studies	NNS	O	study	nsubj	21	SENT_171	[p15l1163t448r1430b518],
21	provided	VBD	O	provide	dep	24	SENT_171	[p15l1465t448r1818b538],
22	explicit	JJ	O	explicit	amod	23	SENT_171	[p15l1851t448r2148b538],
23	data	NNS	O	datum	dobj	21	SENT_171	[p15l10t556r173b625],
24	(	VBP	O	(	_	0	SENT_171	[p15l207t556r712b641],
25	Kirchheiner	NNP	O	Kirchheiner	dobj	24	SENT_171	[p15l207t556r712b641],
26	et	FW	O	et	nn	27	SENT_171	[p15l741t569r812b625],
27	al.	FW	O	al.	nsubj	24	SENT_171	[p15l840t556r961b638],
28	,	,	O	,	_	0	SENT_171	[p15l840t556r961b638],
29	2001	CD	DATE	2001	num	30	SENT_171	[p15l998t556r1245b641],
30	)	NN	O	)	appos	27	SENT_171	[p15l998t556r1245b641],
31	.	.	O	.	_	0	SENT_171	[p15l998t556r1245b641],

1	In	IN	O	in	_	0	SENT_172	[p15l1283t557r1363b624],
2	all	DT	O	all	det	4	SENT_172	[p15l1396t556r1491b625],
3	ﬁve	JJ	O	ﬁve	amod	4	SENT_172	[p15l1525t556r1665b625],
4	studies	NNS	O	study	prep_in	11	SENT_172	[p15l1701t556r1991b638],
5	,	,	O	,	_	0	SENT_172	[p15l1701t556r1991b638],
6	the	DT	O	the	det	7	SENT_172	[p15l2027t556r2145b625],
7	number	NN	O	number	nsubj	11	SENT_172	[p15l9t664r312b734],
8	of	IN	O	of	_	0	SENT_172	[p15l349t664r434b734],
9	PMs	NNS	O	pm	prep_of	7	SENT_172	[p15l466t666r642b734],
10	was	VBD	O	be	cop	11	SENT_172	[p15l683t686r832b734],
11	small	JJ	O	small	_	0	SENT_172	[p15l875t664r1106b746],
12	,	,	O	,	_	0	SENT_172	[p15l875t664r1106b746],
13	leading	VBG	O	lead	xcomp	11	SENT_172	[p15l1148t664r1437b754],
14	to	TO	O	to	_	0	SENT_172	[p15l1477t675r1550b734],
15	low	JJ	O	low	amod	17	SENT_172	[p15l1590t664r1733b734],
16	statistical	JJ	O	statistical	amod	17	SENT_172	[p15l1776t664r2146b734],
17	power	NN	O	power	prep_to	13	SENT_172	[p15l8t794r266b862],
18	.	.	O	.	_	0	SENT_172	[p15l8t794r266b862],

1	Indeed	RB	O	indeed	advmod	6	SENT_173	[p15l315t772r604b854],
2	,	,	O	,	_	0	SENT_173	[p15l315t772r604b854],
3	only	RB	O	only	advmod	5	SENT_173	[p15l653t772r825b862],
4	one	CD	NUMBER	one	num	5	SENT_173	[p15l870t794r1009b842],
5	study	NN	O	study	nsubj	6	SENT_173	[p15l1057t772r1265b862],
6	showed	VBD	O	show	_	0	SENT_173	[p15l1313t772r1607b842],
7	a	DT	O	a	det	9	SENT_173	[p15l1653t794r1694b842],
8	signiﬁcant	NN	O	signiﬁcant	nn	9	SENT_173	[p15l1739t772r2148b862],
9	difference	NN	O	difference	dobj	6	SENT_173	[p15l10t880r407b950],
10	between	IN	O	between	_	0	SENT_173	[p15l446t880r777b950],
11	EM	NNP	O	EM	prep_between	9	SENT_173	[p15l815t882r961b949],
12	and	CC	O	and	_	0	SENT_173	[p15l1003t880r1142b950],
13	PM	NNP	O	PM	conj_and	11	SENT_173	[p15l1181t882r1321b949],
14	in	IN	O	in	_	0	SENT_173	[p15l1360t880r1435b949],
15	the	DT	O	the	det	16	SENT_173	[p15l1475t880r1593b950],
16	frequency	NN	O	frequency	prep_in	6	SENT_173	[p15l1634t880r2027b970],
17	of	IN	O	of	_	0	SENT_173	[p15l2067t880r2153b950],
18	side	JJ	O	side	amod	19	SENT_173	[p15l12t988r165b1058],
19	effects	NNS	O	effect	prep_of	16	SENT_173	[p15l200t988r457b1058],
20	on	IN	O	on	_	0	SENT_173	[p15l493t1010r588b1058],
21	desipramine	NN	O	desipramine	nn	23	SENT_173	[p15l622t988r1104b1078],
22	(	CD	NUMBER	(	num	23	SENT_173	[p15l1141t988r1395b1078],
23	Spina	NNP	O	Spina	prep_on	6	SENT_173	[p15l1141t988r1395b1078],
24	et	FW	O	et	nn	25	SENT_173	[p15l1429t1001r1500b1058],
25	al.	FW	O	al.	dep	23	SENT_173	[p15l1530t988r1651b1070],
26	,	,	O	,	_	0	SENT_173	[p15l1530t988r1651b1070],
27	1997	CD	DATE	1997	num	28	SENT_173	[p15l1696t988r1935b1074],
28	)	NN	O	)	appos	23	SENT_173	[p15l1696t988r1935b1074],
29	.	.	O	.	_	0	SENT_173	[p15l1696t988r1935b1074],

1	Our	PRP$	O	we	poss	2	SENT_174	[p15l110t1097r261b1166],
2	data	NNS	O	datum	nsubj	4	SENT_174	[p15l297t1096r461b1166],
3	strongly	RB	O	strongly	advmod	4	SENT_174	[p15l499t1096r818b1186],
4	suggest	VBP	O	suggest	_	0	SENT_174	[p15l858t1107r1152b1186],
5	that	IN	O	that	complm	14	SENT_174	[p15l1186t1096r1335b1166],
6	CYPZD6	NN	O	cypzd6	nn	8	SENT_174	[p15l1375t1096r1724b1167],
7	genotypic	JJ	O	genotypic	amod	8	SENT_174	[p15l1758t1096r2144b1186],
8	PMs	NNS	O	pm	nsubj	14	SENT_174	[p15l9t1206r185b1274],
9	receiving	VBG	O	receive	partmod	8	SENT_174	[p15l231t1204r597b1294],
10	solely	RB	O	solely	prep	9	SENT_174	[p15l647t1204r877b1294],
11	ﬂuoxetine	NN	O	ﬂuoxetine	pobj	10	SENT_174	[p15l924t1204r1317b1274],
12	or	CC	O	or	_	0	SENT_174	[p15l1363t1227r1444b1274],
13	nortriptyline	NN	O	nortriptyline	pobj	10	SENT_174	[p15l1487t1204r1981b1294],
14	are	VBP	O	be	ccomp	4	SENT_174	[p15l2029t1227r2146b1274],
15	at	IN	O	at	_	0	SENT_174	[p15l11t1323r79b1382],
16	no	DT	O	no	det	18	SENT_174	[p15l143t1334r239b1382],
17	greater	JJR	O	greater	amod	18	SENT_174	[p15l306t1323r581b1402],
18	risk	NN	O	risk	prep_at	14	SENT_174	[p15l643t1312r793b1382],
19	of	IN	O	of	_	0	SENT_174	[p15l858t1312r943b1382],
20	ADRs	NNS	MISC	adr	prep_of	18	SENT_174	[p15l1001t1313r1244b1382],
21	than	IN	O	than	_	0	SENT_174	[p15l1310t1312r1480b1382],
22	genotypic	JJ	O	genotypic	amod	24	SENT_174	[p15l1546t1312r1932b1402],
23	EM	NN	O	em	nn	24	SENT_174	[p15l2000t1314r2146b1381],
24	patients	NNS	O	patient	prep_than	20	SENT_174	[p15l8t1420r335b1510],
25	.	.	O	.	_	0	SENT_174	[p15l8t1420r335b1510],

1	However	RB	O	however	advmod	13	SENT_175	[p15l372t1422r746b1503],
2	,	,	O	,	_	0	SENT_175	[p15l372t1422r746b1503],
3	an	DT	O	a	det	5	SENT_175	[p15l783t1443r872b1490],
4	accurate	JJ	O	accurate	amod	5	SENT_175	[p15l904t1431r1232b1490],
5	assessment	NN	O	assessment	nsubj	13	SENT_175	[p15l1266t1431r1702b1490],
6	of	IN	O	of	_	0	SENT_175	[p15l1735t1420r1820b1490],
7	the	DT	O	the	det	9	SENT_175	[p15l1844t1420r1962b1490],
8	true	JJ	O	true	amod	9	SENT_175	[p15l1994t1431r2145b1490],
9	rate	NN	O	rate	prep_of	5	SENT_175	[p15l8t1539r155b1598],
10	of	IN	O	of	_	0	SENT_175	[p15l180t1528r266b1598],
11	antidepressant	JJ	O	antidepressant	amod	12	SENT_175	[p15l284t1528r1197b1618],
12	—	NN	O	—	prep_of	9	SENT_175	[p15l284t1528r1197b1618],
13	induced	VBD	O	induce	_	0	SENT_175	[p15l284t1528r1197b1618],
14	ADRs	NNS	MISC	adr	nsubj	18	SENT_175	[p15l1220t1529r1462b1598],
15	in	IN	O	in	_	0	SENT_175	[p15l1488t1528r1562b1597],
16	CYPZD6	NN	O	cypzd6	nn	17	SENT_175	[p15l1586t1528r1944b1598],
17	PMs	NNS	O	pm	prep_in	14	SENT_175	[p15l1968t1530r2144b1598],
18	remains	VBZ	O	remain	ccomp	13	SENT_175	[p15l8t1636r320b1706],
19	to	TO	O	to	aux	21	SENT_175	[p15l360t1647r434b1706],
20	be	VB	O	be	auxpass	21	SENT_175	[p15l473t1636r566b1706],
21	carried	VBN	O	carry	xcomp	18	SENT_175	[p15l606t1636r881b1706],
22	out	RP	O	out	prt	21	SENT_175	[p15l920t1647r1065b1718],
23	,	,	O	,	_	0	SENT_175	[p15l920t1647r1065b1718],
24	and	CC	O	and	_	0	SENT_175	[p15l1110t1636r1249b1706],
25	this	DT	O	this	nsubj	27	SENT_175	[p15l1287t1636r1427b1706],
26	will	MD	O	will	aux	27	SENT_175	[p15l1469t1636r1619b1706],
27	require	VB	O	require	conj_and	13	SENT_175	[p15l1659t1636r1938b1726],
28	substantially	RB	O	substantially	advmod	29	SENT_175	[p15l1982t1636r2143b1706, p15l12t1744r371b1834],
29	larger	JJR	O	larger	amod	30	SENT_175	[p15l396t1744r627b1834],
30	groups	NNS	O	group	dobj	27	SENT_175	[p15l649t1767r913b1834],
31	than	IN	O	than	mark	34	SENT_175	[p15l940t1744r1109b1814],
32	have	VBP	O	have	aux	34	SENT_175	[p15l1132t1744r1315b1814],
33	been	VBN	O	be	auxpass	34	SENT_175	[p15l1339t1744r1526b1814],
34	studied	VBN	O	study	advcl	27	SENT_175	[p15l1554t1744r1835b1814],
35	to	TO	O	to	_	0	SENT_175	[p15l1859t1755r1932b1814],
36	date	NN	O	date	prep_to	34	SENT_175	[p15l1959t1744r2141b1814],
37	.	.	O	.	_	0	SENT_175	[p15l1959t1744r2141b1814],

1	Hum	NNP	O	Hum	nn	4	SENT_176	[p15l314t2016r486b2076],
2	Psychopharmacol	NNP	O	Psychopharmacol	nn	4	SENT_176	[p15l514t2014r1158b2093],
3	Clin	NNP	O	Clin	nn	4	SENT_176	[p15l1191t2014r1337b2077],
4	Exp	NNP	O	Exp	_	0	SENT_176	[p15l1365t2016r1503b2093],
5	2004	CD	DATE	2004	num	4	SENT_176	[p15l1534t2014r1730b2087],
6	;	:	O	;	_	0	SENT_176	[p15l1534t2014r1730b2087],
7	19	CD	NUMBER	19	num	9	SENT_176	[p15l1767t2013r1869b2076],
8	:	:	O	:	_	0	SENT_176	[p15l1767t2013r1869b2076],
9	17-23	CD	DATE	17-23	dep	4	SENT_176	[p15l1912t2014r2142b2076],
10	.	.	O	.	_	0	SENT_176	[p15l1912t2014r2142b2076],

1	22	CD	NUMBER	22	_	0	SENT_177	[p15l539t2168r578b2197],
2	R.	NNP	PERSON	R.	nn	5	SENT_177	[p15l1294t2176r1322b2197],
3	L.	NNP	PERSON	L.	nn	5	SENT_177	[p15l1338t2176r1365b2197],
4	ROBERTS	NNP	PERSON	ROBERTS	nn	5	SENT_177	[p15l1381t2176r1522b2197],
5	ETAL	NNP	O	ETAL	dep	1	SENT_177	[p15l1536t2175r1621b2197],
6	.	.	O	.	_	0	SENT_177	[p15l1536t2175r1621b2197],

1	ACKNOWLEDGEMENTS	NNS	O	acknowledgement	_	0	SENT_178	[p15l8t2346r1103b2414],

1	We	PRP	O	we	nsubj	2	SENT_179	[p15l7t2510r135b2578],
2	thank	VBP	O	thank	_	0	SENT_179	[p15l177t2508r399b2578],
3	Allison	NNP	PERSON	Allison	nn	4	SENT_179	[p15l437t2508r727b2578],
4	Miller	NNP	PERSON	Miller	dobj	2	SENT_179	[p15l768t2508r1032b2591],
5	,	,	O	,	_	0	SENT_179	[p15l768t2508r1032b2591],
6	Isobel	NNP	PERSON	Isobel	nn	7	SENT_179	[p15l1077t2508r1317b2578],
7	Stevens	NNP	PERSON	Stevens	dobj	2	SENT_179	[p15l1361t2509r1661b2578],
8	and	CC	O	and	_	0	SENT_179	[p15l1705t2508r1845b2578],
9	Robyn	NNP	PERSON	Robyn	nn	10	SENT_179	[p15l1885t2508r2148b2598],
10	Abbott	NNP	PERSON	Abbott	conj_and	4	SENT_179	[p15l8t2616r282b2685],
11	for	IN	O	for	_	0	SENT_179	[p15l322t2616r437b2685],
12	contributions	NNS	O	contribution	prep_for	2	SENT_179	[p15l476t2616r997b2685],
13	to	TO	O	to	_	0	SENT_179	[p15l1038t2626r1112b2685],
14	this	DT	O	this	det	15	SENT_179	[p15l1154t2616r1293b2685],
15	research	NN	O	research	prep_to	12	SENT_179	[p15l1335t2616r1685b2685],
16	.	.	O	.	_	0	SENT_179	[p15l1335t2616r1685b2685],

1	This	DT	O	this	det	2	SENT_180	[p15l1731t2616r1904b2685],
2	work	NN	O	work	nsubjpass	4	SENT_180	[p15l1946t2616r2150b2685],
3	was	VBD	O	be	auxpass	4	SENT_180	[p15l8t2747r157b2795],
4	supported	VBN	O	support	_	0	SENT_180	[p15l209t2725r596b2815],
5	by	IN	O	by	_	0	SENT_180	[p15l640t2725r737b2815],
6	grants	NNS	O	grant	agent	4	SENT_180	[p15l786t2736r1023b2815],
7	from	IN	O	from	_	0	SENT_180	[p15l1072t2725r1263b2795],
8	the	DT	O	the	det	11	SENT_180	[p15l1309t2725r1428b2795],
9	Health	NNP	ORGANIZATION	Health	nn	11	SENT_180	[p15l1475t2725r1739b2795],
10	Research	NNP	ORGANIZATION	Research	nn	11	SENT_180	[p15l1785t2725r2147b2795],
11	Council	NNP	ORGANIZATION	Council	prep_from	4	SENT_180	[p15l9t2834r320b2904],
12	of	IN	ORGANIZATION	of	_	0	SENT_180	[p15l371t2834r456b2904],
13	New	NNP	ORGANIZATION	New	nn	14	SENT_180	[p15l498t2836r681b2904],
14	Zealand	NNP	ORGANIZATION	Zealand	prep_of	11	SENT_180	[p15l730t2834r1050b2904],
15	and	CC	O	and	_	0	SENT_180	[p15l1101t2834r1240b2904],
16	University	NNP	ORGANIZATION	University	prep_of	11	SENT_180	[p15l1289t2834r1704b2924],
17	of	IN	ORGANIZATION	of	_	0	SENT_180	[p15l1754t2834r1840b2904],
18	Otago	NNP	ORGANIZATION	Otago	prep_of	11	SENT_180	[p15l1884t2835r2142b2924],
19	.	.	O	.	_	0	SENT_180	[p15l1884t2835r2142b2924],

1	Rebecca	NNP	PERSON	Rebecca	nn	2	SENT_181	[p15l8t2942r345b3011],
2	Roberts	NNP	PERSON	Roberts	nsubj	7	SENT_181	[p15l383t2942r688b3011],
3	was	VBD	O	be	cop	7	SENT_181	[p15l731t2964r879b3011],
4	a	DT	O	a	det	7	SENT_181	[p15l924t2964r964b3011],
5	Leslie	NNP	PERSON	Leslie	nn	7	SENT_181	[p15l1003t2942r1244b3011],
6	Averill	NNP	PERSON	Averill	nn	7	SENT_181	[p15l1285t2942r1556b3011],
7	Fellow	NNP	O	Fellow	_	0	SENT_181	[p15l1596t2942r1868b3011],
8	of	IN	O	of	_	0	SENT_181	[p15l1909t2942r1995b3011],
9	the	DT	O	the	det	13	SENT_181	[p15l2028t2942r2146b3011],
10	Canterbury	NNP	ORGANIZATION	Canterbury	nn	13	SENT_181	[p15l9t3051r452b3141],
11	Medical	NNP	ORGANIZATION	Medical	nn	13	SENT_181	[p15l476t3051r801b3121],
12	Research	NNP	ORGANIZATION	Research	nn	13	SENT_181	[p15l826t3051r1188b3121],
13	Foundation	NNP	ORGANIZATION	Foundation	prep_of	7	SENT_181	[p15l1214t3051r1685b3134],
14	,	,	O	,	_	0	SENT_181	[p15l1214t3051r1685b3134],
15	and	CC	O	and	_	0	SENT_181	[p15l1715t3051r1855b3121],
16	Martin	NNP	PERSON	Martin	nn	17	SENT_181	[p15l1878t3051r2148b3121],
17	Kennedy	NNP	PERSON	Kennedy	nsubj	22	SENT_181	[p15l9t3160r361b3250],
18	is	VBZ	O	be	cop	22	SENT_181	[p15l403t3160r464b3230],
19	a	DT	O	a	det	22	SENT_181	[p15l509t3183r550b3230],
20	Senior	NNP	O	Senior	nn	22	SENT_181	[p15l592t3160r848b3230],
21	Research	NNP	O	Research	nn	22	SENT_181	[p15l887t3160r1250b3230],
22	Fellow	NNP	O	Fellow	conj_and	7	SENT_181	[p15l1290t3160r1562b3230],
23	of	IN	O	of	_	0	SENT_181	[p15l1605t3160r1690b3230],
24	the	DT	O	the	det	27	SENT_181	[p15l1724t3160r1843b3230],
25	Health	NNP	ORGANIZATION	Health	nn	27	SENT_181	[p15l1885t3160r2147b3230],
26	Research	NNP	ORGANIZATION	Research	nn	27	SENT_181	[p15l8t3268r369b3337],
27	Council	NNP	ORGANIZATION	Council	prep_of	22	SENT_181	[p15l404t3268r715b3337],
28	of	IN	O	of	_	0	SENT_181	[p15l750t3268r835b3337],
29	New	NNP	LOCATION	New	nn	30	SENT_181	[p15l860t3270r1043b3337],
30	Zealand	NNP	LOCATION	Zealand	prep_of	27	SENT_181	[p15l1075t3268r1415b3337],
31	.	.	O	.	_	0	SENT_181	[p15l1075t3268r1415b3337],

1	REFERENCES	NNS	O	reference	_	0	SENT_182	[p15l8t3516r624b3585],

1	Baumann	NNP	PERSON	Baumann	nn	2	SENT_183	[p16l8t63r309b117],
2	P	NN	O	p	_	0	SENT_183	[p16l341t63r392b127],
3	,	,	O	,	_	0	SENT_183	[p16l341t63r392b127],
4	Jonzier-Perey	NNP	O	Jonzier-Perey	nn	5	SENT_183	[p16l426t61r859b133],
5	M	NNP	O	M	appos	2	SENT_183	[p16l891t63r976b127],
6	,	,	O	,	_	0	SENT_183	[p16l891t63r976b127],
7	Koeb	NNP	LOCATION	Koeb	nn	8	SENT_183	[p16l1013t61r1177b117],
8	L	NNP	LOCATION	L	appos	2	SENT_183	[p16l1210t63r1275b127],
9	,	,	O	,	_	0	SENT_183	[p16l1210t63r1275b127],
10	et	FW	O	et	nn	11	SENT_183	[p16l1310t72r1367b117],
11	al.	FW	O	al.	appos	2	SENT_183	[p16l1397t61r1470b117],
12	1986	CD	DATE	1986	dep	11	SENT_183	[p16l1517t61r1681b118],
13	.	.	O	.	_	0	SENT_183	[p16l1517t61r1681b118],

1	Amitriptyline	NNP	MISC	Amitriptyline	nn	2	SENT_184	[p16l1717t61r2147b133],
2	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_184	[p16l95t150r654b222],
3	and	CC	O	and	_	0	SENT_184	[p16l706t150r817b205],
4	clinical	JJ	O	clinical	amod	5	SENT_184	[p16l866t150r1098b205],
5	response	NN	O	response	conj_and	2	SENT_184	[p16l1147t168r1440b222],
6	:	:	O	:	_	0	SENT_184	[p16l1147t168r1440b222],
7	II	CD	NUMBER	ii	dep	2	SENT_184	[p16l1494t151r1560b205],
8	.	.	O	.	_	0	SENT_184	[p16l1494t151r1560b205],

1	Metabolic	JJ	O	metabolic	amod	2	SENT_185	[p16l1613t150r1933b205],
2	polymorphism	NN	O	polymorphism	nsubj	3	SENT_185	[p16l1982t150r2146b222, p16l96t240r418b312],
3	assessed	VBN	O	assess	_	0	SENT_185	[p16l436t240r701b295],
4	by	IN	O	by	_	0	SENT_185	[p16l717t240r794b312],
5	hydroxylation	NN	O	hydroxylation	prep_by	3	SENT_185	[p16l812t240r1256b312],
6	of	IN	O	of	_	0	SENT_185	[p16l1275t240r1343b295],
7	debrisoquine	NN	O	debrisoquine	prep_of	5	SENT_185	[p16l1357t240r1763b312],
8	and	CC	O	and	_	0	SENT_185	[p16l1783t240r1895b295],
9	mephenytoin	NN	O	mephenytoin	prep_of	5	SENT_185	[p16l1912t240r2146b312, p16l97t328r312b400],
10	.	.	O	.	_	0	SENT_185	[p16l1912t240r2146b312, p16l97t328r312b400],

1	Int	NNP	O	Int	nn	3	SENT_186	[p16l340t330r431b384],
2	Clin	NNP	O	Clin	nn	3	SENT_186	[p16l458t328r588b385],
3	Psychopharmacol	NNP	O	Psychopharmacol	_	0	SENT_186	[p16l614t328r1185b400],
4	1	CD	NUMBER	1	num	3	SENT_186	[p16l1214t328r1264b384],
5	:	:	O	:	_	0	SENT_186	[p16l1214t328r1264b384],
6	102-112	CD	NUMBER	102-112	dep	3	SENT_186	[p16l1303t329r1586b384],
7	.	.	O	.	_	0	SENT_186	[p16l1303t329r1586b384],

1	Bertilsson	NN	PERSON	bertilsson	nn	2	SENT_187	[p16l7t417r327b472],
2	L	NN	PERSON	l	_	0	SENT_187	[p16l351t418r415b483],
3	,	,	O	,	_	0	SENT_187	[p16l351t418r415b483],
4	Dahl	NNP	PERSON	Dahl	nn	5	SENT_187	[p16l442t417r594b472],
5	ML	NNP	O	ML	appos	2	SENT_187	[p16l617t418r752b483],
6	,	,	O	,	_	0	SENT_187	[p16l617t418r752b483],
7	Dalen	NNP	PERSON	Dalen	nn	8	SENT_187	[p16l779t417r967b472],
8	P	NN	PERSON	p	appos	2	SENT_187	[p16l991t418r1042b483],
9	,	,	O	,	_	0	SENT_187	[p16l991t418r1042b483],
10	et	FW	O	et	nn	11	SENT_187	[p16l1070t428r1127b472],
11	al.	FW	O	al.	appos	2	SENT_187	[p16l1149t417r1221b472],
12	2002	CD	DATE	2002	dep	11	SENT_187	[p16l1254t417r1426b473],
13	.	.	O	.	_	0	SENT_187	[p16l1254t417r1426b473],

1	Molecular	JJ	O	molecular	amod	2	SENT_188	[p16l1453t417r1779b472],
2	genetics	NNS	O	genetics	_	0	SENT_188	[p16l1803t417r2059b489],
3	of	IN	O	of	_	0	SENT_188	[p16l2085t417r2153b472],
4	CYP2D6	NN	O	cyp2d6	prep_of	2	SENT_188	[p16l98t506r400b562],
5	:	:	O	:	_	0	SENT_188	[p16l98t506r400b562],
6	clinical	JJ	O	clinical	amod	7	SENT_188	[p16l425t506r657b562],
7	relevance	NN	O	relevance	dep	2	SENT_188	[p16l675t507r975b562],
8	with	IN	O	with	_	0	SENT_188	[p16l993t507r1132b562],
9	focus	NN	O	focus	prep_with	7	SENT_188	[p16l1150t506r1318b562],
10	on	IN	O	on	_	0	SENT_188	[p16l1338t524r1415b562],
11	psychotropic	JJ	O	psychotropic	amod	12	SENT_188	[p16l1432t506r1839b579],
12	drugs	NNS	O	drug	prep_on	9	SENT_188	[p16l1860t507r2049b579],
13	.	.	O	.	_	0	SENT_188	[p16l1860t507r2049b579],

1	Br	NN	PERSON	br	nn	4	SENT_189	[p16l2069t509r2152b561],
2	J	NN	PERSON	j	nn	4	SENT_189	[p16l95t598r135b652],
3	Clin	NN	PERSON	clin	nn	4	SENT_189	[p16l160t596r290b651],
4	Pharmacol	NN	PERSON	pharmacol	_	0	SENT_189	[p16l315t596r668b651],
5	53	CD	NUMBER	53	num	7	SENT_189	[p16l693t595r786b651],
6	:	:	O	:	_	0	SENT_189	[p16l693t595r786b651],
7	111-122	CD	NUMBER	111-122	dep	4	SENT_189	[p16l825t596r1108b651],
8	.	.	O	.	_	0	SENT_189	[p16l825t596r1108b651],

1	Bertilsson	NN	PERSON	bertilsson	nn	2	SENT_190	[p16l7t683r327b739],
2	L	NN	PERSON	l	_	0	SENT_190	[p16l346t685r411b749],
3	,	,	O	,	_	0	SENT_190	[p16l346t685r411b749],
4	Dahl	NNP	PERSON	Dahl	nn	8	SENT_190	[p16l434t683r586b739],
5	ML	NNP	O	ML	nn	8	SENT_190	[p16l607t685r741b749],
6	,	,	O	,	_	0	SENT_190	[p16l607t685r741b749],
7	Tybring	NNP	O	Tybring	appos	8	SENT_190	[p16l764t683r1011b755],
8	G.	NNP	O	G.	appos	2	SENT_190	[p16l1033t684r1103b739],
9	1997	CD	DATE	1997	num	8	SENT_190	[p16l1135t684r1299b740],
10	.	.	O	.	_	0	SENT_190	[p16l1135t684r1299b740],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_191	[p16l1324t683r1898b755],
2	of	IN	O	of	_	0	SENT_191	[p16l1921t683r1989b739],
3	antidepressants	NNS	O	antidepressant	prep_of	1	SENT_191	[p16l2006t683r2146b739, p16l98t772r476b844],
4	:	:	O	:	_	0	SENT_191	[p16l2006t683r2146b739, p16l98t772r476b844],
5	clinical	JJ	O	clinical	amod	6	SENT_191	[p16l516t772r748b827],
6	aspects	NNS	O	aspect	dep	1	SENT_191	[p16l783t780r1024b844],
7	.	.	O	.	_	0	SENT_191	[p16l783t780r1024b844],

1	Acta	NNP	O	Acta	nn	4	SENT_192	[p16l1056t773r1204b827],
2	Psychiatr	NNP	O	Psychiatr	nn	4	SENT_192	[p16l1237t772r1543b843],
3	Scand	NNP	O	Scand	nn	4	SENT_192	[p16l1573t772r1768b828],
4	Suppl	NNP	O	Suppl	_	0	SENT_192	[p16l1798t772r1977b843],
5	391	CD	NUMBER	391	num	4	SENT_192	[p16l2009t772r2142b828],
6	:	:	O	:	_	0	SENT_192	[p16l2009t772r2142b828],
7	14-21	CD	NUMBER	14-21	dep	4	SENT_192	[p16l104t862r308b917],
8	.	.	O	.	_	0	SENT_192	[p16l104t862r308b917],

1	Bertilsson	NN	PERSON	bertilsson	nn	2	SENT_193	[p16l7t950r327b1006],
2	L	NN	PERSON	l	_	0	SENT_193	[p16l349t952r413b1016],
3	,	,	O	,	_	0	SENT_193	[p16l349t952r413b1016],
4	Mellstrom	NN	PERSON	mellstrom	nn	5	SENT_193	[p16l438t950r769b1006],
5	B	NN	O	b	appos	2	SENT_193	[p16l790t952r858b1016],
6	,	,	O	,	_	0	SENT_193	[p16l790t952r858b1016],
7	Sjokvist	NN	O	sjokvist	nn	8	SENT_193	[p16l885t950r1142b1022],
8	F	NN	O	f	appos	2	SENT_193	[p16l1162t952r1216b1016],
9	,	,	O	,	_	0	SENT_193	[p16l1162t952r1216b1016],
10	et	FW	O	et	nn	11	SENT_193	[p16l1242t961r1300b1006],
11	al.	FW	O	al.	appos	2	SENT_193	[p16l1320t950r1392b1006],
12	1981	CD	DATE	1981	dep	11	SENT_193	[p16l1430t951r1594b1007],
13	.	.	O	.	_	0	SENT_193	[p16l1430t951r1594b1007],

1	Slow	JJ	O	slow	amod	4	SENT_194	[p16l1623t950r1779b1006],
2	hydroXyla	NN	O	hydroxylum	nn	4	SENT_194	[p16l1802t950r2146b1022],
3	—	NN	O	—	nn	4	SENT_194	[p16l1802t950r2146b1022],
4	tion	NN	O	tion	_	0	SENT_194	[p16l97t1039r219b1094],
5	of	IN	O	of	_	0	SENT_194	[p16l238t1039r306b1094],
6	nortriptyline	NN	O	nortriptyline	prep_of	4	SENT_194	[p16l319t1039r714b1111],
7	and	CC	O	and	_	0	SENT_194	[p16l733t1039r846b1094],
8	concomitant	JJ	O	concomitant	amod	11	SENT_194	[p16l864t1039r1256b1094],
9	poor	JJ	O	poor	amod	11	SENT_194	[p16l1271t1057r1417b1111],
10	debrisoquine	NN	O	debrisoquine	nn	11	SENT_194	[p16l1435t1039r1841b1111],
11	hydroXylation	NN	O	hydroxylation	prep_of	4	SENT_194	[p16l1859t1039r2147b1111, p16l97t1128r293b1184],
12	:	:	O	:	_	0	SENT_194	[p16l1859t1039r2147b1111, p16l97t1128r293b1184],
13	clinical	JJ	O	clinical	amod	14	SENT_194	[p16l325t1128r557b1184],
14	implications	NNS	O	implication	dep	4	SENT_194	[p16l583t1128r989b1200],
15	.	.	O	.	_	0	SENT_194	[p16l583t1128r989b1200],

1	Lancet	NNP	O	Lancet	_	0	SENT_195	[p16l1018t1130r1237b1184],
2	1	CD	NUMBER	1	num	1	SENT_195	[p16l1264t1128r1313b1184],
3	:	:	O	:	_	0	SENT_195	[p16l1264t1128r1313b1184],
4	560-561	CD	NUMBER	560-561	dep	1	SENT_195	[p16l1346t1128r1636b1184],
5	.	.	O	.	_	0	SENT_195	[p16l1346t1128r1636b1184],

1	Bluhm	NNP	PERSON	Bluhm	nn	2	SENT_196	[p16l7t1218r223b1273],
2	RE	NNP	O	RE	_	0	SENT_196	[p16l239t1219r356b1283],
3	,	,	O	,	_	0	SENT_196	[p16l239t1219r356b1283],
4	Wilkinson	NNP	PERSON	Wilkinson	nn	5	SENT_196	[p16l376t1218r704b1273],
5	GR	NN	O	gr	appos	2	SENT_196	[p16l724t1218r847b1283],
6	,	,	O	,	_	0	SENT_196	[p16l724t1218r847b1283],
7	Shelton	NNP	PERSON	Shelton	nn	8	SENT_196	[p16l870t1218r1109b1273],
8	R	NNP	PERSON	R	appos	2	SENT_196	[p16l1127t1219r1195b1283],
9	,	,	O	,	_	0	SENT_196	[p16l1127t1219r1195b1283],
10	et	FW	O	et	nn	11	SENT_196	[p16l1217t1229r1274b1273],
11	al.	FW	O	al.	appos	2	SENT_196	[p16l1290t1218r1362b1273],
12	1993	CD	DATE	1993	dep	11	SENT_196	[p16l1395t1218r1560b1274],
13	.	.	O	.	_	0	SENT_196	[p16l1395t1218r1560b1274],

1	Genetically	RB	O	genetically	advmod	2	SENT_197	[p16l1584t1218r1947b1290],
2	determined	VBN	O	determine	_	0	SENT_197	[p16l1966t1218r2146b1273, p16l96t1306r294b1362],
3	drug-metabolizing	JJ	O	drug-metabolizing	amod	4	SENT_197	[p16l339t1306r923b1378],
4	activity	NN	O	activity	nsubj	2	SENT_197	[p16l971t1306r1204b1378],
5	and	CC	O	and	_	0	SENT_197	[p16l1252t1306r1363b1362],
6	desipramine-associated	JJ	O	desipramine-associated	amod	7	SENT_197	[p16l1410t1306r2149b1378],
7	cardiotoxicityz	NN	O	cardiotoxicityz	nsubj	2	SENT_197	[p16l98t1395r553b1467],
8	a	DT	O	a	det	10	SENT_197	[p16l586t1413r619b1450],
9	case	NN	O	case	nn	10	SENT_197	[p16l645t1413r778b1450],
10	report	NN	O	report	dep	7	SENT_197	[p16l804t1403r1008b1467],
11	.	.	O	.	_	0	SENT_197	[p16l804t1403r1008b1467],

1	Clin	NNP	O	Clin	nn	3	SENT_198	[p16l1042t1395r1172b1451],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_198	[p16l1197t1395r1550b1450],
3	Ther	NNP	O	Ther	_	0	SENT_198	[p16l1578t1395r1725b1450],
4	53	CD	NUMBER	53	num	3	SENT_198	[p16l1747t1395r1841b1451],
5	:	:	O	:	_	0	SENT_198	[p16l1747t1395r1841b1451],
6	89-95	CD	NUMBER	89-95	dep	3	SENT_198	[p16l1875t1395r2084b1452],
7	.	.	O	.	_	0	SENT_198	[p16l1875t1395r2084b1452],

1	Carter	NNP	PERSON	Carter	nn	2	SENT_199	[p16l8t1485r206b1540],
2	JD	NNP	O	JD	_	0	SENT_199	[p16l227t1486r330b1550],
3	,	,	O	,	_	0	SENT_199	[p16l227t1486r330b1550],
4	Joyce	NNP	PERSON	Joyce	nn	5	SENT_199	[p16l355t1486r533b1557],
5	PR	NNP	O	PR	appos	2	SENT_199	[p16l556t1486r668b1550],
6	,	,	O	,	_	0	SENT_199	[p16l556t1486r668b1550],
7	Mulder	NNP	ORGANIZATION	Mulder	nn	8	SENT_199	[p16l694t1485r927b1540],
8	RT	NN	ORGANIZATION	rt	appos	2	SENT_199	[p16l948t1486r1055b1550],
9	,	,	O	,	_	0	SENT_199	[p16l948t1486r1055b1550],
10	et	FW	O	et	nn	11	SENT_199	[p16l1082t1496r1139b1540],
11	al.	FW	O	al.	appos	2	SENT_199	[p16l1160t1485r1232b1540],
12	2000	CD	DATE	2000	dep	11	SENT_199	[p16l1264t1485r1435b1540],
13	.	.	O	.	_	0	SENT_199	[p16l1264t1485r1435b1540],

1	Gender	NN	O	gender	nn	2	SENT_200	[p16l1463t1485r1695b1540],
2	differences	NNS	O	difference	_	0	SENT_200	[p16l1717t1485r2064b1540],
3	in	IN	O	in	_	0	SENT_200	[p16l2088t1485r2148b1539],
4	the	DT	O	the	det	5	SENT_200	[p16l97t1573r191b1629],
5	presentation	NN	O	presentation	prep_in	2	SENT_200	[p16l242t1573r631b1645],
6	of	IN	O	of	_	0	SENT_200	[p16l682t1573r751b1629],
7	depressed	JJ	O	depressed	amod	8	SENT_200	[p16l798t1573r1108b1645],
8	outpatients	NNS	O	outpatient	prep_of	5	SENT_200	[p16l1160t1573r1522b1645],
9	:	:	O	:	_	0	SENT_200	[p16l1160t1573r1522b1645],
10	a	DT	O	a	det	11	SENT_200	[p16l1581t1591r1614b1629],
11	comparison	NN	O	comparison	dep	2	SENT_200	[p16l1665t1573r2034b1645],
12	of	IN	O	of	_	0	SENT_200	[p16l2085t1573r2153b1629],
13	descriptive	JJ	O	descriptive	amod	14	SENT_200	[p16l98t1662r440b1734],
14	variables	NNS	O	variable	prep_of	11	SENT_200	[p16l465t1662r765b1718],
15	.	.	O	.	_	0	SENT_200	[p16l465t1662r765b1718],

1	I	PRP	O	I	nsubj	2	SENT_201	[p16l792t1664r832b1718],
2	Aﬂect	VBP	O	aﬂect	_	0	SENT_201	[p16l845t1662r1037b1733],
3	Disord	NN	O	disord	dobj	2	SENT_201	[p16l1058t1662r1278b1718],
4	61	CD	NUMBER	61	num	3	SENT_201	[p16l1301t1662r1394b1718],
5	:	:	O	:	_	0	SENT_201	[p16l1301t1662r1394b1718],
6	59-67	CD	NUMBER	59-67	dep	3	SENT_201	[p16l1426t1662r1638b1718],
7	.	.	O	.	_	0	SENT_201	[p16l1426t1662r1638b1718],

1	Chen	NNP	PERSON	Chen	nn	2	SENT_202	[p16l8t1751r173b1807],
2	S	NNP	PERSON	S	_	0	SENT_202	[p16l201t1751r257b1817],
3	,	,	O	,	_	0	SENT_202	[p16l201t1751r257b1817],
4	Chou	NNP	PERSON	Chou	nn	5	SENT_202	[p16l287t1751r456b1807],
5	WH	NNP	PERSON	WH	appos	2	SENT_202	[p16l481t1752r629b1817],
6	,	,	O	,	_	0	SENT_202	[p16l481t1752r629b1817],
7	Blouin	NNP	PERSON	Blouin	nn	8	SENT_202	[p16l658t1751r872b1807],
8	RA	NN	O	ra	appos	2	SENT_202	[p16l898t1752r1023b1817],
9	,	,	O	,	_	0	SENT_202	[p16l898t1752r1023b1817],
10	et	FW	O	et	nn	11	SENT_202	[p16l1053t1762r1110b1807],
11	al.	FW	O	al.	appos	2	SENT_202	[p16l1134t1751r1206b1807],
12	1996	CD	DATE	1996	dep	11	SENT_202	[p16l1247t1751r1411b1808],
13	.	.	O	.	_	0	SENT_202	[p16l1247t1751r1411b1808],

1	The	DT	O	the	det	7	SENT_203	[p16l1442t1751r1563b1807],
2	cytochrome	NN	O	cytochrome	nn	7	SENT_203	[p16l1590t1751r1961b1823],
3	P450	NN	O	p450	nn	7	SENT_203	[p16l1988t1751r2148b1807],
4	2D6	NN	O	2d6	nn	7	SENT_203	[p16l98t1841r229b1896],
5	(	CD	NUMBER	(	num	7	SENT_203	[p16l279t1841r615b1910],
6	CYP2D6	NN	O	cyp2d6	nn	7	SENT_203	[p16l279t1841r615b1910],
7	)	NN	O	)	_	0	SENT_203	[p16l279t1841r615b1910],
8	enzyme	NN	O	enzyme	nn	9	SENT_203	[p16l664t1858r908b1913],
9	polymorphism	NN	O	polymorphism	dep	7	SENT_203	[p16l954t1841r1432b1913],
10	:	:	O	:	_	0	SENT_203	[p16l954t1841r1432b1913],
11	screening	NN	O	screening	nn	12	SENT_203	[p16l1487t1841r1786b1913],
12	costs	NNS	O	cost	dep	7	SENT_203	[p16l1834t1849r1988b1896],
13	and	CC	O	and	_	0	SENT_203	[p16l2037t1841r2149b1896],
14	inﬂuence	NN	O	inﬂuence	conj_and	12	SENT_203	[p16l96t1929r386b1985],
15	on	IN	O	on	_	0	SENT_203	[p16l424t1947r501b1985],
16	clinical	JJ	O	clinical	amod	17	SENT_203	[p16l538t1929r770b1985],
17	outcomes	NNS	O	outcome	prep_on	12	SENT_203	[p16l809t1938r1109b1985],
18	in	IN	O	in	_	0	SENT_203	[p16l1148t1929r1208b1984],
19	psychiatry	NN	O	psychiatry	prep_in	17	SENT_203	[p16l1243t1929r1584b2001],
20	.	.	O	.	_	0	SENT_203	[p16l1243t1929r1584b2001],

1	Clin	NNP	O	Clin	nn	3	SENT_204	[p16l1630t1929r1760b1986],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_204	[p16l1797t1929r2150b1985],
3	Ther	NNP	O	Ther	_	0	SENT_204	[p16l100t2017r247b2072],
4	60	CD	NUMBER	60	num	3	SENT_204	[p16l270t2017r363b2072],
5	:	:	O	:	_	0	SENT_204	[p16l270t2017r363b2072],
6	522-534	CD	NUMBER	522-534	dep	3	SENT_204	[p16l396t2017r686b2072],
7	.	.	O	.	_	0	SENT_204	[p16l396t2017r686b2072],

1	Chomczynski	NNP	PERSON	Chomczynski	nn	2	SENT_205	[p16l8t2107r441b2179],
2	P	NN	PERSON	p	_	0	SENT_205	[p16l463t2108r514b2172],
3	,	,	O	,	_	0	SENT_205	[p16l463t2108r514b2172],
4	Qasba	NNP	O	Qasba	nn	5	SENT_205	[p16l540t2107r736b2176],
5	P.	NNP	O	P.	appos	2	SENT_205	[p16l756t2108r805b2162],
6	1984	CD	DATE	1984	dep	5	SENT_205	[p16l840t2107r1005b2163],
7	.	.	O	.	_	0	SENT_205	[p16l840t2107r1005b2163],

1	Alkaline	NN	O	alkaline	nn	2	SENT_206	[p16l1030t2107r1301b2162],
2	transfer	NN	O	transfer	_	0	SENT_206	[p16l1324t2107r1566b2162],
3	of	IN	O	of	_	0	SENT_206	[p16l1587t2107r1656b2162],
4	DNA	NN	MISC	dna	prep_of	2	SENT_206	[p16l1672t2107r1839b2162],
5	to	TO	O	to	_	0	SENT_206	[p16l1860t2115r1920b2162],
6	plastic	JJ	O	plastic	amod	7	SENT_206	[p16l1942t2107r2147b2179],
7	membrane	NN	O	membrane	prep_to	2	SENT_206	[p16l96t2195r446b2251],
8	.	.	O	.	_	0	SENT_206	[p16l96t2195r446b2251],

1	Biochim	NNP	PERSON	Biochim	nn	3	SENT_207	[p16l473t2195r737b2251],
2	Biophys	NNP	PERSON	Biophys	nn	3	SENT_207	[p16l762t2195r1017b2267],
3	Acta	NNP	PERSON	Acta	_	0	SENT_207	[p16l1037t2196r1186b2251],
4	122	CD	NUMBER	122	num	3	SENT_207	[p16l1216t2195r1346b2251],
5	:	:	O	:	_	0	SENT_207	[p16l1216t2195r1346b2251],
6	340-344	CD	NUMBER	340-344	dep	3	SENT_207	[p16l1379t2196r1668b2251],
7	.	.	O	.	_	0	SENT_207	[p16l1379t2196r1668b2251],

1	Chou	NNP	PERSON	Chou	nn	2	SENT_208	[p16l8t2284r177b2340],
2	WH	NNP	PERSON	WH	_	0	SENT_208	[p16l209t2286r357b2350],
3	,	,	O	,	_	0	SENT_208	[p16l209t2286r357b2350],
4	Yan	NNP	PERSON	Yan	nn	5	SENT_208	[p16l393t2286r515b2340],
5	FX	NNP	O	FX	appos	2	SENT_208	[p16l548t2286r664b2350],
6	,	,	O	,	_	0	SENT_208	[p16l548t2286r664b2350],
7	de	FW	PERSON	de	appos	2	SENT_208	[p16l700t2284r772b2340],
8	Leon	NNP	PERSON	Leon	nn	9	SENT_208	[p16l805t2286r968b2340],
9	J	NNP	PERSON	J	dep	7	SENT_208	[p16l1000t2286r1045b2350],
10	,	,	O	,	_	0	SENT_208	[p16l1000t2286r1045b2350],
11	et	FW	O	et	nn	12	SENT_208	[p16l1083t2295r1140b2340],
12	al.	FW	O	al.	appos	2	SENT_208	[p16l1171t2284r1243b2340],
13	2000	CD	DATE	2000	dep	12	SENT_208	[p16l1284t2285r1455b2340],
14	.	.	O	.	_	0	SENT_208	[p16l1284t2285r1455b2340],

1	Extension	NNP	O	Extension	_	0	SENT_209	[p16l1492t2284r1808b2340],
2	of	IN	O	of	_	0	SENT_209	[p16l1841t2284r1910b2340],
3	a	DT	O	a	det	5	SENT_209	[p16l1939t2302r1972b2340],
4	pilot	NN	O	pilot	nn	5	SENT_209	[p16l2003t2284r2149b2356],
5	study	NN	O	study	prep_of	1	SENT_209	[p16l99t2373r283b2445],
6	:	:	O	:	_	0	SENT_209	[p16l99t2373r283b2445],
7	impact	NN	O	impact	dep	1	SENT_209	[p16l327t2373r543b2445],
8	from	IN	O	from	_	0	SENT_209	[p16l581t2373r734b2429],
9	the	DT	O	the	det	13	SENT_209	[p16l771t2373r866b2429],
10	cytochrome	NN	O	cytochrome	nn	13	SENT_209	[p16l905t2373r1277b2445],
11	P450	NN	O	p450	nn	13	SENT_209	[p16l1316t2373r1476b2429],
12	2D6	NN	O	2d6	nn	13	SENT_209	[p16l1516t2373r1648b2429],
13	polymorphism	NN	O	polymorphism	prep_from	7	SENT_209	[p16l1687t2373r2149b2445],
14	on	IN	O	on	_	0	SENT_209	[p16l98t2480r174b2518],
15	outcome	NN	O	outcome	prep_on	13	SENT_209	[p16l209t2471r479b2518],
16	and	CC	O	and	_	0	SENT_209	[p16l515t2463r626b2518],
17	costs	NNS	O	cost	prep_on	13	SENT_209	[p16l659t2471r814b2518],
18	associated	VBN	O	associate	partmod	7	SENT_209	[p16l851t2463r1175b2518],
19	with	IN	O	with	_	0	SENT_209	[p16l1207t2463r1346b2518],
20	severe	JJ	O	severe	amod	22	SENT_209	[p16l1382t2480r1577b2518],
21	mental	JJ	O	mental	amod	22	SENT_209	[p16l1612t2463r1826b2518],
22	illness	NN	O	illness	prep_with	18	SENT_209	[p16l1860t2463r2077b2518],
23	.	.	O	.	_	0	SENT_209	[p16l1860t2463r2077b2518],

1	J	NN	O	j	_	0	SENT_210	[p16l2113t2465r2153b2518],

1	Clin	NNP	PERSON	Clin	nn	2	SENT_211	[p16l100t2550r231b2607],
2	Psychopharmacol	NNP	PERSON	Psychopharmacol	_	0	SENT_211	[p16l255t2550r828b2622],
3	20	CD	NUMBER	20	num	2	SENT_211	[p16l853t2550r946b2606],
4	:	:	O	:	_	0	SENT_211	[p16l853t2550r946b2606],
5	246-251	CD	NUMBER	246-251	dep	2	SENT_211	[p16l978t2550r1269b2606],
6	.	.	O	.	_	0	SENT_211	[p16l978t2550r1269b2606],

1	Ciulla	NNP	PERSON	Ciulla	nn	2	SENT_212	[p16l8t2639r201b2695],
2	T	NN	O	t	_	0	SENT_212	[p16l223t2640r281b2705],
3	,	,	O	,	_	0	SENT_212	[p16l223t2640r281b2705],
4	Slar	JJ	PERSON	slar	amod	5	SENT_212	[p16l309t2639r435b2695],
5	R	NN	PERSON	r	appos	2	SENT_212	[p16l456t2640r524b2705],
6	,	,	O	,	_	0	SENT_212	[p16l456t2640r524b2705],
7	Hauser	NNP	PERSON	Hauser	nn	8	SENT_212	[p16l550t2640r774b2694],
8	S.	NNP	O	S.	appos	2	SENT_212	[p16l798t2639r853b2695],
9	1988	CD	DATE	1988	dep	8	SENT_212	[p16l888t2639r1053b2696],
10	.	.	O	.	_	0	SENT_212	[p16l888t2639r1053b2696],

1	A	DT	O	a	det	3	SENT_213	[p16l1079t2639r1135b2694],
2	simple	JJ	O	simple	amod	3	SENT_213	[p16l1160t2639r1367b2711],
3	method	NN	O	method	_	0	SENT_213	[p16l1391t2639r1627b2694],
4	for	IN	O	for	_	0	SENT_213	[p16l1650t2639r1742b2694],
5	DNA	NN	O	dna	nn	6	SENT_213	[p16l1763t2639r1931b2694],
6	puriﬁcation	NN	O	puriﬁcation	prep_for	3	SENT_213	[p16l1952t2639r2146b2711, p16l98t2729r289b2784],

1	from	IN	O	from	_	0	SENT_214	[p16l315t2729r468b2784],
2	peripheral	JJ	O	peripheral	amod	3	SENT_214	[p16l492t2729r812b2801],
3	blood	NN	O	blood	pobj	1	SENT_214	[p16l838t2729r1034b2784],
4	.	.	O	.	_	0	SENT_214	[p16l838t2729r1034b2784],

1	Anal	NNP	O	Anal	nn	2	SENT_215	[p16l1057t2729r1213b2784],
2	Biochem	NNP	O	Biochem	_	0	SENT_215	[p16l1235t2729r1512b2784],
3	174	CD	NUMBER	174	num	2	SENT_215	[p16l1542t2728r1671b2784],
4	:	:	O	:	_	0	SENT_215	[p16l1542t2728r1671b2784],
5	485-488	CD	NUMBER	485-488	dep	2	SENT_215	[p16l1702t2729r1993b2784],
6	.	.	O	.	_	0	SENT_215	[p16l1702t2729r1993b2784],

1	de	IN	PERSON	de	dep	6	SENT_216	[p16l8t2818r80b2873],
2	Leon	NNP	PERSON	Leon	nn	3	SENT_216	[p16l103t2819r265b2873],
3	J	NNP	PERSON	J	pobj	1	SENT_216	[p16l287t2819r333b2883],
4	,	,	O	,	_	0	SENT_216	[p16l287t2819r333b2883],
5	Bamhill	NNP	PERSON	Bamhill	nn	6	SENT_216	[p16l358t2818r617b2873],
6	J	NNP	PERSON	J	_	0	SENT_216	[p16l639t2819r685b2883],
7	,	,	O	,	_	0	SENT_216	[p16l639t2819r685b2883],
8	Rogers	NNP	ORGANIZATION	Rogers	nn	9	SENT_216	[p16l711t2819r932b2890],
9	T	NN	ORGANIZATION	t	appos	6	SENT_216	[p16l956t2819r1013b2883],
10	,	,	O	,	_	0	SENT_216	[p16l956t2819r1013b2883],
11	et	FW	O	et	nn	12	SENT_216	[p16l1040t2829r1097b2873],
12	al.	FW	O	al.	appos	6	SENT_216	[p16l1118t2818r1190b2873],
13	1998	CD	DATE	1998	dep	12	SENT_216	[p16l1228t2818r1393b2874],
14	.	.	O	.	_	0	SENT_216	[p16l1228t2818r1393b2874],

1	Pilot	NN	O	pilot	nn	2	SENT_217	[p16l1419t2818r1569b2873],
2	study	NN	O	study	_	0	SENT_217	[p16l1593t2818r1760b2890],
3	of	IN	O	of	_	0	SENT_217	[p16l1784t2818r1852b2873],
4	the	DT	O	the	det	7	SENT_217	[p16l1870t2818r1964b2873],
5	cytochrome	NN	O	cytochrome	nn	7	SENT_217	[p16l1988t2826r2146b2890, p16l98t2906r332b2962],
6	P450-2D6	NN	O	p450-2d6	nn	7	SENT_217	[p16l356t2906r679b2962],
7	genotype	NN	O	genotype	prep_of	2	SENT_217	[p16l704t2915r992b2978],
8	in	IN	O	in	_	0	SENT_217	[p16l1015t2906r1076b2961],
9	a	DT	O	a	det	12	SENT_217	[p16l1101t2924r1134b2962],
10	psychiatric	JJ	O	psychiatric	amod	12	SENT_217	[p16l1155t2906r1501b2978],
11	state	NN	O	state	nn	12	SENT_217	[p16l1529t2915r1670b2962],
12	hospital	NN	O	hospital	prep_in	2	SENT_217	[p16l1694t2906r1960b2978],
13	.	.	O	.	_	0	SENT_217	[p16l1694t2906r1960b2978],

1	Am	VBP	O	be	_	0	SENT_218	[p16l1982t2907r2091b2962],
2	J	NN	O	j	prep	1	SENT_218	[p16l2113t2908r2153b2963],
3	Psychiatry	NNP	O	Psychiatry	dep	2	SENT_218	[p16l95t2995r433b3065],
4	155	CD	NUMBER	155	num	3	SENT_218	[p16l463t2995r592b3050],
5	:	:	O	:	_	0	SENT_218	[p16l463t2995r592b3050],
6	1278-1280	CD	DATE	1278-1280	num	3	SENT_218	[p16l632t2996r995b3051],
7	.	.	O	.	_	0	SENT_218	[p16l632t2996r995b3051],

1	de	IN	O	de	dep	6	SENT_219	[p16l8t3084r80b3139],
2	Vries	NNP	O	Vries	nn	3	SENT_219	[p16l100t3084r268b3139],
3	EM	NNP	O	EM	pobj	1	SENT_219	[p16l289t3085r423b3149],
4	,	,	O	,	_	0	SENT_219	[p16l289t3085r423b3149],
5	Pot	NNP	O	Pot	nn	6	SENT_219	[p16l444t3085r550b3139],
6	HJ	NNP	O	HJ	_	0	SENT_219	[p16l568t3085r671b3149],
7	,	,	O	,	_	0	SENT_219	[p16l568t3085r671b3149],
8	Conemans	NNP	O	Conemans	nn	9	SENT_219	[p16l694t3084r1024b3139],
9	JMH	NNP	O	JMH	appos	6	SENT_219	[p16l1045t3085r1218b3149],
10	,	,	O	,	_	0	SENT_219	[p16l1045t3085r1218b3149],
11	et	FW	O	et	nn	12	SENT_219	[p16l1241t3095r1299b3139],
12	al.	FW	O	al.	appos	6	SENT_219	[p16l1315t3084r1387b3139],
13	2001	CD	DATE	2001	dep	12	SENT_219	[p16l1416t3084r1587b3139],
14	.	.	O	.	_	0	SENT_219	[p16l1416t3084r1587b3139],

1	The	DT	O	the	det	3	SENT_220	[p16l1610t3084r1731b3139],
2	clinical	JJ	O	clinical	amod	3	SENT_220	[p16l1753t3084r1985b3139],
3	relevance	NN	O	relevance	_	0	SENT_220	[p16l2003t3084r2146b3139, p16l97t3190r278b3228],
4	of	IN	O	of	_	0	SENT_220	[p16l297t3172r366b3228],
5	routine	JJ	O	routine	amod	6	SENT_220	[p16l377t3172r601b3228],
6	genotyping	NN	O	genotyping	prep_of	3	SENT_220	[p16l620t3172r974b3244],
7	of	IN	O	of	_	0	SENT_220	[p16l993t3172r1061b3228],
8	CYP2D6/2Cl9	NN	O	cyp2d6/2cl9	nn	10	SENT_220	[p16l1075t3172r1553b3229],
9	null	JJ	O	null	amod	10	SENT_220	[p16l1573t3172r1694b3228],
10	alleles	NNS	O	allele	prep_of	3	SENT_220	[p16l1714t3172r1913b3228],
11	of	IN	O	of	_	0	SENT_220	[p16l1933t3172r2001b3228],
12	psychiatric	JJ	O	psychiatric	amod	13	SENT_220	[p16l2013t3190r2146b3244, p16l98t3261r332b3316],
13	patients	NNS	O	patient	prep_of	3	SENT_220	[p16l358t3261r620b3333],
14	.	.	O	.	_	0	SENT_220	[p16l358t3261r620b3333],

1	Br	NN	PERSON	br	nn	3	SENT_221	[p16l648t3263r731b3316],
2	J	NN	PERSON	j	nn	3	SENT_221	[p16l751t3263r791b3317],
3	Clin	NN	PERSON	clin	_	0	SENT_221	[p16l816t3261r946b3317],
4	Pharmacol	NN	PERSON	pharmacol	dep	3	SENT_221	[p16l972t3261r1325b3316],
5	53	CD	NUMBER	53	num	4	SENT_221	[p16l1349t3261r1443b3317],
6	:	:	O	:	_	0	SENT_221	[p16l1349t3261r1443b3317],
7	543P-559P	NN	O	543p-559p	dep	3	SENT_221	[p16l1475t3261r1844b3318],
8	.	.	O	.	_	0	SENT_221	[p16l1475t3261r1844b3318],

1	Eichelbaum	NNP	PERSON	Eichelbaum	nn	2	SENT_222	[p16l7t3351r386b3406],
2	M	NNP	O	M	_	0	SENT_222	[p16l406t3352r491b3416],
3	,	,	O	,	_	0	SENT_222	[p16l406t3352r491b3416],
4	Gross	NNP	NUMBER	Gross	nn	5	SENT_222	[p16l516t3351r695b3406],
5	AS	NNP	O	AS	appos	2	SENT_222	[p16l717t3351r831b3406],
6	.	.	O	.	_	0	SENT_222	[p16l717t3351r831b3406],

1	1990	CD	DATE	1990	_	0	SENT_223	[p16l864t3351r1029b3407],
2	.	.	O	.	_	0	SENT_223	[p16l864t3351r1029b3407],

1	The	DT	O	the	det	3	SENT_224	[p16l1053t3351r1174b3406],
2	genetic	JJ	O	genetic	amod	3	SENT_224	[p16l1196t3351r1422b3423],
3	polymorphism	NN	O	polymorphism	_	0	SENT_224	[p16l1443t3351r1905b3423],
4	of	IN	O	of	_	0	SENT_224	[p16l1926t3351r1994b3406],
5	debrisoquine/sparteine	NN	O	debrisoquine/sparteine	nn	9	SENT_224	[p16l2010t3351r2146b3406, p16l95t3440r698b3512],
6	metabolism	NN	O	metabolism	nn	9	SENT_224	[p16l750t3440r1447b3495],
7	—	CD	NUMBER	—	num	9	SENT_224	[p16l750t3440r1447b3495],
8	clinical	JJ	O	clinical	amod	9	SENT_224	[p16l750t3440r1447b3495],
9	aspects	NNS	O	aspect	prep_of	3	SENT_224	[p16l1501t3448r1742b3512],
10	.	.	O	.	_	0	SENT_224	[p16l1501t3448r1742b3512],

1	Pharmacol	NN	O	pharmacol	nn	2	SENT_225	[p16l1797t3440r2150b3495],
2	T	NN	O	t	_	0	SENT_225	[p16l100t3529r146b3582],
3	her	PRP$	O	she	poss	4	SENT_225	[p16l141t3527r247b3583],
4	46	CD	NUMBER	46	dep	2	SENT_225	[p16l270t3527r363b3583],
5	:	:	O	:	_	0	SENT_225	[p16l270t3527r363b3583],
6	377-394	CD	NUMBER	377-394	dep	4	SENT_225	[p16l397t3528r686b3583],
7	.	.	O	.	_	0	SENT_225	[p16l397t3528r686b3583],

1	Fjordside	NN	MISC	fjordside	nn	2	SENT_226	[p17l7t23r305b95],
2	L	NN	O	l	_	0	SENT_226	[p17l332t24r396b89],
3	,	,	O	,	_	0	SENT_226	[p17l332t24r396b89],
4	Jeppesen	NNP	ORGANIZATION	Jeppesen	nn	5	SENT_226	[p17l426t24r711b95],
5	U	NNP	ORGANIZATION	U	appos	2	SENT_226	[p17l738t24r810b89],
6	,	,	O	,	_	0	SENT_226	[p17l738t24r810b89],
7	Eap	NNP	O	Eap	nn	8	SENT_226	[p17l840t24r962b95],
8	CB	NNP	O	CB	appos	2	SENT_226	[p17l990t23r1110b89],
9	,	,	O	,	_	0	SENT_226	[p17l990t23r1110b89],
10	et	FW	O	et	nn	11	SENT_226	[p17l1142t34r1199b79],
11	al.	FW	O	al.	appos	2	SENT_226	[p17l1224t23r1296b79],
12	1999	CD	DATE	1999	dep	11	SENT_226	[p17l1339t24r1503b80],
13	.	.	O	.	_	0	SENT_226	[p17l1339t24r1503b80],

1	The	DT	O	the	det	3	SENT_227	[p17l1535t23r1656b79],
2	stereoselective	JJ	O	stereoselective	amod	3	SENT_227	[p17l1687t23r2148b79],
3	metabolism	NN	O	metabolism	_	0	SENT_227	[p17l96t113r466b168],
4	of	IN	O	of	_	0	SENT_227	[p17l495t113r564b168],
5	ﬂuoxetine	NN	O	ﬂuoxetine	prep_of	3	SENT_227	[p17l585t113r898b168],
6	in	IN	O	in	_	0	SENT_227	[p17l927t113r988b167],
7	poor	JJ	O	poor	amod	10	SENT_227	[p17l1015t130r1160b185],
8	and	CC	O	and	_	0	SENT_227	[p17l1189t113r1300b168],
9	extensive	JJ	O	extensive	amod	10	SENT_227	[p17l1329t113r1623b168],
10	metabolizers	NNS	O	metabolizer	prep_in	3	SENT_227	[p17l1651t113r2055b168],
11	of	IN	O	of	_	0	SENT_227	[p17l2085t113r2153b168],
12	sparteine	NN	O	sparteine	prep_of	3	SENT_227	[p17l99t201r398b273],
13	.	.	O	.	_	0	SENT_227	[p17l99t201r398b273],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_228	[p17l425t201r1015b273],
2	9	CD	NUMBER	9	num	1	SENT_228	[p17l1042t201r1095b257],
3	:	:	O	:	_	0	SENT_228	[p17l1042t201r1095b257],
4	55-60	CD	NUMBER	55-60	dep	1	SENT_228	[p17l1128t201r1339b257],
5	.	.	O	.	_	0	SENT_228	[p17l1128t201r1339b257],

1	Gaedigk	NNP	MISC	Gaedigk	nn	2	SENT_229	[p17l9t290r276b362],
2	A	NNP	MISC	A	_	0	SENT_229	[p17l297t290r369b356],
3	,	,	O	,	_	0	SENT_229	[p17l297t290r369b356],
4	Blum	NNP	PERSON	Blum	nn	5	SENT_229	[p17l395t290r571b345],
5	M	NNP	O	M	appos	2	SENT_229	[p17l592t291r678b356],
6	,	,	O	,	_	0	SENT_229	[p17l592t291r678b356],
7	Gaedigk	NNP	PERSON	Gaedigk	nn	8	SENT_229	[p17l705t290r973b362],
8	R	NNP	PERSON	R	appos	2	SENT_229	[p17l994t291r1061b356],
9	,	,	O	,	_	0	SENT_229	[p17l994t291r1061b356],
10	et	FW	O	et	nn	11	SENT_229	[p17l1088t301r1146b345],
11	al.	FW	O	al.	appos	2	SENT_229	[p17l1166t290r1238b345],
12	1991	CD	DATE	1991	dep	11	SENT_229	[p17l1277t290r1441b347],
13	.	.	O	.	_	0	SENT_229	[p17l1277t290r1441b347],

1	Deletion	NN	O	deletion	_	0	SENT_230	[p17l1468t290r1741b345],
2	of	IN	O	of	_	0	SENT_230	[p17l1764t290r1833b345],
3	the	DT	O	the	det	8	SENT_230	[p17l1851t290r1945b345],
4	entire	JJ	O	entire	amod	8	SENT_230	[p17l1970t290r2148b345],
5	cytochrome	NN	O	cytochrome	nn	8	SENT_230	[p17l98t379r469b451],
6	P450	NN	O	p450	nn	8	SENT_230	[p17l505t379r665b435],
7	CYP2D6	NN	O	cyp2d6	nn	8	SENT_230	[p17l702t379r988b435],
8	gene	NN	O	gene	prep_of	1	SENT_230	[p17l1026t397r1172b451],
9	as	IN	O	as	_	0	SENT_230	[p17l1210t397r1271b435],
10	a	DT	O	a	det	11	SENT_230	[p17l1311t397r1344b435],
11	cause	NN	O	cause	prep_as	8	SENT_230	[p17l1379t397r1552b435],
12	of	IN	O	of	_	0	SENT_230	[p17l1590t379r1658b435],
13	impaired	JJ	O	impaired	amod	15	SENT_230	[p17l1688t379r1969b451],
14	drug	NN	O	drug	nn	15	SENT_230	[p17l2006t379r2147b451],
15	metabolism	NN	O	metabolism	prep_of	11	SENT_230	[p17l96t469r466b524],
16	in	IN	O	in	_	0	SENT_230	[p17l498t469r559b523],
17	poor	JJ	O	poor	amod	18	SENT_230	[p17l591t486r736b541],
18	metabolizers	NNS	O	metabolizer	prep_in	15	SENT_230	[p17l768t469r1171b524],
19	of	IN	O	of	_	0	SENT_230	[p17l1207t469r1275b524],
20	the	DT	O	the	det	22	SENT_230	[p17l1303t469r1398b524],
21	debrisoquine/sparteine	NN	O	debrisoquine/sparteine	nn	22	SENT_230	[p17l1432t469r2147b541],
22	polymorphism	NN	O	polymorphism	prep_of	1	SENT_230	[p17l95t557r572b629],
23	.	.	O	.	_	0	SENT_230	[p17l95t557r572b629],

1	Am	VBP	O	be	cop	4	SENT_231	[p17l597t558r706b613],
2	J	NN	O	j	nn	4	SENT_231	[p17l730t559r770b614],
3	Hum	NNP	O	Hum	nn	4	SENT_231	[p17l789t559r943b613],
4	Genet	NNP	O	Genet	_	0	SENT_231	[p17l971t558r1158b614],
5	48	CD	NUMBER	48	num	4	SENT_231	[p17l1182t557r1275b613],
6	:	:	O	:	_	0	SENT_231	[p17l1182t557r1275b613],
7	943-950	CD	NUMBER	943-950	dep	4	SENT_231	[p17l1308t557r1597b614],
8	.	.	O	.	_	0	SENT_231	[p17l1308t557r1597b614],

1	Copyright	NN	O	copyright	nn	5	SENT_232	[p17l9t808r369b888],
2	©	CD	NUMBER	©	num	5	SENT_232	[p17l402t808r478b884],
3	2004	CD	DATE	2004	num	5	SENT_232	[p17l514t808r688b870],
4	John	NNP	ORGANIZATION	John	nn	5	SENT_232	[p17l718t808r884b870],
5	Wiley	NNP	ORGANIZATION	Wiley	_	0	SENT_232	[p17l912t808r1127b888],
6	&	CC	ORGANIZATION	&	_	0	SENT_232	[p17l1158t808r1221b870],
7	Sons	NNP	ORGANIZATION	Sons	conj_and	5	SENT_232	[p17l1254t808r1442b881],
8	,	,	ORGANIZATION	,	_	0	SENT_232	[p17l1254t808r1442b881],
9	Ltd.	NNP	ORGANIZATION	Ltd.	appos	5	SENT_232	[p17l1474t808r1614b870],
10	.	.	O	.	_	0	SENT_232	[p17l1474t808r1614b870],

1	Hamelin	NNP	PERSON	Hamelin	nn	2	SENT_233	[p17l8t903r280b959],
2	BA	NN	O	ba	_	0	SENT_233	[p17l309t904r431b969],
3	,	,	O	,	_	0	SENT_233	[p17l309t904r431b969],
4	Turgeon	NN	PERSON	turgeon	nn	5	SENT_233	[p17l466t904r729b975],
5	J	NN	PERSON	j	appos	2	SENT_233	[p17l758t904r804b969],
6	,	,	O	,	_	0	SENT_233	[p17l758t904r804b969],
7	Vallee	NNP	PERSON	Vallee	nn	8	SENT_233	[p17l837t903r1035b959],
8	F	NN	O	f	appos	2	SENT_233	[p17l1066t904r1118b969],
9	,	,	O	,	_	0	SENT_233	[p17l1066t904r1118b969],
10	et	FW	O	et	nn	11	SENT_233	[p17l1154t914r1210b959],
11	al.	FW	O	al.	appos	2	SENT_233	[p17l1239t903r1311b959],
12	1996	CD	DATE	1996	dep	11	SENT_233	[p17l1357t903r1521b960],
13	.	.	O	.	_	0	SENT_233	[p17l1357t903r1521b960],

1	The	DT	O	the	det	2	SENT_234	[p17l1555t903r1677b959],
2	disposition	NN	O	disposition	nsubjpass	9	SENT_234	[p17l1709t903r2055b975],
3	of	IN	O	of	_	0	SENT_234	[p17l2085t903r2153b959],
4	ﬂuoxetine	NN	O	ﬂuoxetine	prep_of	2	SENT_234	[p17l98t993r411b1048],
5	but	CC	O	but	_	0	SENT_234	[p17l444t993r545b1048],
6	not	RB	O	not	_	0	SENT_234	[p17l578t1001r679b1048],
7	sertraline	NN	O	sertraline	prep_of	2	SENT_234	[p17l715t993r1006b1048],
8	is	VBZ	O	be	auxpass	9	SENT_234	[p17l1040t993r1089b1048],
9	altered	VBN	O	alter	_	0	SENT_234	[p17l1127t993r1341b1048],
10	in	IN	O	in	_	0	SENT_234	[p17l1374t993r1434b1047],
11	poor	JJ	O	poor	amod	12	SENT_234	[p17l1467t1010r1613b1065],
12	metabolizers	NNS	O	metabolizer	prep_in	9	SENT_234	[p17l1645t993r2049b1048],
13	of	IN	O	of	_	0	SENT_234	[p17l2085t993r2153b1048],
14	debrisoquin	NN	O	debrisoquin	prep_of	12	SENT_234	[p17l98t1081r484b1153],
15	.	.	O	.	_	0	SENT_234	[p17l98t1081r484b1153],

1	Clin	NNP	O	Clin	nn	3	SENT_235	[p17l518t1081r649b1137],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_235	[p17l674t1081r1027b1136],
3	Ther	NNP	O	Ther	_	0	SENT_235	[p17l1054t1081r1202b1136],
4	60	CD	NUMBER	60	num	3	SENT_235	[p17l1225t1081r1318b1137],
5	:	:	O	:	_	0	SENT_235	[p17l1225t1081r1318b1137],
6	512-521	CD	NUMBER	512-521	dep	3	SENT_235	[p17l1351t1081r1639b1137],
7	.	.	O	.	_	0	SENT_235	[p17l1351t1081r1639b1137],

1	Hamilton	NNP	PERSON	Hamilton	nn	2	SENT_236	[p17l8t1170r306b1226],
2	M.	NNP	O	M.	_	0	SENT_236	[p17l332t1172r416b1226],
3	1960	CD	DATE	1960	dep	2	SENT_236	[p17l455t1170r620b1227],
4	.	.	O	.	_	0	SENT_236	[p17l455t1170r620b1227],

1	A	DT	O	a	det	3	SENT_237	[p17l650t1171r706b1225],
2	rating	NN	O	rating	nn	3	SENT_237	[p17l731t1171r914b1243],
3	scale	NN	O	scale	_	0	SENT_237	[p17l945t1171r1099b1226],
4	for	IN	O	for	_	0	SENT_237	[p17l1126t1170r1218b1226],
5	depression	NN	O	depression	prep_for	3	SENT_237	[p17l1245t1170r1597b1243],
6	.	.	O	.	_	0	SENT_237	[p17l1245t1170r1597b1243],

1	J	NNP	O	J	nn	3	SENT_238	[p17l1626t1173r1665b1226],
2	Neural	NNP	O	Neural	nn	3	SENT_238	[p17l1684t1170r1903b1226],
3	Neurosurg	NNP	O	Neurosurg	_	0	SENT_238	[p17l1927t1173r2146b1226, p17l97t1278r232b1331],

1	Psychiatry	NNP	O	Psychiatry	_	0	SENT_239	[p17l257t1259r595b1331],
2	12	CD	NUMBER	12	num	1	SENT_239	[p17l625t1259r715b1315],
3	:	:	O	:	_	0	SENT_239	[p17l625t1259r715b1315],
4	56-62	CD	NUMBER	56-62	dep	1	SENT_239	[p17l747t1259r958b1315],
5	.	.	O	.	_	0	SENT_239	[p17l747t1259r958b1315],

1	Heim	NNP	PERSON	Heim	nn	2	SENT_240	[p17l8t1348r183b1403],
2	M	NNP	O	M	_	0	SENT_240	[p17l200t1349r286b1414],
3	,	,	O	,	_	0	SENT_240	[p17l200t1349r286b1414],
4	Meyer	NNP	PERSON	Meyer	nn	5	SENT_240	[p17l307t1349r513b1420],
5	UA	NNP	O	UA	appos	2	SENT_240	[p17l530t1348r655b1404],
6	.	.	O	.	_	0	SENT_240	[p17l530t1348r655b1404],

1	1990	CD	DATE	1990	_	0	SENT_241	[p17l686t1348r851b1405],
2	.	.	O	.	_	0	SENT_241	[p17l686t1348r851b1405],

1	Genotyping	NN	O	genotyping	_	0	SENT_242	[p17l874t1348r1245b1420],
2	of	IN	O	of	_	0	SENT_242	[p17l1265t1348r1333b1403],
3	poor	JJ	O	poor	amod	4	SENT_242	[p17l1345t1366r1491b1420],
4	metabolisers	NNS	O	metaboliser	prep_of	1	SENT_242	[p17l1509t1348r1906b1403],
5	of	IN	O	of	_	0	SENT_242	[p17l1928t1348r1996b1403],
6	debrisoquine	NN	O	debrisoquine	prep_of	1	SENT_242	[p17l2010t1348r2146b1403, p17l95t1438r390b1510],
7	by	IN	O	by	_	0	SENT_242	[p17l410t1438r488b1510],
8	allele-speciﬁc	JJ	O	allele-speciﬁc	amod	10	SENT_242	[p17l511t1437r948b1510],
9	PCR	NN	O	pcr	nn	10	SENT_242	[p17l970t1438r1118b1493],
10	ampliﬁcation	NN	O	ampliﬁcation	prep_by	1	SENT_242	[p17l1141t1437r1571b1510],
11	.	.	O	.	_	0	SENT_242	[p17l1141t1437r1571b1510],

1	Lancet	NNP	O	Lancet	_	0	SENT_243	[p17l1595t1440r1814b1493],
2	336	CD	NUMBER	336	num	1	SENT_243	[p17l1832t1437r1965b1493],
3	:	:	O	:	_	0	SENT_243	[p17l1832t1437r1965b1493],
4	529532	CD	NUMBER	529532	dep	1	SENT_243	[p17l1994t1437r2151b1494, p17l98t1525r229b1581],
5	.	.	O	.	_	0	SENT_243	[p17l1994t1437r2151b1494, p17l98t1525r229b1581],

1	Johansson	NNP	PERSON	Johansson	_	0	SENT_244	[p17l7t1614r331b1670],
2	1	CD	NUMBER	1	num	1	SENT_244	[p17l356t1616r397b1680],
3	,	,	O	,	_	0	SENT_244	[p17l356t1616r397b1680],
4	Lundqvist	NNP	PERSON	Lundqvist	nn	5	SENT_244	[p17l425t1614r747b1686],
5	E	NNP	O	E	appos	1	SENT_244	[p17l770t1616r834b1680],
6	,	,	O	,	_	0	SENT_244	[p17l770t1616r834b1680],
7	Dahl	NNP	PERSON	Dahl	nn	8	SENT_244	[p17l863t1614r1014b1670],
8	ML	NNP	O	ML	appos	1	SENT_244	[p17l1039t1616r1174b1680],
9	,	,	O	,	_	0	SENT_244	[p17l1039t1616r1174b1680],
10	et	FW	O	et	nn	11	SENT_244	[p17l1203t1625r1260b1670],
11	al.	FW	O	al.	appos	1	SENT_244	[p17l1283t1614r1355b1670],
12	1996	CD	DATE	1996	dep	11	SENT_244	[p17l1397t1614r1561b1671],
13	.	.	O	.	_	0	SENT_244	[p17l1397t1614r1561b1671],

1	PCR-based	JJ	MISC	pcr-based	amod	2	SENT_245	[p17l1590t1614r1945b1670],
2	genotyping	NN	O	genotyping	_	0	SENT_245	[p17l1971t1632r2146b1686, p17l97t1703r297b1775],
3	for	IN	O	for	_	0	SENT_245	[p17l323t1703r415b1758],
4	duplicated	JJ	O	duplicated	amod	8	SENT_245	[p17l439t1703r769b1775],
5	and	CC	O	and	_	0	SENT_245	[p17l794t1703r906b1758],
6	deleted	JJ	O	deleted	conj_and	4	SENT_245	[p17l931t1703r1159b1758],
7	CYP2D6	NN	O	cyp2d6	nn	8	SENT_245	[p17l1184t1703r1470b1759],
8	genes	NNS	O	gene	prep_for	2	SENT_245	[p17l1497t1721r1691b1775],
9	.	.	O	.	_	0	SENT_245	[p17l1497t1721r1691b1775],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_246	[p17l1718t1703r2145b1774, p17l96t1794r280b1847],
2	6	CD	NUMBER	6	num	1	SENT_246	[p17l307t1791r360b1847],
3	:	:	O	:	_	0	SENT_246	[p17l307t1791r360b1847],
4	351-355	CD	NUMBER	351-355	dep	1	SENT_246	[p17l394t1791r683b1847],
5	.	.	O	.	_	0	SENT_246	[p17l394t1791r683b1847],

1	Joyce	NNP	PERSON	Joyce	nn	2	SENT_247	[p17l7t1882r185b1952],
2	PR	NNP	O	PR	_	0	SENT_247	[p17l210t1882r321b1946],
3	,	,	O	,	_	0	SENT_247	[p17l210t1882r321b1946],
4	Mulder	NNP	ORGANIZATION	Mulder	nn	5	SENT_247	[p17l346t1880r580b1936],
5	RT	NN	ORGANIZATION	rt	appos	2	SENT_247	[p17l602t1882r708b1946],
6	,	,	O	,	_	0	SENT_247	[p17l602t1882r708b1946],
7	Luty	NNP	O	Luty	nn	8	SENT_247	[p17l734t1882r883b1952],
8	SE	NN	O	se	appos	2	SENT_247	[p17l908t1881r1013b1946],
9	,	,	O	,	_	0	SENT_247	[p17l908t1881r1013b1946],
10	et	FW	O	et	nn	11	SENT_247	[p17l1040t1891r1098b1936],
11	al.	FW	O	al.	appos	2	SENT_247	[p17l1118t1880r1190b1936],
12	2002	CD	DATE	2002	dep	11	SENT_247	[p17l1222t1881r1393b1936],
13	.	.	O	.	_	0	SENT_247	[p17l1222t1881r1393b1936],

1	Patterns	NN	O	pattern	nsubj	13	SENT_248	[p17l1421t1882r1673b1936],
2	and	CC	O	and	_	0	SENT_248	[p17l1699t1880r1810b1936],
3	predictors	NNS	O	predictor	conj_and	1	SENT_248	[p17l1832t1880r2147b1952],
4	of	IN	O	of	_	0	SENT_248	[p17l98t1969r166b2024],
5	response	NN	O	response	prep_of	1	SENT_248	[p17l186t1987r478b2041],
6	,	,	O	,	_	0	SENT_248	[p17l186t1987r478b2041],
7	remission	NN	O	remission	prep_of	1	SENT_248	[p17l505t1969r814b2024],
8	and	CC	O	and	_	0	SENT_248	[p17l840t1969r951b2024],
9	recovery	NN	O	recovery	conj_and	5	SENT_248	[p17l976t1987r1250b2041],
10	in	IN	O	in	_	0	SENT_248	[p17l1277t1969r1337b2024],
11	major	JJ	O	major	amod	12	SENT_248	[p17l1362t1969r1547b2041],
12	depression	NN	O	depression	prep_in	1	SENT_248	[p17l1572t1969r1909b2041],
13	treated	VBN	O	treat	_	0	SENT_248	[p17l1934t1969r2149b2024],
14	with	IN	O	with	_	0	SENT_248	[p17l97t2059r237b2114],
15	ﬂuoxetine	NN	O	ﬂuoxetine	prep_with	13	SENT_248	[p17l260t2058r572b2114],
16	or	CC	O	or	_	0	SENT_248	[p17l598t2076r662b2114],
17	nortriptyline	NN	O	nortriptyline	prep_with	13	SENT_248	[p17l684t2058r1096b2131],
18	.	.	O	.	_	0	SENT_248	[p17l684t2058r1096b2131],

1	Aust	NNP	O	Aust	nn	3	SENT_249	[p17l1117t2059r1264b2114],
2	NZJ	NNP	O	NZJ	nn	3	SENT_249	[p17l1281t2060r1418b2115],
3	Psychiat	NNP	O	Psychiat	_	0	SENT_249	[p17l1435t2059r1710b2130],
4	36	CD	NUMBER	36	num	3	SENT_249	[p17l1731t2058r1825b2114],
5	:	:	O	:	_	0	SENT_249	[p17l1731t2058r1825b2114],
6	384-391	CD	NUMBER	384-391	dep	3	SENT_249	[p17l1855t2059r2145b2115],
7	.	.	O	.	_	0	SENT_249	[p17l1855t2059r2145b2115],

1	Kirchheiner	NNP	PERSON	Kirchheiner	nn	2	SENT_250	[p17l9t2147r387b2203],
2	J	NNP	PERSON	J	_	0	SENT_250	[p17l426t2148r472b2213],
3	,	,	O	,	_	0	SENT_250	[p17l426t2148r472b2213],
4	Brosen	NNP	PERSON	Brosen	nn	5	SENT_250	[p17l517t2148r740b2203],
5	K	NNP	PERSON	K	appos	2	SENT_250	[p17l782t2148r853b2213],
6	,	,	O	,	_	0	SENT_250	[p17l782t2148r853b2213],
7	Dahl	NNP	PERSON	Dahl	nn	8	SENT_250	[p17l897t2147r1049b2203],
8	ML	NNP	O	ML	appos	2	SENT_250	[p17l1091t2148r1225b2213],
9	,	,	O	,	_	0	SENT_250	[p17l1091t2148r1225b2213],
10	et	FW	O	et	nn	11	SENT_250	[p17l1271t2158r1328b2203],
11	al.	FW	O	al.	appos	2	SENT_250	[p17l1368t2147r1440b2203],
12	2001	CD	DATE	2001	dep	11	SENT_250	[p17l1490t2148r1661b2203],
13	.	.	O	.	_	0	SENT_250	[p17l1490t2148r1661b2203],

1	CYP2D6	NN	O	cyp2d6	nn	5	SENT_251	[p17l1707t2147r1993b2203],
2	and	CC	O	and	_	0	SENT_251	[p17l2037t2147r2149b2203],
3	CYP2Cl9	NN	O	cyp2cl9	conj_and	1	SENT_251	[p17l98t2237r418b2293],
4	genotype	NN	O	genotype	nn	5	SENT_251	[p17l464t2236r959b2308],
5	—	NN	O	—	_	0	SENT_251	[p17l464t2236r959b2308],
6	based	VBN	O	base	partmod	5	SENT_251	[p17l464t2236r959b2308],
7	dose	NN	O	dose	nn	8	SENT_251	[p17l1003t2236r1146b2292],
8	recommendations	NNS	O	recommendation	dobj	6	SENT_251	[p17l1188t2236r1750b2292],
9	for	IN	O	for	_	0	SENT_251	[p17l1796t2236r1887b2292],
10	antidepressants	NNS	O	antidepressant	prep_for	6	SENT_251	[p17l1931t2236r2147b2292, p17l95t2333r402b2397],
11	:	:	O	:	_	0	SENT_251	[p17l1931t2236r2147b2292, p17l95t2333r402b2397],
12	a	DT	O	a	det	14	SENT_251	[p17l447t2343r480b2380],
13	ﬁrst	JJ	O	ﬁrst	amod	14	SENT_251	[p17l519t2325r639b2380],
14	step	NN	O	step	dep	5	SENT_251	[p17l679t2333r802b2397],
15	towards	IN	O	towards	_	0	SENT_251	[p17l841t2325r1086b2381],
16	subpopulation-speciﬁc	JJ	O	subpopulation-speciﬁc	amod	17	SENT_251	[p17l1129t2325r1840b2397],
17	dosages	NNS	O	dosage	prep_towards	14	SENT_251	[p17l1881t2325r2145b2397],
18	.	.	O	.	_	0	SENT_251	[p17l1881t2325r2145b2397],

1	Acta	NNP	O	Acta	nn	3	SENT_252	[p17l91t2416r240b2470],
2	Psychiatr	NNP	O	Psychiatr	nn	3	SENT_252	[p17l265t2414r572b2486],
3	Scand	NNP	O	Scand	_	0	SENT_252	[p17l594t2415r789b2471],
4	104	CD	NUMBER	104	num	3	SENT_252	[p17l815t2414r945b2471],
5	:	:	O	:	_	0	SENT_252	[p17l815t2414r945b2471],
6	173-192	CD	NUMBER	173-192	dep	3	SENT_252	[p17l983t2415r1267b2471],
7	.	.	O	.	_	0	SENT_252	[p17l983t2415r1267b2471],

1	Koyama	NNP	PERSON	Koyama	nn	2	SENT_253	[p17l9t2505r273b2575],
2	E	NNP	PERSON	E	_	0	SENT_253	[p17l289t2505r353b2569],
3	,	,	O	,	_	0	SENT_253	[p17l289t2505r353b2569],
4	Tanaka	NNP	PERSON	Tanaka	nn	5	SENT_253	[p17l375t2503r602b2559],
5	T	NN	O	t	appos	2	SENT_253	[p17l620t2505r677b2569],
6	,	,	O	,	_	0	SENT_253	[p17l620t2505r677b2569],
7	Chiba	NNP	ORGANIZATION	Chiba	nn	8	SENT_253	[p17l699t2503r888b2559],
8	K	NNP	ORGANIZATION	K	appos	2	SENT_253	[p17l906t2505r976b2569],
9	,	,	O	,	_	0	SENT_253	[p17l906t2505r976b2569],
10	et	FW	O	et	nn	11	SENT_253	[p17l998t2515r1055b2559],
11	al.	FW	O	al.	appos	2	SENT_253	[p17l1071t2503r1143b2559],
12	1996	CD	DATE	1996	dep	11	SENT_253	[p17l1177t2503r1342b2560],
13	.	.	O	.	_	0	SENT_253	[p17l1177t2503r1342b2560],

1	Steady-state	JJ	O	steady-state	amod	3	SENT_254	[p17l1365t2503r1750b2575],
2	plasma	NN	O	plasma	nn	3	SENT_254	[p17l1767t2503r1993b2575],
3	concentrations	NNS	O	concentration	_	0	SENT_254	[p17l2010t2521r2146b2559, p17l98t2592r442b2647],
4	of	IN	O	of	_	0	SENT_254	[p17l487t2592r556b2647],
5	imipramine	NN	O	imipramine	prep_of	3	SENT_254	[p17l594t2592r959b2664],
6	and	CC	O	and	_	0	SENT_254	[p17l1004t2592r1116b2647],
7	desipramine	NN	O	desipramine	prep_of	3	SENT_254	[p17l1159t2592r1545b2664],
8	in	IN	O	in	_	0	SENT_254	[p17l1589t2592r1649b2647],
9	relation	NN	O	relation	prep_in	3	SENT_254	[p17l1691t2592r1933b2647],
10	to	TO	O	to	_	0	SENT_254	[p17l1977t2600r2036b2647],
11	Smephenytoin	NNP	O	Smephenytoin	prep_to	3	SENT_254	[p17l2082t2592r2146b2648, p17l96t2682r509b2754],
12	4	CD	NUMBER	4	number	13	SENT_254	[p17l559t2682r1096b2754],
13	’	CD	NUMBER	’	num	11	SENT_254	[p17l559t2682r1096b2754],
14	.	.	O	.	_	0	SENT_254	[p17l559t2682r1096b2754],

1	—	NN	O	—	_	0	SENT_255	[p17l559t2682r1096b2754],
2	.	.	O	.	_	0	SENT_255	[p17l559t2682r1096b2754],

1	hydroxylation	NN	O	hydroxylation	nn	2	SENT_256	[p17l559t2682r1096b2754],
2	status	NN	O	status	_	0	SENT_256	[p17l1149t2690r1323b2737],
3	in	IN	O	in	_	0	SENT_256	[p17l1376t2681r1436b2736],
4	Japanese	JJ	MISC	japanese	amod	6	SENT_256	[p17l1486t2683r1767b2754],
5	depressive	JJ	O	depressive	amod	6	SENT_256	[p17l1818t2682r2148b2754],
6	patients	NNS	O	patient	prep_in	2	SENT_256	[p17l96t2771r358b2843],
7	.	.	O	.	_	0	SENT_256	[p17l96t2771r358b2843],

1	J	NNP	O	J	nn	3	SENT_257	[p17l386t2773r426b2827],
2	Clin	NNP	PERSON	Clin	nn	3	SENT_257	[p17l450t2771r581b2827],
3	Psychopharmacol	NNP	PERSON	Psychopharmacol	_	0	SENT_257	[p17l606t2771r1178b2842],
4	16	CD	NUMBER	16	num	3	SENT_257	[p17l1206t2770r1296b2826],
5	:	:	O	:	_	0	SENT_257	[p17l1206t2770r1296b2826],
6	286-293	CD	NUMBER	286-293	dep	3	SENT_257	[p17l1329t2771r1618b2827],
7	.	.	O	.	_	0	SENT_257	[p17l1329t2771r1618b2827],

1	Kroemer	NNP	PERSON	Kroemer	nn	2	SENT_258	[p17l9t2861r289b2915],
2	HK	NNP	O	HK	_	0	SENT_258	[p17l314t2861r443b2925],
3	,	,	O	,	_	0	SENT_258	[p17l314t2861r443b2925],
4	Eichelbaum	NNP	PERSON	Eichelbaum	nn	5	SENT_258	[p17l472t2859r852b2915],
5	M.	NNP	O	M.	appos	2	SENT_258	[p17l877t2861r961b2915],
6	1995	CD	DATE	1995	dep	5	SENT_258	[p17l999t2859r1164b2916],
7	.	.	O	.	_	0	SENT_258	[p17l999t2859r1164b2916],

1	‘	RB	O	‘	advmod	8	SENT_259	[p17l1202t2860r1318b2915],
2	It	PRP	O	it	poss	8	SENT_259	[p17l1202t2860r1318b2915],
3	’s	POS	O	’s	_	0	SENT_259	[p17l1202t2860r1318b2915],
4	the	DT	O	the	det	5	SENT_259	[p17l1346t2859r1441b2915],
5	genes	NNS	O	gene	amod	8	SENT_259	[p17l1468t2877r1663b2931],
6	,	,	O	,	_	0	SENT_259	[p17l1468t2877r1663b2931],
7	stupid	JJ	O	stupid	amod	8	SENT_259	[p17l1695t2859r1926b2931],
8	’	NN	O	’	_	0	SENT_259	[p17l1695t2859r1926b2931],
9	.	.	O	.	_	0	SENT_259	[p17l1695t2859r1926b2931],

1	Molecular	JJ	O	molecular	amod	2	SENT_260	[p17l1956t2859r2146b2915, p17l98t2948r256b3003],
2	bases	NNS	O	basis	_	0	SENT_260	[p17l293t2948r461b3003],
3	and	CC	O	and	_	0	SENT_260	[p17l505t2948r617b3003],
4	clinical	JJ	O	clinical	amod	5	SENT_260	[p17l657t2948r889b3003],
5	consequences	NNS	O	consequence	conj_and	2	SENT_260	[p17l930t2966r1362b3020],
6	of	IN	O	of	_	0	SENT_260	[p17l1405t2948r1473b3003],
7	genetic	JJ	O	genetic	amod	11	SENT_260	[p17l1509t2948r1735b3020],
8	cytochrome	NN	O	cytochrome	nn	11	SENT_260	[p17l1777t2948r2148b3020],
9	P450	NN	O	p450	nn	11	SENT_260	[p17l96t3037r257b3093],
10	2D6	NN	O	2d6	nn	11	SENT_260	[p17l284t3037r416b3093],
11	polymorphism	NN	O	polymorphism	prep_of	5	SENT_260	[p17l442t3038r919b3110],
12	.	.	O	.	_	0	SENT_260	[p17l442t3038r919b3110],

1	Life	NNP	O	Life	nn	2	SENT_261	[p17l946t3038r1069b3109],
2	Sci	NNP	O	Sci	_	0	SENT_261	[p17l1097t3039r1192b3094],
3	56	CD	NUMBER	56	num	2	SENT_261	[p17l1217t3037r1311b3093],
4	:	:	O	:	_	0	SENT_261	[p17l1217t3037r1311b3093],
5	2285-2298	CD	DATE	2285-2298	dep	2	SENT_261	[p17l1344t3037r1712b3094],
6	.	.	O	.	_	0	SENT_261	[p17l1344t3037r1712b3094],

1	Lessard	NNP	PERSON	Lessard	nn	2	SENT_262	[p17l7t3126r253b3182],
2	E	NNP	O	E	_	0	SENT_262	[p17l289t3128r354b3192],
3	,	,	O	,	_	0	SENT_262	[p17l289t3128r354b3192],
4	Yessine	NNP	PERSON	Yessine	nn	5	SENT_262	[p17l395t3126r635b3182],
5	MA	NNP	PERSON	MA	appos	2	SENT_262	[p17l673t3127r815b3192],
6	,	,	O	,	_	0	SENT_262	[p17l673t3127r815b3192],
7	Hamelin	NNP	ORGANIZATION	Hamelin	nn	8	SENT_262	[p17l856t3126r1128b3182],
8	BA	NN	ORGANIZATION	ba	appos	2	SENT_262	[p17l1166t3127r1287b3192],
9	,	,	O	,	_	0	SENT_262	[p17l1166t3127r1287b3192],
10	et	FW	O	et	nn	11	SENT_262	[p17l1330t3137r1386b3182],
11	al.	FW	O	al.	appos	2	SENT_262	[p17l1422t3126r1494b3182],
12	1999	CD	DATE	1999	dep	11	SENT_262	[p17l1547t3127r1712b3183],
13	.	.	O	.	_	0	SENT_262	[p17l1547t3127r1712b3183],

1	Inﬂuence	NN	O	inﬂuence	_	0	SENT_263	[p17l1754t3126r2047b3182],
2	of	IN	O	of	_	0	SENT_263	[p17l2085t3126r2153b3182],
3	CYP2D6	NN	O	cyp2d6	nn	4	SENT_263	[p17l98t3215r384b3271],
4	activity	NN	O	activity	prep_of	1	SENT_263	[p17l414t3215r647b3287],
5	on	IN	O	on	_	0	SENT_263	[p17l677t3233r753b3270],
6	the	DT	O	the	det	7	SENT_263	[p17l781t3215r876b3270],
7	disposition	NN	O	disposition	prep_on	1	SENT_263	[p17l906t3215r1252b3287],
8	and	CC	O	and	_	0	SENT_263	[p17l1281t3215r1392b3270],
9	cardiovascular	JJ	O	cardiovascular	amod	10	SENT_263	[p17l1420t3215r1881b3271],
10	toxicity	NN	O	toxicity	prep_on	1	SENT_263	[p17l1907t3215r2148b3287],
11	of	IN	O	of	_	0	SENT_263	[p17l98t3304r166b3360],
12	the	DT	O	the	det	15	SENT_263	[p17l182t3305r277b3360],
13	antidepressant	JJ	O	antidepressant	amod	15	SENT_263	[p17l300t3305r752b3377],
14	agent	NN	O	agent	nn	15	SENT_263	[p17l773t3313r943b3377],
15	venlafaxine	NN	O	venlafaxine	prep_of	1	SENT_263	[p17l963t3304r1331b3360],
16	in	IN	O	in	_	0	SENT_263	[p17l1352t3304r1413b3359],
17	humans	NNS	O	human	prep_in	15	SENT_263	[p17l1433t3305r1694b3360],
18	.	.	O	.	_	0	SENT_263	[p17l1433t3305r1694b3360],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_264	[p17l1718t3305r2146b3376, p17l97t3395r280b3448],
2	9	CD	NUMBER	9	num	1	SENT_264	[p17l307t3392r360b3448],
3	:	:	O	:	_	0	SENT_264	[p17l307t3392r360b3448],
4	435-443	CD	NUMBER	435-443	dep	1	SENT_264	[p17l391t3392r683b3448],
5	.	.	O	.	_	0	SENT_264	[p17l391t3392r683b3448],

1	Luty	NNP	O	Luty	nn	2	SENT_265	[p18l7t25r155b95],
2	SE	NN	O	se	_	0	SENT_265	[p18l188t24r293b89],
3	,	,	O	,	_	0	SENT_265	[p18l188t24r293b89],
4	Joyce	NNP	PERSON	Joyce	nn	5	SENT_265	[p18l326t25r504b95],
5	PR	NNP	O	PR	appos	2	SENT_265	[p18l535t25r647b89],
6	,	,	O	,	_	0	SENT_265	[p18l535t25r647b89],
7	Mulder	NNP	PERSON	Mulder	nn	8	SENT_265	[p18l679t23r913b79],
8	RT	NN	O	rt	appos	2	SENT_265	[p18l941t25r1048b89],
9	,	,	O	,	_	0	SENT_265	[p18l941t25r1048b89],
10	et	FW	O	et	nn	11	SENT_265	[p18l1083t34r1140b79],
11	al.	FW	O	al.	appos	2	SENT_265	[p18l1167t23r1240b79],
12	2002	CD	DATE	2002	dep	11	SENT_265	[p18l1278t24r1450b79],
13	.	.	O	.	_	0	SENT_265	[p18l1278t24r1450b79],

1	Social	NNP	O	Social	nn	2	SENT_266	[p18l1486t23r1681b79],
2	adjustment	NN	O	adjustment	_	0	SENT_266	[p18l1713t23r2060b95],
3	in	IN	O	in	_	0	SENT_266	[p18l2088t23r2148b78],
4	depression	NN	O	depression	prep_in	2	SENT_266	[p18l98t112r451b184],
5	:	:	O	:	_	0	SENT_266	[p18l98t112r451b184],
6	the	DT	O	the	det	7	SENT_266	[p18l491t112r585b167],
7	impact	NN	O	impact	conj_and	2	SENT_266	[p18l620t112r836b184],
8	of	IN	O	of	_	0	SENT_266	[p18l871t112r939b167],
9	depression	NN	O	depression	nn	10	SENT_266	[p18l969t112r1305b184],
10	severity	NN	O	severity	prep_of	7	SENT_266	[p18l1342t112r1598b184],
11	,	,	O	,	_	0	SENT_266	[p18l1342t112r1598b184],
12	personality	NN	O	personality	appos	10	SENT_266	[p18l1634t112r1998b184],
13	,	,	O	,	_	0	SENT_266	[p18l1634t112r1998b184],
14	and	CC	O	and	_	0	SENT_266	[p18l2037t112r2149b167],
15	clinic	NN	O	clinic	conj_and	2	SENT_266	[p18l98t202r271b257],
16	versus	CC	O	versus	prep	15	SENT_266	[p18l295t219r493b257],
17	community	NN	O	community	nn	18	SENT_266	[p18l518t201r877b274],
18	sampling	NN	O	sampling	dep	16	SENT_266	[p18l903t201r1206b274],
19	.	.	O	.	_	0	SENT_266	[p18l903t201r1206b274],

1	J	NNP	O	J	nn	3	SENT_267	[p18l1231t204r1271b258],
2	Aﬁect	NNP	O	Aﬁect	nn	3	SENT_267	[p18l1282t202r1472b273],
3	Disord	NNP	O	Disord	_	0	SENT_267	[p18l1491t202r1711b257],
4	70	CD	NUMBER	70	num	3	SENT_267	[p18l1731t201r1824b257],
5	:	:	O	:	_	0	SENT_267	[p18l1731t201r1824b257],
6	143-154	CD	NUMBER	143-154	dep	3	SENT_267	[p18l1861t201r2145b257],
7	.	.	O	.	_	0	SENT_267	[p18l1861t201r2145b257],

1	Marchioni	NNP	PERSON	Marchioni	nn	2	SENT_268	[p18l7t290r336b346],
2	E	NNP	PERSON	E	_	0	SENT_268	[p18l364t292r428b356],
3	,	,	O	,	_	0	SENT_268	[p18l364t292r428b356],
4	Perucca	NNP	PERSON	Perucca	nn	5	SENT_268	[p18l459t292r710b346],
5	E	NNP	PERSON	E	appos	2	SENT_268	[p18l737t292r800b356],
6	,	,	O	,	_	0	SENT_268	[p18l737t292r800b356],
7	Soragna	NNP	ORGANIZATION	Soragna	nn	8	SENT_268	[p18l834t291r1091b362],
8	D	NNP	ORGANIZATION	D	appos	2	SENT_268	[p18l1118t292r1190b356],
9	,	,	O	,	_	0	SENT_268	[p18l1118t292r1190b356],
10	et	FW	O	et	nn	11	SENT_268	[p18l1222t301r1279b346],
11	al.	FW	O	al.	appos	2	SENT_268	[p18l1306t290r1378b346],
12	1996	CD	DATE	1996	dep	11	SENT_268	[p18l1421t290r1586b347],
13	.	.	O	.	_	0	SENT_268	[p18l1421t290r1586b347],

1	Choreiform	NN	O	choreiform	nn	2	SENT_269	[p18l1619t290r1988b346],
2	syndrome	NN	O	syndrome	nsubj	3	SENT_269	[p18l2017t308r2146b362, p18l98t379r297b434],
3	associated	VBN	O	associate	_	0	SENT_269	[p18l320t379r643b434],
4	with	IN	O	with	_	0	SENT_269	[p18l663t379r802b435],
5	ﬂuoxetine	NN	O	ﬂuoxetine	nn	6	SENT_269	[p18l824t379r1137b434],
6	treatment	NN	O	treatment	prep_with	3	SENT_269	[p18l1158t387r1458b434],
7	in	IN	O	in	_	0	SENT_269	[p18l1477t379r1537b434],
8	a	DT	O	a	det	9	SENT_269	[p18l1559t397r1592b434],
9	patient	NN	O	patient	prep_in	3	SENT_269	[p18l1610t379r1827b451],
10	with	IN	O	with	_	0	SENT_269	[p18l1847t379r1986b435],
11	deﬁcient	JJ	O	deﬁcient	amod	13	SENT_269	[p18l2007t379r2146b434, p18l98t468r251b523],
12	CYP2D6	NN	O	cyp2d6	nn	13	SENT_269	[p18l277t468r562b524],
13	activity	NN	O	activity	prep_with	3	SENT_269	[p18l590t468r835b540],
14	.	.	O	.	_	0	SENT_269	[p18l590t468r835b540],

1	Neurology	NN	O	neurology	_	0	SENT_270	[p18l861t468r1194b539],
2	46	CD	NUMBER	46	num	1	SENT_270	[p18l1220t467r1314b524],
3	:	:	O	:	_	0	SENT_270	[p18l1220t467r1314b524],
4	853	CD	NUMBER	853	dep	1	SENT_270	[p18l1348t468r1477b524],
5	.	.	O	.	_	0	SENT_270	[p18l1348t468r1477b524],

1	Mellstrom	NNP	PERSON	Mellstrom	nn	2	SENT_271	[p18l7t558r338b613],
2	B	NNP	PERSON	B	_	0	SENT_271	[p18l358t559r426b624],
3	,	,	O	,	_	0	SENT_271	[p18l358t559r426b624],
4	Bertilsson	NNP	PERSON	Bertilsson	nn	5	SENT_271	[p18l452t558r773b613],
5	L	NNP	PERSON	L	appos	2	SENT_271	[p18l794t559r859b623],
6	,	,	O	,	_	0	SENT_271	[p18l794t559r859b623],
7	Sawe	NNP	O	Sawe	nn	8	SENT_271	[p18l886t558r1053b613],
8	J	NNP	O	J	appos	2	SENT_271	[p18l1075t559r1121b623],
9	,	,	O	,	_	0	SENT_271	[p18l1075t559r1121b623],
10	et	FW	O	et	nn	11	SENT_271	[p18l1148t569r1206b613],
11	al.	FW	O	al.	appos	2	SENT_271	[p18l1226t558r1298b613],
12	1981	CD	DATE	1981	dep	11	SENT_271	[p18l1336t558r1501b614],
13	.	.	O	.	_	0	SENT_271	[p18l1336t558r1501b614],

1	E	NN	O	e	_	0	SENT_272	[p18l1527t559r1598b612],
2	-	:	O	-	_	0	SENT_272	[p18l1527t559r1598b612],
3	and	CC	O	and	dep	4	SENT_272	[p18l1625t558r1736b613],
4	Z10hydroxylation	NN	O	z10hydroxylation	dep	1	SENT_272	[p18l1758t558r2147b630, p18l97t646r356b718],
5	of	IN	O	of	_	0	SENT_272	[p18l393t646r461b702],
6	nortriptyline	NN	O	nortriptyline	prep_of	4	SENT_272	[p18l492t646r903b718],
7	:	:	O	:	_	0	SENT_272	[p18l492t646r903b718],
8	relationship	NN	O	relationship	dep	4	SENT_272	[p18l944t646r1318b718],
9	to	TO	O	to	_	0	SENT_272	[p18l1355t655r1414b702],
10	polymorphic	JJ	O	polymorphic	amod	12	SENT_272	[p18l1450t646r1852b718],
11	debrisoquine	NN	O	debrisoquine	nn	12	SENT_272	[p18l1891t646r2146b702, p18l97t735r271b807],
12	hydroxylation	NN	O	hydroxylation	prep_to	8	SENT_272	[p18l296t735r756b807],
13	.	.	O	.	_	0	SENT_272	[p18l296t735r756b807],

1	Clin	NNP	O	Clin	nn	3	SENT_273	[p18l789t735r920b791],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_273	[p18l945t735r1298b790],
3	Ther	NNP	O	Ther	_	0	SENT_273	[p18l1326t735r1473b790],
4	30	CD	NUMBER	30	num	3	SENT_273	[p18l1495t735r1589b791],
5	:	:	O	:	_	0	SENT_273	[p18l1495t735r1589b791],
6	189-193	CD	NUMBER	189-193	dep	3	SENT_273	[p18l1628t735r1911b792],
7	.	.	O	.	_	0	SENT_273	[p18l1628t735r1911b792],

1	Meyer	NNP	PERSON	Meyer	nn	2	SENT_274	[p18l7t826r213b897],
2	JW	NNP	O	JW	_	0	SENT_274	[p18l244t826r358b890],
3	,	,	O	,	_	0	SENT_274	[p18l244t826r358b890],
4	Woggon	NNP	PERSON	Woggon	nn	8	SENT_274	[p18l393t826r661b897],
5	B	NNP	PERSON	B	nn	8	SENT_274	[p18l692t826r760b890],
6	,	,	O	,	_	0	SENT_274	[p18l692t826r760b890],
7	Kupfer	NNP	PERSON	Kupfer	appos	8	SENT_274	[p18l797t824r1018b897],
8	A.	NNP	O	A.	appos	2	SENT_274	[p18l1050t825r1121b880],
9	1988	CD	DATE	1988	num	8	SENT_274	[p18l1166t825r1330b881],
10	.	.	O	.	_	0	SENT_274	[p18l1166t825r1330b881],

1	Importance	NN	O	importance	_	0	SENT_275	[p18l1367t826r1727b897],
2	of	IN	O	of	_	0	SENT_275	[p18l1761t824r1829b880],
3	oxidative	JJ	O	oxidative	amod	4	SENT_275	[p18l1858t824r2148b880],
4	polymorphism	NN	O	polymorphism	prep_of	1	SENT_275	[p18l95t913r559b985],
5	on	IN	O	on	_	0	SENT_275	[p18l596t931r673b969],
6	clinical	JJ	O	clinical	amod	7	SENT_275	[p18l710t913r943b969],
7	efﬁcacy	NN	O	efﬁcacy	prep_on	4	SENT_275	[p18l981t913r1227b985],
8	and	CC	O	and	_	0	SENT_275	[p18l1266t913r1378b969],
9	side	NN	O	side	prep_on	4	SENT_275	[p18l1418t913r1776b969],
10	—	JJ	O	—	amod	11	SENT_275	[p18l1418t913r1776b969],
11	effects	NNS	O	effect	dep	1	SENT_275	[p18l1418t913r1776b969],
12	of	IN	O	of	_	0	SENT_275	[p18l1816t913r1884b969],
13	imipramine	NN	O	imipramine	prep_of	11	SENT_275	[p18l1916t913r2146b985, p18l97t1002r382b1057],
14	—	CD	NUMBER	—	num	13	SENT_275	[p18l1916t913r2146b985, p18l97t1002r382b1057],
15	a	DT	O	a	det	17	SENT_275	[p18l1916t913r2146b985, p18l97t1002r382b1057],
16	retrospective	JJ	O	retrospective	amod	17	SENT_275	[p18l406t1002r813b1074],
17	study	NN	O	study	dep	11	SENT_275	[p18l840t1002r1017b1074],
18	.	.	O	.	_	0	SENT_275	[p18l840t1002r1017b1074],

1	Pharmacopsychiatry	NNP	O	Pharmacopsychiatry	_	0	SENT_276	[p18l1045t1002r1704b1073],
2	21	CD	NUMBER	21	num	1	SENT_276	[p18l1729t1002r1822b1057],
3	:	:	O	:	_	0	SENT_276	[p18l1729t1002r1822b1057],
4	365-366	CD	NUMBER	365-366	dep	1	SENT_276	[p18l1855t1002r2145b1058],
5	.	.	O	.	_	0	SENT_276	[p18l1855t1002r2145b1058],

1	Meyer	NNP	PERSON	Meyer	nn	2	SENT_277	[p18l7t1092r213b1163],
2	UA	NNP	O	UA	_	0	SENT_277	[p18l244t1091r369b1147],
3	.	.	O	.	_	0	SENT_277	[p18l244t1091r369b1147],

1	1994	CD	DATE	1994	_	0	SENT_278	[p18l414t1091r578b1148],
2	.	.	O	.	_	0	SENT_278	[p18l414t1091r578b1148],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_279	[p18l614t1091r1207b1163],
2	:	:	O	:	_	0	SENT_279	[p18l614t1091r1207b1163],
3	the	DT	O	the	det	4	SENT_279	[p18l1246t1091r1340b1146],
4	slow	JJ	O	slow	dep	1	SENT_279	[p18l1376t1091r1531b1157],
5	,	,	O	,	_	0	SENT_279	[p18l1376t1091r1531b1157],
6	the	DT	O	the	det	7	SENT_279	[p18l1566t1091r1661b1146],
7	rapid	JJ	O	rapid	conj_and	4	SENT_279	[p18l1693t1091r1872b1163],
8	,	,	O	,	_	0	SENT_279	[p18l1693t1091r1872b1163],
9	and	CC	O	and	_	0	SENT_279	[p18l1909t1091r2021b1146],
10	the	DT	O	the	det	11	SENT_279	[p18l2053t1091r2148b1146],
11	ultrarapid	NN	O	ultrarapid	dep	1	SENT_279	[p18l96t1181r420b1253],
12	.	.	O	.	_	0	SENT_279	[p18l96t1181r420b1253],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_280	[p18l448t1183r598b1236],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_280	[p18l621t1181r760b1236],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_280	[p18l780t1181r950b1236],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_280	[p18l971t1182r1067b1237],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_280	[p18l1099t1182r1233b1237],
6	91	CD	NUMBER	91	num	5	SENT_280	[p18l1263t1180r1355b1236],
7	:	:	O	:	_	0	SENT_280	[p18l1263t1180r1355b1236],
8	1983-1984	CD	DATE	1983-1984	dep	5	SENT_280	[p18l1394t1181r1757b1237],
9	.	.	O	.	_	0	SENT_280	[p18l1394t1181r1757b1237],

1	Montgomery	NNP	ORGANIZATION	Montgomery	nn	2	SENT_281	[p18l7t1271r418b1341],
2	SA	NNP	ORGANIZATION	SA	_	0	SENT_281	[p18l440t1270r553b1335],
3	,	,	O	,	_	0	SENT_281	[p18l440t1270r553b1335],
4	Asberg	NNP	O	Asberg	nn	5	SENT_281	[p18l574t1269r799b1341],
5	M.	NNP	O	M.	appos	2	SENT_281	[p18l818t1271r902b1325],
6	1979	CD	DATE	1979	dep	5	SENT_281	[p18l932t1270r1097b1326],
7	.	.	O	.	_	0	SENT_281	[p18l932t1270r1097b1326],

1	A	DT	O	a	det	4	SENT_282	[p18l1118t1270r1174b1324],
2	new	JJ	O	new	amod	4	SENT_282	[p18l1191t1287r1319b1325],
3	depression	NN	O	depression	nn	4	SENT_282	[p18l1339t1269r1675b1341],
4	scale	NN	O	scale	nsubj	5	SENT_282	[p18l1696t1269r1850b1325],
5	designed	VBN	O	design	_	0	SENT_282	[p18l1870t1269r2150b1341],
6	to	TO	O	to	aux	8	SENT_282	[p18l97t1367r155b1413],
7	be	VB	O	be	cop	8	SENT_282	[p18l181t1358r255b1413],
8	sensitive	JJ	O	sensitive	xcomp	5	SENT_282	[p18l284t1358r555b1413],
9	to	TO	O	to	aux	10	SENT_282	[p18l581t1367r639b1413],
10	change	VB	O	change	xcomp	8	SENT_282	[p18l666t1358r905b1430],
11	.	.	O	.	_	0	SENT_282	[p18l666t1358r905b1430],

1	Br	NN	O	br	nn	2	SENT_283	[p18l933t1360r1015b1413],
2	J	NN	O	j	_	0	SENT_283	[p18l1036t1360r1076b1414],
3	Psychiatry	NNP	O	Psychiatry	dep	2	SENT_283	[p18l1095t1358r1433b1429],
4	134	CD	NUMBER	134	num	3	SENT_283	[p18l1463t1357r1593b1414],
5	:	:	O	:	_	0	SENT_283	[p18l1463t1357r1593b1414],
6	382-389	CD	NUMBER	382-389	dep	2	SENT_283	[p18l1626t1358r1914b1415],
7	.	.	O	.	_	0	SENT_283	[p18l1626t1358r1914b1415],

1	Morinobu	NNP	PERSON	Morinobu	nn	2	SENT_284	[p18l7t1448r320b1503],
2	S	NNP	PERSON	S	_	0	SENT_284	[p18l345t1448r402b1513],
3	,	,	O	,	_	0	SENT_284	[p18l345t1448r402b1513],
4	Tanaka	NNP	ORGANIZATION	Tanaka	nn	5	SENT_284	[p18l427t1448r655b1503],
5	T	NN	ORGANIZATION	t	appos	2	SENT_284	[p18l675t1449r733b1513],
6	,	,	O	,	_	0	SENT_284	[p18l675t1449r733b1513],
7	Kawakatsu	NNP	LOCATION	Kawakatsu	nn	8	SENT_284	[p18l760t1448r1107b1503],
8	S	NNP	LOCATION	S	appos	2	SENT_284	[p18l1131t1448r1188b1513],
9	,	,	O	,	_	0	SENT_284	[p18l1131t1448r1188b1513],
10	et	FW	O	et	nn	11	SENT_284	[p18l1215t1459r1271b1503],
11	al.	FW	O	al.	appos	2	SENT_284	[p18l1290t1447r1363b1503],
12	1997	CD	DATE	1997	dep	11	SENT_284	[p18l1400t1448r1565b1504],
13	.	.	O	.	_	0	SENT_284	[p18l1400t1448r1565b1504],

1	Effects	NNS	O	effect	_	0	SENT_285	[p18l1590t1447r1811b1503],
2	of	IN	O	of	_	0	SENT_285	[p18l1835t1447r1903b1503],
3	genetic	JJ	O	genetic	amod	4	SENT_285	[p18l1921t1447r2147b1520],
4	defects	NNS	O	defect	prep_of	1	SENT_285	[p18l98t1536r318b1592],
5	in	IN	O	in	_	0	SENT_285	[p18l341t1536r402b1591],
6	the	DT	O	the	det	8	SENT_285	[p18l424t1536r518b1592],
7	CYP2C19	NN	O	cyp2c19	nn	8	SENT_285	[p18l542t1537r863b1593],
8	gene	NN	O	gene	prep_in	1	SENT_285	[p18l886t1554r1034b1608],
9	on	IN	O	on	_	0	SENT_285	[p18l1057t1554r1134b1592],
10	the	DT	O	the	det	13	SENT_285	[p18l1155t1536r1250b1592],
11	N	NN	O	n	nn	13	SENT_285	[p18l1272t1536r1809b1608],
12	—	NN	O	—	nn	13	SENT_285	[p18l1272t1536r1809b1608],
13	demethylation	NN	O	demethylation	prep_on	1	SENT_285	[p18l1272t1536r1809b1608],
14	of	IN	O	of	_	0	SENT_285	[p18l1832t1536r1900b1592],
15	imipramine	NN	O	imipramine	prep_of	13	SENT_285	[p18l1916t1536r2146b1608, p18l96t1625r271b1691],
16	,	,	O	,	_	0	SENT_285	[p18l1916t1536r2146b1608, p18l96t1625r271b1691],
17	and	CC	O	and	_	0	SENT_285	[p18l309t1625r421b1681],
18	clinical	JJ	O	clinical	amod	19	SENT_285	[p18l456t1625r688b1681],
19	outcome	NN	O	outcome	conj_and	13	SENT_285	[p18l724t1634r994b1681],
20	of	IN	O	of	_	0	SENT_285	[p18l1030t1625r1098b1681],
21	imipramine	NN	O	imipramine	nn	22	SENT_285	[p18l1126t1625r1491b1697],
22	therapy	NN	O	therapy	prep_of	19	SENT_285	[p18l1526t1625r1773b1697],
23	.	.	O	.	_	0	SENT_285	[p18l1526t1625r1773b1697],

1	Psychiatry	NNP	O	Psychiatry	nn	3	SENT_286	[p18l1810t1625r2148b1697],
2	Clin	NNP	PERSON	Clin	nn	3	SENT_286	[p18l100t1713r231b1769],
3	Nearosci	NNP	PERSON	Nearosci	_	0	SENT_286	[p18l255t1715r538b1768],
4	51	CD	NUMBER	51	num	3	SENT_286	[p18l565t1713r658b1768],
5	:	:	O	:	_	0	SENT_286	[p18l565t1713r658b1768],
6	253-257	CD	NUMBER	253-257	dep	3	SENT_286	[p18l690t1713r980b1768],
7	.	.	O	.	_	0	SENT_286	[p18l690t1713r980b1768],

1	Morita	NNP	PERSON	Morita	nn	2	SENT_287	[p18l7t1803r223b1858],
2	S	NNP	O	S	_	0	SENT_287	[p18l251t1803r308b1868],
3	,	,	O	,	_	0	SENT_287	[p18l251t1803r308b1868],
4	Shimoda	NNP	PERSON	Shimoda	nn	5	SENT_287	[p18l340t1803r620b1858],
5	K	NNP	PERSON	K	appos	2	SENT_287	[p18l647t1804r718b1868],
6	,	,	O	,	_	0	SENT_287	[p18l647t1804r718b1868],
7	Someya	NNP	ORGANIZATION	Someya	nn	8	SENT_287	[p18l750t1803r1001b1875],
8	T	NN	ORGANIZATION	t	appos	2	SENT_287	[p18l1029t1804r1086b1868],
9	,	,	O	,	_	0	SENT_287	[p18l1029t1804r1086b1868],
10	et	FW	O	et	nn	11	SENT_287	[p18l1118t1814r1175b1858],
11	al.	FW	O	al.	appos	2	SENT_287	[p18l1200t1803r1273b1858],
12	2000	CD	DATE	2000	dep	11	SENT_287	[p18l1308t1803r1480b1858],
13	.	.	O	.	_	0	SENT_287	[p18l1308t1803r1480b1858],

1	Steady-state	JJ	O	steady-state	amod	3	SENT_288	[p18l1514t1803r1897b1875],
2	plasma	NN	O	plasma	nn	3	SENT_288	[p18l1924t1803r2150b1875],
3	levels	NNS	O	level	_	0	SENT_288	[p18l97t1891r277b1947],
4	of	IN	O	of	_	0	SENT_288	[p18l333t1891r402b1947],
5	nortriptyline	NN	O	nortriptyline	prep_of	3	SENT_288	[p18l451t1891r847b1963],
6	and	CC	O	and	_	0	SENT_288	[p18l903t1891r1015b1947],
7	its	PRP$	O	its	conj_and	3	SENT_288	[p18l1069t1891r1141b1947],
8	hydroxylated	VBN	O	hydroxylate	partmod	7	SENT_288	[p18l1196t1891r1615b1963],
9	metabolites	NNS	O	metabolite	dobj	8	SENT_288	[p18l1669t1891r2033b1947],
10	in	IN	O	in	_	0	SENT_288	[p18l2088t1891r2148b1946],
11	Japanese	JJ	MISC	japanese	amod	12	SENT_288	[p18l96t1981r376b2052],
12	patients	NNS	O	patient	prep_in	9	SENT_288	[p18l400t1980r663b2052],
13	:	:	O	:	_	0	SENT_288	[p18l400t1980r663b2052],
14	impact	NN	O	impact	dep	3	SENT_288	[p18l691t1980r907b2052],
15	of	IN	O	of	_	0	SENT_288	[p18l931t1980r999b2035],
16	CYP2D6	NN	O	cyp2d6	nn	17	SENT_288	[p18l1018t1980r1304b2036],
17	genotype	NN	O	genotype	prep_of	14	SENT_288	[p18l1329t1988r1617b2052],
18	on	IN	O	on	_	0	SENT_288	[p18l1641t1998r1718b2035],
19	the	DT	O	the	det	20	SENT_288	[p18l1742t1980r1837b2035],
20	hydroXylation	NN	O	hydroxylation	prep_on	17	SENT_288	[p18l1859t1980r2147b2052, p18l97t2069r277b2125],
21	of	IN	O	of	_	0	SENT_288	[p18l303t2069r371b2125],
22	nortriptyline	NN	O	nortriptyline	prep_of	20	SENT_288	[p18l391t2070r803b2142],
23	.	.	O	.	_	0	SENT_288	[p18l391t2070r803b2142],

1	J	NNP	O	J	nn	3	SENT_289	[p18l830t2072r871b2126],
2	Clin	NNP	PERSON	Clin	nn	3	SENT_289	[p18l896t2069r1025b2126],
3	Psychopharmacol	NNP	PERSON	Psychopharmacol	_	0	SENT_289	[p18l1051t2070r1622b2141],
4	20	CD	NUMBER	20	num	3	SENT_289	[p18l1647t2069r1741b2125],
5	:	:	O	:	_	0	SENT_289	[p18l1647t2069r1741b2125],
6	141-149	CD	NUMBER	141-149	dep	3	SENT_289	[p18l1780t2070r2063b2126],
7	.	.	O	.	_	0	SENT_289	[p18l1780t2070r2063b2126],

1	Nordin	NNP	PERSON	Nordin	nn	2	SENT_290	[p18l7t2158r230b2214],
2	C	NNP	PERSON	C	_	0	SENT_290	[p18l252t2159r318b2224],
3	,	,	O	,	_	0	SENT_290	[p18l252t2159r318b2224],
4	Bertilsson	NNP	PERSON	Bertilsson	nn	5	SENT_290	[p18l343t2158r663b2214],
5	L.	NNP	O	L.	appos	2	SENT_290	[p18l682t2160r745b2214],
6	1995	CD	DATE	1995	dep	5	SENT_290	[p18l777t2158r942b2215],
7	.	.	O	.	_	0	SENT_290	[p18l777t2158r942b2215],

1	Active	JJ	O	active	amod	2	SENT_291	[p18l966t2158r1173b2214],
2	hydroxymetabolites	NNS	O	hydroxymetabolite	_	0	SENT_291	[p18l1195t2158r1822b2230],
3	of	IN	O	of	_	0	SENT_291	[p18l1845t2158r1914b2214],
4	antidepressants	NNS	O	antidepressant	prep_of	2	SENT_291	[p18l1931t2158r2147b2214, p18l95t2256r401b2319],
5	.	.	O	.	_	0	SENT_291	[p18l1931t2158r2147b2214, p18l95t2256r401b2319],

1	Emphasis	NN	O	emphasis	_	0	SENT_292	[p18l431t2247r737b2319],
2	on	IN	O	on	_	0	SENT_292	[p18l765t2265r841b2303],
3	E-10-hydroXy	NN	O	e-10-hydroxy	prep_on	1	SENT_292	[p18l867t2247r1334b2319],
4	-	:	O	-	_	0	SENT_292	[p18l867t2247r1334b2319],
5	nortriptyline	NN	O	nortriptyline	dep	1	SENT_292	[p18l1363t2247r1774b2319],
6	.	.	O	.	_	0	SENT_292	[p18l1363t2247r1774b2319],

1	Clin	NNP	PERSON	Clin	nn	2	SENT_293	[p18l1809t2247r1939b2304],
2	Pharmacokinet	NNP	PERSON	Pharmacokinet	_	0	SENT_293	[p18l1965t2247r2146b2303, p18l97t2335r424b2390],
3	28	CD	NUMBER	28	num	2	SENT_293	[p18l447t2335r541b2391],
4	:	:	O	:	_	0	SENT_293	[p18l447t2335r541b2391],
5	26-40	CD	NUMBER	26-40	dep	2	SENT_293	[p18l573t2335r784b2391],
6	.	.	O	.	_	0	SENT_293	[p18l573t2335r784b2391],

1	Perucca	NNP	PERSON	Perucca	nn	2	SENT_294	[p18l7t2426r258b2480],
2	E	NNP	PERSON	E	_	0	SENT_294	[p18l275t2426r339b2490],
3	,	,	O	,	_	0	SENT_294	[p18l275t2426r339b2490],
4	Marchioni	NNP	PERSON	Marchioni	nn	5	SENT_294	[p18l361t2425r690b2480],
5	E	NNP	PERSON	E	appos	2	SENT_294	[p18l708t2426r773b2490],
6	,	,	O	,	_	0	SENT_294	[p18l708t2426r773b2490],
7	Soragna	NNP	ORGANIZATION	Soragna	nn	8	SENT_294	[p18l797t2425r1054b2497],
8	D	NNP	ORGANIZATION	D	appos	2	SENT_294	[p18l1071t2426r1143b2491],
9	,	,	O	,	_	0	SENT_294	[p18l1071t2426r1143b2491],
10	et	FW	O	et	nn	11	SENT_294	[p18l1167t2436r1224b2480],
11	al.	FW	O	al.	appos	2	SENT_294	[p18l1240t2425r1312b2480],
12	1997	CD	DATE	1997	dep	11	SENT_294	[p18l1346t2425r1511b2481],
13	.	.	O	.	_	0	SENT_294	[p18l1346t2425r1511b2481],

1	Fluoxetine-induced	JJ	O	fluoxetine-induced	amod	2	SENT_295	[p18l1534t2425r2149b2480],
2	movement	NN	O	movement	_	0	SENT_295	[p18l96t2522r430b2569],
3	disorders	NNS	O	disorder	dep	2	SENT_295	[p18l448t2513r734b2569],
4	and	CC	O	and	_	0	SENT_295	[p18l754t2513r866b2569],
5	deﬁcient	JJ	O	deﬁcient	amod	8	SENT_295	[p18l884t2513r1155b2569],
6	CYP2D6	NN	O	cyp2d6	nn	8	SENT_295	[p18l1173t2513r1459b2569],
7	enzyme	NN	O	enzyme	nn	8	SENT_295	[p18l1479t2531r1723b2585],
8	activity	NN	O	activity	dep	2	SENT_295	[p18l1743t2513r1987b2585],
9	.	.	O	.	_	0	SENT_295	[p18l1743t2513r1987b2585],

1	Mov	NNP	MISC	Mov	nn	2	SENT_296	[p18l2006t2515r2148b2569],
2	Disord	NNP	MISC	Disord	_	0	SENT_296	[p18l95t2601r315b2656],
3	12	CD	NUMBER	12	num	2	SENT_296	[p18l341t2601r430b2656],
4	:	:	O	:	_	0	SENT_296	[p18l341t2601r430b2656],
5	624-625	CD	NUMBER	624-625	dep	2	SENT_296	[p18l464t2601r754b2656],
6	.	.	O	.	_	0	SENT_296	[p18l464t2601r754b2656],

1	Roberts	NNP	ORGANIZATION	Roberts	nn	2	SENT_297	[p18l7t2691r251b2746],
2	R	NNP	ORGANIZATION	R	_	0	SENT_297	[p18l276t2692r343b2756],
3	,	,	O	,	_	0	SENT_297	[p18l276t2692r343b2756],
4	Joyce	NNP	PERSON	Joyce	nn	5	SENT_297	[p18l369t2692r548b2763],
5	P	NN	PERSON	p	appos	2	SENT_297	[p18l572t2692r623b2756],
6	,	,	O	,	_	0	SENT_297	[p18l572t2692r623b2756],
7	Kennedy	NNP	PERSON	Kennedy	nn	8	SENT_297	[p18l651t2691r932b2763],
8	MA	NNP	O	MA	appos	5	SENT_297	[p18l955t2691r1097b2746],
9	.	.	O	.	_	0	SENT_297	[p18l955t2691r1097b2746],

1	2000	CD	DATE	2000	_	0	SENT_298	[p18l1125t2691r1297b2746],
2	.	.	O	.	_	0	SENT_298	[p18l1125t2691r1297b2746],

1	Rapid	JJ	O	rapid	amod	4	SENT_299	[p18l1325t2690r1513b2763],
2	and	CC	O	and	_	0	SENT_299	[p18l1537t2691r1649b2746],
3	comprehensive	JJ	O	comprehensive	conj_and	1	SENT_299	[p18l1673t2690r2147b2763],
4	determination	NN	O	determination	_	0	SENT_299	[p18l98t2780r537b2835],
5	of	IN	O	of	_	0	SENT_299	[p18l572t2780r641b2835],
6	cytochrome	NN	O	cytochrome	nn	8	SENT_299	[p18l671t2780r1043b2852],
7	P450	NN	O	p450	nn	8	SENT_299	[p18l1078t2780r1239b2835],
8	CYP2D6	NN	O	cyp2d6	prep_of	4	SENT_299	[p18l1275t2780r1560b2835],
9	poor	JJ	O	poor	amod	11	SENT_299	[p18l1595t2797r1741b2852],
10	metabolizer	NN	O	metabolizer	nn	11	SENT_299	[p18l1774t2780r2151b2835],
11	genotypes	NNS	O	genotype	dep	4	SENT_299	[p18l98t2877r416b2940],
12	by	IN	O	by	_	0	SENT_299	[p18l444t2868r522b2940],
13	multiplex	JJ	O	multiplex	amod	16	SENT_299	[p18l552t2868r854b2940],
14	polymerase	NN	O	polymerase	nn	16	SENT_299	[p18l883t2868r1246b2940],
15	chain	NN	O	chain	nn	16	SENT_299	[p18l1278t2868r1448b2924],
16	reaction	NN	O	reaction	prep_by	11	SENT_299	[p18l1475t2868r1747b2924],
17	.	.	O	.	_	0	SENT_299	[p18l1475t2868r1747b2924],

1	Hum	NNP	O	Hum	nn	2	SENT_300	[p18l1778t2870r1932b2924],
2	Mutat	NNP	O	Mutat	_	0	SENT_300	[p18l1958t2870r2151b2924],
3	16	CD	NUMBER	16	num	2	SENT_300	[p18l100t2956r190b3012],
4	:	:	O	:	_	0	SENT_300	[p18l100t2956r190b3012],
5	77-85	CD	NUMBER	77-85	dep	2	SENT_300	[p18l222t2956r434b3012],
6	.	.	O	.	_	0	SENT_300	[p18l222t2956r434b3012],

1	Hum	NNP	O	Hum	nn	4	SENT_301	[p18l313t3194r485b3254],
2	Psychopharmacol	NNP	O	Psychopharmacol	nn	4	SENT_301	[p18l514t3192r1158b3271],
3	Clin	NNP	O	Clin	nn	4	SENT_301	[p18l1191t3192r1337b3255],
4	Exp	NNP	O	Exp	_	0	SENT_301	[p18l1365t3194r1503b3271],
5	2004	CD	DATE	2004	num	4	SENT_301	[p18l1535t3192r1731b3265],
6	;	:	O	;	_	0	SENT_301	[p18l1535t3192r1731b3265],
7	19	CD	NUMBER	19	num	9	SENT_301	[p18l1768t3191r1869b3254],
8	:	:	O	:	_	0	SENT_301	[p18l1768t3191r1869b3254],
9	17-23	CD	DATE	17-23	dep	4	SENT_301	[p18l1913t3192r2144b3254],
10	.	.	O	.	_	0	SENT_301	[p18l1913t3192r2144b3254],

1	CYPZD6	NN	O	cypzd6	_	0	SENT_302	[p18l446t3351r557b3375],
2	AND	CC	O	and	_	0	SENT_302	[p18l569t3346r657b3375],
3	ANTIDEPRESSANT	JJ	O	antidepressant	amod	4	SENT_302	[p18l671t3346r1032b3375],
4	ADRs	NNS	MISC	adr	conj_and	1	SENT_302	[p18l1046t3346r1144b3375],
5	23	CD	NUMBER	23	dep	1	SENT_302	[p18l1677t3346r1714b3375],

1	Roberts	NNP	ORGANIZATION	Roberts	nn	2	SENT_303	[p19l7t78r251b134],
2	RL	NNP	ORGANIZATION	RL	_	0	SENT_303	[p19l272t79r388b144],
3	,	,	O	,	_	0	SENT_303	[p19l272t79r388b144],
4	Joyce	NNP	PERSON	Joyce	nn	5	SENT_303	[p19l413t79r591b150],
5	PR	NNP	O	PR	appos	2	SENT_303	[p19l612t79r724b144],
6	,	,	O	,	_	0	SENT_303	[p19l612t79r724b144],
7	Mulder	NNP	PERSON	Mulder	nn	8	SENT_303	[p19l747t78r981b134],
8	RT	NN	O	rt	appos	2	SENT_303	[p19l1000t79r1106b144],
9	,	,	O	,	_	0	SENT_303	[p19l1000t79r1106b144],
10	et	FW	O	et	nn	11	SENT_303	[p19l1131t89r1188b134],
11	al.	FW	O	al.	appos	2	SENT_303	[p19l1207t78r1279b134],
12	2002	CD	DATE	2002	dep	11	SENT_303	[p19l1309t79r1480b134],
13	.	.	O	.	_	0	SENT_303	[p19l1309t79r1480b134],

1	A	DT	O	a	det	3	SENT_304	[p19l1504t79r1560b133],
2	common	JJ	O	common	amod	3	SENT_304	[p19l1581t96r1857b134],
3	P	NN	O	p	_	0	SENT_304	[p19l1877t79r1943b133],
4	-	:	O	-	_	0	SENT_304	[p19l1877t79r1943b133],
5	glycoprotein	NN	O	glycoprotein	nn	6	SENT_304	[p19l1949t78r2146b150, p19l95t168r320b240],
6	polymorphism	NN	O	polymorphism	nsubjpass	8	SENT_304	[p19l355t168r818b240],
7	is	VBZ	O	be	auxpass	8	SENT_304	[p19l852t168r901b223],
8	associated	VBN	O	associate	dep	3	SENT_304	[p19l941t168r1264b223],
9	with	IN	O	with	_	0	SENT_304	[p19l1300t168r1440b223],
10	nortriptyline-induced	JJ	O	nortriptyline-induced	amod	12	SENT_304	[p19l1475t168r2149b240],
11	postural	JJ	O	postural	amod	12	SENT_304	[p19l95t256r350b328],
12	hypotension	NN	O	hypotension	prep_with	8	SENT_304	[p19l387t256r773b328],
13	in	IN	O	in	_	0	SENT_304	[p19l810t256r871b311],
14	patients	NNS	O	patient	prep_in	8	SENT_304	[p19l907t256r1152b328],
15	treated	VBN	O	treat	partmod	14	SENT_304	[p19l1190t256r1406b311],
16	for	IN	O	for	_	0	SENT_304	[p19l1443t256r1534b311],
17	major	JJ	O	major	amod	18	SENT_304	[p19l1570t256r1755b328],
18	depression	NN	O	depression	prep_for	15	SENT_304	[p19l1792t256r2145b328],
19	.	.	O	.	_	0	SENT_304	[p19l1792t256r2145b328],

1	Pharmacogeriom	NN	O	pharmacogeriom	nn	2	SENT_305	[p19l95t346r635b417],
2	J	NN	O	j	_	0	SENT_305	[p19l659t348r699b402],
3	2	CD	NUMBER	2	num	5	SENT_305	[p19l720t345r774b401],
4	:	:	O	:	_	0	SENT_305	[p19l720t345r774b401],
5	191-196	CD	NUMBER	191-196	dep	2	SENT_305	[p19l813t345r1096b402],
6	.	.	O	.	_	0	SENT_305	[p19l813t345r1096b402],

1	Sachse	NNP	PERSON	Sachse	nn	2	SENT_306	[p19l9t434r225b490],
2	C	NNP	O	C	_	0	SENT_306	[p19l255t434r322b500],
3	,	,	O	,	_	0	SENT_306	[p19l255t434r322b500],
4	Brockmoller	NNP	PERSON	Brockmoller	nn	5	SENT_306	[p19l354t434r756b490],
5	J	NNP	PERSON	J	appos	2	SENT_306	[p19l783t435r828b500],
6	,	,	O	,	_	0	SENT_306	[p19l783t435r828b500],
7	Bauer	NNP	PERSON	Bauer	nn	8	SENT_306	[p19l861t435r1050b490],
8	S	NNP	O	S	appos	2	SENT_306	[p19l1080t434r1136b500],
9	,	,	O	,	_	0	SENT_306	[p19l1080t434r1136b500],
10	et	FW	O	et	nn	11	SENT_306	[p19l1169t445r1227b490],
11	al.	FW	O	al.	appos	2	SENT_306	[p19l1253t434r1325b490],
12	1997	CD	DATE	1997	dep	11	SENT_306	[p19l1370t435r1535b491],
13	.	.	O	.	_	0	SENT_306	[p19l1370t435r1535b491],

1	Cytochrome	NN	O	cytochrome	nn	4	SENT_307	[p19l1569t434r1957b506],
2	P450	NN	O	p450	nn	4	SENT_307	[p19l1987t434r2147b490],
3	2D6	NN	O	2d6	nn	4	SENT_307	[p19l97t524r229b579],
4	variants	NNS	O	variant	_	0	SENT_307	[p19l261t524r508b579],
5	in	IN	O	in	_	0	SENT_307	[p19l540t524r600b578],
6	a	DT	O	a	det	8	SENT_307	[p19l632t541r664b579],
7	Caucasian	JJ	LOCATION	caucasian	amod	8	SENT_307	[p19l694t524r1019b579],
8	population	NN	O	population	prep_in	4	SENT_307	[p19l1048t524r1404b596],
9	:	:	O	:	_	0	SENT_307	[p19l1048t524r1404b596],
10	allele	NN	O	allele	nn	11	SENT_307	[p19l1441t524r1610b579],
11	frequencies	NNS	O	frequency	dep	4	SENT_307	[p19l1641t524r2004b596],
12	and	CC	O	and	_	0	SENT_307	[p19l2037t524r2148b579],
13	phenotypic	JJ	O	phenotypic	amod	14	SENT_307	[p19l95t613r447b685],
14	consequences	NNS	O	consequence	dep	4	SENT_307	[p19l473t630r923b685],
15	.	.	O	.	_	0	SENT_307	[p19l473t630r923b685],

1	Am	VBP	O	be	cop	4	SENT_308	[p19l947t613r1056b668],
2	J	NN	O	j	nn	4	SENT_308	[p19l1080t615r1120b669],
3	Hum	NNP	O	Hum	nn	4	SENT_308	[p19l1139t614r1293b668],
4	Genet	NNP	O	Genet	_	0	SENT_308	[p19l1321t614r1509b669],
5	60	CD	NUMBER	60	num	4	SENT_308	[p19l1533t612r1625b668],
6	:	:	O	:	_	0	SENT_308	[p19l1533t612r1625b668],
7	284-295	CD	NUMBER	284-295	dep	4	SENT_308	[p19l1658t612r1947b669],
8	.	.	O	.	_	0	SENT_308	[p19l1658t612r1947b669],

1	Sallee	NNP	PERSON	Sallee	nn	2	SENT_309	[p19l9t701r200b757],
2	FR	NN	O	fr	_	0	SENT_309	[p19l226t702r338b767],
3	,	,	O	,	_	0	SENT_309	[p19l226t702r338b767],
4	DeVane	NNP	ORGANIZATION	DeVane	nn	5	SENT_309	[p19l367t702r615b757],
5	CL	NN	ORGANIZATION	cl	appos	2	SENT_309	[p19l643t701r759b767],
6	,	,	O	,	_	0	SENT_309	[p19l643t701r759b767],
7	Ferrell	NNP	ORGANIZATION	Ferrell	nn	8	SENT_309	[p19l787t701r997b757],
8	RE	NNP	O	RE	appos	5	SENT_309	[p19l1024t702r1139b757],
9	.	.	O	.	_	0	SENT_309	[p19l1024t702r1139b757],

1	2000	CD	DATE	2000	_	0	SENT_310	[p19l1171t702r1342b757],
2	.	.	O	.	_	0	SENT_310	[p19l1171t702r1342b757],

1	Fluoxetine-related	JJ	O	fluoxetine-related	amod	2	SENT_311	[p19l1371t701r1952b757],
2	death	NN	O	death	_	0	SENT_311	[p19l1978t701r2148b757],
3	in	IN	O	in	_	0	SENT_311	[p19l96t790r157b845],
4	a	DT	O	a	det	5	SENT_311	[p19l178t808r210b846],
5	child	NN	O	child	prep_in	2	SENT_311	[p19l229t790r387b846],
6	with	IN	O	with	_	0	SENT_311	[p19l406t790r545b846],
7	cytochrome	NN	O	cytochrome	nn	8	SENT_311	[p19l565t790r936b862],
8	P	NN	O	p	prep_with	5	SENT_311	[p19l956t790r1142b846],
9	—	CD	NUMBER	—	number	10	SENT_311	[p19l956t790r1142b846],
10	450	CD	NUMBER	450	dep	2	SENT_311	[p19l956t790r1142b846],
11	2D6	NN	O	2d6	nn	13	SENT_311	[p19l1163t790r1295b846],
12	genetic	JJ	O	genetic	amod	13	SENT_311	[p19l1316t790r1542b862],
13	deﬁciency	NN	O	deﬁciency	dep	10	SENT_311	[p19l1564t790r1897b862],
14	.	.	O	.	_	0	SENT_311	[p19l1564t790r1897b862],

1	J	NNP	O	J	nn	4	SENT_312	[p19l1919t792r1959b847],
2	Child	NNP	O	Child	nn	4	SENT_312	[p19l1978t790r2152b847],
3	Adolesc	NNP	O	Adolesc	nn	4	SENT_312	[p19l91t879r345b935],
4	Psychopharmacol	NNP	O	Psychopharmacol	_	0	SENT_312	[p19l370t879r942b950],
5	10	CD	NUMBER	10	num	4	SENT_312	[p19l970t879r1060b935],
6	:	:	O	:	_	0	SENT_312	[p19l970t879r1060b935],
7	27-34	CD	NUMBER	27-34	dep	4	SENT_312	[p19l1093t879r1304b935],
8	.	.	O	.	_	0	SENT_312	[p19l1093t879r1304b935],

1	Spigset	NNP	O	Spigset	nn	2	SENT_313	[p19l9t968r240b1041],
2	O	NNP	O	O	_	0	SENT_313	[p19l261t969r331b1034],
3	,	,	O	,	_	0	SENT_313	[p19l261t969r331b1034],
4	Hedenmalm	NNP	PERSON	Hedenmalm	nn	5	SENT_313	[p19l355t969r743b1024],
5	K	NNP	PERSON	K	appos	2	SENT_313	[p19l763t970r834b1034],
6	,	,	O	,	_	0	SENT_313	[p19l763t970r834b1034],
7	Dahl	NNP	PERSON	Dahl	nn	8	SENT_313	[p19l857t969r1009b1024],
8	ML	NNP	O	ML	appos	2	SENT_313	[p19l1030t970r1164b1034],
9	,	,	O	,	_	0	SENT_313	[p19l1030t970r1164b1034],
10	et	FW	O	et	nn	11	SENT_313	[p19l1189t980r1245b1024],
11	al.	FW	O	al.	appos	2	SENT_313	[p19l1264t968r1336b1024],
12	1997	CD	DATE	1997	dep	11	SENT_313	[p19l1373t969r1537b1025],
13	.	.	O	.	_	0	SENT_313	[p19l1373t969r1537b1025],

1	Seizures	NNS	O	seizure	nsubj	4	SENT_314	[p19l1564t969r1827b1024],
2	and	CC	O	and	_	0	SENT_314	[p19l1851t969r1962b1024],
3	myoclonus	NN	O	myoclonus	conj_and	1	SENT_314	[p19l1983t986r2146b1041, p19l97t1057r300b1113],
4	associated	VBN	O	associate	_	0	SENT_314	[p19l335t1057r659b1113],
5	with	IN	O	with	_	0	SENT_314	[p19l692t1057r830b1113],
6	antidepressant	JJ	O	antidepressant	amod	7	SENT_314	[p19l865t1057r1316b1129],
7	treatment	NN	O	treatment	prep_with	4	SENT_314	[p19l1348t1065r1663b1113],
8	:	:	O	:	_	0	SENT_314	[p19l1348t1065r1663b1113],
9	assessment	NN	O	assessment	dep	7	SENT_314	[p19l1703t1065r2053b1113],
10	of	IN	O	of	_	0	SENT_314	[p19l2085t1057r2153b1113],
11	potential	JJ	O	potential	amod	13	SENT_314	[p19l95t1147r373b1219],
12	risk	NN	O	risk	nn	13	SENT_314	[p19l406t1147r526b1202],
13	factors	NNS	O	factor	prep_of	9	SENT_314	[p19l558t1147r789b1212],
14	,	,	O	,	_	0	SENT_314	[p19l558t1147r789b1212],
15	including	VBG	O	include	_	0	SENT_314	[p19l825t1147r1123b1219],
16	CYP2D6	NN	O	cyp2d6	nn	19	SENT_314	[p19l1159t1147r1445b1202],
17	and	CC	O	and	_	0	SENT_314	[p19l1481t1147r1593b1202],
18	CYP2Cl9	NN	O	cyp2cl9	nn	19	SENT_314	[p19l1626t1147r1947b1203],
19	polymorphisms	NNS	O	polymorphism	prep_including	13	SENT_314	[p19l1982t1147r2146b1219, p19l96t1236r464b1308],
20	,	,	O	,	_	0	SENT_314	[p19l1982t1147r2146b1219, p19l96t1236r464b1308],
21	and	CC	O	and	_	0	SENT_314	[p19l502t1235r614b1291],
22	treatment	NN	O	treatment	conj_and	4	SENT_314	[p19l647t1244r948b1291],
23	with	IN	O	with	_	0	SENT_314	[p19l981t1236r1120b1291],
24	CYP2D6	NN	O	cyp2d6	nn	25	SENT_314	[p19l1154t1235r1440b1291],
25	inhibitors	NNS	O	inhibitor	prep_with	22	SENT_314	[p19l1474t1235r1793b1291],
26	.	.	O	.	_	0	SENT_314	[p19l1474t1235r1793b1291],

1	Acta	NNP	O	Acta	nn	3	SENT_315	[p19l1825t1236r1974b1291],
2	Psychiatr	NNP	O	Psychiatr	nn	3	SENT_315	[p19l2007t1238r2145b1307, p19l97t1323r287b1378],
3	Scand	NNP	O	Scand	_	0	SENT_315	[p19l309t1323r505b1379],
4	96	CD	NUMBER	96	num	3	SENT_315	[p19l527t1323r620b1379],
5	:	:	O	:	_	0	SENT_315	[p19l527t1323r620b1379],
6	379-384	CD	NUMBER	379-384	dep	3	SENT_315	[p19l654t1323r942b1379],
7	.	.	O	.	_	0	SENT_315	[p19l654t1323r942b1379],

1	Spina	NNP	O	Spina	nn	2	SENT_316	[p19l9t1412r187b1484],
2	E	NNP	O	E	_	0	SENT_316	[p19l220t1414r283b1478],
3	,	,	O	,	_	0	SENT_316	[p19l220t1414r283b1478],
4	Gitto	NNP	PERSON	Gitto	nn	5	SENT_316	[p19l322t1412r482b1468],
5	C	NNP	O	C	appos	2	SENT_316	[p19l517t1413r584b1478],
6	,	,	O	,	_	0	SENT_316	[p19l517t1413r584b1478],
7	Avenoso	NNP	O	Avenoso	nn	8	SENT_316	[p19l621t1413r893b1468],
8	A	NNP	O	A	appos	2	SENT_316	[p19l928t1413r1000b1478],
9	,	,	O	,	_	0	SENT_316	[p19l928t1413r1000b1478],
10	et	FW	O	et	nn	11	SENT_316	[p19l1038t1423r1096b1468],
11	al.	FW	O	al.	appos	2	SENT_316	[p19l1127t1412r1199b1468],
12	1997	CD	DATE	1997	dep	11	SENT_316	[p19l1249t1413r1413b1469],
13	.	.	O	.	_	0	SENT_316	[p19l1249t1413r1413b1469],

1	Relationship	NN	O	relationship	_	0	SENT_317	[p19l1451t1412r1850b1484],
2	between	IN	O	between	_	0	SENT_317	[p19l1884t1412r2148b1468],
3	plasma	NN	O	plasma	nn	5	SENT_317	[p19l95t1501r320b1573],
4	desipramine	NN	O	desipramine	nn	5	SENT_317	[p19l367t1501r753b1573],
5	levels	NNS	O	level	prep_between	1	SENT_317	[p19l799t1501r998b1567],
6	,	,	O	,	_	0	SENT_317	[p19l799t1501r998b1567],
7	CYP2D6	NN	O	cyp2d6	nn	8	SENT_317	[p19l1047t1501r1333b1557],
8	phenotype	NN	O	phenotype	prep_between	1	SENT_317	[p19l1380t1501r1709b1573],
9	and	CC	O	and	_	0	SENT_317	[p19l1757t1501r1869b1556],
10	clinical	JJ	O	clinical	amod	11	SENT_317	[p19l1916t1501r2148b1556],
11	response	NN	O	response	conj_and	5	SENT_317	[p19l95t1608r371b1663],
12	to	TO	O	to	_	0	SENT_317	[p19l390t1599r449b1646],
13	desipramine	NN	O	desipramine	prep_to	1	SENT_317	[p19l468t1590r871b1663],
14	:	:	O	:	_	0	SENT_317	[p19l468t1590r871b1663],
15	a	DT	O	a	det	17	SENT_317	[p19l896t1608r929b1646],
16	prospective	JJ	O	prospective	amod	17	SENT_317	[p19l946t1591r1307b1663],
17	study	NN	O	study	dep	1	SENT_317	[p19l1329t1591r1507b1663],
18	.	.	O	.	_	0	SENT_317	[p19l1329t1591r1507b1663],

1	Eur	NNP	MISC	Eur	nn	5	SENT_318	[p19l1528t1593r1650b1646],
2	J	NNP	O	J	nn	5	SENT_318	[p19l1662t1593r1702b1647],
3	C	NNP	O	C	nn	5	SENT_318	[p19l1720t1592r1770b1647],
4	lin	NNP	O	lin	nn	5	SENT_318	[p19l1771t1591r1850b1646],
5	Pharmacal	NNP	O	Pharmacal	_	0	SENT_318	[p19l1867t1590r2146b1646, p19l97t1678r193b1733],
6	51	CD	NUMBER	51	num	5	SENT_318	[p19l218t1678r311b1733],
7	:	:	O	:	_	0	SENT_318	[p19l218t1678r311b1733],
8	395-398	CD	NUMBER	395-398	dep	5	SENT_318	[p19l345t1678r634b1734],
9	.	.	O	.	_	0	SENT_318	[p19l345t1678r634b1734],

1	Copyright	NN	O	copyright	nn	5	SENT_319	[p19l8t1913r368b1993],
2	©	CD	NUMBER	©	num	5	SENT_319	[p19l402t1913r478b1989],
3	2004	CD	DATE	2004	num	5	SENT_319	[p19l514t1913r688b1975],
4	John	NNP	ORGANIZATION	John	nn	5	SENT_319	[p19l718t1913r884b1975],
5	Wiley	NNP	ORGANIZATION	Wiley	_	0	SENT_319	[p19l913t1913r1127b1993],
6	&	CC	ORGANIZATION	&	_	0	SENT_319	[p19l1158t1913r1221b1975],
7	Sons	NNP	ORGANIZATION	Sons	conj_and	5	SENT_319	[p19l1254t1913r1442b1986],
8	,	,	ORGANIZATION	,	_	0	SENT_319	[p19l1254t1913r1442b1986],
9	Ltd.	NNP	ORGANIZATION	Ltd.	appos	5	SENT_319	[p19l1474t1913r1614b1975],
10	.	.	O	.	_	0	SENT_319	[p19l1474t1913r1614b1975],

1	Spitzer	NNP	PERSON	Spitzer	nn	2	SENT_320	[p19l8t2008r231b2080],
2	RL	NNP	O	RL	_	0	SENT_320	[p19l303t2009r419b2074],
3	,	,	O	,	_	0	SENT_320	[p19l303t2009r419b2074],
4	Williams	NNP	PERSON	Williams	nn	5	SENT_320	[p19l494t2008r782b2064],
5	JB	NNP	O	JB	appos	2	SENT_320	[p19l856t2009r955b2074],
6	,	,	O	,	_	0	SENT_320	[p19l856t2009r955b2074],
7	Gibbon	NNP	PERSON	Gibbon	nn	8	SENT_320	[p19l1031t2008r1267b2064],
8	M	NNP	O	M	appos	2	SENT_320	[p19l1339t2009r1424b2074],
9	,	,	O	,	_	0	SENT_320	[p19l1339t2009r1424b2074],
10	et	FW	O	et	nn	11	SENT_320	[p19l1501t2019r1558b2064],
11	al.	FW	O	al.	appos	2	SENT_320	[p19l1629t2008r1701b2064],
12	1992	CD	DATE	1992	dep	11	SENT_320	[p19l1790t2009r1954b2065],
13	.	.	O	.	_	0	SENT_320	[p19l1790t2009r1954b2065],

1	The	DT	O	the	det	4	SENT_321	[p19l2031t2008r2152b2064],
2	Structured	NNP	O	Structured	nn	4	SENT_321	[p19l98t2098r427b2153],
3	Clinical	JJ	O	clinical	amod	4	SENT_321	[p19l498t2098r748b2153],
4	Interview	NN	O	interview	_	0	SENT_321	[p19l820t2098r1121b2153],
5	for	IN	O	for	_	0	SENT_321	[p19l1194t2098r1286b2153],
6	DSM-III-R	NN	O	dsm-iii-r	nn	9	SENT_321	[p19l1357t2098r1712b2153],
7	(	CD	NUMBER	(	num	9	SENT_321	[p19l1785t2098r2030b2166],
8	SCID	NN	O	scid	nn	9	SENT_321	[p19l1785t2098r2030b2166],
9	)	NN	O	)	prep_for	4	SENT_321	[p19l1785t2098r2030b2166],
10	.	.	O	.	_	0	SENT_321	[p19l1785t2098r2030b2166],

1	I	PRP	O	I	_	0	SENT_322	[p19l2106t2099r2147b2153],
2	:	:	O	:	_	0	SENT_322	[p19l2106t2099r2147b2153],
3	History	NN	O	history	dep	1	SENT_322	[p19l96t2185r344b2257],
4	,	,	O	,	_	0	SENT_322	[p19l96t2185r344b2257],
5	rationale	NN	O	rationale	dep	1	SENT_322	[p19l389t2185r685b2251],
6	,	,	O	,	_	0	SENT_322	[p19l389t2185r685b2251],
7	and	CC	O	and	_	0	SENT_322	[p19l733t2185r845b2240],
8	description	NN	O	description	conj_and	3	SENT_322	[p19l889t2185r1257b2257],
9	.	.	O	.	_	0	SENT_322	[p19l889t2185r1257b2257],

1	Arch	NNP	O	Arch	nn	3	SENT_323	[p19l1299t2185r1454b2240],
2	Gen	NN	O	gen	nn	3	SENT_323	[p19l1500t2186r1627b2241],
3	Psychiatry	NNP	O	Psychiatry	_	0	SENT_323	[p19l1670t2185r2009b2256],
4	49	CD	NUMBER	49	num	6	SENT_323	[p19l2054t2184r2147b2240],
5	:	:	O	:	_	0	SENT_323	[p19l2054t2184r2147b2240],
6	624-629	CD	NUMBER	624-629	dep	3	SENT_323	[p19l97t2275r388b2333],
7	.	.	O	.	_	0	SENT_323	[p19l97t2275r388b2333],

1	Steen	NNP	PERSON	Steen	nn	2	SENT_324	[p19l8t2365r181b2420],
2	VM	NNP	O	VM	_	0	SENT_324	[p19l206t2365r348b2430],
3	,	,	O	,	_	0	SENT_324	[p19l206t2365r348b2430],
4	Andreassen	NNP	PERSON	Andreassen	nn	5	SENT_324	[p19l374t2364r743b2420],
5	OA	NNP	O	OA	appos	2	SENT_324	[p19l768t2365r893b2430],
6	,	,	O	,	_	0	SENT_324	[p19l768t2365r893b2430],
7	Daly	NNP	PERSON	Daly	nn	8	SENT_324	[p19l920t2364r1072b2436],
8	AK	NNP	PERSON	AK	appos	2	SENT_324	[p19l1097t2365r1226b2430],
9	,	,	O	,	_	0	SENT_324	[p19l1097t2365r1226b2430],
10	et	FW	O	et	nn	11	SENT_324	[p19l1254t2375r1311b2420],
11	al.	FW	O	al.	appos	2	SENT_324	[p19l1333t2364r1405b2420],
12	1995	CD	DATE	1995	dep	11	SENT_324	[p19l1445t2364r1609b2421],
13	.	.	O	.	_	0	SENT_324	[p19l1445t2364r1609b2421],

1	Detection	NN	O	detection	_	0	SENT_325	[p19l1638t2364r1946b2420],
2	of	IN	O	of	_	0	SENT_325	[p19l1970t2364r2039b2420],
3	the	DT	O	the	det	12	SENT_325	[p19l2057t2364r2152b2420],
4	poor	JJ	O	poor	amod	12	SENT_325	[p19l95t2471r241b2525],
5	metabolizer-associated	JJ	O	metabolizer-associated	amod	12	SENT_325	[p19l262t2453r991b2508],
6	CYP2D6	NN	O	cyp2d6	nn	12	SENT_325	[p19l1013t2453r1408b2522],
7	(	NN	O	(	nn	12	SENT_325	[p19l1013t2453r1408b2522],
8	D	NN	O	d	nn	12	SENT_325	[p19l1013t2453r1408b2522],
9	)	NN	O	)	nn	12	SENT_325	[p19l1013t2453r1408b2522],
10	gene	NN	O	gene	nn	12	SENT_325	[p19l1434t2471r1581b2525],
11	deletion	NN	O	deletion	nn	12	SENT_325	[p19l1605t2453r1860b2508],
12	allele	NN	O	allele	prep_of	1	SENT_325	[p19l1883t2453r2053b2508],
13	by	IN	O	by	_	0	SENT_325	[p19l2074t2453r2152b2525],
14	long-PCR	NN	O	long-pcr	nn	15	SENT_325	[p19l96t2542r412b2615],
15	technology	NN	O	technology	prep_by	1	SENT_325	[p19l437t2543r799b2615],
16	.	.	O	.	_	0	SENT_325	[p19l437t2543r799b2615],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_326	[p19l829t2543r1419b2614],
2	5	CD	NUMBER	5	num	1	SENT_326	[p19l1445t2543r1499b2598],
3	:	:	O	:	_	0	SENT_326	[p19l1445t2543r1499b2598],
4	215-223	CD	NUMBER	215-223	dep	1	SENT_326	[p19l1532t2542r1823b2598],
5	.	.	O	.	_	0	SENT_326	[p19l1532t2542r1823b2598],

1	Swanson	NNP	PERSON	Swanson	nn	2	SENT_327	[p19l8t2632r291b2687],
2	JR	NNP	O	JR	_	0	SENT_327	[p19l315t2632r414b2697],
3	,	,	O	,	_	0	SENT_327	[p19l315t2632r414b2697],
4	Jones	NNP	PERSON	Jones	nn	5	SENT_327	[p19l441t2632r614b2687],
5	GR	NN	O	gr	appos	2	SENT_327	[p19l641t2632r765b2697],
6	,	,	O	,	_	0	SENT_327	[p19l641t2632r765b2697],
7	Krasselt	NNP	O	Krasselt	nn	8	SENT_327	[p19l794t2631r1052b2687],
8	W	NNP	O	W	appos	2	SENT_327	[p19l1076t2632r1160b2697],
9	,	,	O	,	_	0	SENT_327	[p19l1076t2632r1160b2697],
10	et	FW	O	et	nn	11	SENT_327	[p19l1188t2642r1246b2687],
11	al.	FW	O	al.	appos	2	SENT_327	[p19l1269t2631r1341b2687],
12	1997	CD	DATE	1997	dep	11	SENT_327	[p19l1381t2632r1546b2688],
13	.	.	O	.	_	0	SENT_327	[p19l1381t2632r1546b2688],

1	Death	NN	O	death	_	0	SENT_328	[p19l1574t2631r1763b2687],
2	of	IN	O	of	_	0	SENT_328	[p19l1789t2631r1857b2687],
3	two	CD	NUMBER	two	num	4	SENT_328	[p19l1877t2639r1993b2687],
4	subjects	NNS	O	subject	prep_of	1	SENT_328	[p19l2021t2631r2151b2687, p19l89t2720r239b2792],
5	due	JJ	O	due	_	0	SENT_328	[p19l271t2720r382b2776],
6	to	TO	O	to	_	0	SENT_328	[p19l413t2728r472b2776],
7	imipramine	NN	O	imipramine	nn	11	SENT_328	[p19l502t2720r868b2792],
8	and	CC	O	and	_	0	SENT_328	[p19l899t2720r1011b2776],
9	desipramine	NN	O	desipramine	nn	11	SENT_328	[p19l1041t2720r1428b2792],
10	metabolite	NN	O	metabolite	nn	11	SENT_328	[p19l1457t2720r1793b2776],
11	accumulation	NN	O	accumulation	prep_due_to	4	SENT_328	[p19l1824t2720r2151b2776, p19l96t2809r218b2864],
12	during	IN	O	during	_	0	SENT_328	[p19l266t2809r470b2881],
13	chronic	JJ	O	chronic	amod	14	SENT_328	[p19l520t2809r755b2864],
14	therapy	NN	O	therapy	prep_during	11	SENT_328	[p19l803t2809r1057b2881],
15	:	:	O	:	_	0	SENT_328	[p19l803t2809r1057b2881],
16	a	DT	O	a	det	17	SENT_328	[p19l1112t2827r1145b2864],
17	review	NN	O	review	dep	1	SENT_328	[p19l1191t2809r1402b2865],
18	of	IN	O	of	_	0	SENT_328	[p19l1452t2809r1520b2864],
19	the	DT	O	the	det	20	SENT_328	[p19l1562t2809r1658b2864],
20	literature	NN	O	literature	prep_of	17	SENT_328	[p19l1706t2809r1993b2864],
21	and	CC	O	and	_	0	SENT_328	[p19l2041t2809r2153b2864],
22	possible	JJ	O	possible	amod	23	SENT_328	[p19l95t2899r354b2971],
23	mechanisms	NNS	O	mechanism	prep_of	17	SENT_328	[p19l380t2899r787b2954],
24	.	.	O	.	_	0	SENT_328	[p19l380t2899r787b2954],

1	J	NNP	O	J	nn	3	SENT_329	[p19l816t2901r856b2955],
2	Forensic	NNP	O	Forensic	nn	3	SENT_329	[p19l876t2901r1146b2954],
3	Sci	NNP	O	Sci	_	0	SENT_329	[p19l1173t2900r1268b2955],
4	42	CD	NUMBER	42	num	3	SENT_329	[p19l1294t2898r1388b2954],
5	:	:	O	:	_	0	SENT_329	[p19l1294t2898r1388b2954],
6	335-339	CD	NUMBER	335-339	dep	3	SENT_329	[p19l1421t2898r1711b2955],
7	.	.	O	.	_	0	SENT_329	[p19l1421t2898r1711b2955],

1	Vandel	NNP	PERSON	Vandel	nn	2	SENT_330	[p19l6t2987r225b3043],
2	P	NN	PERSON	p	_	0	SENT_330	[p19l247t2988r297b3053],
3	,	,	O	,	_	0	SENT_330	[p19l247t2988r297b3053],
4	Haffen	NN	PERSON	haffen	nn	5	SENT_330	[p19l321t2987r538b3043],
5	E	NN	PERSON	e	appos	2	SENT_330	[p19l558t2988r622b3053],
6	,	,	O	,	_	0	SENT_330	[p19l558t2988r622b3053],
7	Vandel	NNP	PERSON	Vandel	nn	8	SENT_330	[p19l647t2987r865b3043],
8	S	NNP	O	S	appos	2	SENT_330	[p19l889t2987r945b3053],
9	,	,	O	,	_	0	SENT_330	[p19l889t2987r945b3053],
10	et	FW	O	et	nn	11	SENT_330	[p19l971t2998r1028b3043],
11	al.	FW	O	al.	appos	2	SENT_330	[p19l1046t2987r1118b3043],
12	1999	CD	DATE	1999	dep	11	SENT_330	[p19l1155t2988r1319b3044],
13	.	.	O	.	_	0	SENT_330	[p19l1155t2988r1319b3044],

1	Drug	NN	O	drug	_	0	SENT_331	[p19l1344t2988r1505b3059],
2	extrapyramidal	JJ	O	extrapyramidal	amod	4	SENT_331	[p19l1526t2987r2006b3059],
3	side	JJ	O	side	amod	4	SENT_331	[p19l2029t2987r2153b3043],
4	effects	NNS	O	effect	dep	1	SENT_331	[p19l96t3076r320b3131],
5	.	.	O	.	_	0	SENT_331	[p19l96t3076r320b3131],

1	CYP2D6	NN	O	cyp2d6	_	0	SENT_332	[p19l345t3076r632b3132],
2	genotypes	NNS	O	genotype	dep	1	SENT_332	[p19l654t3084r973b3148],
3	and	CC	O	and	_	0	SENT_332	[p19l995t3076r1107b3131],
4	phenotypes	NNS	O	phenotype	dep	1	SENT_332	[p19l1125t3076r1503b3148],
5	.	.	O	.	_	0	SENT_332	[p19l1125t3076r1503b3148],

1	Eur	NNP	O	Eur	nn	4	SENT_333	[p19l1525t3078r1647b3131],
2	J	NNP	O	J	nn	4	SENT_333	[p19l1662t3078r1702b3132],
3	Clin	NNP	O	Clin	nn	4	SENT_333	[p19l1722t3076r1852b3132],
4	Pharmacal	NNP	O	Pharmacal	_	0	SENT_333	[p19l1871t3076r2151b3131, p19l97t3167r192b3223],
5	55	CD	NUMBER	55	num	4	SENT_333	[p19l218t3167r311b3223],
6	:	:	O	:	_	0	SENT_333	[p19l218t3167r311b3223],
7	659-665	CD	NUMBER	659-665	dep	4	SENT_333	[p19l344t3166r635b3223],
8	.	.	O	.	_	0	SENT_333	[p19l344t3166r635b3223],

1	Venkatakrishnan	NNP	PERSON	Venkatakrishnan	nn	2	SENT_334	[p19l6t3255r534b3311],
2	K	NNP	PERSON	K	_	0	SENT_334	[p19l555t3256r626b3321],
3	,	,	O	,	_	0	SENT_334	[p19l555t3256r626b3321],
4	von	NNP	PERSON	von	nn	6	SENT_334	[p19l647t3273r763b3311],
5	Moltke	NNP	PERSON	Moltke	nn	6	SENT_334	[p19l781t3255r1009b3311],
6	LL	NNP	O	LL	appos	2	SENT_334	[p19l1027t3256r1140b3321],
7	,	,	O	,	_	0	SENT_334	[p19l1027t3256r1140b3321],
8	Greenblatt	NNP	PERSON	Greenblatt	nn	9	SENT_334	[p19l1162t3255r1497b3311],
9	DJ	NNP	O	DJ	appos	6	SENT_334	[p19l1514t3256r1615b3311],
10	.	.	O	.	_	0	SENT_334	[p19l1514t3256r1615b3311],

1	1999	CD	DATE	1999	_	0	SENT_335	[p19l1645t3256r1810b3312],
2	.	.	O	.	_	0	SENT_335	[p19l1645t3256r1810b3312],

1	Nortriptyline	NN	O	nortriptyline	nn	2	SENT_336	[p19l1832t3255r2151b3327, p19l96t3344r213b3400],
2	E	NN	O	e	nsubjpass	8	SENT_336	[p19l237t3344r863b3416],
3	—	CD	NUMBER	—	num	4	SENT_336	[p19l237t3344r863b3416],
4	10-hydroxylation	NN	O	10-hydroxylation	dep	6	SENT_336	[p19l237t3344r863b3416],
5	in	FW	O	in	nn	6	SENT_336	[p19l889t3346r945b3400],
6	vitro	FW	O	vitro	advmod	8	SENT_336	[p19l968t3346r1111b3401],
7	is	VBZ	O	be	auxpass	8	SENT_336	[p19l1137t3344r1186b3400],
8	mediated	VBN	O	mediate	_	0	SENT_336	[p19l1211t3344r1503b3400],
9	by	IN	O	by	_	0	SENT_336	[p19l1524t3344r1602b3416],
10	human	JJ	O	human	amod	11	SENT_336	[p19l1626t3344r1842b3400],
11	CYP2D6	NN	O	cyp2d6	nn	15	SENT_336	[p19l1866t3344r2152b3400],
12	(	RB	O	(	advmod	13	SENT_336	[p19l98t3433r262b3505],
13	high	JJ	O	high	amod	15	SENT_336	[p19l98t3433r262b3505],
14	afﬁnity	NN	O	afﬁnity	nn	15	SENT_336	[p19l285t3433r532b3505],
15	)	NN	O	)	agent	8	SENT_336	[p19l285t3433r532b3505],
16	and	CC	O	and	_	0	SENT_336	[p19l557t3433r670b3488],
17	CYP3A4	NN	O	cyp3a4	conj_and	8	SENT_336	[p19l691t3433r978b3489],
18	(	RB	O	(	advmod	19	SENT_336	[p19l1002t3433r1141b3502],
19	low	JJ	O	low	amod	21	SENT_336	[p19l1002t3433r1141b3502],
20	afﬁnity	NN	O	afﬁnity	nn	21	SENT_336	[p19l1164t3433r1431b3505],
21	)	NN	O	)	dep	17	SENT_336	[p19l1164t3433r1431b3505],
22	:	:	O	:	_	0	SENT_336	[p19l1164t3433r1431b3505],
23	implications	NNS	O	implication	dep	17	SENT_336	[p19l1457t3433r1849b3505],
24	for	IN	O	for	_	0	SENT_336	[p19l1871t3433r1963b3488],
25	interactions	NNS	O	interaction	prep_for	23	SENT_336	[p19l1984t3433r2151b3488, p19l97t3522r318b3578],
26	with	IN	O	with	_	0	SENT_336	[p19l367t3522r507b3578],
27	enzyme-inducing	JJ	O	enzyme-inducing	amod	28	SENT_336	[p19l553t3523r1103b3595],
28	drugs	NNS	O	drug	prep_with	17	SENT_336	[p19l1152t3523r1341b3595],
29	.	.	O	.	_	0	SENT_336	[p19l1152t3523r1341b3595],

1	J	NN	O	j	nn	3	SENT_337	[p19l1391t3525r1431b3579],
2	C	NN	O	c	nn	3	SENT_337	[p19l1477t3524r1527b3579],
3	[	NN	O	[	_	0	SENT_337	[p19l1528t3523r1607b3578],
4	in	IN	O	in	_	0	SENT_337	[p19l1528t3523r1607b3578],
5	Pharmacol	NNP	O	Pharmacol	prep_in	3	SENT_337	[p19l1653t3523r2008b3578],
6	39	CD	NUMBER	39	num	5	SENT_337	[p19l2053t3522r2147b3578],
7	:	:	O	:	_	0	SENT_337	[p19l2053t3522r2147b3578],
8	567-577	CD	NUMBER	567-577	num	5	SENT_337	[p19l97t3612r388b3668],
9	.	.	O	.	_	0	SENT_337	[p19l97t3612r388b3668],

1	Hum	NNP	O	Hum	nn	4	SENT_338	[p20l313t107r485b167],
2	Psychopharmacol	NNP	O	Psychopharmacol	nn	4	SENT_338	[p20l514t105r1160b184],
3	Clin	NNP	O	Clin	nn	4	SENT_338	[p20l1193t105r1340b168],
4	Exp	NNP	O	Exp	_	0	SENT_338	[p20l1368t107r1506b184],
5	2004	CD	DATE	2004	num	4	SENT_338	[p20l1537t105r1734b178],
6	;	:	O	;	_	0	SENT_338	[p20l1537t105r1734b178],
7	19	CD	NUMBER	19	num	9	SENT_338	[p20l1772t104r1874b167],
8	:	:	O	:	_	0	SENT_338	[p20l1772t104r1874b167],
9	17-23	CD	DATE	17-23	dep	4	SENT_338	[p20l1917t105r2148b167],
10	.	.	O	.	_	0	SENT_338	[p20l1917t105r2148b167],

